The table below lists the options of the executed module.
| Option | Value |
|---|---|
| analyze.sites | no |
| region.types | cpgislands, genes, promoters, tiling1kb, gencode22promoters, ensembleRegBuildBPall |
| differential.permutations | 0 |
| differential.comparison.columns | cmp_ct_mono_vs_neut, cmp_ct_mono_vs_neut_VB, cmp_ct_mono_vs_mf, cmp_ct_mono_vs_mf_VB, cmp_ct_TCD4_TN_vs_CM, cmp_ct_TCD4_TN_vs_EM, cmp_ct_TCD4_CM_vs_EM, cmp_ct_TCD8_TN_vs_CM, cmp_ct_TCD8_TN_vs_EM, cmp_ct_TCD8_CM_vs_EM, cmp_ct_neut_myel_vs_meta, cmp_ct_neut_meta_vs_band, cmp_ct_neut_band_vs_segm, cmp_ct_neut_early_vs_mature |
| differential.comparison.columns.all.pairwise | default |
| columns.pairing | default |
| differential.site.test.method | limma |
| covariate.adjustment.columns | tissueTypeShort, DONOR_SEX |
| differential.adjustment.sva | yes |
| differential.adjustment.celltype | yes |
| differential.enrichment.go | yes |
| differential.enrichment.lola | yes |
| differential.enrichment.lola.dbs | ${LOLACore}, ${LOLAExt} |
Differential methylation analysis was conducted on site and region level according to the sample groups specified in the analysis.
The following comparisons were made:
The table below summarizes information on the comparisons.
| comparison | adjustment | covariateTable | |
| 1 | mono vs. neut (based on cmp_ct_mono_vs_neut) | tissueTypeShort,DONOR_SEX | csv |
| 2 | mono vs. neut (based on cmp_ct_mono_vs_neut_VB) | DONOR_SEX | csv |
| 3 | Mf vs. mono (based on cmp_ct_mono_vs_mf) | tissueTypeShort,DONOR_SEX | csv |
| 4 | Mf vs. mono (based on cmp_ct_mono_vs_mf_VB) | DONOR_SEX | csv |
| 5 | EM vs. TN (based on cmp_ct_TCD4_TN_vs_CM) | DONOR_SEX | csv |
| 6 | EM vs. TN (based on cmp_ct_TCD4_TN_vs_EM) | DONOR_SEX | csv |
| 7 | CM vs. EM (based on cmp_ct_TCD4_CM_vs_EM) | DONOR_SEX | csv |
| 8 | EM vs. TN (based on cmp_ct_TCD8_TN_vs_CM) | tissueTypeShort,DONOR_SEX | csv |
| 9 | EM vs. TN (based on cmp_ct_TCD8_TN_vs_EM) | tissueTypeShort,DONOR_SEX | csv |
| 10 | CM vs. EM (based on cmp_ct_TCD8_CM_vs_EM) | DONOR_SEX | csv |
| 11 | meta vs. myel (based on cmp_ct_neut_myel_vs_meta) | DONOR_SEX | csv |
| 12 | band vs. meta (based on cmp_ct_neut_meta_vs_band) | DONOR_SEX | csv |
| 13 | band vs. segm (based on cmp_ct_neut_band_vs_segm) | DONOR_SEX | csv |
| 14 | early vs. mature (based on cmp_ct_neut_early_vs_mature) | tissueTypeShort,DONOR_SEX | csv |
In the following anlyses, p-values on the site level were computed using the limma method. I.e. hierarchical linear models from the limma package were employed and fitted using an empirical Bayes approach on derived M-values.
Differential methylation on the region level was computed based on a variety of metrics. Of particular interest for the following plots and analyses are the following quantities for each region: the mean methylation difference in a region of the two groups being and of quotient of mean methylation levelsas well as a p-value obtained from statistical testing (limma or t-test; depending on parameter settings). Additionally each region was assigned a rank based on each of these three criteria. A combined rank is computed as the maximum (i.e. worst) value among the three ranks. The smaller the combined rank for a region, the more evidence for differential methylation it exhibits. Regions were defined based on the region types specified in the analysis. This section includes scatterplots of the region group means as well as volcano plots of each pairwise comparison colored according to the combined rank of a given region.
The following rank cutfoffs have been automatically selected for the analysis of differentially methylated regions:
| cpgislands | genes | promoters | tiling1kb | gencode22promoters | ensembleRegBuildBPall | |
| mono vs. neut (based on cmp_ct_mono_vs_neut) | 0 | 0 | 0 | 0 | 0 | 0 |
| mono vs. neut (based on cmp_ct_mono_vs_neut_VB) | 0 | 0 | 0 | 0 | 0 | 0 |
| Mf vs. mono (based on cmp_ct_mono_vs_mf) | 0 | 0 | 0 | 0 | 0 | 0 |
| Mf vs. mono (based on cmp_ct_mono_vs_mf_VB) | 0 | 0 | 0 | 0 | 0 | 0 |
| EM vs. TN (based on cmp_ct_TCD4_TN_vs_CM) | 0 | 0 | 0 | 0 | 0 | 0 |
| EM vs. TN (based on cmp_ct_TCD4_TN_vs_EM) | 0 | 0 | 0 | 0 | 0 | 0 |
| CM vs. EM (based on cmp_ct_TCD4_CM_vs_EM) | 0 | 0 | 0 | 0 | 0 | 0 |
| EM vs. TN (based on cmp_ct_TCD8_TN_vs_CM) | 0 | 0 | 0 | 0 | 0 | 0 |
| EM vs. TN (based on cmp_ct_TCD8_TN_vs_EM) | 0 | 0 | 0 | 0 | 0 | 0 |
| CM vs. EM (based on cmp_ct_TCD8_CM_vs_EM) | 0 | 0 | 0 | 0 | 0 | 0 |
| meta vs. myel (based on cmp_ct_neut_myel_vs_meta) | 0 | 0 | 0 | 0 | 0 | 0 |
| band vs. meta (based on cmp_ct_neut_meta_vs_band) | 0 | 0 | 0 | 0 | 0 | 0 |
| band vs. segm (based on cmp_ct_neut_band_vs_segm) | 0 | 0 | 0 | 0 | 0 | 0 |
| early vs. mature (based on cmp_ct_neut_early_vs_mature) | 0 | 0 | 0 | 0 | 0 | 0 |
| comparison | |
| regions | |
| differential methylation measure |
Scatterplot for differential methylation (regions). If the selected criterion is not rankGradient:
The transparency corresponds to point density. The 1% of the points in the sparsest populated plot regions are drawn explicitly.
Additionally, the colored points represent differentially methylated regions (according to the selected criterion).
If the selected criterion is rankGradient: median combined ranks accross hexagonal bins are shown
as a gradient according to the color legend.
| comparison | |
| regions | |
| difference metric | |
| significance metric |
Volcano plot for differential methylation quantified by various metrics. Color scale according to combined ranking.
A tabular overview of measures for differential methylation on the region level for the individual comparisons are provided in this section.
The tables for the individual comparisons can be found here:
| cpgislands | genes | promoters | tiling1kb | gencode22promoters | ensembleRegBuildBPall | |
| mono vs. neut (based on cmp_ct_mono_vs_neut) | csv | csv | csv | csv | csv | csv |
| mono vs. neut (based on cmp_ct_mono_vs_neut_VB) | csv | csv | csv | csv | csv | csv |
| Mf vs. mono (based on cmp_ct_mono_vs_mf) | csv | csv | csv | csv | csv | csv |
| Mf vs. mono (based on cmp_ct_mono_vs_mf_VB) | csv | csv | csv | csv | csv | csv |
| EM vs. TN (based on cmp_ct_TCD4_TN_vs_CM) | csv | csv | csv | csv | csv | csv |
| EM vs. TN (based on cmp_ct_TCD4_TN_vs_EM) | csv | csv | csv | csv | csv | csv |
| CM vs. EM (based on cmp_ct_TCD4_CM_vs_EM) | csv | csv | csv | csv | csv | csv |
| EM vs. TN (based on cmp_ct_TCD8_TN_vs_CM) | csv | csv | csv | csv | csv | csv |
| EM vs. TN (based on cmp_ct_TCD8_TN_vs_EM) | csv | csv | csv | csv | csv | csv |
| CM vs. EM (based on cmp_ct_TCD8_CM_vs_EM) | csv | csv | csv | csv | csv | csv |
| meta vs. myel (based on cmp_ct_neut_myel_vs_meta) | csv | csv | csv | csv | csv | csv |
| band vs. meta (based on cmp_ct_neut_meta_vs_band) | csv | csv | csv | csv | csv | csv |
| band vs. segm (based on cmp_ct_neut_band_vs_segm) | csv | csv | csv | csv | csv | csv |
| early vs. mature (based on cmp_ct_neut_early_vs_mature) | csv | csv | csv | csv | csv | csv |
Differential variability on the region level was computed similar to differential methylation, but the mean of variances, the log-ratio of the quotient of variances as well as the p-values from the differentiality test were employed. Ranking was performed in line with the ranking of differential methylation.
The following rank cutoffs have been automatically selected for the analysis of differentially variable regions:
| cpgislands | genes | promoters | tiling1kb | gencode22promoters | ensembleRegBuildBPall | |
| mono vs. neut (based on cmp_ct_mono_vs_neut) | 0 | 0 | 0 | 0 | 0 | 0 |
| mono vs. neut (based on cmp_ct_mono_vs_neut_VB) | 0 | 0 | 0 | 0 | 0 | 0 |
| Mf vs. mono (based on cmp_ct_mono_vs_mf) | 0 | 0 | 0 | 0 | 0 | 0 |
| Mf vs. mono (based on cmp_ct_mono_vs_mf_VB) | 0 | 0 | 0 | 0 | 0 | 0 |
| EM vs. TN (based on cmp_ct_TCD4_TN_vs_CM) | 0 | 0 | 0 | 0 | 0 | 0 |
| EM vs. TN (based on cmp_ct_TCD4_TN_vs_EM) | 0 | 0 | 0 | 0 | 0 | 0 |
| CM vs. EM (based on cmp_ct_TCD4_CM_vs_EM) | 0 | 0 | 0 | 0 | 0 | 0 |
| EM vs. TN (based on cmp_ct_TCD8_TN_vs_CM) | 0 | 0 | 0 | 0 | 0 | 0 |
| EM vs. TN (based on cmp_ct_TCD8_TN_vs_EM) | 0 | 0 | 0 | 0 | 0 | 0 |
| CM vs. EM (based on cmp_ct_TCD8_CM_vs_EM) | 0 | 0 | 0 | 0 | 0 | 0 |
| meta vs. myel (based on cmp_ct_neut_myel_vs_meta) | 0 | 0 | 0 | 0 | 0 | 0 |
| band vs. meta (based on cmp_ct_neut_meta_vs_band) | 0 | 0 | 0 | 0 | 0 | 0 |
| band vs. segm (based on cmp_ct_neut_band_vs_segm) | 0 | 0 | 0 | 0 | 0 | 0 |
| early vs. mature (based on cmp_ct_neut_early_vs_mature) | 0 | 0 | 0 | 0 | 0 | 0 |
| comparison | |
| regions | |
| differential variability measure |
Scatterplot for differential variable regions. The transparency corresponds to point density. The 1% of the points in the sparsest populated plot regions are drawn explicitly. Additionally, the colored points represent differentially methylated regions (according to the selected criterion).
| comparison | |
| regions | |
| difference metric | |
| significance metric |
Volcano plot for differential variability quantified by various metrics. Color scale according to combined ranking.
GO Enrichment Analysis was conducted. The wordclouds and tables below contains significant GO terms as determined by a hypergeometric test.
| comparison | |
| Hypermethylation/hypomethylation | |
| ontology | |
| regions | |
| differential methylation measure |
Wordclouds for GO enrichment terms.
| comparison | |
| Hypermethylation/hypomethylation | |
| ontology | |
| regions | |
| differential methylation measure |
| NA. |
| n/a |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:2000113 | 0 | 9.2514 | 2.0861 | 11 | 1472 | negative regulation of cellular macromolecule biosynthetic process |
| GO:0009890 | 0 | 8.2421 | 2.3143 | 11 | 1633 | negative regulation of biosynthetic process |
| GO:0010629 | 0 | 7.2953 | 2.5793 | 11 | 1820 | negative regulation of gene expression |
| GO:0009790 | 0 | 8.8411 | 1.318 | 8 | 930 | embryo development |
| GO:2000774 | 1e-04 | 171.3968 | 0.0156 | 2 | 11 | positive regulation of cellular senescence |
| GO:0042127 | 2e-04 | 6.044 | 2.2208 | 9 | 1567 | regulation of cell proliferation |
| GO:0043583 | 2e-04 | 16.8484 | 0.2891 | 4 | 204 | ear development |
| GO:0009653 | 2e-04 | 5.286 | 3.4098 | 11 | 2406 | anatomical structure morphogenesis |
| GO:0080090 | 2e-04 | 5.093 | 8.234 | 17 | 5810 | regulation of primary metabolic process |
| GO:0007389 | 2e-04 | 10.865 | 0.5796 | 5 | 409 | pattern specification process |
| GO:0090596 | 4e-04 | 13.8298 | 0.3501 | 4 | 247 | sensory organ morphogenesis |
| GO:0044271 | 5e-04 | 4.4463 | 6.8338 | 15 | 4822 | cellular nitrogen compound biosynthetic process |
| GO:0000122 | 5e-04 | 7.2531 | 1.0742 | 6 | 758 | negative regulation of transcription from RNA polymerase II promoter |
| GO:0021884 | 6e-04 | 64.2143 | 0.0368 | 2 | 26 | forebrain neuron development |
| GO:1903507 | 7e-04 | 5.8314 | 1.6128 | 7 | 1138 | negative regulation of nucleic acid-templated transcription |
| GO:0051094 | 0.001 | 5.4808 | 1.7077 | 7 | 1205 | positive regulation of developmental process |
| GO:0051253 | 0.0011 | 5.4464 | 1.7177 | 7 | 1212 | negative regulation of RNA metabolic process |
| GO:0060429 | 0.0011 | 5.4464 | 1.7177 | 7 | 1212 | epithelium development |
| GO:0021723 | 0.0014 | Inf | 0.0014 | 1 | 1 | medullary reticular formation development |
| GO:0048894 | 0.0014 | Inf | 0.0014 | 1 | 1 | efferent axon development in a lateral line nerve |
| GO:0061452 | 0.0014 | Inf | 0.0014 | 1 | 1 | retrotrapezoid nucleus neuron differentiation |
| GO:1903769 | 0.0014 | Inf | 0.0014 | 1 | 1 | negative regulation of cell proliferation in bone marrow |
| GO:0090342 | 0.0015 | 39.4799 | 0.0581 | 2 | 41 | regulation of cell aging |
| GO:0034249 | 0.0016 | 9.2404 | 0.5173 | 4 | 365 | negative regulation of cellular amide metabolic process |
| GO:0010556 | 0.0017 | 10.3166 | 0.5579 | 4 | 593 | regulation of macromolecule biosynthetic process |
| GO:0021545 | 0.0021 | 33.4576 | 0.068 | 2 | 48 | cranial nerve development |
| GO:0048519 | 0.0022 | 3.6114 | 6.9344 | 14 | 4893 | negative regulation of biological process |
| GO:0065007 | 0.0026 | 9.6495 | 15.9961 | 22 | 11287 | biological regulation |
| GO:0021852 | 0.0028 | 736.5909 | 0.0028 | 1 | 2 | pyramidal neuron migration |
| GO:0021934 | 0.0028 | 736.5909 | 0.0028 | 1 | 2 | hindbrain tangential cell migration |
| GO:0048925 | 0.0028 | 736.5909 | 0.0028 | 1 | 2 | lateral line system development |
| GO:0071228 | 0.0028 | 736.5909 | 0.0028 | 1 | 2 | cellular response to tumor cell |
| GO:0072272 | 0.0028 | 736.5909 | 0.0028 | 1 | 2 | proximal/distal pattern formation involved in metanephric nephron development |
| GO:0110023 | 0.0028 | 736.5909 | 0.0028 | 1 | 2 | negative regulation of cardiac muscle myoblast proliferation |
| GO:1901003 | 0.0028 | 736.5909 | 0.0028 | 1 | 2 | negative regulation of fermentation |
| GO:0048731 | 0.0029 | 3.4751 | 6.2712 | 13 | 4425 | system development |
| GO:0021872 | 0.0031 | 26.9825 | 0.0836 | 2 | 59 | forebrain generation of neurons |
| GO:0042733 | 0.0036 | 25.2069 | 0.0893 | 2 | 63 | embryonic digit morphogenesis |
| GO:0006355 | 0.0041 | 3.4056 | 4.8866 | 11 | 3448 | regulation of transcription, DNA-templated |
| GO:0010660 | 0.0041 | 23.29 | 0.0964 | 2 | 68 | regulation of muscle cell apoptotic process |
| GO:0048663 | 0.0041 | 23.29 | 0.0964 | 2 | 68 | neuron fate commitment |
| GO:0003358 | 0.0042 | 368.2727 | 0.0043 | 1 | 3 | noradrenergic neuron development |
| GO:0030538 | 0.0042 | 368.2727 | 0.0043 | 1 | 3 | embryonic genitalia morphogenesis |
| GO:0035986 | 0.0042 | 368.2727 | 0.0043 | 1 | 3 | senescence-associated heterochromatin focus assembly |
| GO:0036023 | 0.0042 | 368.2727 | 0.0043 | 1 | 3 | embryonic skeletal limb joint morphogenesis |
| GO:0044336 | 0.0042 | 368.2727 | 0.0043 | 1 | 3 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process |
| GO:0048619 | 0.0042 | 368.2727 | 0.0043 | 1 | 3 | embryonic hindgut morphogenesis |
| GO:0140076 | 0.0042 | 368.2727 | 0.0043 | 1 | 3 | negative regulation of lipoprotein transport |
| GO:2000111 | 0.0042 | 368.2727 | 0.0043 | 1 | 3 | positive regulation of macrophage apoptotic process |
| GO:2001141 | 0.0044 | 3.3719 | 4.9248 | 11 | 3475 | regulation of RNA biosynthetic process |
| GO:0031326 | 0.0048 | 7.6056 | 0.7433 | 4 | 790 | regulation of cellular biosynthetic process |
| GO:0035195 | 0.0056 | 9.3829 | 0.3656 | 3 | 258 | gene silencing by miRNA |
| GO:0007198 | 0.0057 | 245.5 | 0.0057 | 1 | 4 | adenylate cyclase-inhibiting serotonin receptor signaling pathway |
| GO:0072086 | 0.0057 | 245.5 | 0.0057 | 1 | 4 | specification of loop of Henle identity |
| GO:1901166 | 0.0057 | 245.5 | 0.0057 | 1 | 4 | neural crest cell migration involved in autonomic nervous system development |
| GO:0048562 | 0.0059 | 9.214 | 0.3742 | 3 | 276 | embryonic organ morphogenesis |
| GO:0006417 | 0.006 | 6.313 | 0.7469 | 4 | 527 | regulation of translation |
| GO:0016441 | 0.006 | 9.1282 | 0.3756 | 3 | 265 | posttranscriptional gene silencing |
| GO:0001656 | 0.0062 | 18.7271 | 0.119 | 2 | 84 | metanephros development |
| GO:1901576 | 0.0066 | 3.1178 | 8.6464 | 15 | 6101 | organic substance biosynthetic process |
| GO:0043009 | 0.0068 | 6.0727 | 0.7752 | 4 | 547 | chordate embryonic development |
| GO:0002568 | 0.0071 | 184.1136 | 0.0071 | 1 | 5 | somatic diversification of T cell receptor genes |
| GO:0015870 | 0.0071 | 184.1136 | 0.0071 | 1 | 5 | acetylcholine transport |
| GO:0016199 | 0.0071 | 184.1136 | 0.0071 | 1 | 5 | axon midline choice point recognition |
| GO:0033153 | 0.0071 | 184.1136 | 0.0071 | 1 | 5 | T cell receptor V(D)J recombination |
| GO:0051172 | 0.0071 | 3.9564 | 2.4469 | 7 | 2043 | negative regulation of nitrogen compound metabolic process |
| GO:0035282 | 0.0074 | 17.054 | 0.1304 | 2 | 92 | segmentation |
| GO:0007568 | 0.0075 | 8.4095 | 0.4067 | 3 | 287 | aging |
| GO:0031047 | 0.0075 | 8.3795 | 0.4082 | 3 | 288 | gene silencing by RNA |
| GO:0031324 | 0.0076 | 3.9739 | 2.4897 | 7 | 2194 | negative regulation of cellular metabolic process |
| GO:0042472 | 0.0078 | 16.6812 | 0.1332 | 2 | 94 | inner ear morphogenesis |
| GO:0009953 | 0.0079 | 16.5008 | 0.1346 | 2 | 95 | dorsal/ventral pattern formation |
| GO:0003360 | 0.0085 | 147.2818 | 0.0085 | 1 | 6 | brainstem development |
| GO:0014062 | 0.0085 | 147.2818 | 0.0085 | 1 | 6 | regulation of serotonin secretion |
| GO:0033504 | 0.0099 | 122.7273 | 0.0099 | 1 | 7 | floor plate development |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0070475 | 0 | 514.6349 | 0.0061 | 2 | 9 | rRNA base methylation |
| GO:0000154 | 3e-04 | 105.7778 | 0.0244 | 2 | 36 | rRNA modification |
| GO:1901506 | 7e-04 | Inf | 7e-04 | 1 | 1 | regulation of acylglycerol transport |
| GO:1905884 | 7e-04 | Inf | 7e-04 | 1 | 1 | negative regulation of triglyceride transport |
| GO:0001510 | 8e-04 | 59.8444 | 0.042 | 2 | 62 | RNA methylation |
| GO:0003245 | 0.002 | 810.8 | 0.002 | 1 | 3 | cardiac muscle tissue growth involved in heart morphogenesis |
| GO:0010868 | 0.002 | 810.8 | 0.002 | 1 | 3 | negative regulation of triglyceride biosynthetic process |
| GO:0071072 | 0.0034 | 405.35 | 0.0034 | 1 | 5 | negative regulation of phospholipid biosynthetic process |
| GO:1904684 | 0.0054 | 231.5857 | 0.0054 | 1 | 8 | negative regulation of metalloendopeptidase activity |
| GO:1905205 | 0.0088 | 135.05 | 0.0088 | 1 | 13 | positive regulation of connective tissue replacement |
| GO:0010666 | 0.0095 | 124.6538 | 0.0095 | 1 | 14 | positive regulation of cardiac muscle cell apoptotic process |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0050911 | 4e-04 | 32.3111 | 0.16 | 3 | 371 | detection of chemical stimulus involved in sensory perception of smell |
| GO:0009593 | 7e-04 | 26.4681 | 0.1941 | 3 | 450 | detection of chemical stimulus |
| GO:0050906 | 7e-04 | 25.7565 | 0.1993 | 3 | 462 | detection of stimulus involved in sensory perception |
| GO:0007606 | 8e-04 | 25.4145 | 0.2019 | 3 | 468 | sensory perception of chemical stimulus |
| GO:0021891 | 0.0026 | 540.5667 | 0.0026 | 1 | 6 | olfactory bulb interneuron development |
| GO:0021930 | 0.0043 | 300.2407 | 0.0043 | 1 | 10 | cerebellar granule cell precursor proliferation |
| GO:0021534 | 0.0047 | 270.2 | 0.0047 | 1 | 11 | cell proliferation in hindbrain |
| GO:0015671 | 0.0065 | 192.9524 | 0.0065 | 1 | 15 | oxygen transport |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:1904628 | 0 | 1351.4167 | 0.003 | 2 | 8 | cellular response to phorbol 13-acetate 12-myristate |
| GO:0050918 | 2e-04 | 146.9818 | 0.0211 | 2 | 57 | positive chemotaxis |
| GO:0002548 | 2e-04 | 134.6917 | 0.0229 | 2 | 62 | monocyte chemotaxis |
| GO:0050829 | 3e-04 | 109.1149 | 0.0281 | 2 | 76 | defense response to Gram-negative bacterium |
| GO:0050830 | 4e-04 | 97.2289 | 0.0314 | 2 | 85 | defense response to Gram-positive bacterium |
| GO:0060326 | 0.0037 | 30.9399 | 0.0961 | 2 | 260 | cell chemotaxis |
| GO:0050900 | 0.0088 | 19.578 | 0.1501 | 2 | 406 | leukocyte migration |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0050832 | 2e-04 | 124.9653 | 0.0216 | 2 | 39 | defense response to fungus |
| GO:0061844 | 3e-04 | 94.2915 | 0.0283 | 2 | 51 | antimicrobial humoral immune response mediated by antimicrobial peptide |
| GO:0007634 | 6e-04 | Inf | 6e-04 | 1 | 1 | optokinetic behavior |
| GO:0021560 | 0.0011 | 2027.375 | 0.0011 | 1 | 2 | abducens nerve development |
| GO:0021599 | 0.0011 | 2027.375 | 0.0011 | 1 | 2 | abducens nerve formation |
| GO:0035606 | 0.0011 | 2027.375 | 0.0011 | 1 | 2 | peptidyl-cysteine S-trans-nitrosylation |
| GO:0044657 | 0.0011 | 2027.375 | 0.0011 | 1 | 2 | pore formation in membrane of other organism during symbiotic interaction |
| GO:0052043 | 0.0011 | 2027.375 | 0.0011 | 1 | 2 | modification by symbiont of host cellular component |
| GO:0052185 | 0.0011 | 2027.375 | 0.0011 | 1 | 2 | modification of structure of other organism involved in symbiotic interaction |
| GO:0052332 | 0.0011 | 2027.375 | 0.0011 | 1 | 2 | modification by organism of membrane in other organism involved in symbiotic interaction |
| GO:0060876 | 0.0011 | 2027.375 | 0.0011 | 1 | 2 | semicircular canal formation |
| GO:0070488 | 0.0011 | 2027.375 | 0.0011 | 1 | 2 | neutrophil aggregation |
| GO:0048702 | 0.0033 | 405.375 | 0.0033 | 1 | 6 | embryonic neurocranium morphogenesis |
| GO:0051673 | 0.0033 | 405.375 | 0.0033 | 1 | 6 | membrane disruption in other organism |
| GO:0042473 | 0.005 | 253.3125 | 0.005 | 1 | 9 | outer ear morphogenesis |
| GO:0060872 | 0.005 | 253.3125 | 0.005 | 1 | 9 | semicircular canal development |
| GO:0070475 | 0.005 | 253.3125 | 0.005 | 1 | 9 | rRNA base methylation |
| GO:0097398 | 0.005 | 253.3125 | 0.005 | 1 | 9 | cellular response to interleukin-17 |
| GO:0030595 | 0.0051 | 23.2386 | 0.1104 | 2 | 199 | leukocyte chemotaxis |
| GO:0006959 | 0.0061 | 21.1693 | 0.1209 | 2 | 218 | humoral immune response |
| GO:0017014 | 0.0066 | 184.1932 | 0.0067 | 1 | 12 | protein nitrosylation |
| GO:0032119 | 0.0066 | 184.1932 | 0.0067 | 1 | 12 | sequestering of zinc ion |
| GO:0042742 | 0.0072 | 19.3511 | 0.132 | 2 | 238 | defense response to bacterium |
| GO:0002523 | 0.0077 | 155.8365 | 0.0078 | 1 | 14 | leukocyte migration involved in inflammatory response |
| GO:0051852 | 0.0077 | 155.8365 | 0.0078 | 1 | 14 | disruption by host of symbiont cells |
| GO:0030322 | 0.0088 | 135.0417 | 0.0089 | 1 | 16 | stabilization of membrane potential |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0002263 | 1e-04 | 31.588 | 0.2851 | 4 | 661 | cell activation involved in immune response |
| GO:0002275 | 6e-04 | 31.1647 | 0.1876 | 3 | 507 | myeloid cell activation involved in immune response |
| GO:0050868 | 7e-04 | 67.1917 | 0.0423 | 2 | 98 | negative regulation of T cell activation |
| GO:0043312 | 8e-04 | 25.4709 | 0.2014 | 3 | 467 | neutrophil degranulation |
| GO:0042119 | 8e-04 | 24.8637 | 0.2062 | 3 | 478 | neutrophil activation |
| GO:0002444 | 0.0011 | 22.6471 | 0.2256 | 3 | 523 | myeloid leukocyte mediated immunity |
| GO:0071626 | 0.0013 | 1351.6667 | 0.0013 | 1 | 3 | mastication |
| GO:0098583 | 0.0013 | 1351.6667 | 0.0013 | 1 | 3 | learned vocalization behavior |
| GO:1905747 | 0.0013 | 1351.6667 | 0.0013 | 1 | 3 | negative regulation of saliva secretion |
| GO:1905748 | 0.0013 | 1351.6667 | 0.0013 | 1 | 3 | hard palate morphogenesis |
| GO:0002695 | 0.0017 | 43.7415 | 0.0643 | 2 | 149 | negative regulation of leukocyte activation |
| GO:2000552 | 0.0017 | 901.0556 | 0.0017 | 1 | 4 | negative regulation of T-helper 2 cell cytokine production |
| GO:0022408 | 0.0018 | 43.149 | 0.0651 | 2 | 151 | negative regulation of cell-cell adhesion |
| GO:0045321 | 0.002 | 23.3071 | 0.3032 | 3 | 975 | leukocyte activation |
| GO:0046903 | 0.002 | 13.1151 | 0.6474 | 4 | 1501 | secretion |
| GO:0007356 | 0.0022 | 675.75 | 0.0022 | 1 | 5 | thorax and anterior abdomen determination |
| GO:0021650 | 0.0022 | 675.75 | 0.0022 | 1 | 5 | vestibulocochlear nerve formation |
| GO:1901078 | 0.0022 | 675.75 | 0.0022 | 1 | 5 | negative regulation of relaxation of muscle |
| GO:0045055 | 0.0025 | 16.483 | 0.3058 | 3 | 709 | regulated exocytosis |
| GO:0045343 | 0.003 | 450.4444 | 0.003 | 1 | 7 | regulation of MHC class I biosynthetic process |
| GO:0006959 | 0.0036 | 29.6407 | 0.094 | 2 | 218 | humoral immune response |
| GO:0021562 | 0.0039 | 337.7917 | 0.0039 | 1 | 9 | vestibulocochlear nerve development |
| GO:0042742 | 0.0043 | 27.0949 | 0.1027 | 2 | 238 | defense response to bacterium |
| GO:0030432 | 0.0043 | 300.2407 | 0.0043 | 1 | 10 | peristalsis |
| GO:0021559 | 0.0047 | 270.2 | 0.0047 | 1 | 11 | trigeminal nerve development |
| GO:0002281 | 0.0052 | 245.6212 | 0.0052 | 1 | 12 | macrophage activation involved in immune response |
| GO:0016998 | 0.0052 | 245.6212 | 0.0052 | 1 | 12 | cell wall macromolecule catabolic process |
| GO:0031223 | 0.0052 | 245.6212 | 0.0052 | 1 | 12 | auditory behavior |
| GO:0035112 | 0.0056 | 225.1389 | 0.0056 | 1 | 13 | genitalia morphogenesis |
| GO:0071360 | 0.006 | 207.8077 | 0.006 | 1 | 14 | cellular response to exogenous dsRNA |
| GO:0071554 | 0.006 | 207.8077 | 0.006 | 1 | 14 | cell wall organization or biogenesis |
| GO:0008595 | 0.0065 | 192.9524 | 0.0065 | 1 | 15 | anterior/posterior axis specification, embryo |
| GO:0035458 | 0.0065 | 192.9524 | 0.0065 | 1 | 15 | cellular response to interferon-beta |
| GO:0009605 | 0.0066 | 9.1817 | 0.889 | 4 | 2061 | response to external stimulus |
| GO:0002710 | 0.0077 | 158.8725 | 0.0078 | 1 | 18 | negative regulation of T cell mediated immunity |
| GO:0007350 | 0.0077 | 158.8725 | 0.0078 | 1 | 18 | blastoderm segmentation |
| GO:0097094 | 0.0077 | 158.8725 | 0.0078 | 1 | 18 | craniofacial suture morphogenesis |
| GO:1903037 | 0.0079 | 19.6272 | 0.1406 | 2 | 326 | regulation of leukocyte cell-cell adhesion |
| GO:0035743 | 0.0082 | 150.037 | 0.0082 | 1 | 19 | CD4-positive, alpha-beta T cell cytokine production |
| GO:0033141 | 0.009 | 135.0167 | 0.0091 | 1 | 21 | positive regulation of peptidyl-serine phosphorylation of STAT protein |
| GO:0002724 | 0.0095 | 128.5794 | 0.0095 | 1 | 22 | regulation of T cell cytokine production |
| GO:0090103 | 0.0099 | 122.7273 | 0.0099 | 1 | 23 | cochlea morphogenesis |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0002263 | 2e-04 | 23.6895 | 0.3258 | 4 | 661 | cell activation involved in immune response |
| GO:0002275 | 0.001 | 23.372 | 0.2188 | 3 | 507 | myeloid cell activation involved in immune response |
| GO:0050868 | 0.001 | 55.9896 | 0.0483 | 2 | 98 | negative regulation of T cell activation |
| GO:0043312 | 0.0012 | 20.3754 | 0.2302 | 3 | 467 | neutrophil degranulation |
| GO:0042119 | 0.0013 | 19.8897 | 0.2356 | 3 | 478 | neutrophil activation |
| GO:0071626 | 0.0015 | 1158.5 | 0.0015 | 1 | 3 | mastication |
| GO:0098583 | 0.0015 | 1158.5 | 0.0015 | 1 | 3 | learned vocalization behavior |
| GO:1905747 | 0.0015 | 1158.5 | 0.0015 | 1 | 3 | negative regulation of saliva secretion |
| GO:1905748 | 0.0015 | 1158.5 | 0.0015 | 1 | 3 | hard palate morphogenesis |
| GO:0002444 | 0.0017 | 18.1165 | 0.2578 | 3 | 523 | myeloid leukocyte mediated immunity |
| GO:2000552 | 0.002 | 772.2857 | 0.002 | 1 | 4 | negative regulation of T-helper 2 cell cytokine production |
| GO:0002695 | 0.0023 | 36.449 | 0.0734 | 2 | 149 | negative regulation of leukocyte activation |
| GO:0022408 | 0.0023 | 35.9553 | 0.0744 | 2 | 151 | negative regulation of cell-cell adhesion |
| GO:0007356 | 0.0025 | 579.1786 | 0.0025 | 1 | 5 | thorax and anterior abdomen determination |
| GO:0021650 | 0.0025 | 579.1786 | 0.0025 | 1 | 5 | vestibulocochlear nerve formation |
| GO:1901078 | 0.0025 | 579.1786 | 0.0025 | 1 | 5 | negative regulation of relaxation of muscle |
| GO:0060348 | 0.0032 | 30.2147 | 0.0882 | 2 | 179 | bone development |
| GO:0045343 | 0.0034 | 386.0714 | 0.0035 | 1 | 7 | regulation of MHC class I biosynthetic process |
| GO:0046903 | 0.0038 | 9.8357 | 0.7399 | 4 | 1501 | secretion |
| GO:0045321 | 0.0039 | 15.537 | 0.3638 | 3 | 975 | leukocyte activation |
| GO:0045055 | 0.0039 | 13.1856 | 0.3495 | 3 | 709 | regulated exocytosis |
| GO:0050896 | 0.0043 | Inf | 4.0446 | 8 | 8205 | response to stimulus |
| GO:0048705 | 0.0044 | 25.7874 | 0.103 | 2 | 209 | skeletal system morphogenesis |
| GO:0021562 | 0.0044 | 289.5179 | 0.0044 | 1 | 9 | vestibulocochlear nerve development |
| GO:0006959 | 0.0048 | 24.6991 | 0.1075 | 2 | 218 | humoral immune response |
| GO:0030432 | 0.0049 | 257.3333 | 0.0049 | 1 | 10 | peristalsis |
| GO:0021559 | 0.0054 | 231.5857 | 0.0054 | 1 | 11 | trigeminal nerve development |
| GO:0042742 | 0.0057 | 22.5777 | 0.1173 | 2 | 238 | defense response to bacterium |
| GO:0002281 | 0.0059 | 210.5195 | 0.0059 | 1 | 12 | macrophage activation involved in immune response |
| GO:0016998 | 0.0059 | 210.5195 | 0.0059 | 1 | 12 | cell wall macromolecule catabolic process |
| GO:0031223 | 0.0059 | 210.5195 | 0.0059 | 1 | 12 | auditory behavior |
| GO:0035112 | 0.0064 | 192.9643 | 0.0064 | 1 | 13 | genitalia morphogenesis |
| GO:0071360 | 0.0069 | 178.1099 | 0.0069 | 1 | 14 | cellular response to exogenous dsRNA |
| GO:0071554 | 0.0069 | 178.1099 | 0.0069 | 1 | 14 | cell wall organization or biogenesis |
| GO:0008595 | 0.0074 | 165.3776 | 0.0074 | 1 | 15 | anterior/posterior axis specification, embryo |
| GO:0035458 | 0.0074 | 165.3776 | 0.0074 | 1 | 15 | cellular response to interferon-beta |
| GO:0002710 | 0.0088 | 136.1681 | 0.0089 | 1 | 18 | negative regulation of T cell mediated immunity |
| GO:0007350 | 0.0088 | 136.1681 | 0.0089 | 1 | 18 | blastoderm segmentation |
| GO:0097094 | 0.0088 | 136.1681 | 0.0089 | 1 | 18 | craniofacial suture morphogenesis |
| GO:0035743 | 0.0093 | 128.5952 | 0.0094 | 1 | 19 | CD4-positive, alpha-beta T cell cytokine production |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0006614 | 4e-04 | 96.0655 | 0.0318 | 2 | 86 | SRP-dependent cotranslational protein targeting to membrane |
| GO:0072599 | 5e-04 | 83.1237 | 0.0366 | 2 | 99 | establishment of protein localization to endoplasmic reticulum |
| GO:0000184 | 7e-04 | 72.5766 | 0.0418 | 2 | 113 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay |
| GO:0006612 | 0.0013 | 52.8651 | 0.0569 | 2 | 154 | protein targeting to membrane |
| GO:0019083 | 0.0016 | 47.497 | 0.0632 | 2 | 171 | viral transcription |
| GO:0006413 | 0.0017 | 46.3873 | 0.0647 | 2 | 175 | translational initiation |
| GO:0043043 | 0.0021 | 19.3041 | 0.2965 | 3 | 802 | peptide biosynthetic process |
| GO:0031424 | 0.0028 | 35.7121 | 0.0836 | 2 | 226 | keratinization |
| GO:0006364 | 0.0033 | 32.8807 | 0.0906 | 2 | 245 | rRNA processing |
| GO:0043603 | 0.0053 | 13.7885 | 0.4067 | 3 | 1100 | cellular amide metabolic process |
| GO:0006402 | 0.0058 | 24.4585 | 0.1209 | 2 | 327 | mRNA catabolic process |
| GO:0009913 | 0.0065 | 22.8761 | 0.129 | 2 | 349 | epidermal cell differentiation |
| GO:0043588 | 0.0088 | 19.4791 | 0.1508 | 2 | 408 | skin development |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0002517 | 0.003 | 491.3333 | 0.003 | 1 | 12 | T cell tolerance induction |
| GO:0030511 | 0.0059 | 234.8116 | 0.0059 | 1 | 24 | positive regulation of transforming growth factor beta receptor signaling pathway |
| GO:0033198 | 0.0074 | 186.1609 | 0.0074 | 1 | 30 | response to ATP |
| GO:0048536 | 0.0088 | 154.1905 | 0.0089 | 1 | 36 | spleen development |
| GO:0031670 | 0.0096 | 141.9912 | 0.0096 | 1 | 39 | cellular response to nutrient |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0060044 | 0.0033 | 476.7353 | 0.0033 | 1 | 18 | negative regulation of cardiac muscle cell proliferation |
| GO:0071800 | 0.0039 | 405.15 | 0.0039 | 1 | 21 | podosome assembly |
| GO:0061117 | 0.0042 | 368.2727 | 0.0043 | 1 | 23 | negative regulation of heart growth |
| GO:0055026 | 0.0059 | 261.2097 | 0.0059 | 1 | 32 | negative regulation of cardiac muscle tissue development |
| GO:0048635 | 0.0092 | 165.0714 | 0.0092 | 1 | 50 | negative regulation of muscle organ development |
| GO:1901862 | 0.0092 | 165.0714 | 0.0092 | 1 | 50 | negative regulation of muscle tissue development |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0070488 | 0 | Inf | 9e-04 | 2 | 2 | neutrophil aggregation |
| GO:0032119 | 0 | 648.48 | 0.0052 | 2 | 12 | sequestering of zinc ion |
| GO:0002523 | 0 | 540.3333 | 0.006 | 2 | 14 | leukocyte migration involved in inflammatory response |
| GO:0055069 | 1e-04 | 249.1692 | 0.0121 | 2 | 28 | zinc ion homeostasis |
| GO:0050832 | 1e-04 | 174.973 | 0.0168 | 2 | 39 | defense response to fungus |
| GO:2001244 | 2e-04 | 124.3846 | 0.0233 | 2 | 54 | positive regulation of intrinsic apoptotic signaling pathway |
| GO:0032602 | 4e-04 | 87.2865 | 0.0328 | 2 | 76 | chemokine production |
| GO:0006919 | 5e-04 | 83.8701 | 0.0341 | 2 | 79 | activation of cysteine-type endopeptidase activity involved in apoptotic process |
| GO:0030593 | 6e-04 | 75.0512 | 0.038 | 2 | 88 | neutrophil chemotaxis |
| GO:0019730 | 7e-04 | 70.1304 | 0.0405 | 2 | 94 | antimicrobial humoral response |
| GO:0046916 | 7e-04 | 70.1304 | 0.0405 | 2 | 94 | cellular transition metal ion homeostasis |
| GO:0043312 | 8e-04 | 25.4709 | 0.2014 | 3 | 467 | neutrophil degranulation |
| GO:0042119 | 8e-04 | 24.8637 | 0.2062 | 3 | 478 | neutrophil activation |
| GO:0035606 | 9e-04 | 2703.5 | 9e-04 | 1 | 2 | peptidyl-cysteine S-trans-nitrosylation |
| GO:0050729 | 9e-04 | 59.6815 | 0.0474 | 2 | 110 | positive regulation of inflammatory response |
| GO:0002275 | 0.001 | 22.8285 | 0.2239 | 3 | 519 | myeloid cell activation involved in immune response |
| GO:0002444 | 0.0011 | 22.6471 | 0.2256 | 3 | 523 | myeloid leukocyte mediated immunity |
| GO:0097530 | 0.0011 | 53.6733 | 0.0526 | 2 | 122 | granulocyte migration |
| GO:2001056 | 0.0012 | 52.3545 | 0.0539 | 2 | 125 | positive regulation of cysteine-type endopeptidase activity |
| GO:0002224 | 0.0012 | 51.5104 | 0.0548 | 2 | 127 | toll-like receptor signaling pathway |
| GO:0051092 | 0.0013 | 49.9008 | 0.0565 | 2 | 131 | positive regulation of NF-kappaB transcription factor activity |
| GO:0043065 | 0.0015 | 20.1188 | 0.2528 | 3 | 586 | positive regulation of apoptotic process |
| GO:0030307 | 0.0017 | 43.4432 | 0.0647 | 2 | 150 | positive regulation of cell growth |
| GO:0010942 | 0.0019 | 18.4098 | 0.2752 | 3 | 638 | positive regulation of cell death |
| GO:0002263 | 0.0021 | 17.7401 | 0.2851 | 3 | 661 | cell activation involved in immune response |
| GO:0010952 | 0.0021 | 38.9261 | 0.072 | 2 | 167 | positive regulation of peptidase activity |
| GO:0045055 | 0.0025 | 16.483 | 0.3058 | 3 | 709 | regulated exocytosis |
| GO:0071947 | 0.0026 | 540.5667 | 0.0026 | 1 | 6 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process |
| GO:0030595 | 0.003 | 32.5381 | 0.0858 | 2 | 199 | leukocyte chemotaxis |
| GO:0043281 | 0.003 | 32.5381 | 0.0858 | 2 | 199 | regulation of cysteine-type endopeptidase activity involved in apoptotic process |
| GO:0018119 | 0.0037 | 360.2667 | 0.0037 | 1 | 10 | peptidyl-cysteine S-nitrosylation |
| GO:0042742 | 0.0043 | 27.0949 | 0.1027 | 2 | 238 | defense response to bacterium |
| GO:0002758 | 0.0055 | 23.8119 | 0.1165 | 2 | 270 | innate immune response-activating signal transduction |
| GO:0051235 | 0.0063 | 22.1306 | 0.1251 | 2 | 290 | maintenance of location |
| GO:0060397 | 0.0065 | 192.9524 | 0.0065 | 1 | 15 | JAK-STAT cascade involved in growth hormone signaling pathway |
| GO:0045089 | 0.0081 | 19.3228 | 0.1428 | 2 | 331 | positive regulation of innate immune response |
| GO:0002544 | 0.009 | 135.0167 | 0.0091 | 1 | 21 | chronic inflammatory response |
| GO:0007159 | 0.0094 | 17.9299 | 0.1536 | 2 | 356 | leukocyte cell-cell adhesion |
| GO:0045321 | 0.0094 | 10.1033 | 0.4848 | 3 | 1124 | leukocyte activation |
| GO:0071378 | 0.0099 | 122.7273 | 0.0099 | 1 | 23 | cellular response to growth hormone stimulus |
| GO:2001233 | 0.0099 | 17.3775 | 0.1583 | 2 | 367 | regulation of apoptotic signaling pathway |
| GO:0051090 | 0.01 | 17.329 | 0.1587 | 2 | 368 | regulation of DNA binding transcription factor activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0070475 | 0 | 661.7551 | 0.005 | 2 | 9 | rRNA base methylation |
| GO:0030593 | 0 | 94.9118 | 0.0488 | 3 | 88 | neutrophil chemotaxis |
| GO:0097530 | 0 | 67.6513 | 0.0677 | 3 | 122 | granulocyte migration |
| GO:0000154 | 2e-04 | 136.0168 | 0.02 | 2 | 36 | rRNA modification |
| GO:0060326 | 3e-04 | 31.0564 | 0.1442 | 3 | 260 | cell chemotaxis |
| GO:0048247 | 4e-04 | 82.4694 | 0.0322 | 2 | 58 | lymphocyte chemotaxis |
| GO:0001510 | 5e-04 | 76.9524 | 0.0344 | 2 | 62 | RNA methylation |
| GO:0002548 | 5e-04 | 76.9524 | 0.0344 | 2 | 62 | monocyte chemotaxis |
| GO:0070098 | 8e-04 | 59.1282 | 0.0444 | 2 | 80 | chemokine-mediated signaling pathway |
| GO:0071347 | 0.0011 | 52.3766 | 0.0499 | 2 | 90 | cellular response to interleukin-1 |
| GO:0035606 | 0.0011 | 2027.375 | 0.0011 | 1 | 2 | peptidyl-cysteine S-trans-nitrosylation |
| GO:0070488 | 0.0011 | 2027.375 | 0.0011 | 1 | 2 | neutrophil aggregation |
| GO:0055076 | 0.0019 | 38.6579 | 0.0671 | 2 | 121 | transition metal ion homeostasis |
| GO:0035821 | 0.0026 | 33.2961 | 0.0776 | 2 | 140 | modification of morphology or physiology of other organism |
| GO:0071346 | 0.0026 | 33.2961 | 0.0776 | 2 | 140 | cellular response to interferon-gamma |
| GO:0042330 | 0.003 | 14.0341 | 0.3111 | 3 | 561 | taxis |
| GO:2000503 | 0.0033 | 405.375 | 0.0033 | 1 | 6 | positive regulation of natural killer cell chemotaxis |
| GO:0070374 | 0.0048 | 23.8512 | 0.1076 | 2 | 194 | positive regulation of ERK1 and ERK2 cascade |
| GO:0009636 | 0.0057 | 21.8879 | 0.117 | 2 | 211 | response to toxic substance |
| GO:0051345 | 0.0057 | 10.971 | 0.3937 | 3 | 710 | positive regulation of hydrolase activity |
| GO:0017014 | 0.0066 | 184.1932 | 0.0067 | 1 | 12 | protein nitrosylation |
| GO:0032119 | 0.0066 | 184.1932 | 0.0067 | 1 | 12 | sequestering of zinc ion |
| GO:0043922 | 0.0066 | 184.1932 | 0.0067 | 1 | 12 | negative regulation by host of viral transcription |
| GO:0002523 | 0.0077 | 155.8365 | 0.0078 | 1 | 14 | leukocyte migration involved in inflammatory response |
| GO:0038092 | 0.0077 | 155.8365 | 0.0078 | 1 | 14 | nodal signaling pathway |
| GO:0045087 | 0.0091 | 9.2126 | 0.4647 | 3 | 838 | innate immune response |
| GO:0032103 | 0.0093 | 16.9421 | 0.1503 | 2 | 271 | positive regulation of response to external stimulus |
| GO:0071356 | 0.0093 | 16.9421 | 0.1503 | 2 | 271 | cellular response to tumor necrosis factor |
| GO:0016072 | 0.0098 | 16.4446 | 0.1547 | 2 | 279 | rRNA metabolic process |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0008201 | 5e-04 | 23.8496 | 0.1561 | 3 | 158 | heparin binding |
| GO:0004252 | 6e-04 | 21.2202 | 0.1749 | 3 | 177 | serine-type endopeptidase activity |
| GO:0017171 | 0.001 | 17.888 | 0.2065 | 3 | 209 | serine hydrolase activity |
| GO:0008233 | 0.0024 | 8.6522 | 0.5969 | 4 | 604 | peptidase activity |
| GO:1903231 | 0.0053 | 21.055 | 0.1097 | 2 | 111 | mRNA binding involved in posttranscriptional gene silencing |
| GO:0004519 | 0.0061 | 19.4383 | 0.1186 | 2 | 120 | endonuclease activity |
| GO:0015643 | 0.0098 | 119.7407 | 0.0099 | 1 | 10 | toxic substance binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0008201 | 5e-04 | 23.8496 | 0.1561 | 3 | 158 | heparin binding |
| GO:0004252 | 6e-04 | 21.2202 | 0.1749 | 3 | 177 | serine-type endopeptidase activity |
| GO:0017171 | 0.001 | 17.888 | 0.2065 | 3 | 209 | serine hydrolase activity |
| GO:0004968 | 0.002 | 1078.2 | 0.002 | 1 | 2 | gonadotropin-releasing hormone receptor activity |
| GO:0008233 | 0.0024 | 8.6522 | 0.5969 | 4 | 604 | peptidase activity |
| GO:1903231 | 0.0053 | 21.055 | 0.1097 | 2 | 111 | mRNA binding involved in posttranscriptional gene silencing |
| GO:0015643 | 0.0098 | 119.7407 | 0.0099 | 1 | 10 | toxic substance binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0005216 | 0.0024 | 5.982 | 0.9482 | 5 | 404 | ion channel activity |
| GO:0017080 | 0.0027 | 28.8907 | 0.0775 | 2 | 33 | sodium channel regulator activity |
| GO:0005547 | 0.0029 | 27.9861 | 0.0798 | 2 | 34 | phosphatidylinositol-3,4,5-trisphosphate binding |
| GO:0022843 | 0.0034 | 10.902 | 0.3028 | 3 | 129 | voltage-gated cation channel activity |
| GO:0015267 | 0.0036 | 5.4359 | 1.0398 | 5 | 443 | channel activity |
| GO:0030366 | 0.0047 | 436.5135 | 0.0047 | 1 | 2 | molybdopterin synthase activity |
| GO:0005544 | 0.0048 | 21.3095 | 0.1033 | 2 | 44 | calcium-dependent phospholipid binding |
| GO:0004663 | 0.007 | 218.2432 | 0.007 | 1 | 3 | Rab geranylgeranyltransferase activity |
| GO:0005250 | 0.007 | 218.2432 | 0.007 | 1 | 3 | A-type (transient outward) potassium channel activity |
| GO:0043120 | 0.007 | 218.2432 | 0.007 | 1 | 3 | tumor necrosis factor binding |
| GO:0022832 | 0.0096 | 7.3978 | 0.4413 | 3 | 188 | voltage-gated channel activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0017080 | 0.0014 | 41.631 | 0.055 | 2 | 33 | sodium channel regulator activity |
| GO:0005547 | 0.0015 | 40.3275 | 0.0567 | 2 | 34 | phosphatidylinositol-3,4,5-trisphosphate binding |
| GO:0005544 | 0.0024 | 30.7067 | 0.0734 | 2 | 44 | calcium-dependent phospholipid binding |
| GO:0005216 | 0.0043 | 6.8535 | 0.6737 | 4 | 404 | ion channel activity |
| GO:0004663 | 0.005 | 310.7885 | 0.005 | 1 | 3 | Rab geranylgeranyltransferase activity |
| GO:0005250 | 0.005 | 310.7885 | 0.005 | 1 | 3 | A-type (transient outward) potassium channel activity |
| GO:0015267 | 0.0059 | 6.2292 | 0.7388 | 4 | 443 | channel activity |
| GO:0046923 | 0.0083 | 155.375 | 0.0083 | 1 | 5 | ER retention sequence binding |
| GO:0008318 | 0.01 | 124.2923 | 0.01 | 1 | 6 | protein prenyltransferase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0061750 | 7e-04 | Inf | 7e-04 | 1 | 1 | acid sphingomyelin phosphodiesterase activity |
| GO:0005277 | 0.0022 | 735.2727 | 0.0022 | 1 | 3 | acetylcholine transmembrane transporter activity |
| GO:0038036 | 0.0059 | 210.013 | 0.0059 | 1 | 8 | sphingosine-1-phosphate receptor activity |
| GO:0051378 | 0.0074 | 163.3232 | 0.0074 | 1 | 10 | serotonin binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0051378 | 1e-04 | 237.6912 | 0.0117 | 2 | 10 | serotonin binding |
| GO:0043565 | 1e-04 | 8.9547 | 1.1689 | 7 | 996 | sequence-specific DNA binding |
| GO:0004861 | 1e-04 | 190.1294 | 0.0141 | 2 | 12 | cyclin-dependent protein serine/threonine kinase inhibitor activity |
| GO:0001227 | 1e-04 | 19.7904 | 0.257 | 4 | 219 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding |
| GO:0004993 | 3e-04 | 100.0124 | 0.0246 | 2 | 21 | G-protein coupled serotonin receptor activity |
| GO:0061750 | 0.0012 | Inf | 0.0012 | 1 | 1 | acid sphingomyelin phosphodiesterase activity |
| GO:0003700 | 0.0018 | 5.8904 | 1.386 | 6 | 1181 | DNA binding transcription factor activity |
| GO:0008013 | 0.0034 | 26.3056 | 0.0868 | 2 | 74 | beta-catenin binding |
| GO:0005277 | 0.0035 | 449.1389 | 0.0035 | 1 | 3 | acetylcholine transmembrane transporter activity |
| GO:0090722 | 0.0047 | 299.4074 | 0.0047 | 1 | 4 | receptor-receptor interaction |
| GO:0030594 | 0.005 | 21.2584 | 0.1068 | 2 | 91 | neurotransmitter receptor activity |
| GO:0004860 | 0.0052 | 20.7886 | 0.1091 | 2 | 93 | protein kinase inhibitor activity |
| GO:0030284 | 0.0059 | 224.5417 | 0.0059 | 1 | 5 | estrogen receptor activity |
| GO:0004857 | 0.0093 | 7.8765 | 0.4448 | 3 | 379 | enzyme inhibitor activity |
| GO:0038036 | 0.0094 | 128.2857 | 0.0094 | 1 | 8 | sphingosine-1-phosphate receptor activity |
| NA. |
| n/a |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0035757 | 0.0011 | Inf | 0.0011 | 1 | 1 | chemokine (C-C motif) ligand 19 binding |
| GO:0035758 | 0.0011 | Inf | 0.0011 | 1 | 1 | chemokine (C-C motif) ligand 21 binding |
| GO:0038117 | 0.0011 | Inf | 0.0011 | 1 | 1 | C-C motif chemokine 19 receptor activity |
| GO:0038121 | 0.0011 | Inf | 0.0011 | 1 | 1 | C-C motif chemokine 21 receptor activity |
| GO:0038100 | 0.0022 | 951.2353 | 0.0022 | 1 | 2 | nodal binding |
| GO:0070405 | 0.0024 | 31.4609 | 0.0734 | 2 | 66 | ammonium ion binding |
| GO:0005111 | 0.0033 | 475.5882 | 0.0033 | 1 | 3 | type 2 fibroblast growth factor receptor binding |
| GO:0005277 | 0.0033 | 475.5882 | 0.0033 | 1 | 3 | acetylcholine transmembrane transporter activity |
| GO:0005105 | 0.0044 | 317.0392 | 0.0044 | 1 | 4 | type 1 fibroblast growth factor receptor binding |
| GO:0090722 | 0.0044 | 317.0392 | 0.0044 | 1 | 4 | receptor-receptor interaction |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0032394 | 0 | Inf | 6e-04 | 2 | 2 | MHC class Ib receptor activity |
| GO:0042288 | 0 | 673.7083 | 0.0056 | 2 | 18 | MHC class I protein binding |
| GO:0005133 | 3e-04 | Inf | 3e-04 | 1 | 1 | interferon-gamma receptor binding |
| GO:0004522 | 0.0012 | 1348.5 | 0.0012 | 1 | 4 | ribonuclease A activity |
| GO:0030246 | 0.0025 | 41.155 | 0.0803 | 2 | 260 | carbohydrate binding |
| GO:0099600 | 0.0038 | 18.4159 | 0.3774 | 3 | 1222 | transmembrane receptor activity |
| GO:0038023 | 0.0044 | 17.4965 | 0.3956 | 3 | 1281 | signaling receptor activity |
| GO:0005102 | 0.0062 | 15.2778 | 0.4478 | 3 | 1450 | receptor binding |
| GO:0004993 | 0.0065 | 202.0625 | 0.0065 | 1 | 21 | G-protein coupled serotonin receptor activity |
| GO:0016894 | 0.0068 | 192.4286 | 0.0068 | 1 | 22 | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 3'-phosphomonoesters |
| GO:0060089 | 0.0074 | 14.3366 | 0.4744 | 3 | 1536 | molecular transducer activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0008173 | 5e-04 | 73.2955 | 0.0352 | 2 | 57 | RNA methyltransferase activity |
| GO:0008757 | 0.0036 | 27.4555 | 0.0914 | 2 | 148 | S-adenosylmethionine-dependent methyltransferase activity |
| GO:0046703 | 0.0055 | 224.6111 | 0.0056 | 1 | 9 | natural killer cell lectin-like receptor binding |
| GO:0016741 | 0.0074 | 18.7406 | 0.1328 | 2 | 215 | transferase activity, transferring one-carbon groups |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004984 | 2e-04 | 42.9783 | 0.1375 | 3 | 371 | olfactory receptor activity |
| GO:0004930 | 0.002 | 19.7222 | 0.2905 | 3 | 784 | G-protein coupled receptor activity |
| GO:0005344 | 0.0052 | 248.7846 | 0.0052 | 1 | 14 | oxygen carrier activity |
| GO:0099600 | 0.0072 | 12.2765 | 0.4529 | 3 | 1222 | transmembrane receptor activity |
| GO:0038023 | 0.0082 | 11.6635 | 0.4747 | 3 | 1281 | signaling receptor activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0042056 | 0 | 299.2037 | 0.0107 | 2 | 29 | chemoattractant activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0035662 | 0.0015 | 1155.7143 | 0.0015 | 1 | 3 | Toll-like receptor 4 binding |
| GO:0050544 | 0.0025 | 577.7857 | 0.0025 | 1 | 5 | arachidonic acid binding |
| GO:0036041 | 0.0054 | 231.0286 | 0.0054 | 1 | 11 | long-chain fatty acid binding |
| GO:0050786 | 0.0054 | 231.0286 | 0.0054 | 1 | 11 | RAGE receptor binding |
| GO:0022841 | 0.0079 | 153.9714 | 0.0079 | 1 | 16 | potassium ion leak channel activity |
| GO:0022842 | 0.0094 | 128.2857 | 0.0094 | 1 | 19 | narrow pore channel activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0008811 | 4e-04 | Inf | 4e-04 | 1 | 1 | chloramphenicol O-acetyltransferase activity |
| GO:0003796 | 0.0048 | 269.5333 | 0.0048 | 1 | 13 | lysozyme activity |
| GO:0005132 | 0.0063 | 202.1 | 0.0063 | 1 | 17 | type I interferon receptor binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0008811 | 4e-04 | Inf | 4e-04 | 1 | 1 | chloramphenicol O-acetyltransferase activity |
| GO:0003796 | 0.0056 | 224.5972 | 0.0056 | 1 | 13 | lysozyme activity |
| GO:0005132 | 0.0073 | 168.4062 | 0.0074 | 1 | 17 | type I interferon receptor binding |
| GO:0017134 | 0.0099 | 122.4318 | 0.0099 | 1 | 23 | fibroblast growth factor binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0035717 | 9e-04 | Inf | 9e-04 | 1 | 1 | chemokine (C-C motif) ligand 7 binding |
| GO:0071791 | 0.0017 | 1244.2308 | 0.0017 | 1 | 2 | chemokine (C-C motif) ligand 5 binding |
| GO:0004698 | 0.0035 | 414.6923 | 0.0035 | 1 | 4 | calcium-dependent protein kinase C activity |
| GO:0031726 | 0.0043 | 311 | 0.0043 | 1 | 5 | CCR1 chemokine receptor binding |
| GO:0001228 | 0.0044 | 10.9243 | 0.3433 | 3 | 397 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding |
| GO:0031730 | 0.0052 | 248.7846 | 0.0052 | 1 | 6 | CCR5 chemokine receptor binding |
| GO:0003680 | 0.0069 | 177.6813 | 0.0069 | 1 | 8 | AT DNA binding |
| GO:0072542 | 0.0069 | 177.6813 | 0.0069 | 1 | 8 | protein phosphatase activator activity |
| GO:0102991 | 0.0069 | 177.6813 | 0.0069 | 1 | 8 | myristoyl-CoA hydrolase activity |
| GO:0042975 | 0.0078 | 155.4615 | 0.0078 | 1 | 9 | peroxisome proliferator activated receptor binding |
| GO:0016004 | 0.0095 | 124.3538 | 0.0095 | 1 | 11 | phospholipase activator activity |
| GO:0016290 | 0.0095 | 124.3538 | 0.0095 | 1 | 11 | palmitoyl-CoA hydrolase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0035717 | 9e-04 | Inf | 9e-04 | 1 | 1 | chemokine (C-C motif) ligand 7 binding |
| GO:0003924 | 0.0014 | 16.5656 | 0.2292 | 3 | 265 | GTPase activity |
| GO:0071791 | 0.0017 | 1244.2308 | 0.0017 | 1 | 2 | chemokine (C-C motif) ligand 5 binding |
| GO:0005525 | 0.0029 | 12.6646 | 0.2975 | 3 | 344 | GTP binding |
| GO:0001883 | 0.003 | 12.4777 | 0.3018 | 3 | 349 | purine nucleoside binding |
| GO:0032549 | 0.0031 | 12.4409 | 0.3027 | 3 | 350 | ribonucleoside binding |
| GO:0019001 | 0.0034 | 12.016 | 0.313 | 3 | 362 | guanyl nucleotide binding |
| GO:0004698 | 0.0035 | 414.6923 | 0.0035 | 1 | 4 | calcium-dependent protein kinase C activity |
| GO:0005200 | 0.0035 | 26.5264 | 0.0891 | 2 | 103 | structural constituent of cytoskeleton |
| GO:0031726 | 0.0043 | 311 | 0.0043 | 1 | 5 | CCR1 chemokine receptor binding |
| GO:0031730 | 0.0052 | 248.7846 | 0.0052 | 1 | 6 | CCR5 chemokine receptor binding |
| GO:0072542 | 0.0069 | 177.6813 | 0.0069 | 1 | 8 | protein phosphatase activator activity |
| GO:0102991 | 0.0069 | 177.6813 | 0.0069 | 1 | 8 | myristoyl-CoA hydrolase activity |
| GO:0008047 | 0.008 | 8.7123 | 0.4272 | 3 | 494 | enzyme activator activity |
| GO:0016004 | 0.0095 | 124.3538 | 0.0095 | 1 | 11 | phospholipase activator activity |
| GO:0016290 | 0.0095 | 124.3538 | 0.0095 | 1 | 11 | palmitoyl-CoA hydrolase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0005544 | 4e-04 | 85.381 | 0.0299 | 2 | 44 | calcium-dependent phospholipid binding |
| GO:0005146 | 0.0014 | 1617.8 | 0.0014 | 1 | 2 | leukemia inhibitory factor receptor binding |
| GO:0001135 | 0.0054 | 231.0286 | 0.0054 | 1 | 8 | transcription factor activity, RNA polymerase II transcription factor recruiting |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0003735 | 0 | 109.0952 | 0.0556 | 3 | 150 | structural constituent of ribosome |
| GO:0017134 | 0.0085 | 146.9273 | 0.0085 | 1 | 23 | fibroblast growth factor binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0043208 | 0.002 | 770.4286 | 0.002 | 1 | 8 | glycosphingolipid binding |
| GO:0004861 | 0.003 | 490.1515 | 0.003 | 1 | 12 | cyclin-dependent protein serine/threonine kinase inhibitor activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0003735 | 0 | 78.9803 | 0.1112 | 5 | 150 | structural constituent of ribosome |
| GO:0019843 | 8e-04 | 59.7185 | 0.0415 | 2 | 56 | rRNA binding |
| GO:0003676 | 0.002 | 6.3824 | 2.867 | 8 | 3868 | nucleic acid binding |
| GO:1903231 | 0.0029 | 29.4844 | 0.0823 | 2 | 111 | mRNA binding involved in posttranscriptional gene silencing |
| GO:0008142 | 0.0037 | 367.5909 | 0.0037 | 1 | 5 | oxysterol binding |
| GO:0003729 | 0.0053 | 22.1927 | 0.1126 | 2 | 181 | mRNA binding |
| GO:0016175 | 0.0067 | 183.75 | 0.0067 | 1 | 9 | superoxide-generating NADPH oxidase activity |
| GO:0016176 | 0.0074 | 163.3232 | 0.0074 | 1 | 10 | superoxide-generating NADPH oxidase activator activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0016175 | 0.0011 | 2022.5 | 0.0011 | 1 | 9 | superoxide-generating NADPH oxidase activity |
| GO:0016176 | 0.0012 | 1797.6667 | 0.0012 | 1 | 10 | superoxide-generating NADPH oxidase activator activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:1903231 | 0 | 89.3 | 0.0548 | 3 | 111 | mRNA binding involved in posttranscriptional gene silencing |
| GO:0048030 | 0.002 | 770.4286 | 0.002 | 1 | 4 | disaccharide binding |
| GO:0005534 | 0.0025 | 577.7857 | 0.0025 | 1 | 5 | galactose binding |
| GO:0030246 | 0.0067 | 20.5736 | 0.1285 | 2 | 260 | carbohydrate binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0035662 | 0 | 6472.8 | 0.0013 | 2 | 3 | Toll-like receptor 4 binding |
| GO:0050544 | 0 | 2157.3333 | 0.0022 | 2 | 5 | arachidonic acid binding |
| GO:0036041 | 0 | 718.8444 | 0.0048 | 2 | 11 | long-chain fatty acid binding |
| GO:0050786 | 0 | 718.8444 | 0.0048 | 2 | 11 | RAGE receptor binding |
| GO:1901567 | 0 | 307.8476 | 0.0099 | 2 | 23 | fatty acid derivative binding |
| GO:0043177 | 0 | 69.0043 | 0.0765 | 3 | 177 | organic acid binding |
| GO:0033293 | 3e-04 | 115.1929 | 0.0251 | 2 | 58 | monocarboxylic acid binding |
| GO:0004966 | 0.003 | 449.3611 | 0.003 | 1 | 7 | galanin receptor activity |
| GO:0008017 | 0.0032 | 31.3314 | 0.0891 | 2 | 206 | microtubule binding |
| GO:0005540 | 0.0095 | 128.2698 | 0.0095 | 1 | 22 | hyaluronic acid binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0008009 | 3e-04 | 100.2174 | 0.0267 | 2 | 48 | chemokine activity |
| GO:0008173 | 4e-04 | 83.7714 | 0.0317 | 2 | 57 | RNA methyltransferase activity |
| GO:0038100 | 0.0011 | 2022.5 | 0.0011 | 1 | 2 | nodal binding |
| GO:0035662 | 0.0017 | 1011.1875 | 0.0017 | 1 | 3 | Toll-like receptor 4 binding |
| GO:0031726 | 0.0028 | 505.5312 | 0.0028 | 1 | 5 | CCR1 chemokine receptor binding |
| GO:0050544 | 0.0028 | 505.5312 | 0.0028 | 1 | 5 | arachidonic acid binding |
| GO:0008757 | 0.0029 | 31.3796 | 0.0823 | 2 | 148 | S-adenosylmethionine-dependent methyltransferase activity |
| GO:0031730 | 0.0033 | 404.4 | 0.0033 | 1 | 6 | CCR5 chemokine receptor binding |
| GO:0016741 | 0.0059 | 21.4192 | 0.1195 | 2 | 215 | transferase activity, transferring one-carbon groups |
| GO:0036041 | 0.0061 | 202.1375 | 0.0061 | 1 | 11 | long-chain fatty acid binding |
| GO:0050786 | 0.0061 | 202.1375 | 0.0061 | 1 | 11 | RAGE receptor binding |
| GO:0001664 | 0.0085 | 17.7734 | 0.1434 | 2 | 258 | G-protein coupled receptor binding |
| GO:0005126 | 0.0088 | 17.4275 | 0.1462 | 2 | 263 | cytokine receptor binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0017176 | 0.0025 | 577.7857 | 0.0025 | 1 | 5 | phosphatidylinositol N-acetylglucosaminyltransferase activity |
| GO:0019763 | 0.003 | 462.2 | 0.003 | 1 | 6 | immunoglobulin receptor activity |
| GO:0097027 | 0.0039 | 330.102 | 0.004 | 1 | 8 | ubiquitin-protein transferase activator activity |
| GO:0019864 | 0.0054 | 231.0286 | 0.0054 | 1 | 11 | IgG binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0003727 | 0.0016 | 40.6692 | 0.0594 | 2 | 74 | single-stranded RNA binding |
| GO:0004082 | 0.0032 | 449.2778 | 0.0032 | 1 | 4 | bisphosphoglycerate mutase activity |
| GO:0046538 | 0.0032 | 449.2778 | 0.0032 | 1 | 4 | 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity |
| GO:0048248 | 0.004 | 336.9375 | 0.004 | 1 | 5 | CXCR3 chemokine receptor binding |
| GO:0043565 | 0.0065 | 6.8033 | 0.7998 | 4 | 996 | sequence-specific DNA binding |
| GO:0019957 | 0.0072 | 168.4271 | 0.0072 | 1 | 9 | C-C chemokine binding |
| GO:0035925 | 0.0096 | 122.4697 | 0.0096 | 1 | 12 | mRNA 3'-UTR AU-rich region binding |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0098542 | 0 | 14.7731 | 0.5705 | 6 | 463 | defense response to other organism |
| GO:0042119 | 0 | 14.3212 | 0.5878 | 6 | 477 | neutrophil activation |
| GO:0002275 | 0 | 13.1136 | 0.6396 | 6 | 519 | myeloid cell activation involved in immune response |
| GO:0002444 | 0 | 13.0349 | 0.6433 | 6 | 522 | myeloid leukocyte mediated immunity |
| GO:0031640 | 0 | 51.8342 | 0.0715 | 3 | 58 | killing of cells of other organism |
| GO:0016045 | 1e-04 | 180 | 0.0148 | 2 | 12 | detection of bacterium |
| GO:0002263 | 1e-04 | 10.194 | 0.8133 | 6 | 660 | cell activation involved in immune response |
| GO:0043312 | 1e-04 | 12.3891 | 0.5376 | 5 | 459 | neutrophil degranulation |
| GO:0045055 | 2e-04 | 9.4676 | 0.8725 | 6 | 708 | regulated exocytosis |
| GO:0098581 | 2e-04 | 112.4583 | 0.0222 | 2 | 18 | detection of external biotic stimulus |
| GO:0035821 | 7e-04 | 20.4033 | 0.175 | 3 | 142 | modification of morphology or physiology of other organism |
| GO:0032940 | 9e-04 | 5.842 | 1.6944 | 7 | 1375 | secretion by cell |
| GO:0019547 | 0.0012 | Inf | 0.0012 | 1 | 1 | arginine catabolic process to ornithine |
| GO:0044356 | 0.0012 | Inf | 0.0012 | 1 | 1 | clearance of foreign intracellular DNA by conversion of DNA cytidine to uridine |
| GO:0061015 | 0.0012 | Inf | 0.0012 | 1 | 1 | snRNA import into nucleus |
| GO:0070965 | 0.0012 | Inf | 0.0012 | 1 | 1 | positive regulation of neutrophil mediated killing of fungus |
| GO:0099046 | 0.0012 | Inf | 0.0012 | 1 | 1 | clearance of foreign intracellular nucleic acids |
| GO:1900150 | 0.0012 | Inf | 0.0012 | 1 | 1 | regulation of defense response to fungus |
| GO:1904676 | 0.0012 | Inf | 0.0012 | 1 | 1 | negative regulation of somatic stem cell division |
| GO:1905175 | 0.0012 | Inf | 0.0012 | 1 | 1 | negative regulation of vascular smooth muscle cell dedifferentiation |
| GO:0031343 | 0.0013 | 43.8184 | 0.053 | 2 | 43 | positive regulation of cell killing |
| GO:0032964 | 0.0014 | 41.7752 | 0.0555 | 2 | 45 | collagen biosynthetic process |
| GO:0043207 | 0.0014 | 7.4697 | 0.886 | 5 | 798 | response to external biotic stimulus |
| GO:0002376 | 0.0017 | 6.5914 | 1.4345 | 6 | 1548 | immune system process |
| GO:0061844 | 0.0018 | 36.6463 | 0.0628 | 2 | 51 | antimicrobial humoral immune response mediated by antimicrobial peptide |
| GO:0045321 | 0.0018 | 5.7965 | 1.3826 | 6 | 1122 | leukocyte activation |
| GO:0009620 | 0.0018 | 35.9111 | 0.0641 | 2 | 52 | response to fungus |
| GO:0006959 | 0.0023 | 13.067 | 0.2699 | 3 | 219 | humoral immune response |
| GO:0010963 | 0.0025 | 853.1053 | 0.0025 | 1 | 2 | regulation of L-arginine import |
| GO:0044663 | 0.0025 | 853.1053 | 0.0025 | 1 | 2 | establishment or maintenance of cell type involved in phenotypic switching |
| GO:0070949 | 0.0025 | 853.1053 | 0.0025 | 1 | 2 | regulation of neutrophil mediated killing of symbiont cell |
| GO:0070960 | 0.0025 | 853.1053 | 0.0025 | 1 | 2 | positive regulation of neutrophil mediated cytotoxicity |
| GO:0045087 | 0.0029 | 6.1533 | 1.0327 | 5 | 838 | innate immune response |
| GO:0010466 | 0.0033 | 11.5473 | 0.3044 | 3 | 247 | negative regulation of peptidase activity |
| GO:0032827 | 0.0037 | 426.5263 | 0.0037 | 1 | 3 | negative regulation of natural killer cell differentiation involved in immune response |
| GO:0035879 | 0.0037 | 426.5263 | 0.0037 | 1 | 3 | plasma membrane lactate transport |
| GO:0051714 | 0.0037 | 426.5263 | 0.0037 | 1 | 3 | positive regulation of cytolysis in other organism |
| GO:0090678 | 0.0037 | 426.5263 | 0.0037 | 1 | 3 | cell dedifferentiation involved in phenotypic switching |
| GO:0016192 | 0.004 | 4.3985 | 2.1873 | 7 | 1775 | vesicle-mediated transport |
| GO:0019732 | 0.0049 | 284.3333 | 0.0049 | 1 | 4 | antifungal humoral response |
| GO:0032792 | 0.0049 | 284.3333 | 0.0049 | 1 | 4 | negative regulation of CREB transcription factor activity |
| GO:0090467 | 0.0049 | 284.3333 | 0.0049 | 1 | 4 | arginine import |
| GO:2000552 | 0.0049 | 284.3333 | 0.0049 | 1 | 4 | negative regulation of T-helper 2 cell cytokine production |
| GO:0050830 | 0.0051 | 21.0784 | 0.1072 | 2 | 87 | defense response to Gram-positive bacterium |
| GO:0036446 | 0.0061 | 213.2368 | 0.0062 | 1 | 5 | myofibroblast differentiation |
| GO:0060414 | 0.0061 | 213.2368 | 0.0062 | 1 | 5 | aorta smooth muscle tissue morphogenesis |
| GO:1902023 | 0.0061 | 213.2368 | 0.0062 | 1 | 5 | L-arginine transport |
| GO:1904673 | 0.0061 | 213.2368 | 0.0062 | 1 | 5 | negative regulation of somatic stem cell population maintenance |
| GO:2000724 | 0.0061 | 213.2368 | 0.0062 | 1 | 5 | positive regulation of cardiac vascular smooth muscle cell differentiation |
| GO:0050896 | 0.0067 | 3.9199 | 10.1084 | 16 | 8203 | response to stimulus |
| GO:2000117 | 0.0073 | 17.3754 | 0.1294 | 2 | 105 | negative regulation of cysteine-type endopeptidase activity |
| GO:0010269 | 0.0074 | 170.5789 | 0.0074 | 1 | 6 | response to selenium ion |
| GO:0015727 | 0.0074 | 170.5789 | 0.0074 | 1 | 6 | lactate transport |
| GO:0060336 | 0.0074 | 170.5789 | 0.0074 | 1 | 6 | negative regulation of interferon-gamma-mediated signaling pathway |
| GO:0070383 | 0.0074 | 170.5789 | 0.0074 | 1 | 6 | DNA cytosine deamination |
| GO:0002697 | 0.0074 | 8.5448 | 0.4079 | 3 | 331 | regulation of immune effector process |
| GO:0001816 | 0.0078 | 5.937 | 0.8121 | 4 | 659 | cytokine production |
| GO:0070268 | 0.0084 | 16.1151 | 0.1392 | 2 | 113 | cornification |
| GO:0009253 | 0.0086 | 142.1404 | 0.0086 | 1 | 7 | peptidoglycan catabolic process |
| GO:0009635 | 0.0086 | 142.1404 | 0.0086 | 1 | 7 | response to herbicide |
| GO:0010668 | 0.0086 | 142.1404 | 0.0086 | 1 | 7 | ectodermal cell differentiation |
| GO:0032815 | 0.0086 | 142.1404 | 0.0086 | 1 | 7 | negative regulation of natural killer cell activation |
| GO:0051597 | 0.0086 | 142.1404 | 0.0086 | 1 | 7 | response to methylmercury |
| GO:0043313 | 0.0098 | 121.8271 | 0.0099 | 1 | 8 | regulation of neutrophil degranulation |
| GO:0043696 | 0.0098 | 121.8271 | 0.0099 | 1 | 8 | dedifferentiation |
| GO:0070269 | 0.0098 | 121.8271 | 0.0099 | 1 | 8 | pyroptosis |
| GO:1900239 | 0.0098 | 121.8271 | 0.0099 | 1 | 8 | regulation of phenotypic switching |
| GO:2000035 | 0.0098 | 121.8271 | 0.0099 | 1 | 8 | regulation of stem cell division |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0008584 | 0.0014 | 15.189 | 0.2243 | 3 | 130 | male gonad development |
| GO:0060010 | 0.0017 | Inf | 0.0017 | 1 | 1 | Sertoli cell fate commitment |
| GO:0061185 | 0.0017 | Inf | 0.0017 | 1 | 1 | negative regulation of dermatome development |
| GO:0061682 | 0.0017 | Inf | 0.0017 | 1 | 1 | seminal vesicle morphogenesis |
| GO:2000287 | 0.0017 | Inf | 0.0017 | 1 | 1 | positive regulation of myotome development |
| GO:0046661 | 0.0023 | 12.8416 | 0.264 | 3 | 153 | male sex differentiation |
| GO:0030850 | 0.003 | 27.6188 | 0.0811 | 2 | 47 | prostate gland development |
| GO:2000041 | 0.0034 | 600.037 | 0.0035 | 1 | 2 | negative regulation of planar cell polarity pathway involved in axis elongation |
| GO:0060350 | 0.0035 | 25.3579 | 0.088 | 2 | 51 | endochondral bone morphogenesis |
| GO:0060348 | 0.0035 | 10.9268 | 0.3088 | 3 | 179 | bone development |
| GO:0051094 | 0.0036 | 4.171 | 2.0806 | 7 | 1206 | positive regulation of developmental process |
| GO:0043124 | 0.004 | 23.4383 | 0.0949 | 2 | 55 | negative regulation of I-kappaB kinase/NF-kappaB signaling |
| GO:0045600 | 0.0043 | 22.5832 | 0.0983 | 2 | 57 | positive regulation of fat cell differentiation |
| GO:0045669 | 0.0045 | 22.1786 | 0.1001 | 2 | 58 | positive regulation of osteoblast differentiation |
| GO:0061458 | 0.005 | 6.5339 | 0.7022 | 4 | 407 | reproductive system development |
| GO:0060741 | 0.0052 | 300 | 0.0052 | 1 | 3 | prostate gland stromal morphogenesis |
| GO:0070458 | 0.0052 | 300 | 0.0052 | 1 | 3 | cellular detoxification of nitrogen compound |
| GO:1904715 | 0.0052 | 300 | 0.0052 | 1 | 3 | negative regulation of chaperone-mediated autophagy |
| GO:1990834 | 0.0052 | 300 | 0.0052 | 1 | 3 | response to odorant |
| GO:0045137 | 0.0052 | 9.4575 | 0.3554 | 3 | 206 | development of primary sexual characteristics |
| GO:0048705 | 0.0054 | 9.3181 | 0.3606 | 3 | 209 | skeletal system morphogenesis |
| GO:0048041 | 0.0066 | 17.9855 | 0.1225 | 2 | 71 | focal adhesion assembly |
| GO:0008588 | 0.0069 | 199.9877 | 0.0069 | 1 | 4 | release of cytoplasmic sequestered NF-kappaB |
| GO:0018916 | 0.0069 | 199.9877 | 0.0069 | 1 | 4 | nitrobenzene metabolic process |
| GO:0042662 | 0.0069 | 199.9877 | 0.0069 | 1 | 4 | negative regulation of mesodermal cell fate specification |
| GO:0090244 | 0.0069 | 199.9877 | 0.0069 | 1 | 4 | Wnt signaling pathway involved in somitogenesis |
| GO:1905903 | 0.0069 | 199.9877 | 0.0069 | 1 | 4 | negative regulation of mesoderm formation |
| GO:0021766 | 0.007 | 17.4767 | 0.1259 | 2 | 73 | hippocampus development |
| GO:0043627 | 0.007 | 17.4767 | 0.1259 | 2 | 73 | response to estrogen |
| GO:0003151 | 0.0072 | 17.2329 | 0.1277 | 2 | 74 | outflow tract morphogenesis |
| GO:0045621 | 0.0083 | 15.9014 | 0.138 | 2 | 80 | positive regulation of lymphocyte differentiation |
| GO:0034333 | 0.0085 | 15.6991 | 0.1397 | 2 | 81 | adherens junction assembly |
| GO:0060591 | 0.0086 | 149.9815 | 0.0086 | 1 | 5 | chondroblast differentiation |
| GO:0061056 | 0.0086 | 149.9815 | 0.0086 | 1 | 5 | sclerotome development |
| GO:1904956 | 0.0086 | 149.9815 | 0.0086 | 1 | 5 | regulation of midbrain dopaminergic neuron differentiation |
| GO:0045944 | 0.0087 | 3.8841 | 1.8442 | 6 | 1069 | positive regulation of transcription from RNA polymerase II promoter |
| GO:0001843 | 0.0094 | 14.9388 | 0.1466 | 2 | 85 | neural tube closure |
| GO:0007044 | 0.0098 | 14.5855 | 0.1501 | 2 | 87 | cell-substrate junction assembly |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:2001236 | 2e-04 | 33.2524 | 0.1185 | 3 | 148 | regulation of extrinsic apoptotic signaling pathway |
| GO:1902042 | 4e-04 | 86.5401 | 0.0288 | 2 | 36 | negative regulation of extrinsic apoptotic signaling pathway via death domain receptors |
| GO:2000351 | 5e-04 | 75.4219 | 0.0328 | 2 | 41 | regulation of endothelial cell apoptotic process |
| GO:2001234 | 5e-04 | 24.2712 | 0.161 | 3 | 201 | negative regulation of apoptotic signaling pathway |
| GO:0042113 | 6e-04 | 22.4341 | 0.1738 | 3 | 217 | B cell activation |
| GO:0002642 | 8e-04 | Inf | 8e-04 | 1 | 1 | positive regulation of immunoglobulin biosynthetic process |
| GO:0030887 | 8e-04 | Inf | 8e-04 | 1 | 1 | positive regulation of myeloid dendritic cell activation |
| GO:1904155 | 8e-04 | Inf | 8e-04 | 1 | 1 | DN2 thymocyte differentiation |
| GO:1904156 | 8e-04 | Inf | 8e-04 | 1 | 1 | DN3 thymocyte differentiation |
| GO:0045321 | 0.0013 | 8.449 | 0.8987 | 5 | 1122 | leukocyte activation |
| GO:0034021 | 0.0016 | 1351.3333 | 0.0016 | 1 | 2 | response to silicon dioxide |
| GO:0036345 | 0.0016 | 1351.3333 | 0.0016 | 1 | 2 | platelet maturation |
| GO:0030098 | 0.0018 | 15.2435 | 0.2531 | 3 | 316 | lymphocyte differentiation |
| GO:0007166 | 0.002 | 6.0519 | 2.105 | 7 | 2628 | cell surface receptor signaling pathway |
| GO:0002377 | 0.0022 | 34.1036 | 0.0705 | 2 | 88 | immunoglobulin production |
| GO:1904019 | 0.0023 | 33.3244 | 0.0721 | 2 | 90 | epithelial cell apoptotic process |
| GO:0021553 | 0.0024 | 675.625 | 0.0024 | 1 | 3 | olfactory nerve development |
| GO:0048388 | 0.0024 | 675.625 | 0.0024 | 1 | 3 | endosomal lumen acidification |
| GO:0061368 | 0.0024 | 675.625 | 0.0024 | 1 | 3 | behavioral response to formalin induced pain |
| GO:0099566 | 0.0024 | 675.625 | 0.0024 | 1 | 3 | regulation of postsynaptic cytosolic calcium ion concentration |
| GO:0030097 | 0.003 | 8.5425 | 0.6456 | 4 | 806 | hemopoiesis |
| GO:0030644 | 0.0032 | 450.3889 | 0.0032 | 1 | 4 | cellular chloride ion homeostasis |
| GO:0045918 | 0.0032 | 450.3889 | 0.0032 | 1 | 4 | negative regulation of cytolysis |
| GO:0046666 | 0.0032 | 450.3889 | 0.0032 | 1 | 4 | retinal cell programmed cell death |
| GO:0060474 | 0.0032 | 450.3889 | 0.0032 | 1 | 4 | positive regulation of flagellated sperm motility involved in capacitation |
| GO:2001274 | 0.0032 | 450.3889 | 0.0032 | 1 | 4 | negative regulation of glucose import in response to insulin stimulus |
| GO:0008219 | 0.0034 | 5.8386 | 1.6677 | 6 | 2082 | cell death |
| GO:0006874 | 0.0034 | 12.0794 | 0.3172 | 3 | 396 | cellular calcium ion homeostasis |
| GO:0043069 | 0.0035 | 8.1977 | 0.6712 | 4 | 838 | negative regulation of programmed cell death |
| GO:0032747 | 0.004 | 337.7708 | 0.004 | 1 | 5 | positive regulation of interleukin-23 production |
| GO:0060385 | 0.004 | 337.7708 | 0.004 | 1 | 5 | axonogenesis involved in innervation |
| GO:0072679 | 0.004 | 337.7708 | 0.004 | 1 | 5 | thymocyte migration |
| GO:0002520 | 0.0043 | 7.6997 | 0.7121 | 4 | 889 | immune system development |
| GO:0051240 | 0.0043 | 6.242 | 1.1863 | 5 | 1481 | positive regulation of multicellular organismal process |
| GO:0072507 | 0.0046 | 10.8585 | 0.3516 | 3 | 439 | divalent inorganic cation homeostasis |
| GO:0051599 | 0.0048 | 270.2 | 0.0048 | 1 | 6 | response to hydrostatic pressure |
| GO:0097527 | 0.0048 | 270.2 | 0.0048 | 1 | 6 | necroptotic signaling pathway |
| GO:0002684 | 0.0051 | 7.3223 | 0.7465 | 4 | 932 | positive regulation of immune system process |
| GO:1902533 | 0.0053 | 7.2477 | 0.7537 | 4 | 941 | positive regulation of intracellular signal transduction |
| GO:0050906 | 0.0053 | 10.3225 | 0.3693 | 3 | 461 | detection of stimulus involved in sensory perception |
| GO:0030223 | 0.0056 | 225.1528 | 0.0056 | 1 | 7 | neutrophil differentiation |
| GO:0048290 | 0.0056 | 225.1528 | 0.0056 | 1 | 7 | isotype switching to IgA isotypes |
| GO:0001821 | 0.0064 | 192.9762 | 0.0064 | 1 | 8 | histamine secretion |
| GO:0038180 | 0.0064 | 192.9762 | 0.0064 | 1 | 8 | nerve growth factor signaling pathway |
| GO:0042045 | 0.0064 | 192.9762 | 0.0064 | 1 | 8 | epithelial fluid transport |
| GO:0071316 | 0.0064 | 192.9762 | 0.0064 | 1 | 8 | cellular response to nicotine |
| GO:1902715 | 0.0064 | 192.9762 | 0.0064 | 1 | 8 | positive regulation of interferon-gamma secretion |
| GO:0050865 | 0.0064 | 9.5884 | 0.3965 | 3 | 495 | regulation of cell activation |
| GO:0010623 | 0.0066 | 184.1591 | 0.0067 | 1 | 9 | programmed cell death involved in cell development |
| GO:0042221 | 0.0067 | 4.6388 | 3.3377 | 8 | 4167 | response to chemical |
| GO:0001766 | 0.0072 | 168.8438 | 0.0072 | 1 | 9 | membrane raft polarization |
| GO:0071803 | 0.0072 | 168.8438 | 0.0072 | 1 | 9 | positive regulation of podosome assembly |
| GO:0097011 | 0.0072 | 168.8438 | 0.0072 | 1 | 9 | cellular response to granulocyte macrophage colony-stimulating factor stimulus |
| GO:2000510 | 0.0072 | 168.8438 | 0.0072 | 1 | 9 | positive regulation of dendritic cell chemotaxis |
| GO:0050966 | 0.008 | 150.0741 | 0.008 | 1 | 10 | detection of mechanical stimulus involved in sensory perception of pain |
| GO:0051665 | 0.008 | 150.0741 | 0.008 | 1 | 10 | membrane raft localization |
| GO:0090331 | 0.0088 | 135.0583 | 0.0088 | 1 | 11 | negative regulation of platelet aggregation |
| GO:0007610 | 0.0088 | 8.5136 | 0.4445 | 3 | 555 | behavior |
| GO:0055065 | 0.0092 | 8.3568 | 0.4526 | 3 | 565 | metal ion homeostasis |
| GO:0043523 | 0.0095 | 15.7563 | 0.1498 | 2 | 187 | regulation of neuron apoptotic process |
| GO:0007623 | 0.0096 | 15.6706 | 0.1506 | 2 | 188 | circadian rhythm |
| GO:0034116 | 0.0096 | 122.7727 | 0.0096 | 1 | 12 | positive regulation of heterotypic cell-cell adhesion |
| GO:0030003 | 0.0099 | 8.1464 | 0.4638 | 3 | 579 | cellular cation homeostasis |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0060349 | 5e-04 | 22.7534 | 0.1518 | 3 | 88 | bone morphogenesis |
| GO:0001958 | 0.001 | 49.7754 | 0.0466 | 2 | 27 | endochondral ossification |
| GO:0048562 | 0.0013 | 9.6527 | 0.4813 | 4 | 279 | embryonic organ morphogenesis |
| GO:0021592 | 0.0017 | Inf | 0.0017 | 1 | 1 | fourth ventricle development |
| GO:0021993 | 0.0017 | Inf | 0.0017 | 1 | 1 | initiation of neural tube closure |
| GO:0060010 | 0.0017 | Inf | 0.0017 | 1 | 1 | Sertoli cell fate commitment |
| GO:0031076 | 0.0018 | 35.5319 | 0.0638 | 2 | 37 | embryonic camera-type eye development |
| GO:0016574 | 0.0021 | 32.7206 | 0.069 | 2 | 40 | histone ubiquitination |
| GO:0045321 | 0.0024 | 4.5103 | 1.9357 | 7 | 1122 | leukocyte activation |
| GO:0048701 | 0.0026 | 29.5971 | 0.0759 | 2 | 44 | embryonic cranial skeleton morphogenesis |
| GO:0051572 | 0.0034 | 600.037 | 0.0035 | 1 | 2 | negative regulation of histone H3-K4 methylation |
| GO:1904815 | 0.0034 | 600.037 | 0.0035 | 1 | 2 | negative regulation of protein localization to chromosome, telomeric region |
| GO:0008283 | 0.0044 | 3.4439 | 3.3952 | 9 | 1968 | cell proliferation |
| GO:0045669 | 0.0045 | 22.1786 | 0.1001 | 2 | 58 | positive regulation of osteoblast differentiation |
| GO:0002351 | 0.0052 | 300 | 0.0052 | 1 | 3 | serotonin production involved in inflammatory response |
| GO:0002554 | 0.0052 | 300 | 0.0052 | 1 | 3 | serotonin secretion by platelet |
| GO:0021678 | 0.0052 | 300 | 0.0052 | 1 | 3 | third ventricle development |
| GO:0033128 | 0.0052 | 300 | 0.0052 | 1 | 3 | negative regulation of histone phosphorylation |
| GO:0071593 | 0.0052 | 300 | 0.0052 | 1 | 3 | lymphocyte aggregation |
| GO:1901837 | 0.0052 | 300 | 0.0052 | 1 | 3 | negative regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter |
| GO:1990834 | 0.0052 | 300 | 0.0052 | 1 | 3 | response to odorant |
| GO:0061035 | 0.0054 | 20.0248 | 0.1104 | 2 | 64 | regulation of cartilage development |
| GO:0008589 | 0.0061 | 18.8065 | 0.1173 | 2 | 68 | regulation of smoothened signaling pathway |
| GO:0006366 | 0.0061 | 3.2591 | 3.5625 | 9 | 2065 | transcription from RNA polymerase II promoter |
| GO:0002051 | 0.0069 | 199.9877 | 0.0069 | 1 | 4 | osteoblast fate commitment |
| GO:0016554 | 0.0069 | 199.9877 | 0.0069 | 1 | 4 | cytidine to uridine editing |
| GO:0021555 | 0.0069 | 199.9877 | 0.0069 | 1 | 4 | midbrain-hindbrain boundary morphogenesis |
| GO:0061086 | 0.0069 | 199.9877 | 0.0069 | 1 | 4 | negative regulation of histone H3-K27 methylation |
| GO:0042110 | 0.0069 | 5.9152 | 0.7729 | 4 | 448 | T cell activation |
| GO:0043627 | 0.007 | 17.4767 | 0.1259 | 2 | 73 | response to estrogen |
| GO:0002521 | 0.0077 | 5.7422 | 0.7953 | 4 | 461 | leukocyte differentiation |
| GO:0045621 | 0.0083 | 15.9014 | 0.138 | 2 | 80 | positive regulation of lymphocyte differentiation |
| GO:0034184 | 0.0086 | 149.9815 | 0.0086 | 1 | 5 | positive regulation of maintenance of mitotic sister chromatid cohesion |
| GO:0060591 | 0.0086 | 149.9815 | 0.0086 | 1 | 5 | chondroblast differentiation |
| GO:0048609 | 0.0091 | 4.417 | 1.3198 | 5 | 765 | multicellular organismal reproductive process |
| GO:0120034 | 0.0092 | 15.122 | 0.1449 | 2 | 84 | positive regulation of plasma membrane bounded cell projection assembly |
| GO:0060606 | 0.0096 | 14.7601 | 0.1484 | 2 | 86 | tube closure |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:2000502 | 0 | 1200 | 0.0054 | 2 | 3 | negative regulation of natural killer cell chemotaxis |
| GO:0060326 | 1e-04 | 12.9761 | 0.4664 | 5 | 261 | cell chemotaxis |
| GO:2000402 | 1e-04 | 171.3651 | 0.0161 | 2 | 9 | negative regulation of lymphocyte migration |
| GO:0002689 | 4e-04 | 85.6455 | 0.0286 | 2 | 16 | negative regulation of leukocyte chemotaxis |
| GO:0070098 | 4e-04 | 24.1618 | 0.1429 | 3 | 80 | chemokine-mediated signaling pathway |
| GO:0045954 | 5e-04 | 70.5185 | 0.0339 | 2 | 19 | positive regulation of natural killer cell mediated cytotoxicity |
| GO:0043547 | 6e-04 | 8.5584 | 0.6969 | 5 | 390 | positive regulation of GTPase activity |
| GO:1901623 | 6e-04 | 63.0877 | 0.0375 | 2 | 21 | regulation of lymphocyte chemotaxis |
| GO:0051336 | 7e-04 | 5.0712 | 2.037 | 8 | 1140 | regulation of hydrolase activity |
| GO:0048247 | 0.0017 | 36.9074 | 0.0616 | 2 | 37 | lymphocyte chemotaxis |
| GO:0002715 | 0.0018 | 36.2918 | 0.0625 | 2 | 35 | regulation of natural killer cell mediated immunity |
| GO:0032078 | 0.0018 | Inf | 0.0018 | 1 | 1 | negative regulation of endodeoxyribonuclease activity |
| GO:1902204 | 0.0018 | Inf | 0.0018 | 1 | 1 | positive regulation of hepatocyte growth factor receptor signaling pathway |
| GO:1904155 | 0.0018 | Inf | 0.0018 | 1 | 1 | DN2 thymocyte differentiation |
| GO:1904156 | 0.0018 | Inf | 0.0018 | 1 | 1 | DN3 thymocyte differentiation |
| GO:0071346 | 0.0019 | 13.5295 | 0.2502 | 3 | 140 | cellular response to interferon-gamma |
| GO:0045429 | 0.0024 | 30.6971 | 0.0733 | 2 | 41 | positive regulation of nitric oxide biosynthetic process |
| GO:0019835 | 0.0025 | 29.9278 | 0.075 | 2 | 42 | cytolysis |
| GO:0031343 | 0.0027 | 29.196 | 0.0768 | 2 | 43 | positive regulation of cell killing |
| GO:0034260 | 0.0028 | 28.4991 | 0.0786 | 2 | 44 | negative regulation of GTPase activity |
| GO:0042330 | 0.0029 | 5.8622 | 1.0024 | 5 | 561 | taxis |
| GO:0002685 | 0.0032 | 11.353 | 0.2966 | 3 | 166 | regulation of leukocyte migration |
| GO:0045087 | 0.0032 | 4.8189 | 1.4974 | 6 | 838 | innate immune response |
| GO:0046373 | 0.0036 | 578.5714 | 0.0036 | 1 | 2 | L-arabinose metabolic process |
| GO:0050920 | 0.0038 | 10.628 | 0.3163 | 3 | 177 | regulation of chemotaxis |
| GO:0001910 | 0.004 | 23.4568 | 0.0947 | 2 | 53 | regulation of leukocyte mediated cytotoxicity |
| GO:0006968 | 0.0042 | 23.0043 | 0.0965 | 2 | 54 | cellular defense response |
| GO:0032729 | 0.0051 | 20.6169 | 0.1072 | 2 | 60 | positive regulation of interferon-gamma production |
| GO:0002548 | 0.0055 | 19.9272 | 0.1108 | 2 | 62 | monocyte chemotaxis |
| GO:0031295 | 0.0063 | 18.3886 | 0.1197 | 2 | 67 | T cell costimulation |
| GO:0046209 | 0.0069 | 17.5741 | 0.1251 | 2 | 70 | nitric oxide metabolic process |
| GO:0060474 | 0.0071 | 192.8333 | 0.0071 | 1 | 4 | positive regulation of flagellated sperm motility involved in capacitation |
| GO:0030101 | 0.0075 | 16.8284 | 0.1304 | 2 | 73 | natural killer cell activation |
| GO:0002708 | 0.0077 | 16.5936 | 0.1322 | 2 | 74 | positive regulation of lymphocyte mediated immunity |
| GO:1903426 | 0.0083 | 15.9269 | 0.1376 | 2 | 77 | regulation of reactive oxygen species biosynthetic process |
| GO:0072679 | 0.0089 | 144.6161 | 0.0089 | 1 | 5 | thymocyte migration |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0006955 | 0 | 28.6195 | 0.3161 | 6 | 257 | immune response |
| GO:0045321 | 0 | 7.7668 | 2.2813 | 12 | 1122 | leukocyte activation |
| GO:0002263 | 0 | 8.9551 | 1.342 | 9 | 660 | cell activation involved in immune response |
| GO:0006954 | 0 | 8.8278 | 1.3603 | 9 | 669 | inflammatory response |
| GO:0007166 | 0 | 4.8951 | 5.3434 | 16 | 2628 | cell surface receptor signaling pathway |
| GO:0070098 | 0 | 29.2577 | 0.1627 | 4 | 80 | chemokine-mediated signaling pathway |
| GO:0045087 | 0 | 6.9517 | 1.7039 | 9 | 838 | innate immune response |
| GO:0071347 | 0 | 25.8396 | 0.183 | 4 | 90 | cellular response to interleukin-1 |
| GO:0002322 | 0 | 348.2581 | 0.0102 | 2 | 5 | B cell proliferation involved in immune response |
| GO:0070374 | 0 | 15.1247 | 0.3945 | 5 | 194 | positive regulation of ERK1 and ERK2 cascade |
| GO:0007194 | 0 | 52.1484 | 0.0691 | 3 | 34 | negative regulation of adenylate cyclase activity |
| GO:0002548 | 1e-04 | 42.1777 | 0.0841 | 3 | 44 | monocyte chemotaxis |
| GO:0002687 | 1e-04 | 18.9567 | 0.246 | 4 | 121 | positive regulation of leukocyte migration |
| GO:0097530 | 1e-04 | 18.7949 | 0.2481 | 4 | 122 | granulocyte migration |
| GO:0031666 | 1e-04 | 174.0968 | 0.0163 | 2 | 8 | positive regulation of lipopolysaccharide-mediated signaling pathway |
| GO:0030803 | 1e-04 | 35.8933 | 0.0976 | 3 | 48 | negative regulation of cyclic nucleotide biosynthetic process |
| GO:0030815 | 1e-04 | 34.3617 | 0.1017 | 3 | 50 | negative regulation of cAMP metabolic process |
| GO:1900372 | 1e-04 | 33.6437 | 0.1037 | 3 | 51 | negative regulation of purine nucleotide biosynthetic process |
| GO:0060326 | 2e-04 | 11.1196 | 0.5307 | 5 | 261 | cell chemotaxis |
| GO:0071346 | 2e-04 | 16.289 | 0.2847 | 4 | 140 | cellular response to interferon-gamma |
| GO:0048247 | 2e-04 | 29.3491 | 0.1179 | 3 | 58 | lymphocyte chemotaxis |
| GO:0045980 | 4e-04 | 23.0386 | 0.1484 | 3 | 73 | negative regulation of nucleotide metabolic process |
| GO:0030502 | 5e-04 | 74.576 | 0.0325 | 2 | 16 | negative regulation of bone mineralization |
| GO:0002275 | 6e-04 | 6.794 | 1.0553 | 6 | 519 | myeloid cell activation involved in immune response |
| GO:0002444 | 6e-04 | 6.7532 | 1.0614 | 6 | 522 | myeloid leukocyte mediated immunity |
| GO:0090026 | 6e-04 | 65.246 | 0.0366 | 2 | 18 | positive regulation of monocyte chemotaxis |
| GO:0030593 | 7e-04 | 18.9553 | 0.1789 | 3 | 88 | neutrophil chemotaxis |
| GO:0031279 | 9e-04 | 17.6989 | 0.1911 | 3 | 94 | regulation of cyclase activity |
| GO:0051339 | 9e-04 | 17.5054 | 0.1932 | 3 | 95 | regulation of lyase activity |
| GO:0007214 | 0.001 | 49.6959 | 0.0468 | 2 | 23 | gamma-aminobutyric acid signaling pathway |
| GO:0002688 | 0.0013 | 15.6252 | 0.2155 | 3 | 106 | regulation of leukocyte chemotaxis |
| GO:0032940 | 0.0013 | 4.0715 | 2.7957 | 9 | 1375 | secretion by cell |
| GO:0002682 | 0.0013 | 7.1121 | 0.8434 | 5 | 479 | regulation of immune system process |
| GO:0050715 | 0.0015 | 14.7596 | 0.2277 | 3 | 112 | positive regulation of cytokine secretion |
| GO:0050900 | 0.0016 | 8.9959 | 0.5131 | 4 | 285 | leukocyte migration |
| GO:0006049 | 0.002 | Inf | 0.002 | 1 | 1 | UDP-N-acetylglucosamine catabolic process |
| GO:0006051 | 0.002 | Inf | 0.002 | 1 | 1 | N-acetylmannosamine metabolic process |
| GO:0048006 | 0.002 | Inf | 0.002 | 1 | 1 | antigen processing and presentation, endogenous lipid antigen via MHC class Ib |
| GO:0090122 | 0.002 | Inf | 0.002 | 1 | 1 | cholesterol ester hydrolysis involved in cholesterol transport |
| GO:0009225 | 0.002 | 33.6441 | 0.0671 | 2 | 33 | nucleotide-sugar metabolic process |
| GO:0030817 | 0.0022 | 12.9621 | 0.2582 | 3 | 127 | regulation of cAMP biosynthetic process |
| GO:0006040 | 0.0022 | 32.5907 | 0.0691 | 2 | 34 | amino sugar metabolic process |
| GO:0050921 | 0.0022 | 12.8576 | 0.2603 | 3 | 128 | positive regulation of chemotaxis |
| GO:0002521 | 0.0022 | 6.1642 | 0.9373 | 5 | 461 | leukocyte differentiation |
| GO:0043312 | 0.0024 | 6.0819 | 0.9495 | 5 | 467 | neutrophil degranulation |
| GO:0042119 | 0.0026 | 5.9492 | 0.9699 | 5 | 477 | neutrophil activation |
| GO:0045055 | 0.0027 | 4.905 | 1.4396 | 6 | 708 | regulated exocytosis |
| GO:0071675 | 0.0031 | 26.7295 | 0.0834 | 2 | 41 | regulation of mononuclear cell migration |
| GO:0002285 | 0.0037 | 10.6265 | 0.3131 | 3 | 154 | lymphocyte activation involved in immune response |
| GO:0030808 | 0.0038 | 10.4863 | 0.3172 | 3 | 156 | regulation of nucleotide biosynthetic process |
| GO:0052652 | 0.0041 | 10.2827 | 0.3233 | 3 | 159 | cyclic purine nucleotide metabolic process |
| GO:0002337 | 0.0041 | 506.125 | 0.0041 | 1 | 2 | B-1a B cell differentiation |
| GO:0071663 | 0.0041 | 506.125 | 0.0041 | 1 | 2 | positive regulation of granzyme B production |
| GO:1904808 | 0.0041 | 506.125 | 0.0041 | 1 | 2 | positive regulation of protein oxidation |
| GO:0071222 | 0.0044 | 9.9602 | 0.3335 | 3 | 164 | cellular response to lipopolysaccharide |
| GO:0030799 | 0.0048 | 9.6572 | 0.3436 | 3 | 169 | regulation of cyclic nucleotide metabolic process |
| GO:0019220 | 0.0051 | 3.2708 | 3.4057 | 9 | 1675 | regulation of phosphate metabolic process |
| GO:0042330 | 0.0052 | 5.0234 | 1.1407 | 5 | 561 | taxis |
| GO:0046651 | 0.0054 | 19.9812 | 0.1104 | 2 | 59 | lymphocyte proliferation |
| GO:0005975 | 0.0056 | 4.9315 | 1.161 | 5 | 571 | carbohydrate metabolic process |
| GO:0048584 | 0.0056 | 3.0497 | 4.1296 | 10 | 2031 | positive regulation of response to stimulus |
| GO:0050918 | 0.006 | 18.9349 | 0.1159 | 2 | 57 | positive chemotaxis |
| GO:0019262 | 0.0061 | 253.0469 | 0.0061 | 1 | 3 | N-acetylneuraminate catabolic process |
| GO:2000566 | 0.0061 | 253.0469 | 0.0061 | 1 | 3 | positive regulation of CD8-positive, alpha-beta T cell proliferation |
| GO:0048870 | 0.0064 | 3.3559 | 2.8832 | 8 | 1418 | cell motility |
| GO:0048534 | 0.0066 | 4.0576 | 1.7222 | 6 | 847 | hematopoietic or lymphoid organ development |
| GO:0070661 | 0.0067 | 17.7757 | 0.1236 | 2 | 66 | leukocyte proliferation |
| GO:0071216 | 0.0068 | 8.5154 | 0.3884 | 3 | 191 | cellular response to biotic stimulus |
| GO:0043900 | 0.0068 | 5.8838 | 0.7625 | 4 | 375 | regulation of multi-organism process |
| GO:0045670 | 0.0068 | 17.6468 | 0.124 | 2 | 61 | regulation of osteoclast differentiation |
| GO:0050670 | 0.0075 | 8.2062 | 0.4026 | 3 | 198 | regulation of lymphocyte proliferation |
| GO:2000391 | 0.0081 | 168.6875 | 0.0081 | 1 | 4 | positive regulation of neutrophil extravasation |
| GO:0050776 | 0.0086 | 3.822 | 1.8218 | 6 | 896 | regulation of immune response |
| GO:0070663 | 0.0086 | 7.7626 | 0.425 | 3 | 209 | regulation of leukocyte proliferation |
| GO:0036230 | 0.0089 | 145.5648 | 0.0089 | 1 | 5 | granulocyte activation |
| GO:0070167 | 0.0091 | 15.0799 | 0.1444 | 2 | 71 | regulation of biomineral tissue development |
| GO:0042113 | 0.0096 | 7.4687 | 0.4412 | 3 | 217 | B cell activation |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0006955 | 0 | 24.5276 | 0.3512 | 6 | 257 | immune response |
| GO:0070374 | 0 | 17.6159 | 0.4184 | 6 | 194 | positive regulation of ERK1 and ERK2 cascade |
| GO:0007166 | 0 | 4.9136 | 5.6673 | 17 | 2628 | cell surface receptor signaling pathway |
| GO:0006954 | 0 | 8.1477 | 1.4427 | 9 | 669 | inflammatory response |
| GO:0045321 | 0 | 6.2228 | 2.4196 | 11 | 1122 | leukocyte activation |
| GO:0070098 | 0 | 27.3667 | 0.1725 | 4 | 80 | chemokine-mediated signaling pathway |
| GO:0071347 | 0 | 24.1695 | 0.1941 | 4 | 90 | cellular response to interleukin-1 |
| GO:0002322 | 0 | 327.1111 | 0.0108 | 2 | 5 | B cell proliferation involved in immune response |
| GO:0007194 | 1e-04 | 48.8831 | 0.0733 | 3 | 34 | negative regulation of adenylate cyclase activity |
| GO:0002263 | 1e-04 | 7.0634 | 1.4233 | 8 | 660 | cell activation involved in immune response |
| GO:0002548 | 1e-04 | 39.361 | 0.0896 | 3 | 44 | monocyte chemotaxis |
| GO:0031666 | 1e-04 | 163.5253 | 0.0173 | 2 | 8 | positive regulation of lipopolysaccharide-mediated signaling pathway |
| GO:0002687 | 1e-04 | 17.7315 | 0.2609 | 4 | 121 | positive regulation of leukocyte migration |
| GO:0097530 | 1e-04 | 17.5801 | 0.2631 | 4 | 122 | granulocyte migration |
| GO:0030803 | 1e-04 | 33.6458 | 0.1035 | 3 | 48 | negative regulation of cyclic nucleotide biosynthetic process |
| GO:0030815 | 2e-04 | 32.2101 | 0.1078 | 3 | 50 | negative regulation of cAMP metabolic process |
| GO:1900372 | 2e-04 | 31.5371 | 0.11 | 3 | 51 | negative regulation of purine nucleotide biosynthetic process |
| GO:0071346 | 2e-04 | 15.2362 | 0.3019 | 4 | 140 | cellular response to interferon-gamma |
| GO:0060326 | 2e-04 | 10.377 | 0.5628 | 5 | 261 | cell chemotaxis |
| GO:0048247 | 3e-04 | 27.5114 | 0.1251 | 3 | 58 | lymphocyte chemotaxis |
| GO:0045087 | 3e-04 | 5.4851 | 1.8071 | 8 | 838 | innate immune response |
| GO:0045980 | 5e-04 | 21.596 | 0.1574 | 3 | 73 | negative regulation of nucleotide metabolic process |
| GO:0030502 | 5e-04 | 70.0476 | 0.0345 | 2 | 16 | negative regulation of bone mineralization |
| GO:0090026 | 7e-04 | 61.2841 | 0.0388 | 2 | 18 | positive regulation of monocyte chemotaxis |
| GO:0048584 | 7e-04 | 3.6633 | 4.3799 | 12 | 2031 | positive regulation of response to stimulus |
| GO:0002275 | 8e-04 | 6.3247 | 1.1192 | 6 | 519 | myeloid cell activation involved in immune response |
| GO:0002444 | 8e-04 | 6.2867 | 1.1257 | 6 | 522 | myeloid leukocyte mediated immunity |
| GO:0030593 | 9e-04 | 17.7684 | 0.1898 | 3 | 88 | neutrophil chemotaxis |
| GO:0031279 | 0.0011 | 16.5907 | 0.2027 | 3 | 94 | regulation of cyclase activity |
| GO:0051339 | 0.0011 | 16.4093 | 0.2049 | 3 | 95 | regulation of lyase activity |
| GO:0007214 | 0.0011 | 46.6782 | 0.0496 | 2 | 23 | gamma-aminobutyric acid signaling pathway |
| GO:0043900 | 0.0012 | 7.1284 | 0.8087 | 5 | 375 | regulation of multi-organism process |
| GO:0002688 | 0.0015 | 14.6468 | 0.2286 | 3 | 106 | regulation of leukocyte chemotaxis |
| GO:0006049 | 0.0022 | Inf | 0.0022 | 1 | 1 | UDP-N-acetylglucosamine catabolic process |
| GO:0006051 | 0.0022 | Inf | 0.0022 | 1 | 1 | N-acetylmannosamine metabolic process |
| GO:0048006 | 0.0022 | Inf | 0.0022 | 1 | 1 | antigen processing and presentation, endogenous lipid antigen via MHC class Ib |
| GO:0090122 | 0.0022 | Inf | 0.0022 | 1 | 1 | cholesterol ester hydrolysis involved in cholesterol transport |
| GO:0046651 | 0.0022 | 8.1306 | 0.5542 | 4 | 257 | lymphocyte proliferation |
| GO:0009225 | 0.0023 | 31.6012 | 0.0712 | 2 | 33 | nucleotide-sugar metabolic process |
| GO:0006040 | 0.0024 | 30.6117 | 0.0733 | 2 | 34 | amino sugar metabolic process |
| GO:0030817 | 0.0026 | 12.1505 | 0.2739 | 3 | 127 | regulation of cAMP biosynthetic process |
| GO:0050921 | 0.0026 | 12.0525 | 0.276 | 3 | 128 | positive regulation of chemotaxis |
| GO:0050776 | 0.0026 | 4.3043 | 1.9322 | 7 | 896 | regulation of immune response |
| GO:0007186 | 0.0027 | 3.9189 | 2.5024 | 8 | 1229 | G-protein coupled receptor signaling pathway |
| GO:0070661 | 0.0028 | 7.582 | 0.593 | 4 | 275 | leukocyte proliferation |
| GO:0002521 | 0.0029 | 5.7526 | 0.9941 | 5 | 461 | leukocyte differentiation |
| GO:0043312 | 0.0031 | 5.6757 | 1.0071 | 5 | 467 | neutrophil degranulation |
| GO:0043408 | 0.0032 | 4.7278 | 1.4772 | 6 | 685 | regulation of MAPK cascade |
| GO:0042119 | 0.0034 | 5.5519 | 1.0287 | 5 | 477 | neutrophil activation |
| GO:0071675 | 0.0035 | 25.1064 | 0.0884 | 2 | 41 | regulation of mononuclear cell migration |
| GO:0045055 | 0.0037 | 4.5662 | 1.5268 | 6 | 708 | regulated exocytosis |
| GO:0002337 | 0.0043 | 476.2941 | 0.0043 | 1 | 2 | B-1a B cell differentiation |
| GO:1904808 | 0.0043 | 476.2941 | 0.0043 | 1 | 2 | positive regulation of protein oxidation |
| GO:0030808 | 0.0046 | 9.8297 | 0.3364 | 3 | 156 | regulation of nucleotide biosynthetic process |
| GO:0052652 | 0.0048 | 9.6388 | 0.3429 | 3 | 159 | cyclic purine nucleotide metabolic process |
| GO:0071222 | 0.0052 | 9.3366 | 0.3537 | 3 | 164 | cellular response to lipopolysaccharide |
| GO:0010647 | 0.0054 | 3.2042 | 3.4245 | 9 | 1588 | positive regulation of cell communication |
| GO:0023056 | 0.0055 | 3.1907 | 3.4375 | 9 | 1594 | positive regulation of signaling |
| GO:0030799 | 0.0057 | 9.0525 | 0.3644 | 3 | 169 | regulation of cyclic nucleotide metabolic process |
| GO:0019262 | 0.0065 | 238.1324 | 0.0065 | 1 | 3 | N-acetylneuraminate catabolic process |
| GO:0042330 | 0.0067 | 4.6879 | 1.2098 | 5 | 561 | taxis |
| GO:0050918 | 0.0067 | 17.7851 | 0.1229 | 2 | 57 | positive chemotaxis |
| GO:0045670 | 0.0076 | 16.5752 | 0.1315 | 2 | 61 | regulation of osteoclast differentiation |
| GO:0019220 | 0.0077 | 3.0188 | 3.6121 | 9 | 1675 | regulation of phosphate metabolic process |
| GO:0032940 | 0.0077 | 3.214 | 2.9652 | 8 | 1375 | secretion by cell |
| GO:0071216 | 0.008 | 7.9822 | 0.4119 | 3 | 191 | cellular response to biotic stimulus |
| GO:0002925 | 0.0086 | 158.7451 | 0.0086 | 1 | 4 | positive regulation of humoral immune response mediated by circulating immunoglobulin |
| GO:2000391 | 0.0086 | 158.7451 | 0.0086 | 1 | 4 | positive regulation of neutrophil extravasation |
| GO:0048534 | 0.0088 | 3.7773 | 1.8266 | 6 | 847 | hematopoietic or lymphoid organ development |
| GO:0036230 | 0.0095 | 135.5086 | 0.0095 | 1 | 5 | granulocyte activation |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0015728 | 7e-04 | Inf | 7e-04 | 1 | 1 | mevalonate transport |
| GO:0051780 | 7e-04 | Inf | 7e-04 | 1 | 1 | behavioral response to nutrient |
| GO:1904155 | 7e-04 | Inf | 7e-04 | 1 | 1 | DN2 thymocyte differentiation |
| GO:1904156 | 7e-04 | Inf | 7e-04 | 1 | 1 | DN3 thymocyte differentiation |
| GO:0021553 | 0.0022 | 737.0909 | 0.0022 | 1 | 3 | olfactory nerve development |
| GO:0035879 | 0.0022 | 737.0909 | 0.0022 | 1 | 3 | plasma membrane lactate transport |
| GO:0048388 | 0.0022 | 737.0909 | 0.0022 | 1 | 3 | endosomal lumen acidification |
| GO:0061368 | 0.0022 | 737.0909 | 0.0022 | 1 | 3 | behavioral response to formalin induced pain |
| GO:0050900 | 0.0029 | 13.0811 | 0.3002 | 3 | 406 | leukocyte migration |
| GO:0030644 | 0.003 | 491.3636 | 0.003 | 1 | 4 | cellular chloride ion homeostasis |
| GO:0046666 | 0.003 | 491.3636 | 0.003 | 1 | 4 | retinal cell programmed cell death |
| GO:0060474 | 0.003 | 491.3636 | 0.003 | 1 | 4 | positive regulation of flagellated sperm motility involved in capacitation |
| GO:0060385 | 0.0037 | 368.5 | 0.0037 | 1 | 5 | axonogenesis involved in innervation |
| GO:0072679 | 0.0037 | 368.5 | 0.0037 | 1 | 5 | thymocyte migration |
| GO:0042110 | 0.0038 | 11.815 | 0.3312 | 3 | 448 | T cell activation |
| GO:0015727 | 0.0044 | 294.7818 | 0.0044 | 1 | 6 | lactate transport |
| GO:0051599 | 0.0044 | 294.7818 | 0.0044 | 1 | 6 | response to hydrostatic pressure |
| GO:0097527 | 0.0044 | 294.7818 | 0.0044 | 1 | 6 | necroptotic signaling pathway |
| GO:0048290 | 0.0052 | 245.6364 | 0.0052 | 1 | 7 | isotype switching to IgA isotypes |
| GO:0002285 | 0.0055 | 21.1395 | 0.1139 | 2 | 154 | lymphocyte activation involved in immune response |
| GO:0050954 | 0.0058 | 20.7265 | 0.1161 | 2 | 157 | sensory perception of mechanical stimulus |
| GO:0002291 | 0.0059 | 210.5325 | 0.0059 | 1 | 8 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell |
| GO:0038180 | 0.0059 | 210.5325 | 0.0059 | 1 | 8 | nerve growth factor signaling pathway |
| GO:0071316 | 0.0059 | 210.5325 | 0.0059 | 1 | 8 | cellular response to nicotine |
| GO:0010623 | 0.0061 | 202.5875 | 0.0061 | 1 | 9 | programmed cell death involved in cell development |
| GO:2000510 | 0.0066 | 184.2045 | 0.0067 | 1 | 9 | positive regulation of dendritic cell chemotaxis |
| GO:0045321 | 0.0072 | 6.7531 | 0.8296 | 4 | 1122 | leukocyte activation |
| GO:0045078 | 0.0074 | 163.7273 | 0.0074 | 1 | 10 | positive regulation of interferon-gamma biosynthetic process |
| GO:0050966 | 0.0074 | 163.7273 | 0.0074 | 1 | 10 | detection of mechanical stimulus involved in sensory perception of pain |
| GO:0006955 | 0.0076 | 5.5611 | 1.3686 | 5 | 1851 | immune response |
| GO:0043523 | 0.0081 | 17.333 | 0.1383 | 2 | 187 | regulation of neuron apoptotic process |
| GO:0030002 | 0.0096 | 122.7727 | 0.0096 | 1 | 13 | cellular anion homeostasis |
| GO:0048266 | 0.0096 | 122.7727 | 0.0096 | 1 | 13 | behavioral response to pain |
| GO:0060009 | 0.0096 | 122.7727 | 0.0096 | 1 | 13 | Sertoli cell development |
| GO:0097296 | 0.0096 | 122.7727 | 0.0096 | 1 | 13 | activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0032078 | 0.001 | Inf | 0.001 | 1 | 1 | negative regulation of endodeoxyribonuclease activity |
| GO:1900758 | 0.001 | Inf | 0.001 | 1 | 1 | negative regulation of D-amino-acid oxidase activity |
| GO:0048247 | 0.0016 | 38.469 | 0.0608 | 2 | 58 | lymphocyte chemotaxis |
| GO:0002548 | 0.0019 | 35.8956 | 0.0649 | 2 | 62 | monocyte chemotaxis |
| GO:0019075 | 0.0021 | 1013.25 | 0.0021 | 1 | 2 | virus maturation |
| GO:0007032 | 0.0023 | 32.4748 | 0.072 | 2 | 73 | endosome organization |
| GO:0070098 | 0.0031 | 27.5812 | 0.0838 | 2 | 80 | chemokine-mediated signaling pathway |
| GO:0048388 | 0.0031 | 506.5938 | 0.0031 | 1 | 3 | endosomal lumen acidification |
| GO:1900005 | 0.0031 | 506.5938 | 0.0031 | 1 | 3 | positive regulation of serine-type endopeptidase activity |
| GO:1901318 | 0.0031 | 506.5938 | 0.0031 | 1 | 3 | negative regulation of flagellated sperm motility |
| GO:0051341 | 0.0033 | 26.8883 | 0.0859 | 2 | 82 | regulation of oxidoreductase activity |
| GO:0042058 | 0.0035 | 25.9116 | 0.089 | 2 | 85 | regulation of epidermal growth factor receptor signaling pathway |
| GO:0030593 | 0.0037 | 25.0031 | 0.0922 | 2 | 88 | neutrophil chemotaxis |
| GO:0071347 | 0.0039 | 24.4318 | 0.0943 | 2 | 90 | cellular response to interleukin-1 |
| GO:0030644 | 0.0042 | 337.7083 | 0.0042 | 1 | 4 | cellular chloride ion homeostasis |
| GO:0046666 | 0.0042 | 337.7083 | 0.0042 | 1 | 4 | retinal cell programmed cell death |
| GO:2001237 | 0.0047 | 22.1526 | 0.1037 | 2 | 99 | negative regulation of extrinsic apoptotic signaling pathway |
| GO:1903772 | 0.0052 | 253.2656 | 0.0052 | 1 | 5 | regulation of viral budding via host ESCRT complex |
| GO:0051345 | 0.0055 | 6.7483 | 0.7447 | 4 | 711 | positive regulation of hydrolase activity |
| GO:0097527 | 0.0063 | 202.6 | 0.0063 | 1 | 6 | necroptotic signaling pathway |
| GO:0097530 | 0.0071 | 17.8811 | 0.1278 | 2 | 122 | granulocyte migration |
| GO:0032074 | 0.0073 | 168.8229 | 0.0073 | 1 | 7 | negative regulation of nuclease activity |
| GO:0071346 | 0.0092 | 15.5314 | 0.1466 | 2 | 140 | cellular response to interferon-gamma |
| GO:0090281 | 0.0094 | 126.6016 | 0.0094 | 1 | 9 | negative regulation of calcium ion import |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0000413 | 0 | 60.2571 | 0.0609 | 3 | 38 | protein peptidyl-prolyl isomerization |
| GO:1904240 | 0.0016 | Inf | 0.0016 | 1 | 1 | negative regulation of VCP-NPL4-UFD1 AAA ATPase complex assembly |
| GO:0038195 | 0.0032 | 648.12 | 0.0032 | 1 | 2 | urokinase plasminogen activator signaling pathway |
| GO:1903070 | 0.0048 | 324.04 | 0.0048 | 1 | 3 | negative regulation of ER-associated ubiquitin-dependent protein catabolic process |
| GO:0006457 | 0.0051 | 9.5648 | 0.354 | 3 | 221 | protein folding |
| GO:1903061 | 0.0064 | 216.0133 | 0.0064 | 1 | 4 | positive regulation of protein lipidation |
| GO:0042985 | 0.008 | 162 | 0.008 | 1 | 5 | negative regulation of amyloid precursor protein biosynthetic process |
| GO:2001268 | 0.008 | 162 | 0.008 | 1 | 5 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway |
| GO:1901570 | 0.0083 | 15.9921 | 0.1378 | 2 | 86 | fatty acid derivative biosynthetic process |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0016810 | 9e-04 | 18.4771 | 0.1902 | 3 | 140 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds |
| GO:0061135 | 0.0015 | 15.2216 | 0.2296 | 3 | 169 | endopeptidase regulator activity |
| GO:0030414 | 0.0015 | 15.0385 | 0.2324 | 3 | 171 | peptidase inhibitor activity |
| GO:0004869 | 0.0026 | 29.8426 | 0.0761 | 2 | 56 | cysteine-type endopeptidase inhibitor activity |
| GO:0004053 | 0.0027 | 769.9048 | 0.0027 | 1 | 2 | arginase activity |
| GO:0004991 | 0.0027 | 769.9048 | 0.0027 | 1 | 2 | parathyroid hormone receptor activity |
| GO:0047844 | 0.0041 | 384.9286 | 0.0041 | 1 | 3 | deoxycytidine deaminase activity |
| GO:0008745 | 0.0054 | 256.6032 | 0.0054 | 1 | 4 | N-acetylmuramoyl-L-alanine amidase activity |
| GO:0004459 | 0.0068 | 192.4405 | 0.0068 | 1 | 5 | L-lactate dehydrogenase activity |
| GO:0016019 | 0.0068 | 192.4405 | 0.0068 | 1 | 5 | peptidoglycan receptor activity |
| GO:0042289 | 0.0081 | 153.9429 | 0.0082 | 1 | 6 | MHC class II protein binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0016810 | 0.0011 | 16.7153 | 0.2075 | 3 | 140 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds |
| GO:0061135 | 0.0019 | 13.7702 | 0.2505 | 3 | 169 | endopeptidase regulator activity |
| GO:0030414 | 0.002 | 13.6046 | 0.2535 | 3 | 171 | peptidase inhibitor activity |
| GO:0004053 | 0.003 | 702.8696 | 0.003 | 1 | 2 | arginase activity |
| GO:0004991 | 0.003 | 702.8696 | 0.003 | 1 | 2 | parathyroid hormone receptor activity |
| GO:0004869 | 0.0031 | 27.1263 | 0.083 | 2 | 56 | cysteine-type endopeptidase inhibitor activity |
| GO:0047844 | 0.0044 | 351.413 | 0.0044 | 1 | 3 | deoxycytidine deaminase activity |
| GO:0008745 | 0.0059 | 234.2609 | 0.0059 | 1 | 4 | N-acetylmuramoyl-L-alanine amidase activity |
| GO:0004459 | 0.0074 | 175.6848 | 0.0074 | 1 | 5 | L-lactate dehydrogenase activity |
| GO:0016019 | 0.0074 | 175.6848 | 0.0074 | 1 | 5 | peptidoglycan receptor activity |
| GO:0042289 | 0.0089 | 140.5391 | 0.0089 | 1 | 6 | MHC class II protein binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0003727 | 3e-04 | 25.18 | 0.1371 | 3 | 74 | single-stranded RNA binding |
| GO:0000334 | 0.0019 | Inf | 0.0019 | 1 | 1 | 3-hydroxyanthranilate 3,4-dioxygenase activity |
| GO:0016504 | 0.002 | 33.8803 | 0.0667 | 2 | 36 | peptidase activator activity |
| GO:0008134 | 0.0021 | 6.2904 | 0.932 | 5 | 503 | transcription factor binding |
| GO:0000253 | 0.0074 | 185.7241 | 0.0074 | 1 | 4 | 3-keto sterol reductase activity |
| GO:0044323 | 0.0074 | 185.7241 | 0.0074 | 1 | 4 | retinoic acid-responsive element binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0003727 | 0.0058 | 19.4372 | 0.1143 | 2 | 74 | single-stranded RNA binding |
| GO:0044323 | 0.0062 | 224.4861 | 0.0062 | 1 | 4 | retinoic acid-responsive element binding |
| GO:0008047 | 0.0065 | 6.1065 | 0.7612 | 4 | 493 | enzyme activator activity |
| GO:0004111 | 0.0092 | 134.675 | 0.0093 | 1 | 6 | creatine kinase activity |
| GO:0004308 | 0.0092 | 134.675 | 0.0093 | 1 | 6 | exo-alpha-sialidase activity |
| GO:0061133 | 0.0092 | 134.675 | 0.0093 | 1 | 6 | endopeptidase activator activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0005102 | 2e-04 | 12.2553 | 0.9844 | 6 | 1449 | receptor binding |
| GO:0004872 | 2e-04 | 11.8924 | 1.0116 | 6 | 1489 | receptor activity |
| GO:0004888 | 6e-04 | 10.6909 | 0.7983 | 5 | 1175 | transmembrane signaling receptor activity |
| GO:0005129 | 7e-04 | Inf | 7e-04 | 1 | 1 | granulocyte macrophage colony-stimulating factor receptor binding |
| GO:0010465 | 0.0014 | 1617.9 | 0.0014 | 1 | 2 | nerve growth factor receptor activity |
| GO:0004971 | 0.002 | 808.9 | 0.002 | 1 | 3 | AMPA glutamate receptor activity |
| GO:0005166 | 0.002 | 808.9 | 0.002 | 1 | 3 | neurotrophin p75 receptor binding |
| GO:0099583 | 0.002 | 808.9 | 0.002 | 1 | 3 | neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration |
| GO:0004871 | 0.0025 | 7.7004 | 1.0768 | 5 | 1585 | signal transducer activity |
| GO:0048406 | 0.0041 | 323.5 | 0.0041 | 1 | 6 | nerve growth factor binding |
| GO:0005004 | 0.0047 | 269.5667 | 0.0048 | 1 | 7 | GPI-linked ephrin receptor activity |
| GO:0004713 | 0.0059 | 20.6822 | 0.1182 | 2 | 174 | protein tyrosine kinase activity |
| GO:0019957 | 0.0061 | 202.15 | 0.0061 | 1 | 9 | C-C chemokine binding |
| GO:0016493 | 0.0081 | 146.9909 | 0.0082 | 1 | 12 | C-C chemokine receptor activity |
| GO:0005125 | 0.009 | 16.5794 | 0.1467 | 2 | 216 | cytokine activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0000979 | 1e-04 | 39.6522 | 0.0899 | 3 | 56 | RNA polymerase II core promoter sequence-specific DNA binding |
| GO:0001047 | 0.0021 | 13.2144 | 0.2585 | 3 | 161 | core promoter binding |
| GO:0001012 | 0.0022 | 6.3187 | 0.9507 | 5 | 592 | RNA polymerase II regulatory region DNA binding |
| GO:0000976 | 0.0038 | 5.5496 | 1.0759 | 5 | 670 | transcription regulatory region sequence-specific DNA binding |
| GO:0043565 | 0.0042 | 4.5985 | 1.5994 | 6 | 996 | sequence-specific DNA binding |
| GO:0000981 | 0.0057 | 5.0342 | 1.1803 | 5 | 735 | RNA polymerase II transcription factor activity, sequence-specific DNA binding |
| GO:0010385 | 0.0064 | 215.4933 | 0.0064 | 1 | 4 | double-stranded methylated DNA binding |
| GO:0044323 | 0.0064 | 215.4933 | 0.0064 | 1 | 4 | retinoic acid-responsive element binding |
| GO:0008270 | 0.0068 | 4.8128 | 1.2317 | 5 | 767 | zinc ion binding |
| GO:0000975 | 0.0088 | 4.5018 | 1.312 | 5 | 817 | regulatory region DNA binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0008502 | 0 | Inf | 0.0042 | 2 | 2 | melatonin receptor activity |
| GO:0008843 | 0.0021 | Inf | 0.0021 | 1 | 1 | endochitinase activity |
| GO:0033798 | 0.0021 | Inf | 0.0021 | 1 | 1 | thyroxine 5-deiodinase activity |
| GO:0015459 | 0.0042 | 22.8878 | 0.0966 | 2 | 46 | potassium channel regulator activity |
| GO:0036461 | 0.0042 | 489.5758 | 0.0042 | 1 | 2 | BLOC-2 complex binding |
| GO:0042284 | 0.0042 | 489.5758 | 0.0042 | 1 | 2 | sphingolipid delta-4 desaturase activity |
| GO:0004800 | 0.0063 | 244.7727 | 0.0063 | 1 | 3 | thyroxine 5'-deiodinase activity |
| GO:0035651 | 0.0063 | 244.7727 | 0.0063 | 1 | 3 | AP-3 adaptor complex binding |
| GO:0035650 | 0.0084 | 163.1717 | 0.0084 | 1 | 4 | AP-1 adaptor complex binding |
| GO:0008236 | 0.0088 | 7.6822 | 0.4284 | 3 | 204 | serine-type peptidase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0032394 | 0 | Inf | 0.0031 | 2 | 2 | MHC class Ib receptor activity |
| GO:0042288 | 0 | 146.8273 | 0.0278 | 3 | 18 | MHC class I protein binding |
| GO:0048020 | 0.0016 | 37.906 | 0.0602 | 2 | 39 | CCR chemokine receptor binding |
| GO:0008009 | 0.0025 | 30.4726 | 0.0741 | 2 | 48 | chemokine activity |
| GO:0004252 | 0.0025 | 12.5329 | 0.2733 | 3 | 177 | serine-type endopeptidase activity |
| GO:0005171 | 0.0031 | 673.5417 | 0.0031 | 1 | 2 | hepatocyte growth factor receptor binding |
| GO:0046556 | 0.0031 | 673.5417 | 0.0031 | 1 | 2 | alpha-L-arabinofuranosidase activity |
| GO:0017171 | 0.004 | 10.5649 | 0.3227 | 3 | 209 | serine hydrolase activity |
| GO:0004663 | 0.0046 | 336.75 | 0.0046 | 1 | 3 | Rab geranylgeranyltransferase activity |
| GO:0030246 | 0.0073 | 8.4413 | 0.4015 | 3 | 260 | carbohydrate binding |
| GO:0004046 | 0.0077 | 168.3542 | 0.0077 | 1 | 5 | aminoacylase activity |
| GO:0005096 | 0.008 | 8.12 | 0.4169 | 3 | 270 | GTPase activator activity |
| GO:0008318 | 0.0092 | 134.675 | 0.0093 | 1 | 6 | protein prenyltransferase activity |
| GO:0016427 | 0.0092 | 134.675 | 0.0093 | 1 | 6 | tRNA (cytosine) methyltransferase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004744 | 0.0016 | Inf | 0.0016 | 1 | 1 | retinal isomerase activity |
| GO:0036487 | 0.0016 | Inf | 0.0016 | 1 | 1 | nitric-oxide synthase inhibitor activity |
| GO:0052884 | 0.0016 | Inf | 0.0016 | 1 | 1 | all-trans-retinyl-palmitate hydrolase, 11-cis retinol forming activity |
| GO:0052885 | 0.0016 | Inf | 0.0016 | 1 | 1 | all-trans-retinyl-ester hydrolase, 11-cis retinol forming activity |
| GO:0046976 | 0.008 | 161.61 | 0.008 | 1 | 5 | histone methyltransferase activity (H3-K27 specific) |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004667 | 0.0031 | 673.5417 | 0.0031 | 1 | 2 | prostaglandin-D synthase activity |
| GO:0004947 | 0.0031 | 673.5417 | 0.0031 | 1 | 2 | bradykinin receptor activity |
| GO:0045029 | 0.0031 | 673.5417 | 0.0031 | 1 | 2 | UDP-activated nucleotide receptor activity |
| GO:0071553 | 0.0031 | 673.5417 | 0.0031 | 1 | 2 | G-protein coupled pyrimidinergic nucleotide receptor activity |
| GO:0004165 | 0.0046 | 336.75 | 0.0046 | 1 | 3 | dodecenoyl-CoA delta-isomerase activity |
| GO:0016508 | 0.0046 | 336.75 | 0.0046 | 1 | 3 | long-chain-enoyl-CoA hydratase activity |
| GO:0032947 | 0.005 | 20.8942 | 0.1065 | 2 | 69 | protein complex scaffold activity |
| GO:0035594 | 0.0062 | 224.4861 | 0.0062 | 1 | 4 | ganglioside binding |
| GO:0051425 | 0.0062 | 224.4861 | 0.0062 | 1 | 4 | PTB domain binding |
| GO:0019534 | 0.0077 | 168.3542 | 0.0077 | 1 | 5 | toxin transmembrane transporter activity |
| GO:0016427 | 0.0092 | 134.675 | 0.0093 | 1 | 6 | tRNA (cytosine) methyltransferase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0032089 | 0.003 | 702.8696 | 0.003 | 1 | 2 | NACHT domain binding |
| GO:0051425 | 0.0059 | 234.2609 | 0.0059 | 1 | 4 | PTB domain binding |
| GO:0016427 | 0.0089 | 140.5391 | 0.0089 | 1 | 6 | tRNA (cytosine) methyltransferase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0005509 | 0.0011 | 5.9372 | 1.221 | 6 | 659 | calcium ion binding |
| GO:0004693 | 0.0014 | 41.1556 | 0.0556 | 2 | 30 | cyclin-dependent protein serine/threonine kinase activity |
| GO:0046523 | 0.0019 | Inf | 0.0019 | 1 | 1 | S-methyl-5-thioribose-1-phosphate isomerase activity |
| GO:0030354 | 0.0037 | 557.2414 | 0.0037 | 1 | 2 | melanin-concentrating hormone activity |
| GO:0004980 | 0.0055 | 278.6034 | 0.0056 | 1 | 3 | melanocyte-stimulating hormone receptor activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0008009 | 1e-04 | 41.3256 | 0.086 | 3 | 48 | chemokine activity |
| GO:0004872 | 2e-04 | 5.2251 | 2.667 | 10 | 1489 | receptor activity |
| GO:0004435 | 0.0011 | 47.8133 | 0.0484 | 2 | 27 | phosphatidylinositol phospholipase C activity |
| GO:0005126 | 0.0012 | 9.8242 | 0.4711 | 4 | 263 | cytokine receptor binding |
| GO:0048020 | 0.0016 | 38.7644 | 0.0588 | 2 | 34 | CCR chemokine receptor binding |
| GO:0003827 | 0.0018 | Inf | 0.0018 | 1 | 1 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity |
| GO:0035717 | 0.0018 | Inf | 0.0018 | 1 | 1 | chemokine (C-C motif) ligand 7 binding |
| GO:0045127 | 0.0018 | Inf | 0.0018 | 1 | 1 | N-acetylglucosamine kinase activity |
| GO:0071791 | 0.0036 | 577.1786 | 0.0036 | 1 | 2 | chemokine (C-C motif) ligand 5 binding |
| GO:0001730 | 0.0054 | 288.5714 | 0.0054 | 1 | 3 | 2'-5'-oligoadenylate synthetase activity |
| GO:0004965 | 0.0054 | 288.5714 | 0.0054 | 1 | 3 | G-protein coupled GABA receptor activity |
| GO:0005124 | 0.0054 | 288.5714 | 0.0054 | 1 | 3 | scavenger receptor binding |
| GO:0047374 | 0.0054 | 288.5714 | 0.0054 | 1 | 3 | methylumbelliferyl-acetate deacetylase activity |
| GO:0004698 | 0.0071 | 192.369 | 0.0072 | 1 | 4 | calcium-dependent protein kinase C activity |
| GO:0004771 | 0.0071 | 192.369 | 0.0072 | 1 | 4 | sterol esterase activity |
| GO:0004982 | 0.0071 | 192.369 | 0.0072 | 1 | 4 | N-formyl peptide receptor activity |
| GO:0048018 | 0.0078 | 5.7038 | 0.797 | 4 | 445 | receptor ligand activity |
| GO:0030883 | 0.0089 | 144.2679 | 0.009 | 1 | 5 | endogenous lipid antigen binding |
| GO:0030884 | 0.0089 | 144.2679 | 0.009 | 1 | 5 | exogenous lipid antigen binding |
| GO:0031726 | 0.0089 | 144.2679 | 0.009 | 1 | 5 | CCR1 chemokine receptor binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004872 | 1e-04 | 5.4635 | 2.8509 | 11 | 1489 | receptor activity |
| GO:0008009 | 1e-04 | 38.369 | 0.0919 | 3 | 48 | chemokine activity |
| GO:0004435 | 0.0012 | 44.5103 | 0.0517 | 2 | 27 | phosphatidylinositol phospholipase C activity |
| GO:0030246 | 0.0015 | 9.2037 | 0.4978 | 4 | 260 | carbohydrate binding |
| GO:0005126 | 0.0015 | 9.0954 | 0.5036 | 4 | 263 | cytokine receptor binding |
| GO:0048020 | 0.0018 | 35.9911 | 0.063 | 2 | 34 | CCR chemokine receptor binding |
| GO:0003827 | 0.0019 | Inf | 0.0019 | 1 | 1 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity |
| GO:0035717 | 0.0019 | Inf | 0.0019 | 1 | 1 | chemokine (C-C motif) ligand 7 binding |
| GO:0045127 | 0.0019 | Inf | 0.0019 | 1 | 1 | N-acetylglucosamine kinase activity |
| GO:0004871 | 0.0022 | 3.7856 | 3.0347 | 9 | 1585 | signal transducer activity |
| GO:0071791 | 0.0038 | 538.6333 | 0.0038 | 1 | 2 | chemokine (C-C motif) ligand 5 binding |
| GO:0001730 | 0.0057 | 269.3 | 0.0057 | 1 | 3 | 2'-5'-oligoadenylate synthetase activity |
| GO:0004965 | 0.0057 | 269.3 | 0.0057 | 1 | 3 | G-protein coupled GABA receptor activity |
| GO:0005124 | 0.0057 | 269.3 | 0.0057 | 1 | 3 | scavenger receptor binding |
| GO:0047374 | 0.0057 | 269.3 | 0.0057 | 1 | 3 | methylumbelliferyl-acetate deacetylase activity |
| GO:0004888 | 0.0058 | 3.7437 | 2.2497 | 7 | 1175 | transmembrane signaling receptor activity |
| GO:0004698 | 0.0076 | 179.5222 | 0.0077 | 1 | 4 | calcium-dependent protein kinase C activity |
| GO:0004771 | 0.0076 | 179.5222 | 0.0077 | 1 | 4 | sterol esterase activity |
| GO:0004982 | 0.0076 | 179.5222 | 0.0077 | 1 | 4 | N-formyl peptide receptor activity |
| GO:0019863 | 0.0095 | 134.6333 | 0.0096 | 1 | 5 | IgE binding |
| GO:0030883 | 0.0095 | 134.6333 | 0.0096 | 1 | 5 | endogenous lipid antigen binding |
| GO:0030884 | 0.0095 | 134.6333 | 0.0096 | 1 | 5 | exogenous lipid antigen binding |
| GO:0031726 | 0.0095 | 134.6333 | 0.0096 | 1 | 5 | CCR1 chemokine receptor binding |
| GO:0048018 | 0.0098 | 5.2806 | 0.852 | 4 | 445 | receptor ligand activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0008009 | 1e-04 | 44.775 | 0.08 | 3 | 48 | chemokine activity |
| GO:0008061 | 1e-04 | 215.44 | 0.0133 | 2 | 8 | chitin binding |
| GO:0001664 | 8e-04 | 10.8935 | 0.4302 | 4 | 258 | G-protein coupled receptor binding |
| GO:0048020 | 8e-04 | 53.9431 | 0.0433 | 2 | 28 | CCR chemokine receptor binding |
| GO:0005126 | 9e-04 | 10.6799 | 0.4386 | 4 | 263 | cytokine receptor binding |
| GO:0008843 | 0.0017 | Inf | 0.0017 | 1 | 1 | endochitinase activity |
| GO:0036470 | 0.0017 | Inf | 0.0017 | 1 | 1 | tyrosine 3-monooxygenase activator activity |
| GO:0036478 | 0.0017 | Inf | 0.0017 | 1 | 1 | L-dopa decarboxylase activator activity |
| GO:0036524 | 0.0017 | Inf | 0.0017 | 1 | 1 | protein deglycase activity |
| GO:0045340 | 0.0017 | Inf | 0.0017 | 1 | 1 | mercury ion binding |
| GO:0016532 | 0.0033 | 621.6538 | 0.0033 | 1 | 2 | superoxide dismutase copper chaperone activity |
| GO:0031731 | 0.005 | 310.8077 | 0.005 | 1 | 3 | CCR6 chemokine receptor binding |
| GO:0047894 | 0.005 | 310.8077 | 0.005 | 1 | 3 | flavonol 3-sulfotransferase activity |
| GO:1903135 | 0.005 | 310.8077 | 0.005 | 1 | 3 | cupric ion binding |
| GO:0004568 | 0.0064 | 215.48 | 0.0064 | 1 | 4 | chitinase activity |
| GO:0004583 | 0.0067 | 207.1923 | 0.0067 | 1 | 4 | dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity |
| GO:0004698 | 0.0067 | 207.1923 | 0.0067 | 1 | 4 | calcium-dependent protein kinase C activity |
| GO:0050294 | 0.0067 | 207.1923 | 0.0067 | 1 | 4 | steroid sulfotransferase activity |
| GO:0016530 | 0.0083 | 155.3846 | 0.0083 | 1 | 5 | metallochaperone activity |
| GO:0031726 | 0.0083 | 155.3846 | 0.0083 | 1 | 5 | CCR1 chemokine receptor binding |
| GO:0032184 | 0.0083 | 155.3846 | 0.0083 | 1 | 5 | SUMO polymer binding |
| GO:0044388 | 0.0083 | 155.3846 | 0.0083 | 1 | 5 | small protein activating enzyme binding |
| GO:1903136 | 0.0083 | 155.3846 | 0.0083 | 1 | 5 | cuprous ion binding |
| GO:0031730 | 0.01 | 124.3 | 0.01 | 1 | 6 | CCR5 chemokine receptor binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0036470 | 0.0014 | Inf | 0.0014 | 1 | 1 | tyrosine 3-monooxygenase activator activity |
| GO:0036478 | 0.0014 | Inf | 0.0014 | 1 | 1 | L-dopa decarboxylase activator activity |
| GO:0036524 | 0.0014 | Inf | 0.0014 | 1 | 1 | protein deglycase activity |
| GO:0045340 | 0.0014 | Inf | 0.0014 | 1 | 1 | mercury ion binding |
| GO:0016532 | 0.0028 | 734.8636 | 0.0028 | 1 | 2 | superoxide dismutase copper chaperone activity |
| GO:1903135 | 0.0043 | 367.4091 | 0.0043 | 1 | 3 | cupric ion binding |
| GO:0004583 | 0.0057 | 244.9242 | 0.0057 | 1 | 4 | dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity |
| GO:0016530 | 0.0071 | 183.6818 | 0.0071 | 1 | 5 | metallochaperone activity |
| GO:0044388 | 0.0071 | 183.6818 | 0.0071 | 1 | 5 | small protein activating enzyme binding |
| GO:1903136 | 0.0071 | 183.6818 | 0.0071 | 1 | 5 | cuprous ion binding |
| GO:0051920 | 0.0099 | 122.4394 | 0.0099 | 1 | 7 | peroxiredoxin activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0001637 | 1e-04 | 140.487 | 0.0185 | 2 | 25 | G-protein coupled chemoattractant receptor activity |
| GO:0070095 | 0.0015 | 1470.7273 | 0.0015 | 1 | 2 | fructose-6-phosphate binding |
| GO:0071791 | 0.0015 | 1470.7273 | 0.0015 | 1 | 2 | chemokine (C-C motif) ligand 5 binding |
| GO:0004896 | 0.0017 | 39.7481 | 0.0615 | 2 | 83 | cytokine receptor activity |
| GO:0031781 | 0.003 | 490.1818 | 0.003 | 1 | 4 | type 3 melanocortin receptor binding |
| GO:0031782 | 0.003 | 490.1818 | 0.003 | 1 | 4 | type 4 melanocortin receptor binding |
| GO:0001653 | 0.0036 | 26.5421 | 0.0912 | 2 | 123 | peptide receptor activity |
| GO:0016494 | 0.0052 | 245.0455 | 0.0052 | 1 | 7 | C-X-C chemokine receptor activity |
| GO:0030215 | 0.0074 | 163.3333 | 0.0074 | 1 | 10 | semaphorin receptor binding |
| GO:0016493 | 0.0089 | 133.6198 | 0.0089 | 1 | 12 | C-C chemokine receptor activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0015130 | 7e-04 | Inf | 7e-04 | 1 | 1 | mevalonate transmembrane transporter activity |
| GO:0010465 | 0.0015 | 1470.7273 | 0.0015 | 1 | 2 | nerve growth factor receptor activity |
| GO:0045523 | 0.0015 | 1470.7273 | 0.0015 | 1 | 2 | interleukin-27 receptor binding |
| GO:0004896 | 0.0017 | 39.7481 | 0.0615 | 2 | 83 | cytokine receptor activity |
| GO:0005166 | 0.0022 | 735.3182 | 0.0022 | 1 | 3 | neurotrophin p75 receptor binding |
| GO:0030369 | 0.0022 | 735.3182 | 0.0022 | 1 | 3 | ICAM-3 receptor activity |
| GO:0015129 | 0.0037 | 367.6136 | 0.0037 | 1 | 5 | lactate transmembrane transporter activity |
| GO:0048406 | 0.0044 | 294.0727 | 0.0044 | 1 | 6 | nerve growth factor binding |
| GO:0005004 | 0.0052 | 245.0455 | 0.0052 | 1 | 7 | GPI-linked ephrin receptor activity |
| GO:0004065 | 0.0059 | 210.026 | 0.0059 | 1 | 8 | arylsulfatase activity |
| GO:0019957 | 0.0067 | 183.7614 | 0.0067 | 1 | 9 | C-C chemokine binding |
| GO:0016493 | 0.0089 | 133.6198 | 0.0089 | 1 | 12 | C-C chemokine receptor activity |
| GO:0099600 | 0.0097 | 6.158 | 0.9035 | 4 | 1219 | transmembrane receptor activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0001227 | 4e-04 | 12.9011 | 0.3652 | 4 | 219 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding |
| GO:0005307 | 0.0017 | Inf | 0.0017 | 1 | 1 | choline:sodium symporter activity |
| GO:0036313 | 0.0033 | 621.6538 | 0.0033 | 1 | 2 | phosphatidylinositol 3-kinase catalytic subunit binding |
| GO:0033829 | 0.005 | 310.8077 | 0.005 | 1 | 3 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity |
| GO:0004095 | 0.0067 | 207.1923 | 0.0067 | 1 | 4 | carnitine O-palmitoyltransferase activity |
| GO:0033265 | 0.0067 | 207.1923 | 0.0067 | 1 | 4 | choline binding |
| GO:0008013 | 0.0067 | 17.88 | 0.1234 | 2 | 74 | beta-catenin binding |
| GO:0005134 | 0.0083 | 155.3846 | 0.0083 | 1 | 5 | interleukin-2 receptor binding |
| GO:0001158 | 0.0094 | 14.9563 | 0.1467 | 2 | 88 | enhancer sequence-specific DNA binding |
| NA. |
| n/a |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0048020 | 5e-04 | 72.7027 | 0.0337 | 2 | 39 | CCR chemokine receptor binding |
| GO:0008009 | 8e-04 | 58.4457 | 0.0415 | 2 | 48 | chemokine activity |
| GO:0005126 | 0.0014 | 16.6962 | 0.2274 | 3 | 263 | cytokine receptor binding |
| GO:0048018 | 0.006 | 9.709 | 0.3848 | 3 | 445 | receptor ligand activity |
| GO:0015467 | 0.0086 | 138.188 | 0.0086 | 1 | 10 | G-protein activated inward rectifier potassium channel activity |
| GO:0039706 | 0.0086 | 138.188 | 0.0086 | 1 | 10 | co-receptor binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0001965 | 3e-04 | 100.0186 | 0.0246 | 2 | 19 | G-protein alpha-subunit binding |
| GO:0033829 | 0.0039 | 404.2 | 0.0039 | 1 | 3 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004033 | 2e-04 | 108.0468 | 0.0232 | 2 | 25 | aldo-keto reductase (NADP) activity |
| GO:0018455 | 9e-04 | Inf | 9e-04 | 1 | 1 | alcohol dehydrogenase [NAD(P)+] activity |
| GO:0047042 | 9e-04 | Inf | 9e-04 | 1 | 1 | androsterone dehydrogenase (B-specific) activity |
| GO:0016655 | 0.001 | 51.6923 | 0.0463 | 2 | 50 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor |
| GO:0047006 | 0.0019 | 1155.3571 | 0.0019 | 1 | 2 | 17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity |
| GO:0018636 | 0.0028 | 577.6429 | 0.0028 | 1 | 3 | phenanthrene 9,10-monooxygenase activity |
| GO:0035662 | 0.0028 | 577.6429 | 0.0028 | 1 | 3 | Toll-like receptor 4 binding |
| GO:0047086 | 0.0028 | 577.6429 | 0.0028 | 1 | 3 | ketosteroid monooxygenase activity |
| GO:0047718 | 0.0028 | 577.6429 | 0.0028 | 1 | 3 | indanol dehydrogenase activity |
| GO:0047844 | 0.0028 | 577.6429 | 0.0028 | 1 | 3 | deoxycytidine deaminase activity |
| GO:0000253 | 0.0037 | 385.0714 | 0.0037 | 1 | 4 | 3-keto sterol reductase activity |
| GO:0004090 | 0.0037 | 385.0714 | 0.0037 | 1 | 4 | carbonyl reductase (NADPH) activity |
| GO:0008745 | 0.0037 | 385.0714 | 0.0037 | 1 | 4 | N-acetylmuramoyl-L-alanine amidase activity |
| GO:0047115 | 0.0037 | 385.0714 | 0.0037 | 1 | 4 | trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity |
| GO:0008270 | 0.0045 | 7.3456 | 0.7106 | 4 | 767 | zinc ion binding |
| GO:0016019 | 0.0046 | 288.7857 | 0.0046 | 1 | 5 | peptidoglycan receptor activity |
| GO:0050544 | 0.0046 | 288.7857 | 0.0046 | 1 | 5 | arachidonic acid binding |
| GO:0016614 | 0.0063 | 19.2885 | 0.1204 | 2 | 130 | oxidoreductase activity, acting on CH-OH group of donors |
| GO:0004032 | 0.0065 | 192.5 | 0.0065 | 1 | 7 | alditol:NADP+ 1-oxidoreductase activity |
| GO:0016810 | 0.0072 | 17.8796 | 0.1297 | 2 | 140 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds |
| GO:0004126 | 0.0074 | 164.9898 | 0.0074 | 1 | 8 | cytidine deaminase activity |
| GO:0032052 | 0.0083 | 144.3571 | 0.0083 | 1 | 9 | bile acid binding |
| GO:0052650 | 0.0083 | 144.3571 | 0.0083 | 1 | 9 | NADP-retinol dehydrogenase activity |
| GO:0070700 | 0.0083 | 144.3571 | 0.0083 | 1 | 9 | BMP receptor binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0003755 | 0 | 55.296 | 0.0657 | 3 | 38 | peptidyl-prolyl cis-trans isomerase activity |
| GO:0030377 | 0.0017 | Inf | 0.0017 | 1 | 1 | urokinase plasminogen activator receptor activity |
| GO:0102339 | 0.0017 | Inf | 0.0017 | 1 | 1 | 3-oxo-arachidoyl-CoA reductase activity |
| GO:0102340 | 0.0017 | Inf | 0.0017 | 1 | 1 | 3-oxo-behenoyl-CoA reductase activity |
| GO:0102341 | 0.0017 | Inf | 0.0017 | 1 | 1 | 3-oxo-lignoceroyl-CoA reductase activity |
| GO:0102342 | 0.0017 | Inf | 0.0017 | 1 | 1 | 3-oxo-cerotoyl-CoA reductase activity |
| GO:0016853 | 0.0018 | 13.8337 | 0.2456 | 3 | 142 | isomerase activity |
| GO:0004666 | 0.0035 | 598.5926 | 0.0035 | 1 | 2 | prostaglandin-endoperoxide synthase activity |
| GO:0016509 | 0.0052 | 299.2778 | 0.0052 | 1 | 3 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0033862 | 0.0023 | Inf | 0.0023 | 1 | 1 | UMP kinase activity |
| GO:0035717 | 0.0023 | Inf | 0.0023 | 1 | 1 | chemokine (C-C motif) ligand 7 binding |
| GO:0047730 | 0.0023 | Inf | 0.0023 | 1 | 1 | carnosine synthase activity |
| GO:0102102 | 0.0023 | Inf | 0.0023 | 1 | 1 | homocarnosine synthase activity |
| GO:0102339 | 0.0023 | Inf | 0.0023 | 1 | 1 | 3-oxo-arachidoyl-CoA reductase activity |
| GO:0102340 | 0.0023 | Inf | 0.0023 | 1 | 1 | 3-oxo-behenoyl-CoA reductase activity |
| GO:0102341 | 0.0023 | Inf | 0.0023 | 1 | 1 | 3-oxo-lignoceroyl-CoA reductase activity |
| GO:0102342 | 0.0023 | Inf | 0.0023 | 1 | 1 | 3-oxo-cerotoyl-CoA reductase activity |
| GO:0004666 | 0.0047 | 436.5405 | 0.0047 | 1 | 2 | prostaglandin-endoperoxide synthase activity |
| GO:0004798 | 0.0047 | 436.5405 | 0.0047 | 1 | 2 | thymidylate kinase activity |
| GO:0047057 | 0.0047 | 436.5405 | 0.0047 | 1 | 2 | vitamin-K-epoxide reductase (warfarin-sensitive) activity |
| GO:0071791 | 0.0047 | 436.5405 | 0.0047 | 1 | 2 | chemokine (C-C motif) ligand 5 binding |
| GO:0004829 | 0.007 | 218.2568 | 0.007 | 1 | 3 | threonine-tRNA ligase activity |
| GO:0016509 | 0.007 | 218.2568 | 0.007 | 1 | 3 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity |
| GO:0004127 | 0.0094 | 145.4955 | 0.0094 | 1 | 4 | cytidylate kinase activity |
| GO:1905394 | 0.0094 | 145.4955 | 0.0094 | 1 | 4 | retromer complex binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0032394 | 0 | Inf | 0.0052 | 2 | 2 | MHC class Ib receptor activity |
| GO:0042288 | 0.001 | 50.4156 | 0.0467 | 2 | 18 | MHC class I protein binding |
| GO:0031855 | 0.0026 | Inf | 0.0026 | 1 | 1 | oxytocin receptor binding |
| GO:0033897 | 0.0026 | Inf | 0.0026 | 1 | 1 | ribonuclease T2 activity |
| GO:0030246 | 0.0045 | 6.535 | 0.6744 | 4 | 260 | carbohydrate binding |
| GO:0005185 | 0.0052 | 393.8537 | 0.0052 | 1 | 2 | neurohypophyseal hormone activity |
| GO:0098640 | 0.0052 | 393.8537 | 0.0052 | 1 | 2 | integrin binding involved in cell-matrix adhesion |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0098542 | 0 | 14.7824 | 0.5702 | 6 | 463 | defense response to other organism |
| GO:0042119 | 0 | 14.3303 | 0.5874 | 6 | 477 | neutrophil activation |
| GO:0002275 | 0 | 13.122 | 0.6392 | 6 | 519 | myeloid cell activation involved in immune response |
| GO:0002444 | 0 | 13.0432 | 0.6429 | 6 | 522 | myeloid leukocyte mediated immunity |
| GO:0031640 | 0 | 51.8663 | 0.0714 | 3 | 58 | killing of cells of other organism |
| GO:0016045 | 1e-04 | 180.1111 | 0.0148 | 2 | 12 | detection of bacterium |
| GO:0002263 | 1e-04 | 10.2005 | 0.8128 | 6 | 660 | cell activation involved in immune response |
| GO:0043312 | 1e-04 | 12.3969 | 0.5373 | 5 | 459 | neutrophil degranulation |
| GO:0045055 | 2e-04 | 9.4737 | 0.8719 | 6 | 708 | regulated exocytosis |
| GO:0098581 | 2e-04 | 112.5278 | 0.0222 | 2 | 18 | detection of external biotic stimulus |
| GO:0035821 | 7e-04 | 20.416 | 0.1749 | 3 | 142 | modification of morphology or physiology of other organism |
| GO:0032940 | 9e-04 | 5.8459 | 1.6933 | 7 | 1375 | secretion by cell |
| GO:0019547 | 0.0012 | Inf | 0.0012 | 1 | 1 | arginine catabolic process to ornithine |
| GO:0044356 | 0.0012 | Inf | 0.0012 | 1 | 1 | clearance of foreign intracellular DNA by conversion of DNA cytidine to uridine |
| GO:0061015 | 0.0012 | Inf | 0.0012 | 1 | 1 | snRNA import into nucleus |
| GO:0070965 | 0.0012 | Inf | 0.0012 | 1 | 1 | positive regulation of neutrophil mediated killing of fungus |
| GO:0099046 | 0.0012 | Inf | 0.0012 | 1 | 1 | clearance of foreign intracellular nucleic acids |
| GO:1900150 | 0.0012 | Inf | 0.0012 | 1 | 1 | regulation of defense response to fungus |
| GO:1904676 | 0.0012 | Inf | 0.0012 | 1 | 1 | negative regulation of somatic stem cell division |
| GO:1905175 | 0.0012 | Inf | 0.0012 | 1 | 1 | negative regulation of vascular smooth muscle cell dedifferentiation |
| GO:0031343 | 0.0013 | 43.8455 | 0.053 | 2 | 43 | positive regulation of cell killing |
| GO:0032964 | 0.0014 | 41.801 | 0.0554 | 2 | 45 | collagen biosynthetic process |
| GO:0043207 | 0.0014 | 7.4745 | 0.8855 | 5 | 798 | response to external biotic stimulus |
| GO:0002376 | 0.0017 | 6.5963 | 1.4335 | 6 | 1548 | immune system process |
| GO:0061844 | 0.0018 | 36.6689 | 0.0628 | 2 | 51 | antimicrobial humoral immune response mediated by antimicrobial peptide |
| GO:0045321 | 0.0018 | 5.8003 | 1.3818 | 6 | 1122 | leukocyte activation |
| GO:0009620 | 0.0018 | 35.9333 | 0.064 | 2 | 52 | response to fungus |
| GO:0006959 | 0.0023 | 13.0752 | 0.2697 | 3 | 219 | humoral immune response |
| GO:0010963 | 0.0025 | 853.6316 | 0.0025 | 1 | 2 | regulation of L-arginine import |
| GO:0044663 | 0.0025 | 853.6316 | 0.0025 | 1 | 2 | establishment or maintenance of cell type involved in phenotypic switching |
| GO:0070949 | 0.0025 | 853.6316 | 0.0025 | 1 | 2 | regulation of neutrophil mediated killing of symbiont cell |
| GO:0070960 | 0.0025 | 853.6316 | 0.0025 | 1 | 2 | positive regulation of neutrophil mediated cytotoxicity |
| GO:0045087 | 0.0029 | 6.1573 | 1.032 | 5 | 838 | innate immune response |
| GO:0010466 | 0.0033 | 11.5545 | 0.3042 | 3 | 247 | negative regulation of peptidase activity |
| GO:0032827 | 0.0037 | 426.7895 | 0.0037 | 1 | 3 | negative regulation of natural killer cell differentiation involved in immune response |
| GO:0035879 | 0.0037 | 426.7895 | 0.0037 | 1 | 3 | plasma membrane lactate transport |
| GO:0051714 | 0.0037 | 426.7895 | 0.0037 | 1 | 3 | positive regulation of cytolysis in other organism |
| GO:0090678 | 0.0037 | 426.7895 | 0.0037 | 1 | 3 | cell dedifferentiation involved in phenotypic switching |
| GO:0016192 | 0.004 | 4.3987 | 2.1872 | 7 | 1776 | vesicle-mediated transport |
| GO:0019732 | 0.0049 | 284.5088 | 0.0049 | 1 | 4 | antifungal humoral response |
| GO:0032792 | 0.0049 | 284.5088 | 0.0049 | 1 | 4 | negative regulation of CREB transcription factor activity |
| GO:0090467 | 0.0049 | 284.5088 | 0.0049 | 1 | 4 | arginine import |
| GO:2000552 | 0.0049 | 284.5088 | 0.0049 | 1 | 4 | negative regulation of T-helper 2 cell cytokine production |
| GO:0050830 | 0.0051 | 21.0915 | 0.1071 | 2 | 87 | defense response to Gram-positive bacterium |
| GO:0036446 | 0.0061 | 213.3684 | 0.0062 | 1 | 5 | myofibroblast differentiation |
| GO:0060414 | 0.0061 | 213.3684 | 0.0062 | 1 | 5 | aorta smooth muscle tissue morphogenesis |
| GO:1902023 | 0.0061 | 213.3684 | 0.0062 | 1 | 5 | L-arginine transport |
| GO:1904673 | 0.0061 | 213.3684 | 0.0062 | 1 | 5 | negative regulation of somatic stem cell population maintenance |
| GO:2000724 | 0.0061 | 213.3684 | 0.0062 | 1 | 5 | positive regulation of cardiac vascular smooth muscle cell differentiation |
| GO:0050896 | 0.0067 | 3.9248 | 10.1022 | 16 | 8203 | response to stimulus |
| GO:2000117 | 0.0073 | 17.3862 | 0.1293 | 2 | 105 | negative regulation of cysteine-type endopeptidase activity |
| GO:0010269 | 0.0074 | 170.6842 | 0.0074 | 1 | 6 | response to selenium ion |
| GO:0015727 | 0.0074 | 170.6842 | 0.0074 | 1 | 6 | lactate transport |
| GO:0060336 | 0.0074 | 170.6842 | 0.0074 | 1 | 6 | negative regulation of interferon-gamma-mediated signaling pathway |
| GO:0070383 | 0.0074 | 170.6842 | 0.0074 | 1 | 6 | DNA cytosine deamination |
| GO:0002697 | 0.0074 | 8.5502 | 0.4076 | 3 | 331 | regulation of immune effector process |
| GO:0001816 | 0.0077 | 5.9408 | 0.8116 | 4 | 659 | cytokine production |
| GO:0070268 | 0.0084 | 16.1251 | 0.1392 | 2 | 113 | cornification |
| GO:0009253 | 0.0086 | 142.2281 | 0.0086 | 1 | 7 | peptidoglycan catabolic process |
| GO:0009635 | 0.0086 | 142.2281 | 0.0086 | 1 | 7 | response to herbicide |
| GO:0010668 | 0.0086 | 142.2281 | 0.0086 | 1 | 7 | ectodermal cell differentiation |
| GO:0032815 | 0.0086 | 142.2281 | 0.0086 | 1 | 7 | negative regulation of natural killer cell activation |
| GO:0051597 | 0.0086 | 142.2281 | 0.0086 | 1 | 7 | response to methylmercury |
| GO:0043313 | 0.0098 | 121.9023 | 0.0099 | 1 | 8 | regulation of neutrophil degranulation |
| GO:0043696 | 0.0098 | 121.9023 | 0.0099 | 1 | 8 | dedifferentiation |
| GO:0070269 | 0.0098 | 121.9023 | 0.0099 | 1 | 8 | pyroptosis |
| GO:1900239 | 0.0098 | 121.9023 | 0.0099 | 1 | 8 | regulation of phenotypic switching |
| GO:2000035 | 0.0098 | 121.9023 | 0.0099 | 1 | 8 | regulation of stem cell division |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0060349 | 0 | 29.5348 | 0.1626 | 4 | 88 | bone morphogenesis |
| GO:0045600 | 2e-04 | 33.2428 | 0.1053 | 3 | 57 | positive regulation of fat cell differentiation |
| GO:0045669 | 2e-04 | 32.6364 | 0.1071 | 3 | 58 | positive regulation of osteoblast differentiation |
| GO:0048534 | 7e-04 | 5.5688 | 1.5647 | 7 | 847 | hematopoietic or lymphoid organ development |
| GO:0002063 | 0.001 | 48.1726 | 0.048 | 2 | 26 | chondrocyte development |
| GO:0032680 | 0.001 | 16.8805 | 0.2014 | 3 | 109 | regulation of tumor necrosis factor production |
| GO:0001958 | 0.0011 | 46.2429 | 0.0499 | 2 | 27 | endochondral ossification |
| GO:0051094 | 0.0012 | 4.5567 | 2.2278 | 8 | 1206 | positive regulation of developmental process |
| GO:0071706 | 0.0013 | 15.8279 | 0.2143 | 3 | 116 | tumor necrosis factor superfamily cytokine production |
| GO:0001569 | 0.0015 | 39.8547 | 0.0573 | 2 | 31 | branching involved in blood vessel morphogenesis |
| GO:0008584 | 0.0017 | 14.0709 | 0.2401 | 3 | 130 | male gonad development |
| GO:0060010 | 0.0018 | Inf | 0.0018 | 1 | 1 | Sertoli cell fate commitment |
| GO:0061185 | 0.0018 | Inf | 0.0018 | 1 | 1 | negative regulation of dermatome development |
| GO:0061682 | 0.0018 | Inf | 0.0018 | 1 | 1 | seminal vesicle morphogenesis |
| GO:1901835 | 0.0018 | Inf | 0.0018 | 1 | 1 | positive regulation of deadenylation-independent decapping of nuclear-transcribed mRNA |
| GO:1904246 | 0.0018 | Inf | 0.0018 | 1 | 1 | negative regulation of polynucleotide adenylyltransferase activity |
| GO:0060562 | 0.0022 | 8.2429 | 0.556 | 4 | 301 | epithelial tube morphogenesis |
| GO:0046661 | 0.0028 | 11.8963 | 0.2826 | 3 | 153 | male sex differentiation |
| GO:0045944 | 0.0028 | 4.3455 | 1.9729 | 7 | 1068 | positive regulation of transcription from RNA polymerase II promoter |
| GO:0048701 | 0.003 | 27.4966 | 0.0813 | 2 | 44 | embryonic cranial skeleton morphogenesis |
| GO:0071478 | 0.0032 | 11.2883 | 0.2974 | 3 | 161 | cellular response to radiation |
| GO:0045892 | 0.0034 | 4.1929 | 2.0394 | 7 | 1104 | negative regulation of transcription, DNA-templated |
| GO:0030850 | 0.0034 | 25.6587 | 0.0868 | 2 | 47 | prostate gland development |
| GO:0045321 | 0.0037 | 4.1203 | 2.0727 | 7 | 1122 | leukocyte activation |
| GO:1904582 | 0.0037 | 558.931 | 0.0037 | 1 | 2 | positive regulation of intracellular mRNA localization |
| GO:2000041 | 0.0037 | 558.931 | 0.0037 | 1 | 2 | negative regulation of planar cell polarity pathway involved in axis elongation |
| GO:0060173 | 0.0037 | 10.674 | 0.314 | 3 | 170 | limb development |
| GO:0051254 | 0.0037 | 3.7527 | 2.6601 | 8 | 1440 | positive regulation of RNA metabolic process |
| GO:1902679 | 0.004 | 4.0538 | 2.1041 | 7 | 1139 | negative regulation of RNA biosynthetic process |
| GO:0061138 | 0.004 | 10.3605 | 0.3233 | 3 | 175 | morphogenesis of a branching epithelium |
| GO:0030278 | 0.0041 | 10.2999 | 0.3251 | 3 | 176 | regulation of ossification |
| GO:0008284 | 0.0043 | 4.4898 | 1.5905 | 6 | 861 | positive regulation of cell proliferation |
| GO:0051240 | 0.0044 | 3.6381 | 2.7358 | 8 | 1481 | positive regulation of multicellular organismal process |
| GO:0048729 | 0.0048 | 5.1587 | 1.1268 | 5 | 610 | tissue morphogenesis |
| GO:0030886 | 0.0055 | 279.4483 | 0.0055 | 1 | 3 | negative regulation of myeloid dendritic cell activation |
| GO:0045085 | 0.0055 | 279.4483 | 0.0055 | 1 | 3 | negative regulation of interleukin-2 biosynthetic process |
| GO:0060741 | 0.0055 | 279.4483 | 0.0055 | 1 | 3 | prostate gland stromal morphogenesis |
| GO:0140076 | 0.0055 | 279.4483 | 0.0055 | 1 | 3 | negative regulation of lipoprotein transport |
| GO:1904715 | 0.0055 | 279.4483 | 0.0055 | 1 | 3 | negative regulation of chaperone-mediated autophagy |
| GO:1990834 | 0.0055 | 279.4483 | 0.0055 | 1 | 3 | response to odorant |
| GO:2000297 | 0.0055 | 279.4483 | 0.0055 | 1 | 3 | negative regulation of synapse maturation |
| GO:0045596 | 0.0059 | 4.8975 | 1.1841 | 5 | 641 | negative regulation of cell differentiation |
| GO:0061035 | 0.0062 | 18.6037 | 0.1182 | 2 | 64 | regulation of cartilage development |
| GO:0045137 | 0.0063 | 8.7614 | 0.3805 | 3 | 206 | development of primary sexual characteristics |
| GO:0061458 | 0.0064 | 6.0344 | 0.7518 | 4 | 407 | reproductive system development |
| GO:1904035 | 0.0066 | 18.0201 | 0.1219 | 2 | 66 | regulation of epithelial cell apoptotic process |
| GO:0010557 | 0.0071 | 3.339 | 2.9557 | 8 | 1600 | positive regulation of macromolecule biosynthetic process |
| GO:0002051 | 0.0074 | 186.2874 | 0.0074 | 1 | 4 | osteoblast fate commitment |
| GO:0008588 | 0.0074 | 186.2874 | 0.0074 | 1 | 4 | release of cytoplasmic sequestered NF-kappaB |
| GO:0019805 | 0.0074 | 186.2874 | 0.0074 | 1 | 4 | quinolinate biosynthetic process |
| GO:0042662 | 0.0074 | 186.2874 | 0.0074 | 1 | 4 | negative regulation of mesodermal cell fate specification |
| GO:0090244 | 0.0074 | 186.2874 | 0.0074 | 1 | 4 | Wnt signaling pathway involved in somitogenesis |
| GO:1904637 | 0.0074 | 186.2874 | 0.0074 | 1 | 4 | cellular response to ionomycin |
| GO:1905903 | 0.0074 | 186.2874 | 0.0074 | 1 | 4 | negative regulation of mesoderm formation |
| GO:0048041 | 0.0076 | 16.7091 | 0.1312 | 2 | 71 | focal adhesion assembly |
| GO:0061448 | 0.0077 | 8.1596 | 0.409 | 3 | 229 | connective tissue development |
| GO:0021766 | 0.008 | 16.2364 | 0.1349 | 2 | 73 | hippocampus development |
| GO:0043627 | 0.008 | 16.2364 | 0.1349 | 2 | 73 | response to estrogen |
| GO:0003151 | 0.0082 | 16.0099 | 0.1367 | 2 | 74 | outflow tract morphogenesis |
| GO:0009890 | 0.0085 | 3.224 | 3.0499 | 8 | 1651 | negative regulation of biosynthetic process |
| GO:0007155 | 0.0087 | 3.4674 | 2.4292 | 7 | 1315 | cell adhesion |
| GO:0042110 | 0.0089 | 5.4629 | 0.8276 | 4 | 448 | T cell activation |
| GO:0060591 | 0.0092 | 139.7069 | 0.0092 | 1 | 5 | chondroblast differentiation |
| GO:0061056 | 0.0092 | 139.7069 | 0.0092 | 1 | 5 | sclerotome development |
| GO:1904956 | 0.0092 | 139.7069 | 0.0092 | 1 | 5 | regulation of midbrain dopaminergic neuron differentiation |
| GO:0051173 | 0.0093 | 2.7561 | 5.2186 | 11 | 2825 | positive regulation of nitrogen compound metabolic process |
| GO:0045621 | 0.0095 | 14.7729 | 0.1478 | 2 | 80 | positive regulation of lymphocyte differentiation |
| GO:0034333 | 0.0098 | 14.585 | 0.1496 | 2 | 81 | adherens junction assembly |
| GO:0002521 | 0.0098 | 5.3031 | 0.8516 | 4 | 461 | leukocyte differentiation |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0008584 | 0.0014 | 15.1984 | 0.2241 | 3 | 130 | male gonad development |
| GO:0060010 | 0.0017 | Inf | 0.0017 | 1 | 1 | Sertoli cell fate commitment |
| GO:0061185 | 0.0017 | Inf | 0.0017 | 1 | 1 | negative regulation of dermatome development |
| GO:0061682 | 0.0017 | Inf | 0.0017 | 1 | 1 | seminal vesicle morphogenesis |
| GO:2000287 | 0.0017 | Inf | 0.0017 | 1 | 1 | positive regulation of myotome development |
| GO:0046661 | 0.0023 | 12.8496 | 0.2638 | 3 | 153 | male sex differentiation |
| GO:0030850 | 0.003 | 27.6359 | 0.081 | 2 | 47 | prostate gland development |
| GO:2000041 | 0.0034 | 600.4074 | 0.0034 | 1 | 2 | negative regulation of planar cell polarity pathway involved in axis elongation |
| GO:0060350 | 0.0035 | 25.3736 | 0.0879 | 2 | 51 | endochondral bone morphogenesis |
| GO:0060348 | 0.0035 | 10.9336 | 0.3086 | 3 | 179 | bone development |
| GO:0051094 | 0.0036 | 4.1738 | 2.0793 | 7 | 1206 | positive regulation of developmental process |
| GO:0043124 | 0.004 | 23.4528 | 0.0948 | 2 | 55 | negative regulation of I-kappaB kinase/NF-kappaB signaling |
| GO:0045600 | 0.0043 | 22.5972 | 0.0983 | 2 | 57 | positive regulation of fat cell differentiation |
| GO:0045669 | 0.0045 | 22.1923 | 0.1 | 2 | 58 | positive regulation of osteoblast differentiation |
| GO:0061458 | 0.0049 | 6.538 | 0.7017 | 4 | 407 | reproductive system development |
| GO:0060741 | 0.0052 | 300.1852 | 0.0052 | 1 | 3 | prostate gland stromal morphogenesis |
| GO:0070458 | 0.0052 | 300.1852 | 0.0052 | 1 | 3 | cellular detoxification of nitrogen compound |
| GO:1904715 | 0.0052 | 300.1852 | 0.0052 | 1 | 3 | negative regulation of chaperone-mediated autophagy |
| GO:1990834 | 0.0052 | 300.1852 | 0.0052 | 1 | 3 | response to odorant |
| GO:0045137 | 0.0052 | 9.4634 | 0.3552 | 3 | 206 | development of primary sexual characteristics |
| GO:0048705 | 0.0054 | 9.3239 | 0.3603 | 3 | 209 | skeletal system morphogenesis |
| GO:0048041 | 0.0066 | 17.9967 | 0.1224 | 2 | 71 | focal adhesion assembly |
| GO:0008588 | 0.0069 | 200.1111 | 0.0069 | 1 | 4 | release of cytoplasmic sequestered NF-kappaB |
| GO:0018916 | 0.0069 | 200.1111 | 0.0069 | 1 | 4 | nitrobenzene metabolic process |
| GO:0042662 | 0.0069 | 200.1111 | 0.0069 | 1 | 4 | negative regulation of mesodermal cell fate specification |
| GO:0090244 | 0.0069 | 200.1111 | 0.0069 | 1 | 4 | Wnt signaling pathway involved in somitogenesis |
| GO:1905903 | 0.0069 | 200.1111 | 0.0069 | 1 | 4 | negative regulation of mesoderm formation |
| GO:0021766 | 0.007 | 17.4875 | 0.1259 | 2 | 73 | hippocampus development |
| GO:0043627 | 0.007 | 17.4875 | 0.1259 | 2 | 73 | response to estrogen |
| GO:0003151 | 0.0072 | 17.2436 | 0.1276 | 2 | 74 | outflow tract morphogenesis |
| GO:0045621 | 0.0083 | 15.9112 | 0.1379 | 2 | 80 | positive regulation of lymphocyte differentiation |
| GO:0034333 | 0.0085 | 15.7089 | 0.1397 | 2 | 81 | adherens junction assembly |
| GO:0060591 | 0.0086 | 150.0741 | 0.0086 | 1 | 5 | chondroblast differentiation |
| GO:0061056 | 0.0086 | 150.0741 | 0.0086 | 1 | 5 | sclerotome development |
| GO:1904956 | 0.0086 | 150.0741 | 0.0086 | 1 | 5 | regulation of midbrain dopaminergic neuron differentiation |
| GO:0045944 | 0.0086 | 3.8906 | 1.8414 | 6 | 1068 | positive regulation of transcription from RNA polymerase II promoter |
| GO:0001843 | 0.0094 | 14.9481 | 0.1466 | 2 | 85 | neural tube closure |
| GO:0007044 | 0.0098 | 14.5946 | 0.15 | 2 | 87 | cell-substrate junction assembly |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:2001236 | 2e-04 | 36.9724 | 0.1094 | 3 | 148 | regulation of extrinsic apoptotic signaling pathway |
| GO:1902042 | 3e-04 | 95.2588 | 0.0266 | 2 | 36 | negative regulation of extrinsic apoptotic signaling pathway via death domain receptors |
| GO:2001234 | 4e-04 | 26.9865 | 0.1485 | 3 | 201 | negative regulation of apoptotic signaling pathway |
| GO:2000351 | 4e-04 | 83.0205 | 0.0303 | 2 | 41 | regulation of endothelial cell apoptotic process |
| GO:0002642 | 7e-04 | Inf | 7e-04 | 1 | 1 | positive regulation of immunoglobulin biosynthetic process |
| GO:0030887 | 7e-04 | Inf | 7e-04 | 1 | 1 | positive regulation of myeloid dendritic cell activation |
| GO:0034021 | 0.0015 | 1475.1818 | 0.0015 | 1 | 2 | response to silicon dioxide |
| GO:0036345 | 0.0015 | 1475.1818 | 0.0015 | 1 | 2 | platelet maturation |
| GO:1904019 | 0.0019 | 36.6818 | 0.0665 | 2 | 90 | epithelial cell apoptotic process |
| GO:0008219 | 0.002 | 6.817 | 1.5384 | 6 | 2082 | cell death |
| GO:0021553 | 0.0022 | 737.5455 | 0.0022 | 1 | 3 | olfactory nerve development |
| GO:0048388 | 0.0022 | 737.5455 | 0.0022 | 1 | 3 | endosomal lumen acidification |
| GO:0061368 | 0.0022 | 737.5455 | 0.0022 | 1 | 3 | behavioral response to formalin induced pain |
| GO:0099566 | 0.0022 | 737.5455 | 0.0022 | 1 | 3 | regulation of postsynaptic cytosolic calcium ion concentration |
| GO:0043069 | 0.0025 | 9.229 | 0.6192 | 4 | 838 | negative regulation of programmed cell death |
| GO:0030644 | 0.003 | 491.6667 | 0.003 | 1 | 4 | cellular chloride ion homeostasis |
| GO:0045918 | 0.003 | 491.6667 | 0.003 | 1 | 4 | negative regulation of cytolysis |
| GO:0046666 | 0.003 | 491.6667 | 0.003 | 1 | 4 | retinal cell programmed cell death |
| GO:2001274 | 0.003 | 491.6667 | 0.003 | 1 | 4 | negative regulation of glucose import in response to insulin stimulus |
| GO:0032747 | 0.0037 | 368.7273 | 0.0037 | 1 | 5 | positive regulation of interleukin-23 production |
| GO:0060385 | 0.0037 | 368.7273 | 0.0037 | 1 | 5 | axonogenesis involved in innervation |
| GO:1902533 | 0.0038 | 8.1596 | 0.6953 | 4 | 941 | positive regulation of intracellular signal transduction |
| GO:0002521 | 0.0041 | 11.4774 | 0.3406 | 3 | 461 | leukocyte differentiation |
| GO:0050906 | 0.0041 | 11.4774 | 0.3406 | 3 | 461 | detection of stimulus involved in sensory perception |
| GO:0051599 | 0.0044 | 294.9636 | 0.0044 | 1 | 6 | response to hydrostatic pressure |
| GO:0097527 | 0.0044 | 294.9636 | 0.0044 | 1 | 6 | necroptotic signaling pathway |
| GO:0050865 | 0.005 | 10.6612 | 0.3658 | 3 | 495 | regulation of cell activation |
| GO:0030223 | 0.0052 | 245.7879 | 0.0052 | 1 | 7 | neutrophil differentiation |
| GO:0001821 | 0.0059 | 210.6623 | 0.0059 | 1 | 8 | histamine secretion |
| GO:0038180 | 0.0059 | 210.6623 | 0.0059 | 1 | 8 | nerve growth factor signaling pathway |
| GO:0042045 | 0.0059 | 210.6623 | 0.0059 | 1 | 8 | epithelial fluid transport |
| GO:0071316 | 0.0059 | 210.6623 | 0.0059 | 1 | 8 | cellular response to nicotine |
| GO:1902715 | 0.0059 | 210.6623 | 0.0059 | 1 | 8 | positive regulation of interferon-gamma secretion |
| GO:0010623 | 0.0061 | 202.7125 | 0.0061 | 1 | 9 | programmed cell death involved in cell development |
| GO:0001766 | 0.0066 | 184.3182 | 0.0067 | 1 | 9 | membrane raft polarization |
| GO:0071803 | 0.0066 | 184.3182 | 0.0067 | 1 | 9 | positive regulation of podosome assembly |
| GO:0097011 | 0.0066 | 184.3182 | 0.0067 | 1 | 9 | cellular response to granulocyte macrophage colony-stimulating factor stimulus |
| GO:0007166 | 0.0068 | 5.1892 | 1.9419 | 6 | 2628 | cell surface receptor signaling pathway |
| GO:0050966 | 0.0074 | 163.8283 | 0.0074 | 1 | 10 | detection of mechanical stimulus involved in sensory perception of pain |
| GO:0051665 | 0.0074 | 163.8283 | 0.0074 | 1 | 10 | membrane raft localization |
| GO:0002376 | 0.0074 | 5.0916 | 1.9729 | 6 | 2670 | immune system process |
| GO:0043523 | 0.0081 | 17.3438 | 0.1382 | 2 | 187 | regulation of neuron apoptotic process |
| GO:0090331 | 0.0081 | 147.4364 | 0.0081 | 1 | 11 | negative regulation of platelet aggregation |
| GO:0007623 | 0.0082 | 17.2495 | 0.1389 | 2 | 188 | circadian rhythm |
| GO:0070374 | 0.0087 | 16.7042 | 0.1433 | 2 | 194 | positive regulation of ERK1 and ERK2 cascade |
| GO:0034116 | 0.0088 | 134.0248 | 0.0089 | 1 | 12 | positive regulation of heterotypic cell-cell adhesion |
| GO:0046649 | 0.0091 | 8.549 | 0.4522 | 3 | 612 | lymphocyte activation |
| GO:0050877 | 0.0093 | 6.228 | 0.8941 | 4 | 1210 | nervous system process |
| GO:0030002 | 0.0096 | 122.8485 | 0.0096 | 1 | 13 | cellular anion homeostasis |
| GO:0048266 | 0.0096 | 122.8485 | 0.0096 | 1 | 13 | behavioral response to pain |
| GO:0060009 | 0.0096 | 122.8485 | 0.0096 | 1 | 13 | Sertoli cell development |
| GO:0097296 | 0.0096 | 122.8485 | 0.0096 | 1 | 13 | activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0060349 | 5e-04 | 22.7675 | 0.1517 | 3 | 88 | bone morphogenesis |
| GO:0001958 | 0.001 | 49.8062 | 0.0466 | 2 | 27 | endochondral ossification |
| GO:0048562 | 0.0013 | 9.6588 | 0.481 | 4 | 279 | embryonic organ morphogenesis |
| GO:0021592 | 0.0017 | Inf | 0.0017 | 1 | 1 | fourth ventricle development |
| GO:0021993 | 0.0017 | Inf | 0.0017 | 1 | 1 | initiation of neural tube closure |
| GO:0060010 | 0.0017 | Inf | 0.0017 | 1 | 1 | Sertoli cell fate commitment |
| GO:0031076 | 0.0018 | 35.5538 | 0.0638 | 2 | 37 | embryonic camera-type eye development |
| GO:0016574 | 0.0021 | 32.7409 | 0.069 | 2 | 40 | histone ubiquitination |
| GO:0045321 | 0.0024 | 4.5133 | 1.9345 | 7 | 1122 | leukocyte activation |
| GO:0048701 | 0.0026 | 29.6154 | 0.0759 | 2 | 44 | embryonic cranial skeleton morphogenesis |
| GO:0051572 | 0.0034 | 600.4074 | 0.0034 | 1 | 2 | negative regulation of histone H3-K4 methylation |
| GO:1904815 | 0.0034 | 600.4074 | 0.0034 | 1 | 2 | negative regulation of protein localization to chromosome, telomeric region |
| GO:0008283 | 0.0044 | 3.4464 | 3.3931 | 9 | 1968 | cell proliferation |
| GO:0045669 | 0.0045 | 22.1923 | 0.1 | 2 | 58 | positive regulation of osteoblast differentiation |
| GO:0002351 | 0.0052 | 300.1852 | 0.0052 | 1 | 3 | serotonin production involved in inflammatory response |
| GO:0002554 | 0.0052 | 300.1852 | 0.0052 | 1 | 3 | serotonin secretion by platelet |
| GO:0021678 | 0.0052 | 300.1852 | 0.0052 | 1 | 3 | third ventricle development |
| GO:0033128 | 0.0052 | 300.1852 | 0.0052 | 1 | 3 | negative regulation of histone phosphorylation |
| GO:0071593 | 0.0052 | 300.1852 | 0.0052 | 1 | 3 | lymphocyte aggregation |
| GO:1901837 | 0.0052 | 300.1852 | 0.0052 | 1 | 3 | negative regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter |
| GO:1990834 | 0.0052 | 300.1852 | 0.0052 | 1 | 3 | response to odorant |
| GO:0061035 | 0.0054 | 20.0372 | 0.1103 | 2 | 64 | regulation of cartilage development |
| GO:0008589 | 0.0061 | 18.8182 | 0.1172 | 2 | 68 | regulation of smoothened signaling pathway |
| GO:0006366 | 0.0061 | 3.2632 | 3.5586 | 9 | 2064 | transcription from RNA polymerase II promoter |
| GO:0002051 | 0.0069 | 200.1111 | 0.0069 | 1 | 4 | osteoblast fate commitment |
| GO:0016554 | 0.0069 | 200.1111 | 0.0069 | 1 | 4 | cytidine to uridine editing |
| GO:0021555 | 0.0069 | 200.1111 | 0.0069 | 1 | 4 | midbrain-hindbrain boundary morphogenesis |
| GO:0061086 | 0.0069 | 200.1111 | 0.0069 | 1 | 4 | negative regulation of histone H3-K27 methylation |
| GO:0042110 | 0.0069 | 5.9189 | 0.7724 | 4 | 448 | T cell activation |
| GO:0043627 | 0.007 | 17.4875 | 0.1259 | 2 | 73 | response to estrogen |
| GO:0002521 | 0.0076 | 5.7458 | 0.7948 | 4 | 461 | leukocyte differentiation |
| GO:0045621 | 0.0083 | 15.9112 | 0.1379 | 2 | 80 | positive regulation of lymphocyte differentiation |
| GO:0034184 | 0.0086 | 150.0741 | 0.0086 | 1 | 5 | positive regulation of maintenance of mitotic sister chromatid cohesion |
| GO:0060591 | 0.0086 | 150.0741 | 0.0086 | 1 | 5 | chondroblast differentiation |
| GO:0120034 | 0.0092 | 15.1313 | 0.1448 | 2 | 84 | positive regulation of plasma membrane bounded cell projection assembly |
| GO:0048609 | 0.0092 | 4.4138 | 1.3207 | 5 | 766 | multicellular organismal reproductive process |
| GO:0060606 | 0.0096 | 14.7692 | 0.1483 | 2 | 86 | tube closure |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:2000502 | 0 | 1200.7407 | 0.0054 | 2 | 3 | negative regulation of natural killer cell chemotaxis |
| GO:2000402 | 1e-04 | 171.4709 | 0.0161 | 2 | 9 | negative regulation of lymphocyte migration |
| GO:0002689 | 4e-04 | 85.6984 | 0.0286 | 2 | 16 | negative regulation of leukocyte chemotaxis |
| GO:0045954 | 5e-04 | 70.5621 | 0.0339 | 2 | 19 | positive regulation of natural killer cell mediated cytotoxicity |
| GO:0043547 | 6e-04 | 8.5639 | 0.6964 | 5 | 390 | positive regulation of GTPase activity |
| GO:1901623 | 6e-04 | 63.1267 | 0.0375 | 2 | 21 | regulation of lymphocyte chemotaxis |
| GO:0051336 | 7e-04 | 5.0745 | 2.0357 | 8 | 1140 | regulation of hydrolase activity |
| GO:0060326 | 0.0011 | 9.9325 | 0.4661 | 4 | 261 | cell chemotaxis |
| GO:0048247 | 0.0017 | 36.9303 | 0.0616 | 2 | 37 | lymphocyte chemotaxis |
| GO:0002715 | 0.0018 | 36.3143 | 0.0625 | 2 | 35 | regulation of natural killer cell mediated immunity |
| GO:0032078 | 0.0018 | Inf | 0.0018 | 1 | 1 | negative regulation of endodeoxyribonuclease activity |
| GO:1902204 | 0.0018 | Inf | 0.0018 | 1 | 1 | positive regulation of hepatocyte growth factor receptor signaling pathway |
| GO:0071346 | 0.0019 | 13.5379 | 0.25 | 3 | 140 | cellular response to interferon-gamma |
| GO:0045429 | 0.0024 | 30.716 | 0.0732 | 2 | 41 | positive regulation of nitric oxide biosynthetic process |
| GO:0019835 | 0.0025 | 29.9463 | 0.075 | 2 | 42 | cytolysis |
| GO:0031343 | 0.0027 | 29.2141 | 0.0768 | 2 | 43 | positive regulation of cell killing |
| GO:0034260 | 0.0028 | 28.5168 | 0.0786 | 2 | 44 | negative regulation of GTPase activity |
| GO:0045087 | 0.0032 | 4.822 | 1.4964 | 6 | 838 | innate immune response |
| GO:0046373 | 0.0036 | 578.9286 | 0.0036 | 1 | 2 | L-arabinose metabolic process |
| GO:0001910 | 0.004 | 23.4713 | 0.0946 | 2 | 53 | regulation of leukocyte mediated cytotoxicity |
| GO:0032729 | 0.0051 | 20.6296 | 0.1071 | 2 | 60 | positive regulation of interferon-gamma production |
| GO:0002548 | 0.0054 | 19.9395 | 0.1107 | 2 | 62 | monocyte chemotaxis |
| GO:0050900 | 0.0056 | 6.2921 | 0.725 | 4 | 406 | leukocyte migration |
| GO:0031295 | 0.0063 | 18.4 | 0.1196 | 2 | 67 | T cell costimulation |
| GO:0046209 | 0.0069 | 17.585 | 0.125 | 2 | 70 | nitric oxide metabolic process |
| GO:0030101 | 0.0075 | 16.8388 | 0.1304 | 2 | 73 | natural killer cell activation |
| GO:0002708 | 0.0077 | 16.6039 | 0.1321 | 2 | 74 | positive regulation of lymphocyte mediated immunity |
| GO:1903426 | 0.0083 | 15.9368 | 0.1375 | 2 | 77 | regulation of reactive oxygen species biosynthetic process |
| GO:0070098 | 0.0089 | 15.321 | 0.1429 | 2 | 80 | chemokine-mediated signaling pathway |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0015728 | 7e-04 | Inf | 7e-04 | 1 | 1 | mevalonate transport |
| GO:0051780 | 7e-04 | Inf | 7e-04 | 1 | 1 | behavioral response to nutrient |
| GO:0021553 | 0.002 | 811.35 | 0.002 | 1 | 3 | olfactory nerve development |
| GO:0035879 | 0.002 | 811.35 | 0.002 | 1 | 3 | plasma membrane lactate transport |
| GO:0048388 | 0.002 | 811.35 | 0.002 | 1 | 3 | endosomal lumen acidification |
| GO:0061368 | 0.002 | 811.35 | 0.002 | 1 | 3 | behavioral response to formalin induced pain |
| GO:0030644 | 0.0027 | 540.8667 | 0.0027 | 1 | 4 | cellular chloride ion homeostasis |
| GO:0046666 | 0.0027 | 540.8667 | 0.0027 | 1 | 4 | retinal cell programmed cell death |
| GO:0060385 | 0.0034 | 405.625 | 0.0034 | 1 | 5 | axonogenesis involved in innervation |
| GO:0015727 | 0.0041 | 324.48 | 0.0041 | 1 | 6 | lactate transport |
| GO:0051599 | 0.0041 | 324.48 | 0.0041 | 1 | 6 | response to hydrostatic pressure |
| GO:0097527 | 0.0041 | 324.48 | 0.0041 | 1 | 6 | necroptotic signaling pathway |
| GO:0002376 | 0.0043 | 6.1104 | 1.8085 | 6 | 2670 | immune system process |
| GO:0050954 | 0.0048 | 23.0452 | 0.1063 | 2 | 157 | sensory perception of mechanical stimulus |
| GO:0002291 | 0.0054 | 231.7429 | 0.0054 | 1 | 8 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell |
| GO:0038180 | 0.0054 | 231.7429 | 0.0054 | 1 | 8 | nerve growth factor signaling pathway |
| GO:0071316 | 0.0054 | 231.7429 | 0.0054 | 1 | 8 | cellular response to nicotine |
| GO:0010623 | 0.0055 | 225.25 | 0.0055 | 1 | 9 | programmed cell death involved in cell development |
| GO:0045078 | 0.0068 | 180.2222 | 0.0068 | 1 | 10 | positive regulation of interferon-gamma biosynthetic process |
| GO:0050966 | 0.0068 | 180.2222 | 0.0068 | 1 | 10 | detection of mechanical stimulus involved in sensory perception of pain |
| GO:0043523 | 0.0068 | 19.2721 | 0.1267 | 2 | 187 | regulation of neuron apoptotic process |
| GO:0046649 | 0.007 | 9.6182 | 0.4145 | 3 | 612 | lymphocyte activation |
| GO:0030002 | 0.0088 | 135.1417 | 0.0088 | 1 | 13 | cellular anion homeostasis |
| GO:0048266 | 0.0088 | 135.1417 | 0.0088 | 1 | 13 | behavioral response to pain |
| GO:0060009 | 0.0088 | 135.1417 | 0.0088 | 1 | 13 | Sertoli cell development |
| GO:0097296 | 0.0088 | 135.1417 | 0.0088 | 1 | 13 | activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway |
| GO:2000353 | 0.0094 | 124.7385 | 0.0095 | 1 | 14 | positive regulation of endothelial cell apoptotic process |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0032078 | 0.001 | Inf | 0.001 | 1 | 1 | negative regulation of endodeoxyribonuclease activity |
| GO:1900758 | 0.001 | Inf | 0.001 | 1 | 1 | negative regulation of D-amino-acid oxidase activity |
| GO:0048247 | 0.0016 | 38.4929 | 0.0607 | 2 | 58 | lymphocyte chemotaxis |
| GO:0002548 | 0.0019 | 35.9178 | 0.0649 | 2 | 62 | monocyte chemotaxis |
| GO:0019075 | 0.0021 | 1013.875 | 0.0021 | 1 | 2 | virus maturation |
| GO:0007032 | 0.0023 | 32.495 | 0.0719 | 2 | 73 | endosome organization |
| GO:0070098 | 0.0031 | 27.5983 | 0.0837 | 2 | 80 | chemokine-mediated signaling pathway |
| GO:0048388 | 0.0031 | 506.9062 | 0.0031 | 1 | 3 | endosomal lumen acidification |
| GO:1900005 | 0.0031 | 506.9062 | 0.0031 | 1 | 3 | positive regulation of serine-type endopeptidase activity |
| GO:1901318 | 0.0031 | 506.9062 | 0.0031 | 1 | 3 | negative regulation of flagellated sperm motility |
| GO:0051341 | 0.0033 | 26.905 | 0.0858 | 2 | 82 | regulation of oxidoreductase activity |
| GO:0042058 | 0.0035 | 25.9277 | 0.089 | 2 | 85 | regulation of epidermal growth factor receptor signaling pathway |
| GO:0030593 | 0.0037 | 25.0186 | 0.0921 | 2 | 88 | neutrophil chemotaxis |
| GO:0071347 | 0.0039 | 24.447 | 0.0942 | 2 | 90 | cellular response to interleukin-1 |
| GO:0030644 | 0.0042 | 337.9167 | 0.0042 | 1 | 4 | cellular chloride ion homeostasis |
| GO:0046666 | 0.0042 | 337.9167 | 0.0042 | 1 | 4 | retinal cell programmed cell death |
| GO:2001237 | 0.0047 | 22.1663 | 0.1036 | 2 | 99 | negative regulation of extrinsic apoptotic signaling pathway |
| GO:1903772 | 0.0052 | 253.4219 | 0.0052 | 1 | 5 | regulation of viral budding via host ESCRT complex |
| GO:0051345 | 0.0055 | 6.7527 | 0.7443 | 4 | 711 | positive regulation of hydrolase activity |
| GO:0097527 | 0.0063 | 202.725 | 0.0063 | 1 | 6 | necroptotic signaling pathway |
| GO:0097530 | 0.0071 | 17.8922 | 0.1277 | 2 | 122 | granulocyte migration |
| GO:0032074 | 0.0073 | 168.9271 | 0.0073 | 1 | 7 | negative regulation of nuclease activity |
| GO:0071346 | 0.0092 | 15.5411 | 0.1466 | 2 | 140 | cellular response to interferon-gamma |
| GO:0090281 | 0.0094 | 126.6797 | 0.0094 | 1 | 9 | negative regulation of calcium ion import |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0000413 | 0 | 60.2944 | 0.0608 | 3 | 38 | protein peptidyl-prolyl isomerization |
| GO:1904240 | 0.0016 | Inf | 0.0016 | 1 | 1 | negative regulation of VCP-NPL4-UFD1 AAA ATPase complex assembly |
| GO:0038195 | 0.0032 | 648.52 | 0.0032 | 1 | 2 | urokinase plasminogen activator signaling pathway |
| GO:1903070 | 0.0048 | 324.24 | 0.0048 | 1 | 3 | negative regulation of ER-associated ubiquitin-dependent protein catabolic process |
| GO:0006457 | 0.0051 | 9.5708 | 0.3538 | 3 | 221 | protein folding |
| GO:1903061 | 0.0064 | 216.1467 | 0.0064 | 1 | 4 | positive regulation of protein lipidation |
| GO:0042985 | 0.008 | 162.1 | 0.008 | 1 | 5 | negative regulation of amyloid precursor protein biosynthetic process |
| GO:2001268 | 0.008 | 162.1 | 0.008 | 1 | 5 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway |
| GO:1901570 | 0.0083 | 16.002 | 0.1377 | 2 | 86 | fatty acid derivative biosynthetic process |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0016810 | 9e-04 | 18.4933 | 0.1901 | 3 | 140 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds |
| GO:0061135 | 0.0015 | 15.2349 | 0.2294 | 3 | 169 | endopeptidase regulator activity |
| GO:0030414 | 0.0015 | 15.0517 | 0.2322 | 3 | 171 | peptidase inhibitor activity |
| GO:0004869 | 0.0026 | 29.8685 | 0.076 | 2 | 56 | cysteine-type endopeptidase inhibitor activity |
| GO:0004053 | 0.0027 | 770.5714 | 0.0027 | 1 | 2 | arginase activity |
| GO:0004991 | 0.0027 | 770.5714 | 0.0027 | 1 | 2 | parathyroid hormone receptor activity |
| GO:0047844 | 0.0041 | 385.2619 | 0.0041 | 1 | 3 | deoxycytidine deaminase activity |
| GO:0008745 | 0.0054 | 256.8254 | 0.0054 | 1 | 4 | N-acetylmuramoyl-L-alanine amidase activity |
| GO:0004459 | 0.0068 | 192.6071 | 0.0068 | 1 | 5 | L-lactate dehydrogenase activity |
| GO:0016019 | 0.0068 | 192.6071 | 0.0068 | 1 | 5 | peptidoglycan receptor activity |
| GO:0042289 | 0.0081 | 154.0762 | 0.0081 | 1 | 6 | MHC class II protein binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0016810 | 0.0011 | 16.7299 | 0.2073 | 3 | 140 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds |
| GO:0061135 | 0.0019 | 13.7823 | 0.2503 | 3 | 169 | endopeptidase regulator activity |
| GO:0030414 | 0.002 | 13.6165 | 0.2533 | 3 | 171 | peptidase inhibitor activity |
| GO:0004053 | 0.003 | 703.4783 | 0.003 | 1 | 2 | arginase activity |
| GO:0004991 | 0.003 | 703.4783 | 0.003 | 1 | 2 | parathyroid hormone receptor activity |
| GO:0004869 | 0.0031 | 27.1498 | 0.0829 | 2 | 56 | cysteine-type endopeptidase inhibitor activity |
| GO:0047844 | 0.0044 | 351.7174 | 0.0044 | 1 | 3 | deoxycytidine deaminase activity |
| GO:0008745 | 0.0059 | 234.4638 | 0.0059 | 1 | 4 | N-acetylmuramoyl-L-alanine amidase activity |
| GO:0004459 | 0.0074 | 175.837 | 0.0074 | 1 | 5 | L-lactate dehydrogenase activity |
| GO:0016019 | 0.0074 | 175.837 | 0.0074 | 1 | 5 | peptidoglycan receptor activity |
| GO:0042289 | 0.0089 | 140.6609 | 0.0089 | 1 | 6 | MHC class II protein binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0003727 | 4e-04 | 24.3003 | 0.1416 | 3 | 74 | single-stranded RNA binding |
| GO:0000334 | 0.0019 | Inf | 0.0019 | 1 | 1 | 3-hydroxyanthranilate 3,4-dioxygenase activity |
| GO:0016504 | 0.0021 | 32.7383 | 0.0689 | 2 | 36 | peptidase activator activity |
| GO:0008134 | 0.0025 | 6.0534 | 0.9622 | 5 | 503 | transcription factor binding |
| GO:0000253 | 0.0076 | 179.6778 | 0.0077 | 1 | 4 | 3-keto sterol reductase activity |
| GO:0044323 | 0.0076 | 179.6778 | 0.0077 | 1 | 4 | retinoic acid-responsive element binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0003727 | 0.0058 | 19.4541 | 0.1142 | 2 | 74 | single-stranded RNA binding |
| GO:0044323 | 0.0062 | 224.6806 | 0.0062 | 1 | 4 | retinoic acid-responsive element binding |
| GO:0008047 | 0.0064 | 6.112 | 0.7606 | 4 | 493 | enzyme activator activity |
| GO:0004111 | 0.0092 | 134.7917 | 0.0093 | 1 | 6 | creatine kinase activity |
| GO:0004308 | 0.0092 | 134.7917 | 0.0093 | 1 | 6 | exo-alpha-sialidase activity |
| GO:0061133 | 0.0092 | 134.7917 | 0.0093 | 1 | 6 | endopeptidase activator activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0005129 | 6e-04 | Inf | 6e-04 | 1 | 1 | granulocyte macrophage colony-stimulating factor receptor binding |
| GO:0004872 | 0.0011 | 9.9131 | 0.9189 | 5 | 1489 | receptor activity |
| GO:0010465 | 0.0012 | 1799.3333 | 0.0012 | 1 | 2 | nerve growth factor receptor activity |
| GO:0004971 | 0.0019 | 899.6111 | 0.0019 | 1 | 3 | AMPA glutamate receptor activity |
| GO:0005166 | 0.0019 | 899.6111 | 0.0019 | 1 | 3 | neurotrophin p75 receptor binding |
| GO:0099583 | 0.0019 | 899.6111 | 0.0019 | 1 | 3 | neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration |
| GO:0048406 | 0.0037 | 359.7778 | 0.0037 | 1 | 6 | nerve growth factor binding |
| GO:0004888 | 0.0041 | 8.5534 | 0.7251 | 4 | 1175 | transmembrane signaling receptor activity |
| GO:0005004 | 0.0043 | 299.7963 | 0.0043 | 1 | 7 | GPI-linked ephrin receptor activity |
| GO:0004713 | 0.0049 | 23.2892 | 0.1074 | 2 | 174 | protein tyrosine kinase activity |
| GO:0005125 | 0.0074 | 18.6694 | 0.1333 | 2 | 216 | cytokine activity |
| GO:0005126 | 0.0087 | 17.511 | 0.1455 | 2 | 262 | cytokine receptor binding |
| GO:0042803 | 0.0092 | 8.8753 | 0.4622 | 3 | 749 | protein homodimerization activity |
| GO:0005123 | 0.0098 | 119.8519 | 0.0099 | 1 | 16 | death receptor binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0000979 | 1e-04 | 39.6866 | 0.0898 | 3 | 56 | RNA polymerase II core promoter sequence-specific DNA binding |
| GO:0001047 | 0.0021 | 13.2259 | 0.2583 | 3 | 161 | core promoter binding |
| GO:0001012 | 0.0022 | 6.3243 | 0.9498 | 5 | 592 | RNA polymerase II regulatory region DNA binding |
| GO:0000976 | 0.0038 | 5.5546 | 1.075 | 5 | 670 | transcription regulatory region sequence-specific DNA binding |
| GO:0043565 | 0.0042 | 4.6027 | 1.598 | 6 | 996 | sequence-specific DNA binding |
| GO:0000981 | 0.0056 | 5.0388 | 1.1793 | 5 | 735 | RNA polymerase II transcription factor activity, sequence-specific DNA binding |
| GO:0010385 | 0.0064 | 215.68 | 0.0064 | 1 | 4 | double-stranded methylated DNA binding |
| GO:0044323 | 0.0064 | 215.68 | 0.0064 | 1 | 4 | retinoic acid-responsive element binding |
| GO:0008270 | 0.0067 | 4.8172 | 1.2306 | 5 | 767 | zinc ion binding |
| GO:0000975 | 0.0087 | 4.5059 | 1.3108 | 5 | 817 | regulatory region DNA binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0008502 | 0 | Inf | 0.0042 | 2 | 2 | melatonin receptor activity |
| GO:0008843 | 0.0021 | Inf | 0.0021 | 1 | 1 | endochitinase activity |
| GO:0033798 | 0.0021 | Inf | 0.0021 | 1 | 1 | thyroxine 5-deiodinase activity |
| GO:0015459 | 0.0042 | 22.9077 | 0.0965 | 2 | 46 | potassium channel regulator activity |
| GO:0036461 | 0.0042 | 490 | 0.0042 | 1 | 2 | BLOC-2 complex binding |
| GO:0042284 | 0.0042 | 490 | 0.0042 | 1 | 2 | sphingolipid delta-4 desaturase activity |
| GO:0004800 | 0.0063 | 244.9848 | 0.0063 | 1 | 3 | thyroxine 5'-deiodinase activity |
| GO:0035651 | 0.0063 | 244.9848 | 0.0063 | 1 | 3 | AP-3 adaptor complex binding |
| GO:0035650 | 0.0084 | 163.3131 | 0.0084 | 1 | 4 | AP-1 adaptor complex binding |
| GO:0008236 | 0.0091 | 7.6123 | 0.4322 | 3 | 206 | serine-type peptidase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0032394 | 0 | Inf | 0.0031 | 2 | 2 | MHC class Ib receptor activity |
| GO:0042288 | 0 | 146.9545 | 0.0278 | 3 | 18 | MHC class I protein binding |
| GO:0048020 | 0.0016 | 37.9389 | 0.0602 | 2 | 39 | CCR chemokine receptor binding |
| GO:0008009 | 0.0025 | 30.4991 | 0.0741 | 2 | 48 | chemokine activity |
| GO:0004252 | 0.0025 | 12.3998 | 0.2761 | 3 | 179 | serine-type endopeptidase activity |
| GO:0005171 | 0.0031 | 674.125 | 0.0031 | 1 | 2 | hepatocyte growth factor receptor binding |
| GO:0046556 | 0.0031 | 674.125 | 0.0031 | 1 | 2 | alpha-L-arabinofuranosidase activity |
| GO:0017171 | 0.0041 | 10.4712 | 0.3255 | 3 | 211 | serine hydrolase activity |
| GO:0004663 | 0.0046 | 337.0417 | 0.0046 | 1 | 3 | Rab geranylgeranyltransferase activity |
| GO:0030246 | 0.0072 | 8.4487 | 0.4011 | 3 | 260 | carbohydrate binding |
| GO:0004046 | 0.0077 | 168.5 | 0.0077 | 1 | 5 | aminoacylase activity |
| GO:0005096 | 0.008 | 8.1272 | 0.4165 | 3 | 270 | GTPase activator activity |
| GO:0008318 | 0.0092 | 134.7917 | 0.0093 | 1 | 6 | protein prenyltransferase activity |
| GO:0016427 | 0.0092 | 134.7917 | 0.0093 | 1 | 6 | tRNA (cytosine) methyltransferase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004744 | 0.0016 | Inf | 0.0016 | 1 | 1 | retinal isomerase activity |
| GO:0036487 | 0.0016 | Inf | 0.0016 | 1 | 1 | nitric-oxide synthase inhibitor activity |
| GO:0052884 | 0.0016 | Inf | 0.0016 | 1 | 1 | all-trans-retinyl-palmitate hydrolase, 11-cis retinol forming activity |
| GO:0052885 | 0.0016 | Inf | 0.0016 | 1 | 1 | all-trans-retinyl-ester hydrolase, 11-cis retinol forming activity |
| GO:0046976 | 0.008 | 161.75 | 0.008 | 1 | 5 | histone methyltransferase activity (H3-K27 specific) |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004667 | 0.0031 | 674.125 | 0.0031 | 1 | 2 | prostaglandin-D synthase activity |
| GO:0004947 | 0.0031 | 674.125 | 0.0031 | 1 | 2 | bradykinin receptor activity |
| GO:0045029 | 0.0031 | 674.125 | 0.0031 | 1 | 2 | UDP-activated nucleotide receptor activity |
| GO:0071553 | 0.0031 | 674.125 | 0.0031 | 1 | 2 | G-protein coupled pyrimidinergic nucleotide receptor activity |
| GO:0004165 | 0.0046 | 337.0417 | 0.0046 | 1 | 3 | dodecenoyl-CoA delta-isomerase activity |
| GO:0016508 | 0.0046 | 337.0417 | 0.0046 | 1 | 3 | long-chain-enoyl-CoA hydratase activity |
| GO:0035594 | 0.0062 | 224.6806 | 0.0062 | 1 | 4 | ganglioside binding |
| GO:0051425 | 0.0062 | 224.6806 | 0.0062 | 1 | 4 | PTB domain binding |
| GO:0019534 | 0.0077 | 168.5 | 0.0077 | 1 | 5 | toxin transmembrane transporter activity |
| GO:0016427 | 0.0092 | 134.7917 | 0.0093 | 1 | 6 | tRNA (cytosine) methyltransferase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0032089 | 0.0031 | 674.125 | 0.0031 | 1 | 2 | NACHT domain binding |
| GO:0051425 | 0.0062 | 224.6806 | 0.0062 | 1 | 4 | PTB domain binding |
| GO:0016427 | 0.0092 | 134.7917 | 0.0093 | 1 | 6 | tRNA (cytosine) methyltransferase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0005509 | 0.0014 | 5.6954 | 1.2626 | 6 | 660 | calcium ion binding |
| GO:0004693 | 0.0015 | 39.7685 | 0.0574 | 2 | 30 | cyclin-dependent protein serine/threonine kinase activity |
| GO:0046523 | 0.0019 | Inf | 0.0019 | 1 | 1 | S-methyl-5-thioribose-1-phosphate isomerase activity |
| GO:0030354 | 0.0038 | 539.1 | 0.0038 | 1 | 2 | melanin-concentrating hormone activity |
| GO:0004980 | 0.0057 | 269.5333 | 0.0057 | 1 | 3 | melanocyte-stimulating hormone receptor activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0008009 | 1e-04 | 41.3615 | 0.0859 | 3 | 48 | chemokine activity |
| GO:0004435 | 0.0011 | 47.8548 | 0.0483 | 2 | 27 | phosphatidylinositol phospholipase C activity |
| GO:0005126 | 0.0012 | 9.8329 | 0.4707 | 4 | 263 | cytokine receptor binding |
| GO:0048020 | 0.0016 | 38.7981 | 0.0588 | 2 | 34 | CCR chemokine receptor binding |
| GO:0003827 | 0.0018 | Inf | 0.0018 | 1 | 1 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity |
| GO:0030107 | 0.0018 | Inf | 0.0018 | 1 | 1 | HLA-A specific inhibitory MHC class I receptor activity |
| GO:0035717 | 0.0018 | Inf | 0.0018 | 1 | 1 | chemokine (C-C motif) ligand 7 binding |
| GO:0045127 | 0.0018 | Inf | 0.0018 | 1 | 1 | N-acetylglucosamine kinase activity |
| GO:0030109 | 0.0036 | 577.6786 | 0.0036 | 1 | 2 | HLA-B specific inhibitory MHC class I receptor activity |
| GO:0071791 | 0.0036 | 577.6786 | 0.0036 | 1 | 2 | chemokine (C-C motif) ligand 5 binding |
| GO:0099600 | 0.0048 | 3.9284 | 2.1815 | 7 | 1219 | transmembrane receptor activity |
| GO:0001730 | 0.0054 | 288.8214 | 0.0054 | 1 | 3 | 2'-5'-oligoadenylate synthetase activity |
| GO:0004965 | 0.0054 | 288.8214 | 0.0054 | 1 | 3 | G-protein coupled GABA receptor activity |
| GO:0005124 | 0.0054 | 288.8214 | 0.0054 | 1 | 3 | scavenger receptor binding |
| GO:0047374 | 0.0054 | 288.8214 | 0.0054 | 1 | 3 | methylumbelliferyl-acetate deacetylase activity |
| GO:0004871 | 0.0054 | 3.5266 | 2.8365 | 8 | 1585 | signal transducer activity |
| GO:0004872 | 0.0069 | 8.6913 | 0.3964 | 3 | 270 | receptor activity |
| GO:0004698 | 0.0071 | 192.5357 | 0.0072 | 1 | 4 | calcium-dependent protein kinase C activity |
| GO:0004771 | 0.0071 | 192.5357 | 0.0072 | 1 | 4 | sterol esterase activity |
| GO:0004982 | 0.0071 | 192.5357 | 0.0072 | 1 | 4 | N-formyl peptide receptor activity |
| GO:0048018 | 0.0077 | 5.7088 | 0.7964 | 4 | 445 | receptor ligand activity |
| GO:0030883 | 0.0089 | 144.3929 | 0.0089 | 1 | 5 | endogenous lipid antigen binding |
| GO:0030884 | 0.0089 | 144.3929 | 0.0089 | 1 | 5 | exogenous lipid antigen binding |
| GO:0031726 | 0.0089 | 144.3929 | 0.0089 | 1 | 5 | CCR1 chemokine receptor binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004872 | 0 | 6.2846 | 2.8484 | 12 | 1489 | receptor activity |
| GO:0008009 | 1e-04 | 38.4024 | 0.0918 | 3 | 48 | chemokine activity |
| GO:0004888 | 0.0013 | 4.4729 | 2.2478 | 8 | 1175 | transmembrane signaling receptor activity |
| GO:0030246 | 0.0014 | 9.2118 | 0.4974 | 4 | 260 | carbohydrate binding |
| GO:0005126 | 0.0015 | 9.1034 | 0.5031 | 4 | 263 | cytokine receptor binding |
| GO:0048020 | 0.0018 | 36.0223 | 0.063 | 2 | 34 | CCR chemokine receptor binding |
| GO:0003827 | 0.0019 | Inf | 0.0019 | 1 | 1 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity |
| GO:0030107 | 0.0019 | Inf | 0.0019 | 1 | 1 | HLA-A specific inhibitory MHC class I receptor activity |
| GO:0035717 | 0.0019 | Inf | 0.0019 | 1 | 1 | chemokine (C-C motif) ligand 7 binding |
| GO:0045127 | 0.0019 | Inf | 0.0019 | 1 | 1 | N-acetylglucosamine kinase activity |
| GO:0004871 | 0.0022 | 3.7893 | 3.0321 | 9 | 1585 | signal transducer activity |
| GO:0030109 | 0.0038 | 539.1 | 0.0038 | 1 | 2 | HLA-B specific inhibitory MHC class I receptor activity |
| GO:0071791 | 0.0038 | 539.1 | 0.0038 | 1 | 2 | chemokine (C-C motif) ligand 5 binding |
| GO:0001730 | 0.0057 | 269.5333 | 0.0057 | 1 | 3 | 2'-5'-oligoadenylate synthetase activity |
| GO:0004965 | 0.0057 | 269.5333 | 0.0057 | 1 | 3 | G-protein coupled GABA receptor activity |
| GO:0005124 | 0.0057 | 269.5333 | 0.0057 | 1 | 3 | scavenger receptor binding |
| GO:0047374 | 0.0057 | 269.5333 | 0.0057 | 1 | 3 | methylumbelliferyl-acetate deacetylase activity |
| GO:0004698 | 0.0076 | 179.6778 | 0.0077 | 1 | 4 | calcium-dependent protein kinase C activity |
| GO:0004771 | 0.0076 | 179.6778 | 0.0077 | 1 | 4 | sterol esterase activity |
| GO:0004982 | 0.0076 | 179.6778 | 0.0077 | 1 | 4 | N-formyl peptide receptor activity |
| GO:0019863 | 0.0095 | 134.75 | 0.0096 | 1 | 5 | IgE binding |
| GO:0030883 | 0.0095 | 134.75 | 0.0096 | 1 | 5 | endogenous lipid antigen binding |
| GO:0030884 | 0.0095 | 134.75 | 0.0096 | 1 | 5 | exogenous lipid antigen binding |
| GO:0031726 | 0.0095 | 134.75 | 0.0096 | 1 | 5 | CCR1 chemokine receptor binding |
| GO:0048018 | 0.0098 | 5.2853 | 0.8513 | 4 | 445 | receptor ligand activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0008009 | 1e-04 | 44.8139 | 0.08 | 3 | 48 | chemokine activity |
| GO:0008061 | 1e-04 | 215.6267 | 0.0133 | 2 | 8 | chitin binding |
| GO:0001664 | 8e-04 | 10.9031 | 0.4299 | 4 | 258 | G-protein coupled receptor binding |
| GO:0048020 | 8e-04 | 53.99 | 0.0432 | 2 | 28 | CCR chemokine receptor binding |
| GO:0005126 | 9e-04 | 10.6893 | 0.4382 | 4 | 263 | cytokine receptor binding |
| GO:0008843 | 0.0017 | Inf | 0.0017 | 1 | 1 | endochitinase activity |
| GO:0036470 | 0.0017 | Inf | 0.0017 | 1 | 1 | tyrosine 3-monooxygenase activator activity |
| GO:0036478 | 0.0017 | Inf | 0.0017 | 1 | 1 | L-dopa decarboxylase activator activity |
| GO:0036524 | 0.0017 | Inf | 0.0017 | 1 | 1 | protein deglycase activity |
| GO:0045340 | 0.0017 | Inf | 0.0017 | 1 | 1 | mercury ion binding |
| GO:0016532 | 0.0033 | 622.1923 | 0.0033 | 1 | 2 | superoxide dismutase copper chaperone activity |
| GO:0031731 | 0.005 | 311.0769 | 0.005 | 1 | 3 | CCR6 chemokine receptor binding |
| GO:0047894 | 0.005 | 311.0769 | 0.005 | 1 | 3 | flavonol 3-sulfotransferase activity |
| GO:1903135 | 0.005 | 311.0769 | 0.005 | 1 | 3 | cupric ion binding |
| GO:0004568 | 0.0064 | 215.6667 | 0.0064 | 1 | 4 | chitinase activity |
| GO:0004583 | 0.0066 | 207.3718 | 0.0067 | 1 | 4 | dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity |
| GO:0004698 | 0.0066 | 207.3718 | 0.0067 | 1 | 4 | calcium-dependent protein kinase C activity |
| GO:0050294 | 0.0066 | 207.3718 | 0.0067 | 1 | 4 | steroid sulfotransferase activity |
| GO:0016530 | 0.0083 | 155.5192 | 0.0083 | 1 | 5 | metallochaperone activity |
| GO:0031726 | 0.0083 | 155.5192 | 0.0083 | 1 | 5 | CCR1 chemokine receptor binding |
| GO:0032184 | 0.0083 | 155.5192 | 0.0083 | 1 | 5 | SUMO polymer binding |
| GO:0044388 | 0.0083 | 155.5192 | 0.0083 | 1 | 5 | small protein activating enzyme binding |
| GO:1903136 | 0.0083 | 155.5192 | 0.0083 | 1 | 5 | cuprous ion binding |
| GO:0031730 | 0.01 | 124.4077 | 0.01 | 1 | 6 | CCR5 chemokine receptor binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0036470 | 0.0015 | Inf | 0.0015 | 1 | 1 | tyrosine 3-monooxygenase activator activity |
| GO:0036478 | 0.0015 | Inf | 0.0015 | 1 | 1 | L-dopa decarboxylase activator activity |
| GO:0036524 | 0.0015 | Inf | 0.0015 | 1 | 1 | protein deglycase activity |
| GO:0045340 | 0.0015 | Inf | 0.0015 | 1 | 1 | mercury ion binding |
| GO:0016532 | 0.003 | 703.4783 | 0.003 | 1 | 2 | superoxide dismutase copper chaperone activity |
| GO:1903135 | 0.0044 | 351.7174 | 0.0044 | 1 | 3 | cupric ion binding |
| GO:0004583 | 0.0059 | 234.4638 | 0.0059 | 1 | 4 | dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity |
| GO:0016530 | 0.0074 | 175.837 | 0.0074 | 1 | 5 | metallochaperone activity |
| GO:0044388 | 0.0074 | 175.837 | 0.0074 | 1 | 5 | small protein activating enzyme binding |
| GO:1903136 | 0.0074 | 175.837 | 0.0074 | 1 | 5 | cuprous ion binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0001637 | 1e-04 | 140.6087 | 0.0185 | 2 | 25 | G-protein coupled chemoattractant receptor activity |
| GO:0070095 | 0.0015 | 1472 | 0.0015 | 1 | 2 | fructose-6-phosphate binding |
| GO:0071791 | 0.0015 | 1472 | 0.0015 | 1 | 2 | chemokine (C-C motif) ligand 5 binding |
| GO:0004896 | 0.0017 | 39.7827 | 0.0615 | 2 | 83 | cytokine receptor activity |
| GO:0031781 | 0.003 | 490.6061 | 0.003 | 1 | 4 | type 3 melanocortin receptor binding |
| GO:0031782 | 0.003 | 490.6061 | 0.003 | 1 | 4 | type 4 melanocortin receptor binding |
| GO:0001653 | 0.0036 | 26.5653 | 0.0911 | 2 | 123 | peptide receptor activity |
| GO:0016494 | 0.0052 | 245.2576 | 0.0052 | 1 | 7 | C-X-C chemokine receptor activity |
| GO:0030215 | 0.0074 | 163.4747 | 0.0074 | 1 | 10 | semaphorin receptor binding |
| GO:0016493 | 0.0089 | 133.7355 | 0.0089 | 1 | 12 | C-C chemokine receptor activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0015130 | 7e-04 | Inf | 7e-04 | 1 | 1 | mevalonate transmembrane transporter activity |
| GO:0010465 | 0.0014 | 1619.3 | 0.0014 | 1 | 2 | nerve growth factor receptor activity |
| GO:0045523 | 0.0014 | 1619.3 | 0.0014 | 1 | 2 | interleukin-27 receptor binding |
| GO:0005166 | 0.002 | 809.6 | 0.002 | 1 | 3 | neurotrophin p75 receptor binding |
| GO:0030369 | 0.002 | 809.6 | 0.002 | 1 | 3 | ICAM-3 receptor activity |
| GO:0015129 | 0.0034 | 404.75 | 0.0034 | 1 | 5 | lactate transmembrane transporter activity |
| GO:0048406 | 0.0041 | 323.78 | 0.0041 | 1 | 6 | nerve growth factor binding |
| GO:0005004 | 0.0047 | 269.8 | 0.0048 | 1 | 7 | GPI-linked ephrin receptor activity |
| GO:0004065 | 0.0054 | 231.2429 | 0.0054 | 1 | 8 | arylsulfatase activity |
| GO:0005509 | 0.0087 | 8.8682 | 0.448 | 3 | 660 | calcium ion binding |
| GO:0005125 | 0.009 | 16.594 | 0.1466 | 2 | 216 | cytokine activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0001227 | 4e-04 | 13.5002 | 0.3514 | 4 | 219 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding |
| GO:0005307 | 0.0016 | Inf | 0.0016 | 1 | 1 | choline:sodium symporter activity |
| GO:0036313 | 0.0032 | 647.12 | 0.0032 | 1 | 2 | phosphatidylinositol 3-kinase catalytic subunit binding |
| GO:0033829 | 0.0048 | 323.54 | 0.0048 | 1 | 3 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity |
| GO:0008013 | 0.0062 | 18.6424 | 0.1187 | 2 | 74 | beta-catenin binding |
| GO:0004095 | 0.0064 | 215.68 | 0.0064 | 1 | 4 | carnitine O-palmitoyltransferase activity |
| GO:0033265 | 0.0064 | 215.68 | 0.0064 | 1 | 4 | choline binding |
| GO:0005134 | 0.008 | 161.75 | 0.008 | 1 | 5 | interleukin-2 receptor binding |
| GO:0001158 | 0.0087 | 15.594 | 0.1412 | 2 | 88 | enhancer sequence-specific DNA binding |
| NA. |
| n/a |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0048020 | 5e-04 | 72.7658 | 0.0337 | 2 | 39 | CCR chemokine receptor binding |
| GO:0008009 | 8e-04 | 58.4964 | 0.0415 | 2 | 48 | chemokine activity |
| GO:0005126 | 0.0013 | 16.7108 | 0.2272 | 3 | 263 | cytokine receptor binding |
| GO:0048018 | 0.006 | 9.7176 | 0.3844 | 3 | 445 | receptor ligand activity |
| GO:0015467 | 0.0086 | 138.3077 | 0.0086 | 1 | 10 | G-protein activated inward rectifier potassium channel activity |
| GO:0039706 | 0.0086 | 138.3077 | 0.0086 | 1 | 10 | co-receptor binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0001965 | 3e-04 | 100.1053 | 0.0246 | 2 | 19 | G-protein alpha-subunit binding |
| GO:0033829 | 0.0039 | 404.55 | 0.0039 | 1 | 3 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004033 | 3e-04 | 103.6282 | 0.0241 | 2 | 26 | aldo-keto reductase (NADP) activity |
| GO:0018455 | 9e-04 | Inf | 9e-04 | 1 | 1 | alcohol dehydrogenase [NAD(P)+] activity |
| GO:0047042 | 9e-04 | Inf | 9e-04 | 1 | 1 | androsterone dehydrogenase (B-specific) activity |
| GO:0016655 | 0.001 | 51.7372 | 0.0463 | 2 | 50 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor |
| GO:0047006 | 0.0019 | 1156.3571 | 0.0019 | 1 | 2 | 17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity |
| GO:0018636 | 0.0028 | 578.1429 | 0.0028 | 1 | 3 | phenanthrene 9,10-monooxygenase activity |
| GO:0035662 | 0.0028 | 578.1429 | 0.0028 | 1 | 3 | Toll-like receptor 4 binding |
| GO:0047086 | 0.0028 | 578.1429 | 0.0028 | 1 | 3 | ketosteroid monooxygenase activity |
| GO:0047718 | 0.0028 | 578.1429 | 0.0028 | 1 | 3 | indanol dehydrogenase activity |
| GO:0047844 | 0.0028 | 578.1429 | 0.0028 | 1 | 3 | deoxycytidine deaminase activity |
| GO:0000253 | 0.0037 | 385.4048 | 0.0037 | 1 | 4 | 3-keto sterol reductase activity |
| GO:0004090 | 0.0037 | 385.4048 | 0.0037 | 1 | 4 | carbonyl reductase (NADPH) activity |
| GO:0008745 | 0.0037 | 385.4048 | 0.0037 | 1 | 4 | N-acetylmuramoyl-L-alanine amidase activity |
| GO:0047115 | 0.0037 | 385.4048 | 0.0037 | 1 | 4 | trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity |
| GO:0008270 | 0.0045 | 7.3523 | 0.71 | 4 | 767 | zinc ion binding |
| GO:0016019 | 0.0046 | 289.0357 | 0.0046 | 1 | 5 | peptidoglycan receptor activity |
| GO:0050544 | 0.0046 | 289.0357 | 0.0046 | 1 | 5 | arachidonic acid binding |
| GO:0016614 | 0.0064 | 19.1544 | 0.1213 | 2 | 131 | oxidoreductase activity, acting on CH-OH group of donors |
| GO:0004032 | 0.0065 | 192.6667 | 0.0065 | 1 | 7 | alditol:NADP+ 1-oxidoreductase activity |
| GO:0016810 | 0.0072 | 17.8952 | 0.1296 | 2 | 140 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds |
| GO:0004126 | 0.0074 | 165.1327 | 0.0074 | 1 | 8 | cytidine deaminase activity |
| GO:0032052 | 0.0083 | 144.4821 | 0.0083 | 1 | 9 | bile acid binding |
| GO:0052650 | 0.0083 | 144.4821 | 0.0083 | 1 | 9 | NADP-retinol dehydrogenase activity |
| GO:0070700 | 0.0083 | 144.4821 | 0.0083 | 1 | 9 | BMP receptor binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0003755 | 0 | 55.344 | 0.0657 | 3 | 38 | peptidyl-prolyl cis-trans isomerase activity |
| GO:0030377 | 0.0017 | Inf | 0.0017 | 1 | 1 | urokinase plasminogen activator receptor activity |
| GO:0102339 | 0.0017 | Inf | 0.0017 | 1 | 1 | 3-oxo-arachidoyl-CoA reductase activity |
| GO:0102340 | 0.0017 | Inf | 0.0017 | 1 | 1 | 3-oxo-behenoyl-CoA reductase activity |
| GO:0102341 | 0.0017 | Inf | 0.0017 | 1 | 1 | 3-oxo-lignoceroyl-CoA reductase activity |
| GO:0102342 | 0.0017 | Inf | 0.0017 | 1 | 1 | 3-oxo-cerotoyl-CoA reductase activity |
| GO:0016853 | 0.0018 | 13.8458 | 0.2454 | 3 | 142 | isomerase activity |
| GO:0004666 | 0.0035 | 599.1111 | 0.0035 | 1 | 2 | prostaglandin-endoperoxide synthase activity |
| GO:0016509 | 0.0052 | 299.537 | 0.0052 | 1 | 3 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0033862 | 0.0024 | Inf | 0.0024 | 1 | 1 | UMP kinase activity |
| GO:0035717 | 0.0024 | Inf | 0.0024 | 1 | 1 | chemokine (C-C motif) ligand 7 binding |
| GO:0047730 | 0.0024 | Inf | 0.0024 | 1 | 1 | carnosine synthase activity |
| GO:0102102 | 0.0024 | Inf | 0.0024 | 1 | 1 | homocarnosine synthase activity |
| GO:0102339 | 0.0024 | Inf | 0.0024 | 1 | 1 | 3-oxo-arachidoyl-CoA reductase activity |
| GO:0102340 | 0.0024 | Inf | 0.0024 | 1 | 1 | 3-oxo-behenoyl-CoA reductase activity |
| GO:0102341 | 0.0024 | Inf | 0.0024 | 1 | 1 | 3-oxo-lignoceroyl-CoA reductase activity |
| GO:0102342 | 0.0024 | Inf | 0.0024 | 1 | 1 | 3-oxo-cerotoyl-CoA reductase activity |
| GO:0004666 | 0.0048 | 425.3947 | 0.0048 | 1 | 2 | prostaglandin-endoperoxide synthase activity |
| GO:0004798 | 0.0048 | 425.3947 | 0.0048 | 1 | 2 | thymidylate kinase activity |
| GO:0047057 | 0.0048 | 425.3947 | 0.0048 | 1 | 2 | vitamin-K-epoxide reductase (warfarin-sensitive) activity |
| GO:0071791 | 0.0048 | 425.3947 | 0.0048 | 1 | 2 | chemokine (C-C motif) ligand 5 binding |
| GO:0004829 | 0.0072 | 212.6842 | 0.0072 | 1 | 3 | threonine-tRNA ligase activity |
| GO:0016509 | 0.0072 | 212.6842 | 0.0072 | 1 | 3 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity |
| GO:0004127 | 0.0096 | 141.7807 | 0.0096 | 1 | 4 | cytidylate kinase activity |
| GO:1905394 | 0.0096 | 141.7807 | 0.0096 | 1 | 4 | retromer complex binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0032394 | 0 | Inf | 0.0052 | 2 | 2 | MHC class Ib receptor activity |
| GO:0042288 | 0.001 | 50.4594 | 0.0467 | 2 | 18 | MHC class I protein binding |
| GO:0031855 | 0.0026 | Inf | 0.0026 | 1 | 1 | oxytocin receptor binding |
| GO:0033897 | 0.0026 | Inf | 0.0026 | 1 | 1 | ribonuclease T2 activity |
| GO:0030246 | 0.0045 | 6.5407 | 0.6739 | 4 | 260 | carbohydrate binding |
| GO:0005185 | 0.0052 | 394.1951 | 0.0052 | 1 | 2 | neurohypophyseal hormone activity |
| GO:0098640 | 0.0052 | 394.1951 | 0.0052 | 1 | 2 | integrin binding involved in cell-matrix adhesion |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0007156 | 0 | 19.9187 | 1.1052 | 17 | 152 | homophilic cell adhesion via plasma membrane adhesion molecules |
| GO:0016339 | 0 | 69.9314 | 0.2036 | 9 | 28 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules |
| GO:0007416 | 0 | 15.7071 | 1.0107 | 13 | 139 | synapse assembly |
| GO:0007267 | 0 | 4.3272 | 11.0518 | 36 | 1520 | cell-cell signaling |
| GO:0032502 | 0 | 4.9522 | 9.3955 | 30 | 1640 | developmental process |
| GO:0007268 | 0 | 5.6153 | 4.2535 | 20 | 585 | chemical synaptic transmission |
| GO:0099537 | 0 | 5.5948 | 4.268 | 20 | 587 | trans-synaptic signaling |
| GO:0098609 | 0 | 4.9105 | 5.6713 | 23 | 780 | cell-cell adhesion |
| GO:0032501 | 0 | 2.9234 | 39.0207 | 65 | 5921 | multicellular organismal process |
| GO:0009890 | 0 | 3.2271 | 11.8734 | 31 | 1633 | negative regulation of biosynthetic process |
| GO:1902679 | 0 | 3.6189 | 8.2816 | 25 | 1139 | negative regulation of RNA biosynthetic process |
| GO:0080090 | 0 | 2.4559 | 42.2441 | 68 | 5810 | regulation of primary metabolic process |
| GO:0051171 | 0 | 2.3843 | 41.1753 | 66 | 5663 | regulation of nitrogen compound metabolic process |
| GO:0048562 | 0 | 6.6665 | 1.8606 | 11 | 260 | embryonic organ morphogenesis |
| GO:0009954 | 0 | 27.3741 | 0.2254 | 5 | 31 | proximal/distal pattern formation |
| GO:0045934 | 0 | 3.1203 | 9.9176 | 26 | 1364 | negative regulation of nucleobase-containing compound metabolic process |
| GO:0031323 | 0 | 2.2975 | 43.1021 | 67 | 5928 | regulation of cellular metabolic process |
| GO:0022610 | 0 | 3.0729 | 9.6049 | 25 | 1321 | biological adhesion |
| GO:0090596 | 0 | 10.8084 | 0.7306 | 7 | 104 | sensory organ morphogenesis |
| GO:0000122 | 0 | 3.7389 | 5.5114 | 18 | 758 | negative regulation of transcription from RNA polymerase II promoter |
| GO:0010605 | 0 | 2.5143 | 18.8899 | 38 | 2598 | negative regulation of macromolecule metabolic process |
| GO:0048663 | 0 | 13.8672 | 0.4944 | 6 | 68 | neuron fate commitment |
| GO:0048598 | 0 | 5.8093 | 1.9223 | 10 | 292 | embryonic morphogenesis |
| GO:0034654 | 0 | 2.2035 | 29.6727 | 50 | 4081 | nucleobase-containing compound biosynthetic process |
| GO:0060173 | 0 | 7.16 | 1.2361 | 8 | 170 | limb development |
| GO:0007405 | 0 | 14.5042 | 0.3926 | 5 | 54 | neuroblast proliferation |
| GO:0072272 | 1e-04 | Inf | 0.0145 | 2 | 2 | proximal/distal pattern formation involved in metanephric nephron development |
| GO:0009952 | 1e-04 | 6.7029 | 1.3161 | 8 | 184 | anterior/posterior pattern specification |
| GO:0021521 | 1e-04 | 52.5098 | 0.08 | 3 | 11 | ventral spinal cord interneuron specification |
| GO:0021872 | 1e-04 | 13.1572 | 0.429 | 5 | 59 | forebrain generation of neurons |
| GO:0055015 | 1e-04 | 46.6725 | 0.0873 | 3 | 12 | ventricular cardiac muscle cell development |
| GO:0045944 | 1e-04 | 2.9303 | 7.7726 | 20 | 1069 | positive regulation of transcription from RNA polymerase II promoter |
| GO:0035107 | 1e-04 | 7.2993 | 1.0543 | 7 | 145 | appendage morphogenesis |
| GO:0034645 | 1e-04 | 2.0145 | 35.8166 | 55 | 4926 | cellular macromolecule biosynthetic process |
| GO:0001708 | 1e-04 | 11.113 | 0.5007 | 5 | 70 | cell fate specification |
| GO:0001755 | 1e-04 | 17.0952 | 0.269 | 4 | 37 | neural crest cell migration |
| GO:0008284 | 2e-04 | 3.0523 | 6.2457 | 17 | 859 | positive regulation of cell proliferation |
| GO:0003350 | 2e-04 | 277.7586 | 0.0218 | 2 | 3 | pulmonary myocardium development |
| GO:0055014 | 2e-04 | 277.7586 | 0.0218 | 2 | 3 | atrial cardiac muscle cell development |
| GO:0061010 | 2e-04 | 277.7586 | 0.0218 | 2 | 3 | gall bladder development |
| GO:0061031 | 2e-04 | 277.7586 | 0.0218 | 2 | 3 | endodermal digestive tract morphogenesis |
| GO:0060581 | 2e-04 | 34.9978 | 0.1091 | 3 | 15 | cell fate commitment involved in pattern specification |
| GO:0043009 | 2e-04 | 3.6116 | 3.9772 | 13 | 547 | chordate embryonic development |
| GO:0097659 | 2e-04 | 2.3707 | 14.8517 | 29 | 2252 | nucleic acid-templated transcription |
| GO:0021514 | 2e-04 | 29.9944 | 0.1236 | 3 | 17 | ventral spinal cord interneuron differentiation |
| GO:1904837 | 3e-04 | 14.0974 | 0.3199 | 4 | 44 | beta-catenin-TCF complex assembly |
| GO:0035270 | 3e-04 | 7.1993 | 0.9089 | 6 | 125 | endocrine system development |
| GO:0060485 | 3e-04 | 5.1118 | 1.7014 | 8 | 234 | mesenchyme development |
| GO:0007198 | 3e-04 | 138.8707 | 0.0291 | 2 | 4 | adenylate cyclase-inhibiting serotonin receptor signaling pathway |
| GO:0009730 | 3e-04 | 138.8707 | 0.0291 | 2 | 4 | detection of carbohydrate stimulus |
| GO:0009732 | 3e-04 | 138.8707 | 0.0291 | 2 | 4 | detection of hexose stimulus |
| GO:0072086 | 3e-04 | 138.8707 | 0.0291 | 2 | 4 | specification of loop of Henle identity |
| GO:0030326 | 3e-04 | 7.1388 | 0.9161 | 6 | 126 | embryonic limb morphogenesis |
| GO:0021854 | 4e-04 | 24.6967 | 0.1454 | 3 | 20 | hypothalamus development |
| GO:0043586 | 5e-04 | 23.3232 | 0.1527 | 3 | 21 | tongue development |
| GO:0048731 | 5e-04 | 2.5306 | 11.3626 | 23 | 2249 | system development |
| GO:0048729 | 5e-04 | 3.223 | 4.428 | 13 | 609 | tissue morphogenesis |
| GO:0002568 | 5e-04 | 92.5747 | 0.0364 | 2 | 5 | somatic diversification of T cell receptor genes |
| GO:0033153 | 5e-04 | 92.5747 | 0.0364 | 2 | 5 | T cell receptor V(D)J recombination |
| GO:0021513 | 5e-04 | 22.0943 | 0.16 | 3 | 22 | spinal cord dorsal/ventral patterning |
| GO:0021953 | 6e-04 | 6.3321 | 1.0267 | 6 | 146 | central nervous system neuron differentiation |
| GO:0051241 | 6e-04 | 2.6165 | 7.6708 | 18 | 1055 | negative regulation of multicellular organismal process |
| GO:0042472 | 6e-04 | 7.9656 | 0.6835 | 5 | 94 | inner ear morphogenesis |
| GO:0043583 | 7e-04 | 5.0943 | 1.4833 | 7 | 204 | ear development |
| GO:0055002 | 7e-04 | 6.0245 | 1.0761 | 6 | 148 | striated muscle cell development |
| GO:0010628 | 7e-04 | 2.2288 | 12.7896 | 25 | 1759 | positive regulation of gene expression |
| GO:0014062 | 8e-04 | 69.4267 | 0.0436 | 2 | 6 | regulation of serotonin secretion |
| GO:0007420 | 8e-04 | 3.0224 | 4.7043 | 13 | 647 | brain development |
| GO:0021884 | 9e-04 | 18.2473 | 0.189 | 3 | 26 | forebrain neuron development |
| GO:0007399 | 0.0011 | 3.3344 | 3.6818 | 11 | 662 | nervous system development |
| GO:0014031 | 0.0012 | 9.3865 | 0.4653 | 4 | 64 | mesenchymal cell development |
| GO:0048864 | 0.0012 | 9.3865 | 0.4653 | 4 | 64 | stem cell development |
| GO:0048869 | 0.0012 | 1.8807 | 27.243 | 42 | 3963 | cellular developmental process |
| GO:0001569 | 0.0015 | 14.9842 | 0.2254 | 3 | 31 | branching involved in blood vessel morphogenesis |
| GO:0014033 | 0.0015 | 8.7977 | 0.4944 | 4 | 68 | neural crest cell differentiation |
| GO:0051254 | 0.0016 | 2.2398 | 10.4774 | 21 | 1441 | positive regulation of RNA metabolic process |
| GO:0060537 | 0.0016 | 3.5821 | 2.7048 | 9 | 372 | muscle tissue development |
| GO:1902742 | 0.0016 | 14.4666 | 0.2327 | 3 | 32 | apoptotic process involved in development |
| GO:0060562 | 0.0016 | 3.9263 | 2.1886 | 8 | 301 | epithelial tube morphogenesis |
| GO:0009953 | 0.0018 | 8.3682 | 0.518 | 4 | 73 | dorsal/ventral pattern formation |
| GO:0061004 | 0.0018 | 39.665 | 0.0654 | 2 | 9 | pattern specification involved in kidney development |
| GO:0090304 | 0.0018 | 1.7648 | 35.6712 | 51 | 4906 | nucleic acid metabolic process |
| GO:0001570 | 0.0019 | 8.2781 | 0.5235 | 4 | 72 | vasculogenesis |
| GO:0035050 | 0.0019 | 8.2781 | 0.5235 | 4 | 72 | embryonic heart tube development |
| GO:0048863 | 0.0019 | 4.9799 | 1.2912 | 6 | 183 | stem cell differentiation |
| GO:0016055 | 0.002 | 3.2078 | 3.3592 | 10 | 462 | Wnt signaling pathway |
| GO:1903508 | 0.002 | 2.2314 | 9.9612 | 20 | 1370 | positive regulation of nucleic acid-templated transcription |
| GO:0060359 | 0.002 | 5.9971 | 0.8943 | 5 | 123 | response to ammonium ion |
| GO:0055006 | 0.0021 | 8.0406 | 0.538 | 4 | 74 | cardiac cell development |
| GO:0009987 | 0.0022 | 8.9104 | 56.1087 | 63 | 10004 | cellular process |
| GO:0035137 | 0.0022 | 12.7099 | 0.2618 | 3 | 36 | hindlimb morphogenesis |
| GO:0048536 | 0.0022 | 12.7099 | 0.2618 | 3 | 36 | spleen development |
| GO:0035295 | 0.0024 | 3.1243 | 3.4503 | 10 | 489 | tube development |
| GO:0071901 | 0.0024 | 5.7515 | 0.9307 | 5 | 128 | negative regulation of protein serine/threonine kinase activity |
| GO:0045596 | 0.0024 | 2.7865 | 4.6607 | 12 | 641 | negative regulation of cell differentiation |
| GO:0030855 | 0.0025 | 2.6582 | 5.3078 | 13 | 730 | epithelial cell differentiation |
| GO:2000026 | 0.0026 | 2.044 | 13.1822 | 24 | 1813 | regulation of multicellular organismal development |
| GO:0021903 | 0.0028 | 30.8467 | 0.08 | 2 | 11 | rostrocaudal neural tube patterning |
| GO:0090009 | 0.0028 | 30.8467 | 0.08 | 2 | 11 | primitive streak formation |
| GO:2000774 | 0.0028 | 30.8467 | 0.08 | 2 | 11 | positive regulation of cellular senescence |
| GO:0001764 | 0.003 | 5.4819 | 0.9743 | 5 | 134 | neuron migration |
| GO:0009798 | 0.0031 | 7.1206 | 0.6035 | 4 | 83 | axis specification |
| GO:0010470 | 0.0033 | 11.0341 | 0.2981 | 3 | 41 | regulation of gastrulation |
| GO:0042659 | 0.0033 | 27.7603 | 0.0873 | 2 | 12 | regulation of cell fate specification |
| GO:0033673 | 0.0034 | 3.8447 | 1.9413 | 7 | 267 | negative regulation of kinase activity |
| GO:0040011 | 0.0035 | 2.0471 | 11.9534 | 22 | 1644 | locomotion |
| GO:0003002 | 0.0036 | 10.6284 | 0.3071 | 3 | 49 | regionalization |
| GO:0010467 | 0.0036 | 1.8614 | 22.0627 | 34 | 3433 | gene expression |
| GO:0021520 | 0.0039 | 25.2351 | 0.0945 | 2 | 13 | spinal cord motor neuron cell fate specification |
| GO:0021535 | 0.0039 | 25.2351 | 0.0945 | 2 | 13 | cell migration in hindbrain |
| GO:0048935 | 0.0039 | 25.2351 | 0.0945 | 2 | 13 | peripheral nervous system neuron development |
| GO:0060911 | 0.0039 | 25.2351 | 0.0945 | 2 | 13 | cardiac cell fate commitment |
| GO:0048592 | 0.0039 | 5.1215 | 1.0397 | 5 | 143 | eye morphogenesis |
| GO:0006837 | 0.0045 | 23.1307 | 0.1018 | 2 | 14 | serotonin transport |
| GO:0048853 | 0.0045 | 23.1307 | 0.1018 | 2 | 14 | forebrain morphogenesis |
| GO:0022008 | 0.0046 | 2.3106 | 7.0914 | 15 | 1020 | neurogenesis |
| GO:0007519 | 0.0049 | 4.8385 | 1.0979 | 5 | 151 | skeletal muscle tissue development |
| GO:0007218 | 0.0051 | 6.177 | 0.6907 | 4 | 95 | neuropeptide signaling pathway |
| GO:0002070 | 0.0052 | 21.3501 | 0.1091 | 2 | 15 | epithelial cell maturation |
| GO:0007379 | 0.0052 | 21.3501 | 0.1091 | 2 | 15 | segment specification |
| GO:0009893 | 0.0052 | 1.7475 | 23.0271 | 35 | 3167 | positive regulation of metabolic process |
| GO:0021510 | 0.0053 | 6.1095 | 0.698 | 4 | 96 | spinal cord development |
| GO:0010557 | 0.0055 | 1.9897 | 11.648 | 21 | 1602 | positive regulation of macromolecule biosynthetic process |
| GO:0007411 | 0.0055 | 3.9608 | 1.6069 | 6 | 221 | axon guidance |
| GO:0007517 | 0.0057 | 3.1551 | 2.6975 | 8 | 371 | muscle organ development |
| GO:0001711 | 0.0059 | 19.8239 | 0.1163 | 2 | 16 | endodermal cell fate commitment |
| GO:0060850 | 0.0059 | 19.8239 | 0.1163 | 2 | 16 | regulation of transcription involved in cell fate commitment |
| GO:0051094 | 0.0062 | 2.1143 | 8.7615 | 17 | 1205 | positive regulation of developmental process |
| GO:0021536 | 0.0063 | 8.595 | 0.376 | 3 | 53 | diencephalon development |
| GO:0009889 | 0.0066 | 1.8882 | 16.0815 | 26 | 2698 | regulation of biosynthetic process |
| GO:0031328 | 0.0067 | 1.9237 | 12.6296 | 22 | 1737 | positive regulation of cellular biosynthetic process |
| GO:0042127 | 0.0067 | 2.5553 | 4.6524 | 11 | 708 | regulation of cell proliferation |
| GO:2001141 | 0.0067 | 1.9084 | 14.3968 | 24 | 2336 | regulation of RNA biosynthetic process |
| GO:0006355 | 0.0068 | 1.9058 | 14.4127 | 24 | 2344 | regulation of transcription, DNA-templated |
| GO:0045892 | 0.0071 | 3.3376 | 2.2364 | 7 | 346 | negative regulation of transcription, DNA-templated |
| GO:0007631 | 0.0072 | 5.5619 | 0.7634 | 4 | 105 | feeding behavior |
| GO:0000433 | 0.0073 | Inf | 0.0073 | 1 | 1 | negative regulation of transcription from RNA polymerase II promoter by glucose |
| GO:0003142 | 0.0073 | Inf | 0.0073 | 1 | 1 | cardiogenic plate morphogenesis |
| GO:0003168 | 0.0073 | Inf | 0.0073 | 1 | 1 | Purkinje myocyte differentiation |
| GO:0014739 | 0.0073 | Inf | 0.0073 | 1 | 1 | positive regulation of muscle hyperplasia |
| GO:0021568 | 0.0073 | Inf | 0.0073 | 1 | 1 | rhombomere 2 development |
| GO:0021723 | 0.0073 | Inf | 0.0073 | 1 | 1 | medullary reticular formation development |
| GO:0021763 | 0.0073 | Inf | 0.0073 | 1 | 1 | subthalamic nucleus development |
| GO:0032597 | 0.0073 | Inf | 0.0073 | 1 | 1 | B cell receptor transport into membrane raft |
| GO:0032600 | 0.0073 | Inf | 0.0073 | 1 | 1 | chemokine receptor transport out of membrane raft |
| GO:0032812 | 0.0073 | Inf | 0.0073 | 1 | 1 | positive regulation of epinephrine secretion |
| GO:0032913 | 0.0073 | Inf | 0.0073 | 1 | 1 | negative regulation of transforming growth factor beta3 production |
| GO:0042404 | 0.0073 | Inf | 0.0073 | 1 | 1 | thyroid hormone catabolic process |
| GO:0048894 | 0.0073 | Inf | 0.0073 | 1 | 1 | efferent axon development in a lateral line nerve |
| GO:0060127 | 0.0073 | Inf | 0.0073 | 1 | 1 | prolactin secreting cell differentiation |
| GO:0060578 | 0.0073 | Inf | 0.0073 | 1 | 1 | superior vena cava morphogenesis |
| GO:0060807 | 0.0073 | Inf | 0.0073 | 1 | 1 | regulation of transcription from RNA polymerase II promoter involved in definitive endodermal cell fate specification |
| GO:0060929 | 0.0073 | Inf | 0.0073 | 1 | 1 | atrioventricular node cell fate commitment |
| GO:0061011 | 0.0073 | Inf | 0.0073 | 1 | 1 | hepatic duct development |
| GO:0061153 | 0.0073 | Inf | 0.0073 | 1 | 1 | trachea gland development |
| GO:0061452 | 0.0073 | Inf | 0.0073 | 1 | 1 | retrotrapezoid nucleus neuron differentiation |
| GO:0061682 | 0.0073 | Inf | 0.0073 | 1 | 1 | seminal vesicle morphogenesis |
| GO:1901980 | 0.0073 | Inf | 0.0073 | 1 | 1 | positive regulation of inward rectifier potassium channel activity |
| GO:1903769 | 0.0073 | Inf | 0.0073 | 1 | 1 | negative regulation of cell proliferation in bone marrow |
| GO:2000971 | 0.0073 | Inf | 0.0073 | 1 | 1 | negative regulation of detection of glucose |
| GO:0045653 | 0.0074 | 17.3438 | 0.1309 | 2 | 18 | negative regulation of megakaryocyte differentiation |
| GO:0001706 | 0.0075 | 8.0564 | 0.3999 | 3 | 55 | endoderm formation |
| GO:0050768 | 0.0077 | 3.6827 | 1.7232 | 6 | 237 | negative regulation of neurogenesis |
| GO:0043279 | 0.008 | 5.4005 | 0.7853 | 4 | 108 | response to alkaloid |
| GO:0002089 | 0.0083 | 16.3225 | 0.1381 | 2 | 19 | lens morphogenesis in camera-type eye |
| GO:0048557 | 0.0083 | 16.3225 | 0.1381 | 2 | 19 | embryonic digestive tract morphogenesis |
| GO:0072079 | 0.0083 | 16.3225 | 0.1381 | 2 | 19 | nephron tubule formation |
| GO:0034641 | 0.0083 | 1.5852 | 45.7415 | 59 | 6291 | cellular nitrogen compound metabolic process |
| GO:0055007 | 0.0085 | 5.2979 | 0.7998 | 4 | 110 | cardiac muscle cell differentiation |
| GO:0060429 | 0.0086 | 2.9428 | 2.8996 | 8 | 435 | epithelium development |
| GO:0003407 | 0.0086 | 7.6155 | 0.4217 | 3 | 58 | neural retina development |
| GO:0006928 | 0.0087 | 1.8505 | 13.7203 | 23 | 1887 | movement of cell or subcellular component |
| GO:0048645 | 0.0091 | 7.479 | 0.429 | 3 | 59 | animal organ formation |
| GO:1900120 | 0.0091 | 15.4148 | 0.1454 | 2 | 20 | regulation of receptor binding |
| GO:0044085 | 0.0096 | 1.6937 | 21.3329 | 32 | 2934 | cellular component biogenesis |
| GO:0042063 | 0.0097 | 3.4982 | 1.8105 | 6 | 249 | gliogenesis |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0007156 | 0 | 19.4984 | 1.1988 | 18 | 152 | homophilic cell adhesion via plasma membrane adhesion molecules |
| GO:0016339 | 0 | 75.7203 | 0.2208 | 10 | 28 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules |
| GO:0007416 | 0 | 15.6957 | 1.0963 | 14 | 139 | synapse assembly |
| GO:0032502 | 0 | 3.8101 | 26.8178 | 57 | 4033 | developmental process |
| GO:0098609 | 0 | 5.1883 | 6.152 | 26 | 780 | cell-cell adhesion |
| GO:0009952 | 0 | 9.8876 | 1.538 | 13 | 195 | anterior/posterior pattern specification |
| GO:0007268 | 0 | 5.4066 | 4.614 | 21 | 585 | chemical synaptic transmission |
| GO:0099537 | 0 | 5.3868 | 4.6297 | 21 | 587 | trans-synaptic signaling |
| GO:0007267 | 0 | 3.5574 | 11.9884 | 34 | 1520 | cell-cell signaling |
| GO:0048568 | 0 | 6.1055 | 3.2416 | 17 | 411 | embryonic organ development |
| GO:0007275 | 0 | 3.2798 | 15.9993 | 36 | 2774 | multicellular organism development |
| GO:0006355 | 0 | 2.477 | 27.1948 | 51 | 3448 | regulation of transcription, DNA-templated |
| GO:0043009 | 0 | 4.4995 | 4.3143 | 17 | 547 | chordate embryonic development |
| GO:0022008 | 0 | 3.0808 | 11.2549 | 29 | 1427 | neurogenesis |
| GO:2001141 | 0 | 2.4522 | 27.4077 | 51 | 3475 | regulation of RNA biosynthetic process |
| GO:0060322 | 0 | 4.0461 | 5.3948 | 19 | 684 | head development |
| GO:0009887 | 0 | 3.6187 | 7.0831 | 22 | 917 | animal organ morphogenesis |
| GO:0022610 | 0 | 3.059 | 10.4189 | 27 | 1321 | biological adhesion |
| GO:0048598 | 0 | 4.9266 | 3.2181 | 14 | 439 | embryonic morphogenesis |
| GO:0035113 | 0 | 9.0299 | 0.9938 | 8 | 126 | embryonic appendage morphogenesis |
| GO:1903508 | 0 | 2.9376 | 10.8053 | 27 | 1370 | positive regulation of nucleic acid-templated transcription |
| GO:0009890 | 0 | 2.7687 | 12.8797 | 30 | 1633 | negative regulation of biosynthetic process |
| GO:0045944 | 0 | 3.1863 | 8.3581 | 23 | 1068 | positive regulation of transcription from RNA polymerase II promoter |
| GO:0035295 | 0 | 4.0776 | 4.4247 | 16 | 561 | tube development |
| GO:2000113 | 0 | 2.8421 | 11.6098 | 28 | 1472 | negative regulation of cellular macromolecule biosynthetic process |
| GO:0001764 | 0 | 8.4524 | 1.0569 | 8 | 134 | neuron migration |
| GO:0019222 | 0 | 2.1588 | 49.8939 | 74 | 6326 | regulation of metabolic process |
| GO:0048663 | 0 | 12.7226 | 0.5363 | 6 | 68 | neuron fate commitment |
| GO:0021854 | 0 | 32.4294 | 0.1577 | 4 | 20 | hypothalamus development |
| GO:0051254 | 0 | 2.7767 | 11.3653 | 27 | 1441 | positive regulation of RNA metabolic process |
| GO:0001501 | 0 | 4.1571 | 3.7543 | 14 | 476 | skeletal system development |
| GO:0007389 | 0 | 11.7036 | 0.5772 | 6 | 85 | pattern specification process |
| GO:0010629 | 0 | 2.5567 | 14.3546 | 31 | 1820 | negative regulation of gene expression |
| GO:0019219 | 0 | 2.1572 | 31.7535 | 53 | 4026 | regulation of nucleobase-containing compound metabolic process |
| GO:0048704 | 0 | 15.5203 | 0.3707 | 5 | 48 | embryonic skeletal system morphogenesis |
| GO:0060173 | 0 | 7.1102 | 1.243 | 8 | 160 | limb development |
| GO:0010557 | 0 | 2.6122 | 12.5294 | 28 | 1601 | positive regulation of macromolecule biosynthetic process |
| GO:0021879 | 0 | 14.8346 | 0.3865 | 5 | 49 | forebrain neuron differentiation |
| GO:0072272 | 1e-04 | Inf | 0.0158 | 2 | 2 | proximal/distal pattern formation involved in metanephric nephron development |
| GO:0007399 | 1e-04 | 5.7764 | 1.7551 | 9 | 308 | nervous system development |
| GO:0060429 | 1e-04 | 2.7472 | 9.5592 | 23 | 1212 | epithelium development |
| GO:0031328 | 1e-04 | 2.4685 | 13.6999 | 29 | 1737 | positive regulation of cellular biosynthetic process |
| GO:0021521 | 1e-04 | 48.279 | 0.0868 | 3 | 11 | ventral spinal cord interneuron specification |
| GO:0034654 | 1e-04 | 2.0501 | 32.1873 | 52 | 4081 | nucleobase-containing compound biosynthetic process |
| GO:0000122 | 1e-04 | 3.1747 | 5.9784 | 17 | 758 | negative regulation of transcription from RNA polymerase II promoter |
| GO:0009954 | 1e-04 | 19.2043 | 0.2445 | 4 | 31 | proximal/distal pattern formation |
| GO:0007423 | 1e-04 | 3.7812 | 3.7944 | 13 | 492 | sensory organ development |
| GO:0021510 | 1e-04 | 8.7492 | 0.7572 | 6 | 96 | spinal cord development |
| GO:0048935 | 1e-04 | 38.6184 | 0.1025 | 3 | 13 | peripheral nervous system neuron development |
| GO:0051094 | 2e-04 | 2.6446 | 9.4225 | 22 | 1204 | positive regulation of developmental process |
| GO:0140076 | 2e-04 | 255.5556 | 0.0237 | 2 | 3 | negative regulation of lipoprotein transport |
| GO:0060581 | 2e-04 | 32.178 | 0.1183 | 3 | 15 | cell fate commitment involved in pattern specification |
| GO:0010628 | 2e-04 | 2.3244 | 13.8734 | 28 | 1759 | positive regulation of gene expression |
| GO:0021543 | 3e-04 | 6.0301 | 1.2619 | 7 | 160 | pallium development |
| GO:0021983 | 3e-04 | 14.0052 | 0.3234 | 4 | 41 | pituitary gland development |
| GO:0021514 | 3e-04 | 27.5777 | 0.1341 | 3 | 17 | ventral spinal cord interneuron differentiation |
| GO:0007198 | 4e-04 | 127.7698 | 0.0315 | 2 | 4 | adenylate cyclase-inhibiting serotonin receptor signaling pathway |
| GO:0061325 | 4e-04 | 127.7698 | 0.0315 | 2 | 4 | cell proliferation involved in outflow tract morphogenesis |
| GO:0072086 | 4e-04 | 127.7698 | 0.0315 | 2 | 4 | specification of loop of Henle identity |
| GO:0072079 | 4e-04 | 24.1275 | 0.1499 | 3 | 19 | nephron tubule formation |
| GO:0042475 | 5e-04 | 8.4595 | 0.6467 | 5 | 82 | odontogenesis of dentin-containing tooth |
| GO:0048839 | 6e-04 | 5.3263 | 1.4197 | 7 | 180 | inner ear development |
| GO:0043586 | 6e-04 | 21.444 | 0.1656 | 3 | 21 | tongue development |
| GO:0031326 | 6e-04 | 3.8949 | 2.893 | 10 | 480 | regulation of cellular biosynthetic process |
| GO:1903507 | 6e-04 | 2.4818 | 8.9755 | 20 | 1138 | negative regulation of nucleic acid-templated transcription |
| GO:0002568 | 6e-04 | 85.1746 | 0.0394 | 2 | 5 | somatic diversification of T cell receptor genes |
| GO:0033153 | 6e-04 | 85.1746 | 0.0394 | 2 | 5 | T cell receptor V(D)J recombination |
| GO:0030900 | 7e-04 | 4.5403 | 1.9043 | 8 | 256 | forebrain development |
| GO:0021513 | 7e-04 | 20.3141 | 0.1735 | 3 | 22 | spinal cord dorsal/ventral patterning |
| GO:0010556 | 7e-04 | 4.1545 | 2.423 | 9 | 406 | regulation of macromolecule biosynthetic process |
| GO:1901576 | 9e-04 | 1.7755 | 48.1193 | 66 | 6101 | organic substance biosynthetic process |
| GO:0007405 | 9e-04 | 10.3555 | 0.4259 | 4 | 54 | neuroblast proliferation |
| GO:0014062 | 9e-04 | 63.877 | 0.0473 | 2 | 6 | regulation of serotonin secretion |
| GO:0008284 | 0.001 | 2.7275 | 6.0254 | 15 | 785 | positive regulation of cell proliferation |
| GO:0003253 | 0.0013 | 51.0984 | 0.0552 | 2 | 7 | cardiac neural crest cell migration involved in outflow tract morphogenesis |
| GO:0003357 | 0.0013 | 51.0984 | 0.0552 | 2 | 7 | noradrenergic neuron differentiation |
| GO:0035726 | 0.0013 | 51.0984 | 0.0552 | 2 | 7 | common myeloid progenitor cell proliferation |
| GO:0048752 | 0.0013 | 51.0984 | 0.0552 | 2 | 7 | semicircular canal morphogenesis |
| GO:0051253 | 0.0013 | 2.3162 | 9.5592 | 20 | 1212 | negative regulation of RNA metabolic process |
| GO:0003002 | 0.0013 | 6.7096 | 0.8042 | 5 | 114 | regionalization |
| GO:0048468 | 0.0013 | 2.0945 | 14.0335 | 26 | 1829 | cell development |
| GO:0035116 | 0.0014 | 15.433 | 0.2208 | 3 | 28 | embryonic hindlimb morphogenesis |
| GO:0042733 | 0.0015 | 8.7709 | 0.4969 | 4 | 63 | embryonic digit morphogenesis |
| GO:0035137 | 0.0016 | 43.5501 | 0.0617 | 2 | 8 | hindlimb morphogenesis |
| GO:0014031 | 0.0016 | 8.6242 | 0.5048 | 4 | 64 | mesenchymal cell development |
| GO:0048864 | 0.0016 | 8.6242 | 0.5048 | 4 | 64 | stem cell development |
| GO:0030182 | 0.0017 | 2.3591 | 8.4234 | 18 | 1134 | neuron differentiation |
| GO:0051173 | 0.0018 | 1.8637 | 22.3205 | 36 | 2830 | positive regulation of nitrogen compound metabolic process |
| GO:0050795 | 0.0018 | 8.345 | 0.5205 | 4 | 66 | regulation of behavior |
| GO:0001569 | 0.0018 | 13.7769 | 0.2445 | 3 | 31 | branching involved in blood vessel morphogenesis |
| GO:0010667 | 0.0018 | 13.7769 | 0.2445 | 3 | 31 | negative regulation of cardiac muscle cell apoptotic process |
| GO:0007417 | 0.0019 | 2.634 | 5.785 | 14 | 765 | central nervous system development |
| GO:0042471 | 0.002 | 6.0196 | 0.8912 | 5 | 113 | ear morphogenesis |
| GO:0009987 | 0.002 | 9.5443 | 25.4539 | 32 | 4746 | cellular process |
| GO:0035115 | 0.002 | 13.301 | 0.2524 | 3 | 32 | embryonic forelimb morphogenesis |
| GO:0014033 | 0.002 | 8.0832 | 0.5363 | 4 | 68 | neural crest cell differentiation |
| GO:0044271 | 0.002 | 2.9174 | 4.6358 | 12 | 741 | cellular nitrogen compound biosynthetic process |
| GO:0048667 | 0.0021 | 2.9827 | 3.9672 | 11 | 503 | cell morphogenesis involved in neuron differentiation |
| GO:0061004 | 0.0021 | 36.4943 | 0.071 | 2 | 9 | pattern specification involved in kidney development |
| GO:0034249 | 0.0024 | 3.3449 | 2.8788 | 9 | 365 | negative regulation of cellular amide metabolic process |
| GO:0050794 | 0.0025 | 1.7652 | 79.4706 | 95 | 10076 | regulation of cellular process |
| GO:0090304 | 0.0026 | 1.6918 | 38.6942 | 54 | 4906 | nucleic acid metabolic process |
| GO:0034393 | 0.0027 | 31.9306 | 0.0789 | 2 | 10 | positive regulation of smooth muscle cell apoptotic process |
| GO:0035878 | 0.0027 | 31.9306 | 0.0789 | 2 | 10 | nail development |
| GO:0090370 | 0.0027 | 31.9306 | 0.0789 | 2 | 10 | negative regulation of cholesterol efflux |
| GO:0060562 | 0.0027 | 3.5968 | 2.374 | 8 | 301 | epithelial tube morphogenesis |
| GO:0007517 | 0.0027 | 3.2882 | 2.9261 | 9 | 371 | muscle organ development |
| GO:0060537 | 0.0028 | 3.279 | 2.934 | 9 | 372 | muscle tissue development |
| GO:0061564 | 0.0028 | 3.052 | 3.5098 | 10 | 445 | axon development |
| GO:0048661 | 0.0028 | 7.3876 | 0.5836 | 4 | 74 | positive regulation of smooth muscle cell proliferation |
| GO:0021761 | 0.0029 | 7.3114 | 0.5891 | 4 | 77 | limbic system development |
| GO:0010985 | 0.0032 | 28.381 | 0.0868 | 2 | 11 | negative regulation of lipoprotein particle clearance |
| GO:0060033 | 0.0032 | 28.381 | 0.0868 | 2 | 11 | anatomical structure regression |
| GO:0061308 | 0.0032 | 28.381 | 0.0868 | 2 | 11 | cardiac neural crest cell development involved in heart development |
| GO:0030879 | 0.0033 | 5.3242 | 1.0017 | 5 | 127 | mammary gland development |
| GO:0071901 | 0.0034 | 5.2806 | 1.0096 | 5 | 128 | negative regulation of protein serine/threonine kinase activity |
| GO:0048870 | 0.0035 | 2.0674 | 11.176 | 21 | 1417 | cell motility |
| GO:2000026 | 0.0037 | 1.943 | 14.2993 | 25 | 1813 | regulation of multicellular organismal development |
| GO:0001708 | 0.004 | 6.6266 | 0.6467 | 4 | 82 | cell fate specification |
| GO:0001656 | 0.0044 | 6.4601 | 0.6625 | 4 | 84 | metanephros development |
| GO:0035195 | 0.0044 | 3.6532 | 2.0349 | 7 | 258 | gene silencing by miRNA |
| GO:0021520 | 0.0045 | 23.2179 | 0.1025 | 2 | 13 | spinal cord motor neuron cell fate specification |
| GO:0021535 | 0.0045 | 23.2179 | 0.1025 | 2 | 13 | cell migration in hindbrain |
| GO:0031274 | 0.0045 | 23.2179 | 0.1025 | 2 | 13 | positive regulation of pseudopodium assembly |
| GO:0048812 | 0.0047 | 2.6683 | 4.4089 | 11 | 559 | neuron projection morphogenesis |
| GO:0006935 | 0.0048 | 2.6583 | 4.4247 | 11 | 561 | chemotaxis |
| GO:0046632 | 0.005 | 6.2254 | 0.6862 | 4 | 87 | alpha-beta T cell differentiation |
| GO:0048701 | 0.005 | 9.401 | 0.347 | 3 | 44 | embryonic cranial skeleton morphogenesis |
| GO:0016441 | 0.0051 | 3.5525 | 2.0901 | 7 | 265 | posttranscriptional gene silencing |
| GO:0072080 | 0.0052 | 6.1509 | 0.6941 | 4 | 88 | nephron tubule development |
| GO:0001667 | 0.0052 | 3.2059 | 2.6501 | 8 | 336 | ameboidal-type cell migration |
| GO:0006837 | 0.0053 | 21.2817 | 0.1104 | 2 | 14 | serotonin transport |
| GO:0021527 | 0.0053 | 21.2817 | 0.1104 | 2 | 14 | spinal cord association neuron differentiation |
| GO:0048646 | 0.0053 | 2.1971 | 7.8792 | 16 | 999 | anatomical structure formation involved in morphogenesis |
| GO:0010656 | 0.0053 | 9.1766 | 0.3549 | 3 | 45 | negative regulation of muscle cell apoptotic process |
| GO:0010718 | 0.0053 | 9.1766 | 0.3549 | 3 | 45 | positive regulation of epithelial to mesenchymal transition |
| GO:2000677 | 0.0053 | 9.1766 | 0.3549 | 3 | 45 | regulation of transcription regulatory region DNA binding |
| GO:0072132 | 0.0057 | 8.9626 | 0.3628 | 3 | 46 | mesenchyme morphogenesis |
| GO:0003300 | 0.0058 | 5.9377 | 0.7177 | 4 | 91 | cardiac muscle hypertrophy |
| GO:0060021 | 0.0058 | 5.9377 | 0.7177 | 4 | 91 | palate development |
| GO:0048858 | 0.0059 | 2.5852 | 4.543 | 11 | 576 | cell projection morphogenesis |
| GO:0010662 | 0.006 | 8.7584 | 0.3707 | 3 | 47 | regulation of striated muscle cell apoptotic process |
| GO:0007379 | 0.0061 | 19.6435 | 0.1183 | 2 | 15 | segment specification |
| GO:0021542 | 0.0061 | 19.6435 | 0.1183 | 2 | 15 | dentate gyrus development |
| GO:0072148 | 0.0061 | 19.6435 | 0.1183 | 2 | 15 | epithelial cell fate commitment |
| GO:0021545 | 0.0064 | 8.5632 | 0.3786 | 3 | 48 | cranial nerve development |
| GO:0043392 | 0.0064 | 8.5632 | 0.3786 | 3 | 48 | negative regulation of DNA binding |
| GO:0014896 | 0.0068 | 5.6753 | 0.7493 | 4 | 95 | muscle hypertrophy |
| GO:0032374 | 0.0068 | 8.3765 | 0.3865 | 3 | 49 | regulation of cholesterol transport |
| GO:0007519 | 0.0069 | 4.4423 | 1.191 | 5 | 151 | skeletal muscle tissue development |
| GO:0050905 | 0.007 | 5.6133 | 0.7572 | 4 | 96 | neuromuscular process |
| GO:0048519 | 0.0073 | 1.5915 | 38.5917 | 52 | 4893 | negative regulation of biological process |
| GO:0003198 | 0.0078 | 17.0222 | 0.1341 | 2 | 17 | epithelial to mesenchymal transition involved in endocardial cushion formation |
| GO:0031268 | 0.0078 | 17.0222 | 0.1341 | 2 | 17 | pseudopodium organization |
| GO:0071294 | 0.0078 | 17.0222 | 0.1341 | 2 | 17 | cellular response to zinc ion |
| GO:2000269 | 0.0078 | 17.0222 | 0.1341 | 2 | 17 | regulation of fibroblast apoptotic process |
| GO:0031047 | 0.0079 | 3.257 | 2.2715 | 7 | 288 | gene silencing by RNA |
| GO:0002642 | 0.0079 | Inf | 0.0079 | 1 | 1 | positive regulation of immunoglobulin biosynthetic process |
| GO:0002651 | 0.0079 | Inf | 0.0079 | 1 | 1 | positive regulation of tolerance induction to self antigen |
| GO:0007634 | 0.0079 | Inf | 0.0079 | 1 | 1 | optokinetic behavior |
| GO:0009444 | 0.0079 | Inf | 0.0079 | 1 | 1 | pyruvate oxidation |
| GO:0009956 | 0.0079 | Inf | 0.0079 | 1 | 1 | radial pattern formation |
| GO:0014739 | 0.0079 | Inf | 0.0079 | 1 | 1 | positive regulation of muscle hyperplasia |
| GO:0021723 | 0.0079 | Inf | 0.0079 | 1 | 1 | medullary reticular formation development |
| GO:0021763 | 0.0079 | Inf | 0.0079 | 1 | 1 | subthalamic nucleus development |
| GO:0038097 | 0.0079 | Inf | 0.0079 | 1 | 1 | positive regulation of mast cell activation by Fc-epsilon receptor signaling pathway |
| GO:0038115 | 0.0079 | Inf | 0.0079 | 1 | 1 | chemokine (C-C motif) ligand 19 signaling pathway |
| GO:0038116 | 0.0079 | Inf | 0.0079 | 1 | 1 | chemokine (C-C motif) ligand 21 signaling pathway |
| GO:0048894 | 0.0079 | Inf | 0.0079 | 1 | 1 | efferent axon development in a lateral line nerve |
| GO:0060127 | 0.0079 | Inf | 0.0079 | 1 | 1 | prolactin secreting cell differentiation |
| GO:0060578 | 0.0079 | Inf | 0.0079 | 1 | 1 | superior vena cava morphogenesis |
| GO:0061153 | 0.0079 | Inf | 0.0079 | 1 | 1 | trachea gland development |
| GO:0061452 | 0.0079 | Inf | 0.0079 | 1 | 1 | retrotrapezoid nucleus neuron differentiation |
| GO:0061682 | 0.0079 | Inf | 0.0079 | 1 | 1 | seminal vesicle morphogenesis |
| GO:0070473 | 0.0079 | Inf | 0.0079 | 1 | 1 | negative regulation of uterine smooth muscle contraction |
| GO:0072051 | 0.0079 | Inf | 0.0079 | 1 | 1 | juxtaglomerular apparatus development |
| GO:0072227 | 0.0079 | Inf | 0.0079 | 1 | 1 | metanephric macula densa development |
| GO:0097022 | 0.0079 | Inf | 0.0079 | 1 | 1 | lymphocyte migration into lymph node |
| GO:1905317 | 0.0079 | Inf | 0.0079 | 1 | 1 | inferior endocardial cushion morphogenesis |
| GO:2000522 | 0.0079 | Inf | 0.0079 | 1 | 1 | positive regulation of immunological synapse formation |
| GO:2000526 | 0.0079 | Inf | 0.0079 | 1 | 1 | positive regulation of glycoprotein biosynthetic process involved in immunological synapse formation |
| GO:2000763 | 0.0079 | Inf | 0.0079 | 1 | 1 | positive regulation of transcription from RNA polymerase II promoter involved in norepinephrine biosynthetic process |
| GO:2000764 | 0.0079 | Inf | 0.0079 | 1 | 1 | positive regulation of semaphorin-plexin signaling pathway involved in outflow tract morphogenesis |
| GO:2001260 | 0.0079 | Inf | 0.0079 | 1 | 1 | regulation of semaphorin-plexin signaling pathway |
| GO:0006915 | 0.008 | 1.8335 | 14.3861 | 24 | 1824 | apoptotic process |
| GO:0007411 | 0.0082 | 3.6339 | 1.7431 | 6 | 221 | axon guidance |
| GO:0043388 | 0.0084 | 7.7045 | 0.418 | 3 | 53 | positive regulation of DNA binding |
| GO:0043010 | 0.0085 | 3.2104 | 2.303 | 7 | 292 | camera-type eye development |
| GO:0032372 | 0.0087 | 15.9573 | 0.142 | 2 | 18 | negative regulation of sterol transport |
| GO:0046597 | 0.0087 | 15.9573 | 0.142 | 2 | 18 | negative regulation of viral entry into host cell |
| GO:0060004 | 0.0087 | 15.9573 | 0.142 | 2 | 18 | reflex |
| GO:0060438 | 0.0087 | 15.9573 | 0.142 | 2 | 18 | trachea development |
| GO:0050678 | 0.0088 | 3.1877 | 2.3188 | 7 | 294 | regulation of epithelial cell proliferation |
| GO:0002562 | 0.0093 | 7.4072 | 0.4338 | 3 | 55 | somatic diversification of immune receptors via germline recombination within a single locus |
| GO:0007631 | 0.0096 | 5.1102 | 0.8281 | 4 | 105 | feeding behavior |
| GO:0044872 | 0.0097 | 15.0177 | 0.1499 | 2 | 19 | lipoprotein localization |
| GO:0048557 | 0.0097 | 15.0177 | 0.1499 | 2 | 19 | embryonic digestive tract morphogenesis |
| GO:0048514 | 0.0098 | 2.5143 | 4.2196 | 10 | 535 | blood vessel morphogenesis |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0045944 | 0 | 6.3322 | 11.1979 | 51 | 1069 | positive regulation of transcription from RNA polymerase II promoter |
| GO:0006351 | 0 | 4.0133 | 37.7731 | 90 | 3606 | transcription, DNA-templated |
| GO:0032774 | 0 | 3.9699 | 38.0874 | 90 | 3636 | RNA biosynthetic process |
| GO:1903508 | 0 | 5.0706 | 14.3509 | 53 | 1370 | positive regulation of nucleic acid-templated transcription |
| GO:0051254 | 0 | 4.9243 | 15.0946 | 54 | 1441 | positive regulation of RNA metabolic process |
| GO:0044271 | 0 | 3.6035 | 50.5108 | 102 | 4822 | cellular nitrogen compound biosynthetic process |
| GO:0009790 | 0 | 5.6058 | 9.7418 | 42 | 930 | embryo development |
| GO:0018130 | 0 | 3.4997 | 43.3668 | 92 | 4140 | heterocycle biosynthetic process |
| GO:0019438 | 0 | 3.4916 | 43.4401 | 92 | 4147 | aromatic compound biosynthetic process |
| GO:0010557 | 0 | 4.3638 | 16.7811 | 54 | 1602 | positive regulation of macromolecule biosynthetic process |
| GO:0010628 | 0 | 4.141 | 18.4257 | 56 | 1759 | positive regulation of gene expression |
| GO:0009952 | 0 | 16.552 | 1.2988 | 17 | 128 | anterior/posterior pattern specification |
| GO:0080090 | 0 | 3.3318 | 60.8602 | 110 | 5810 | regulation of primary metabolic process |
| GO:1901362 | 0 | 3.3357 | 44.9066 | 92 | 4287 | organic cyclic compound biosynthetic process |
| GO:0031328 | 0 | 4.088 | 18.1952 | 55 | 1737 | positive regulation of cellular biosynthetic process |
| GO:0060322 | 0 | 5.9265 | 7.165 | 34 | 684 | head development |
| GO:0030900 | 0 | 8.666 | 3.2296 | 23 | 315 | forebrain development |
| GO:2000112 | 0 | 3.9106 | 21.2018 | 55 | 2503 | regulation of cellular macromolecule biosynthetic process |
| GO:0009889 | 0 | 3.7428 | 22.736 | 56 | 2698 | regulation of biosynthetic process |
| GO:2000113 | 0 | 3.6913 | 15.4193 | 45 | 1472 | negative regulation of cellular macromolecule biosynthetic process |
| GO:0035107 | 0 | 11.8578 | 1.5189 | 15 | 145 | appendage morphogenesis |
| GO:0009890 | 0 | 3.487 | 17.1058 | 47 | 1633 | negative regulation of biosynthetic process |
| GO:0022008 | 0 | 4.9355 | 7.1736 | 29 | 754 | neurogenesis |
| GO:0007417 | 0 | 4.7475 | 7.6344 | 30 | 765 | central nervous system development |
| GO:0060173 | 0 | 10.7546 | 1.6573 | 15 | 160 | limb development |
| GO:0090304 | 0 | 2.6899 | 51.3907 | 91 | 4906 | nucleic acid metabolic process |
| GO:0000122 | 0 | 4.5127 | 7.9401 | 30 | 758 | negative regulation of transcription from RNA polymerase II promoter |
| GO:1903507 | 0 | 3.6464 | 11.9206 | 36 | 1138 | negative regulation of nucleic acid-templated transcription |
| GO:0043009 | 0 | 5.1382 | 4.9699 | 22 | 484 | chordate embryonic development |
| GO:0051173 | 0 | 2.686 | 29.6445 | 61 | 2830 | positive regulation of nitrogen compound metabolic process |
| GO:0010629 | 0 | 2.9872 | 19.0646 | 46 | 1820 | negative regulation of gene expression |
| GO:0051253 | 0 | 3.4 | 12.6958 | 36 | 1212 | negative regulation of RNA metabolic process |
| GO:0009653 | 0 | 7.1245 | 2.671 | 16 | 344 | anatomical structure morphogenesis |
| GO:0031323 | 0 | 2.9424 | 29.3147 | 58 | 3367 | regulation of cellular metabolic process |
| GO:0016339 | 0 | 32.7975 | 0.2933 | 7 | 28 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules |
| GO:0030182 | 0 | 4.0879 | 7.8275 | 27 | 827 | neuron differentiation |
| GO:0007275 | 0 | 3.2762 | 18.7422 | 43 | 2537 | multicellular organism development |
| GO:0060537 | 0 | 5.2537 | 3.8967 | 18 | 372 | muscle tissue development |
| GO:0050789 | 0 | 3.4095 | 46.6158 | 71 | 5807 | regulation of biological process |
| GO:0001764 | 0 | 8.9633 | 1.4037 | 11 | 134 | neuron migration |
| GO:0007416 | 0 | 8.6105 | 1.456 | 11 | 139 | synapse assembly |
| GO:0021983 | 0 | 28.2646 | 0.2797 | 6 | 27 | pituitary gland development |
| GO:0003357 | 0 | 128.9639 | 0.0733 | 4 | 7 | noradrenergic neuron differentiation |
| GO:2000026 | 0 | 2.6472 | 18.9913 | 42 | 1813 | regulation of multicellular organismal development |
| GO:0003002 | 0 | 10.7279 | 0.9623 | 9 | 107 | regionalization |
| GO:0048762 | 0 | 7.0152 | 1.9274 | 12 | 184 | mesenchymal cell differentiation |
| GO:0007156 | 0 | 7.8103 | 1.5922 | 11 | 152 | homophilic cell adhesion via plasma membrane adhesion molecules |
| GO:0021510 | 0 | 10.2626 | 1.0056 | 9 | 96 | spinal cord development |
| GO:0051172 | 0 | 2.421 | 25.224 | 50 | 2408 | negative regulation of nitrogen compound metabolic process |
| GO:0048522 | 0 | 2.3074 | 37.1602 | 64 | 3912 | positive regulation of cellular process |
| GO:0090596 | 0 | 9.8663 | 1.0409 | 9 | 104 | sensory organ morphogenesis |
| GO:0061564 | 0 | 4.3353 | 4.6614 | 18 | 445 | axon development |
| GO:0048562 | 0 | 7.2106 | 1.7147 | 11 | 175 | embryonic organ morphogenesis |
| GO:0048557 | 0 | 34.7294 | 0.199 | 5 | 19 | embryonic digestive tract morphogenesis |
| GO:0043583 | 0 | 6.2765 | 2.1369 | 12 | 204 | ear development |
| GO:0021854 | 0 | 32.4121 | 0.2095 | 5 | 20 | hypothalamus development |
| GO:0048704 | 0 | 11.0951 | 0.8288 | 8 | 80 | embryonic skeletal system morphogenesis |
| GO:0071542 | 0 | 19.5476 | 0.3771 | 6 | 36 | dopaminergic neuron differentiation |
| GO:0007517 | 0 | 4.596 | 3.8863 | 16 | 371 | muscle organ development |
| GO:0048485 | 0 | 30.3845 | 0.22 | 5 | 21 | sympathetic nervous system development |
| GO:0031324 | 0 | 2.3134 | 26.8267 | 51 | 2561 | negative regulation of cellular metabolic process |
| GO:0007519 | 0 | 10.6745 | 0.8576 | 8 | 84 | skeletal muscle tissue development |
| GO:0032502 | 0 | 2.9243 | 17.267 | 36 | 2692 | developmental process |
| GO:0048863 | 0 | 5.4119 | 2.6711 | 13 | 255 | stem cell differentiation |
| GO:0045165 | 0 | 6.4583 | 1.8992 | 11 | 192 | cell fate commitment |
| GO:0021521 | 0 | 55.2565 | 0.1152 | 4 | 11 | ventral spinal cord interneuron specification |
| GO:0007411 | 0 | 5.7598 | 2.315 | 12 | 221 | axon guidance |
| GO:0007267 | 0 | 2.8665 | 11.2036 | 28 | 1115 | cell-cell signaling |
| GO:0001501 | 0 | 4.7937 | 2.9978 | 13 | 297 | skeletal system development |
| GO:0008284 | 0 | 2.9971 | 8.9981 | 24 | 859 | positive regulation of cell proliferation |
| GO:0042127 | 0 | 3.3856 | 6.6702 | 20 | 707 | regulation of cell proliferation |
| GO:0061009 | 0 | 144.2246 | 0.0524 | 3 | 5 | common bile duct development |
| GO:0060581 | 0 | 35.1544 | 0.1571 | 4 | 15 | cell fate commitment involved in pattern specification |
| GO:0009954 | 0 | 18.6865 | 0.3247 | 5 | 31 | proximal/distal pattern formation |
| GO:0048592 | 0 | 6.6434 | 1.4979 | 9 | 143 | eye morphogenesis |
| GO:0048667 | 0 | 3.5604 | 5.269 | 17 | 503 | cell morphogenesis involved in neuron differentiation |
| GO:0061074 | 0 | 96.1437 | 0.0629 | 3 | 6 | regulation of neural retina development |
| GO:0030154 | 0 | 3.6623 | 5.3861 | 17 | 703 | cell differentiation |
| GO:0021514 | 0 | 29.7424 | 0.1781 | 4 | 17 | ventral spinal cord interneuron differentiation |
| GO:0007268 | 0 | 3.2356 | 6.1279 | 18 | 585 | chemical synaptic transmission |
| GO:0099537 | 0 | 3.2238 | 6.1489 | 18 | 587 | trans-synaptic signaling |
| GO:0035137 | 1e-04 | 59.0061 | 0.082 | 3 | 8 | hindlimb morphogenesis |
| GO:0009888 | 1e-04 | 2.8359 | 8.7706 | 22 | 975 | tissue development |
| GO:0042472 | 1e-04 | 7.8841 | 0.9847 | 7 | 94 | inner ear morphogenesis |
| GO:0043586 | 1e-04 | 22.7385 | 0.22 | 4 | 21 | tongue development |
| GO:0035881 | 1e-04 | 57.679 | 0.0838 | 3 | 8 | amacrine cell differentiation |
| GO:0007218 | 1e-04 | 7.794 | 0.9951 | 7 | 95 | neuropeptide signaling pathway |
| GO:0048468 | 1e-04 | 2.684 | 10.1242 | 24 | 1092 | cell development |
| GO:0044260 | 1e-04 | 1.8472 | 86.0423 | 111 | 8214 | cellular macromolecule metabolic process |
| GO:0021513 | 1e-04 | 21.4739 | 0.2305 | 4 | 22 | spinal cord dorsal/ventral patterning |
| GO:0048812 | 1e-04 | 3.181 | 5.8556 | 17 | 559 | neuron projection morphogenesis |
| GO:0051962 | 1e-04 | 3.4433 | 4.7557 | 15 | 454 | positive regulation of nervous system development |
| GO:0045595 | 1e-04 | 2.2267 | 17.3362 | 34 | 1655 | regulation of cell differentiation |
| GO:0043503 | 1e-04 | Inf | 0.021 | 2 | 2 | skeletal muscle fiber adaptation |
| GO:0072272 | 1e-04 | Inf | 0.021 | 2 | 2 | proximal/distal pattern formation involved in metanephric nephron development |
| GO:0060042 | 1e-04 | 11.8389 | 0.4819 | 5 | 46 | retina morphogenesis in camera-type eye |
| GO:0048858 | 1e-04 | 3.0809 | 6.0336 | 17 | 576 | cell projection morphogenesis |
| GO:0045666 | 1e-04 | 3.9494 | 3.2996 | 12 | 315 | positive regulation of neuron differentiation |
| GO:0014032 | 1e-04 | 11.1587 | 0.5076 | 5 | 49 | neural crest cell development |
| GO:0070848 | 2e-04 | 2.9098 | 6.7669 | 18 | 646 | response to growth factor |
| GO:0048870 | 2e-04 | 2.2668 | 14.8432 | 30 | 1417 | cell motility |
| GO:0090009 | 2e-04 | 36.0427 | 0.1152 | 3 | 11 | primitive streak formation |
| GO:0021879 | 2e-04 | 16.4794 | 0.2868 | 4 | 28 | forebrain neuron differentiation |
| GO:0035116 | 2e-04 | 16.0994 | 0.2933 | 4 | 28 | embryonic hindlimb morphogenesis |
| GO:0060441 | 2e-04 | 16.0994 | 0.2933 | 4 | 28 | epithelial tube branching involved in lung morphogenesis |
| GO:0007188 | 2e-04 | 5.4578 | 1.5922 | 8 | 152 | adenylate cyclase-modulating G-protein coupled receptor signaling pathway |
| GO:0001667 | 2e-04 | 3.6885 | 3.5196 | 12 | 336 | ameboidal-type cell migration |
| GO:0009798 | 2e-04 | 7.5936 | 0.8694 | 6 | 83 | axis specification |
| GO:0048513 | 3e-04 | 2.1148 | 19.3979 | 35 | 2258 | animal organ development |
| GO:0009987 | 3e-04 | 11.2697 | 70.0758 | 79 | 9935 | cellular process |
| GO:0021520 | 3e-04 | 28.8305 | 0.1362 | 3 | 13 | spinal cord motor neuron cell fate specification |
| GO:0048935 | 3e-04 | 28.8305 | 0.1362 | 3 | 13 | peripheral nervous system neuron development |
| GO:0010720 | 3e-04 | 3.1812 | 4.7642 | 14 | 460 | positive regulation of cell development |
| GO:0050767 | 3e-04 | 2.8182 | 6.569 | 17 | 645 | regulation of neurogenesis |
| GO:0060349 | 3e-04 | 7.1283 | 0.9218 | 6 | 88 | bone morphogenesis |
| GO:0055001 | 3e-04 | 5.067 | 1.7074 | 8 | 163 | muscle cell development |
| GO:0002877 | 3e-04 | 191.1667 | 0.0314 | 2 | 3 | regulation of acute inflammatory response to non-antigenic stimulus |
| GO:0060741 | 3e-04 | 191.1667 | 0.0314 | 2 | 3 | prostate gland stromal morphogenesis |
| GO:0061010 | 3e-04 | 191.1667 | 0.0314 | 2 | 3 | gall bladder development |
| GO:0061031 | 3e-04 | 191.1667 | 0.0314 | 2 | 3 | endodermal digestive tract morphogenesis |
| GO:0097021 | 3e-04 | 191.1667 | 0.0314 | 2 | 3 | lymphocyte migration into lymphoid organs |
| GO:0140076 | 3e-04 | 191.1667 | 0.0314 | 2 | 3 | negative regulation of lipoprotein transport |
| GO:1905563 | 3e-04 | 191.1667 | 0.0314 | 2 | 3 | negative regulation of vascular endothelial cell proliferation |
| GO:0035115 | 3e-04 | 13.796 | 0.3352 | 4 | 32 | embryonic forelimb morphogenesis |
| GO:0030324 | 4e-04 | 4.9383 | 1.7493 | 8 | 167 | lung development |
| GO:0048565 | 4e-04 | 5.7041 | 1.3303 | 7 | 127 | digestive tract development |
| GO:0051961 | 4e-04 | 4.001 | 2.6921 | 10 | 257 | negative regulation of nervous system development |
| GO:0060021 | 4e-04 | 6.8755 | 0.9532 | 6 | 91 | palate development |
| GO:0051094 | 4e-04 | 2.6684 | 7.3791 | 18 | 751 | positive regulation of developmental process |
| GO:0010468 | 4e-04 | 2.5031 | 10.3617 | 22 | 1521 | regulation of gene expression |
| GO:1903506 | 4e-04 | 2.475 | 10.2848 | 22 | 1431 | regulation of nucleic acid-templated transcription |
| GO:0072148 | 5e-04 | 24.0225 | 0.1571 | 3 | 15 | epithelial cell fate commitment |
| GO:0051171 | 5e-04 | 2.5065 | 10.4974 | 22 | 1509 | regulation of nitrogen compound metabolic process |
| GO:0061138 | 5e-04 | 4.6993 | 1.8331 | 8 | 175 | morphogenesis of a branching epithelium |
| GO:0048665 | 5e-04 | 22.8405 | 0.1628 | 3 | 16 | neuron fate specification |
| GO:0071392 | 5e-04 | 12.0685 | 0.3771 | 4 | 36 | cellular response to estradiol stimulus |
| GO:0098609 | 5e-04 | 2.5295 | 8.1706 | 19 | 780 | cell-cell adhesion |
| GO:0060850 | 6e-04 | 22.1732 | 0.1676 | 3 | 16 | regulation of transcription involved in cell fate commitment |
| GO:0032989 | 6e-04 | 2.3484 | 10.2446 | 22 | 978 | cellular component morphogenesis |
| GO:0060562 | 6e-04 | 4.1282 | 2.3427 | 9 | 228 | epithelial tube morphogenesis |
| GO:0051216 | 6e-04 | 4.5883 | 1.875 | 8 | 179 | cartilage development |
| GO:0007198 | 6e-04 | 95.5774 | 0.0419 | 2 | 4 | adenylate cyclase-inhibiting serotonin receptor signaling pathway |
| GO:0021797 | 6e-04 | 95.5774 | 0.0419 | 2 | 4 | forebrain anterior/posterior pattern specification |
| GO:0048866 | 6e-04 | 95.5774 | 0.0419 | 2 | 4 | stem cell fate specification |
| GO:0061325 | 6e-04 | 95.5774 | 0.0419 | 2 | 4 | cell proliferation involved in outflow tract morphogenesis |
| GO:0072086 | 6e-04 | 95.5774 | 0.0419 | 2 | 4 | specification of loop of Henle identity |
| GO:0035914 | 7e-04 | 7.8187 | 0.7018 | 5 | 67 | skeletal muscle cell differentiation |
| GO:0010721 | 7e-04 | 3.6966 | 2.9016 | 10 | 277 | negative regulation of cell development |
| GO:0048729 | 7e-04 | 2.8041 | 5.7751 | 15 | 563 | tissue morphogenesis |
| GO:0014014 | 8e-04 | 10.7249 | 0.419 | 4 | 40 | negative regulation of gliogenesis |
| GO:0006935 | 8e-04 | 2.7496 | 5.8765 | 15 | 561 | chemotaxis |
| GO:0002089 | 0.001 | 18.0124 | 0.199 | 3 | 19 | lens morphogenesis in camera-type eye |
| GO:0072079 | 0.001 | 18.0124 | 0.199 | 3 | 19 | nephron tubule formation |
| GO:0043010 | 0.001 | 3.8168 | 2.5234 | 9 | 246 | camera-type eye development |
| GO:0021766 | 0.001 | 7.1261 | 0.7647 | 5 | 73 | hippocampus development |
| GO:0009719 | 0.001 | 2.0407 | 15.1155 | 28 | 1443 | response to endogenous stimulus |
| GO:0090287 | 0.0011 | 3.7805 | 2.5454 | 9 | 243 | regulation of cellular response to growth factor stimulus |
| GO:0002568 | 0.0011 | 63.7143 | 0.0524 | 2 | 5 | somatic diversification of T cell receptor genes |
| GO:0021523 | 0.0011 | 63.7143 | 0.0524 | 2 | 5 | somatic motor neuron differentiation |
| GO:0033153 | 0.0011 | 63.7143 | 0.0524 | 2 | 5 | T cell receptor V(D)J recombination |
| GO:0048625 | 0.0011 | 63.7143 | 0.0524 | 2 | 5 | myoblast fate commitment |
| GO:0060729 | 0.0011 | 63.7143 | 0.0524 | 2 | 5 | intestinal epithelial structure maintenance |
| GO:0046883 | 0.0011 | 3.7479 | 2.5664 | 9 | 245 | regulation of hormone secretion |
| GO:0023019 | 0.0011 | 16.9517 | 0.2095 | 3 | 20 | signal transduction involved in regulation of gene expression |
| GO:0010656 | 0.0012 | 9.414 | 0.4714 | 4 | 45 | negative regulation of muscle cell apoptotic process |
| GO:0031018 | 0.0012 | 9.414 | 0.4714 | 4 | 45 | endocrine pancreas development |
| GO:0048732 | 0.0013 | 3.1791 | 3.7027 | 11 | 370 | gland development |
| GO:0002052 | 0.0013 | 16.009 | 0.22 | 3 | 21 | positive regulation of neuroblast proliferation |
| GO:0072132 | 0.0013 | 9.1893 | 0.4819 | 4 | 46 | mesenchyme morphogenesis |
| GO:0042476 | 0.0014 | 5.3045 | 1.2151 | 6 | 116 | odontogenesis |
| GO:0003407 | 0.0015 | 8.9837 | 0.4913 | 4 | 48 | neural retina development |
| GO:0050680 | 0.0015 | 5.2564 | 1.2256 | 6 | 117 | negative regulation of epithelial cell proliferation |
| GO:0010463 | 0.0015 | 8.9751 | 0.4923 | 4 | 47 | mesenchymal cell proliferation |
| GO:2000679 | 0.0015 | 15.1655 | 0.2305 | 3 | 22 | positive regulation of transcription regulatory region DNA binding |
| GO:0048519 | 0.0015 | 1.7102 | 38.284 | 55 | 4029 | negative regulation of biological process |
| GO:0048646 | 0.0015 | 2.9343 | 4.3896 | 12 | 456 | anatomical structure formation involved in morphogenesis |
| GO:0043392 | 0.0016 | 8.7705 | 0.5028 | 4 | 48 | negative regulation of DNA binding |
| GO:0060563 | 0.0016 | 8.7705 | 0.5028 | 4 | 48 | neuroepithelial cell differentiation |
| GO:0014062 | 0.0016 | 47.7827 | 0.0629 | 2 | 6 | regulation of serotonin secretion |
| GO:0045778 | 0.0017 | 6.2896 | 0.859 | 5 | 82 | positive regulation of ossification |
| GO:0035295 | 0.0017 | 3.0552 | 3.847 | 11 | 386 | tube development |
| GO:0048747 | 0.0018 | 8.3882 | 0.5238 | 4 | 50 | muscle fiber development |
| GO:0060487 | 0.0019 | 13.7194 | 0.2514 | 3 | 24 | lung epithelial cell differentiation |
| GO:0060541 | 0.002 | 13.6175 | 0.2521 | 3 | 25 | respiratory system development |
| GO:0021543 | 0.002 | 6.0629 | 0.8885 | 5 | 87 | pallium development |
| GO:0051252 | 0.002 | 2.2145 | 10.7774 | 21 | 1502 | regulation of RNA metabolic process |
| GO:0035136 | 0.0021 | 39.0878 | 0.0717 | 2 | 7 | forelimb morphogenesis |
| GO:1902692 | 0.0021 | 38.8752 | 0.0721 | 2 | 7 | regulation of neuroblast proliferation |
| GO:0045736 | 0.0022 | 13.095 | 0.2619 | 3 | 25 | negative regulation of cyclin-dependent protein serine/threonine kinase activity |
| GO:0060740 | 0.0022 | 13.095 | 0.2619 | 3 | 25 | prostate gland epithelium morphogenesis |
| GO:0003253 | 0.0022 | 38.2238 | 0.0733 | 2 | 7 | cardiac neural crest cell migration involved in outflow tract morphogenesis |
| GO:0021798 | 0.0022 | 38.2238 | 0.0733 | 2 | 7 | forebrain dorsal/ventral pattern formation |
| GO:0060430 | 0.0022 | 38.2238 | 0.0733 | 2 | 7 | lung saccule development |
| GO:2000049 | 0.0022 | 38.2238 | 0.0733 | 2 | 7 | positive regulation of cell-cell adhesion mediated by cadherin |
| GO:0007405 | 0.0023 | 12.8929 | 0.2648 | 3 | 26 | neuroblast proliferation |
| GO:0033993 | 0.0023 | 2.2129 | 9.2495 | 19 | 883 | response to lipid |
| GO:0022603 | 0.0024 | 2.1616 | 9.9827 | 20 | 953 | regulation of anatomical structure morphogenesis |
| GO:0072001 | 0.0024 | 3.3445 | 2.8597 | 9 | 273 | renal system development |
| GO:0002063 | 0.0025 | 12.5249 | 0.2724 | 3 | 26 | chondrocyte development |
| GO:0021846 | 0.0025 | 12.5249 | 0.2724 | 3 | 26 | cell proliferation in forebrain |
| GO:0048857 | 0.0026 | 7.5634 | 0.5761 | 4 | 55 | neural nucleus development |
| GO:0002675 | 0.0027 | 12.0022 | 0.2828 | 3 | 27 | positive regulation of acute inflammatory response |
| GO:0061311 | 0.0027 | 12.0022 | 0.2828 | 3 | 27 | cell surface receptor signaling pathway involved in heart development |
| GO:0048743 | 0.0029 | 31.8512 | 0.0838 | 2 | 8 | positive regulation of skeletal muscle fiber development |
| GO:0071863 | 0.0029 | 31.8512 | 0.0838 | 2 | 8 | regulation of cell proliferation in bone marrow |
| GO:1904684 | 0.0029 | 31.8512 | 0.0838 | 2 | 8 | negative regulation of metalloendopeptidase activity |
| GO:0072073 | 0.003 | 4.5179 | 1.4141 | 6 | 135 | kidney epithelium development |
| GO:0010719 | 0.0031 | 11.5214 | 0.2933 | 3 | 28 | negative regulation of epithelial to mesenchymal transition |
| GO:0051093 | 0.0032 | 2.461 | 6.0806 | 14 | 607 | negative regulation of developmental process |
| GO:0010001 | 0.0033 | 3.8534 | 1.9274 | 7 | 184 | glial cell differentiation |
| GO:0022037 | 0.0034 | 5.3173 | 1.0056 | 5 | 96 | metencephalon development |
| GO:0031128 | 0.0034 | 11.0776 | 0.3038 | 3 | 29 | developmental induction |
| GO:0048645 | 0.0034 | 7.0116 | 0.618 | 4 | 59 | animal organ formation |
| GO:0006357 | 0.0035 | 3.8344 | 1.9579 | 7 | 278 | regulation of transcription from RNA polymerase II promoter |
| GO:0048608 | 0.0036 | 2.7578 | 4.2319 | 11 | 404 | reproductive structure development |
| GO:0023061 | 0.0037 | 2.7506 | 4.2424 | 11 | 405 | signal release |
| GO:0021988 | 0.0037 | 10.6667 | 0.3143 | 3 | 30 | olfactory lobe development |
| GO:0048664 | 0.0037 | 27.2993 | 0.0943 | 2 | 9 | neuron fate determination |
| GO:0061004 | 0.0037 | 27.2993 | 0.0943 | 2 | 9 | pattern specification involved in kidney development |
| GO:2000818 | 0.0037 | 27.2993 | 0.0943 | 2 | 9 | negative regulation of myoblast proliferation |
| GO:0010667 | 0.0041 | 10.2851 | 0.3247 | 3 | 31 | negative regulation of cardiac muscle cell apoptotic process |
| GO:0016331 | 0.0042 | 4.1902 | 1.5189 | 6 | 145 | morphogenesis of embryonic epithelium |
| GO:0001756 | 0.0043 | 6.5346 | 0.6599 | 4 | 63 | somitogenesis |
| GO:0042733 | 0.0043 | 6.5346 | 0.6599 | 4 | 63 | embryonic digit morphogenesis |
| GO:0009914 | 0.0043 | 3.0396 | 3.132 | 9 | 299 | hormone transport |
| GO:0017015 | 0.0044 | 4.9866 | 1.0685 | 5 | 102 | regulation of transforming growth factor beta receptor signaling pathway |
| GO:0019933 | 0.0044 | 4.9866 | 1.0685 | 5 | 102 | cAMP-mediated signaling |
| GO:0060325 | 0.0045 | 9.9298 | 0.3352 | 3 | 32 | face morphogenesis |
| GO:1902742 | 0.0045 | 9.9298 | 0.3352 | 3 | 32 | apoptotic process involved in development |
| GO:0009605 | 0.0045 | 1.7306 | 21.5891 | 34 | 2061 | response to external stimulus |
| GO:0030855 | 0.0045 | 2.2826 | 7.0093 | 15 | 692 | epithelial cell differentiation |
| GO:0007399 | 0.0046 | 3.6434 | 2.0587 | 7 | 296 | nervous system development |
| GO:0003211 | 0.0046 | 23.8854 | 0.1048 | 2 | 10 | cardiac ventricle formation |
| GO:0021877 | 0.0046 | 23.8854 | 0.1048 | 2 | 10 | forebrain neuron fate commitment |
| GO:0034393 | 0.0046 | 23.8854 | 0.1048 | 2 | 10 | positive regulation of smooth muscle cell apoptotic process |
| GO:0035878 | 0.0046 | 23.8854 | 0.1048 | 2 | 10 | nail development |
| GO:0060174 | 0.0046 | 23.8854 | 0.1048 | 2 | 10 | limb bud formation |
| GO:0090370 | 0.0046 | 23.8854 | 0.1048 | 2 | 10 | negative regulation of cholesterol efflux |
| GO:0030509 | 0.0047 | 4.1009 | 1.5503 | 6 | 148 | BMP signaling pathway |
| GO:0030326 | 0.0047 | 9.7042 | 0.3413 | 3 | 34 | embryonic limb morphogenesis |
| GO:0014904 | 0.0049 | 9.5982 | 0.3457 | 3 | 33 | myotube cell development |
| GO:0007631 | 0.0049 | 4.8361 | 1.0999 | 5 | 105 | feeding behavior |
| GO:0001649 | 0.0052 | 3.5304 | 2.095 | 7 | 200 | osteoblast differentiation |
| GO:0071773 | 0.0054 | 21.8217 | 0.1122 | 2 | 11 | cellular response to BMP stimulus |
| GO:0120036 | 0.0054 | 1.8773 | 13.7957 | 24 | 1317 | plasma membrane bounded cell projection organization |
| GO:0010985 | 0.0056 | 21.2302 | 0.1152 | 2 | 11 | negative regulation of lipoprotein particle clearance |
| GO:0021889 | 0.0056 | 21.2302 | 0.1152 | 2 | 11 | olfactory bulb interneuron differentiation |
| GO:0043374 | 0.0056 | 21.2302 | 0.1152 | 2 | 11 | CD8-positive, alpha-beta T cell differentiation |
| GO:0060033 | 0.0056 | 21.2302 | 0.1152 | 2 | 11 | anatomical structure regression |
| GO:0061308 | 0.0056 | 21.2302 | 0.1152 | 2 | 11 | cardiac neural crest cell development involved in heart development |
| GO:2000543 | 0.0056 | 21.2302 | 0.1152 | 2 | 11 | positive regulation of gastrulation |
| GO:2000774 | 0.0056 | 21.2302 | 0.1152 | 2 | 11 | positive regulation of cellular senescence |
| GO:2001053 | 0.0056 | 21.2302 | 0.1152 | 2 | 11 | regulation of mesenchymal cell apoptotic process |
| GO:0042596 | 0.0058 | 8.9972 | 0.3666 | 3 | 35 | fear response |
| GO:0003008 | 0.0058 | 1.7239 | 20.2797 | 32 | 1936 | system process |
| GO:0035195 | 0.0059 | 3.1228 | 2.7026 | 8 | 258 | gene silencing by miRNA |
| GO:0072359 | 0.0062 | 2.0034 | 10.1399 | 19 | 968 | circulatory system development |
| GO:0007422 | 0.0062 | 5.839 | 0.7333 | 4 | 70 | peripheral nervous system development |
| GO:0014003 | 0.0063 | 8.724 | 0.3771 | 3 | 36 | oligodendrocyte development |
| GO:0051146 | 0.0063 | 3.0852 | 2.734 | 8 | 261 | striated muscle cell differentiation |
| GO:0072088 | 0.0065 | 5.7515 | 0.7437 | 4 | 71 | nephron epithelium morphogenesis |
| GO:0010454 | 0.0067 | 19.106 | 0.1257 | 2 | 12 | negative regulation of cell fate commitment |
| GO:0055015 | 0.0067 | 19.106 | 0.1257 | 2 | 12 | ventricular cardiac muscle cell development |
| GO:0060272 | 0.0067 | 19.106 | 0.1257 | 2 | 12 | embryonic skeletal joint morphogenesis |
| GO:0072017 | 0.0067 | 19.106 | 0.1257 | 2 | 12 | distal tubule development |
| GO:0031076 | 0.0068 | 8.4669 | 0.3876 | 3 | 37 | embryonic camera-type eye development |
| GO:0043069 | 0.0069 | 2.0649 | 8.7676 | 17 | 837 | negative regulation of programmed cell death |
| GO:0035050 | 0.0069 | 5.6665 | 0.7542 | 4 | 72 | embryonic heart tube development |
| GO:0016441 | 0.0069 | 3.0364 | 2.7759 | 8 | 265 | posttranscriptional gene silencing |
| GO:0010941 | 0.007 | 1.7725 | 16.4773 | 27 | 1573 | regulation of cell death |
| GO:0072210 | 0.0071 | 8.3242 | 0.3934 | 3 | 38 | metanephric nephron development |
| GO:0071310 | 0.0071 | 1.6425 | 24.7526 | 37 | 2363 | cellular response to organic substance |
| GO:0061333 | 0.0072 | 5.5841 | 0.7647 | 4 | 73 | renal tubule morphogenesis |
| GO:0035315 | 0.0073 | 8.2245 | 0.3981 | 3 | 38 | hair cell differentiation |
| GO:0045844 | 0.0076 | 5.504 | 0.7752 | 4 | 74 | positive regulation of striated muscle tissue development |
| GO:0055006 | 0.0076 | 5.504 | 0.7752 | 4 | 74 | cardiac cell development |
| GO:0001525 | 0.0078 | 2.4673 | 4.7033 | 11 | 449 | angiogenesis |
| GO:0002864 | 0.0079 | 17.368 | 0.1362 | 2 | 13 | regulation of acute inflammatory response to antigenic stimulus |
| GO:0021535 | 0.0079 | 17.368 | 0.1362 | 2 | 13 | cell migration in hindbrain |
| GO:0021978 | 0.0079 | 17.368 | 0.1362 | 2 | 13 | telencephalon regionalization |
| GO:0031274 | 0.0079 | 17.368 | 0.1362 | 2 | 13 | positive regulation of pseudopodium assembly |
| GO:0061029 | 0.0079 | 17.368 | 0.1362 | 2 | 13 | eyelid development in camera-type eye |
| GO:0061548 | 0.0079 | 17.368 | 0.1362 | 2 | 13 | ganglion development |
| GO:0071880 | 0.0079 | 17.368 | 0.1362 | 2 | 13 | adenylate cyclase-activating adrenergic receptor signaling pathway |
| GO:0072080 | 0.008 | 5.4123 | 0.7873 | 4 | 76 | nephron tubule development |
| GO:0003170 | 0.0084 | 7.7789 | 0.419 | 3 | 40 | heart valve development |
| GO:0003206 | 0.0089 | 4.1648 | 1.2675 | 5 | 121 | cardiac chamber morphogenesis |
| GO:0021795 | 0.009 | 7.5737 | 0.4295 | 3 | 41 | cerebral cortex cell migration |
| GO:0007492 | 0.0091 | 5.2051 | 0.8171 | 4 | 78 | endoderm development |
| GO:0016049 | 0.0091 | 2.4107 | 4.8081 | 11 | 459 | cell growth |
| GO:0006837 | 0.0091 | 15.9196 | 0.1467 | 2 | 14 | serotonin transport |
| GO:0007501 | 0.0091 | 15.9196 | 0.1467 | 2 | 14 | mesodermal cell fate specification |
| GO:0021527 | 0.0091 | 15.9196 | 0.1467 | 2 | 14 | spinal cord association neuron differentiation |
| GO:0021984 | 0.0091 | 15.9196 | 0.1467 | 2 | 14 | adenohypophysis development |
| GO:0048853 | 0.0091 | 15.9196 | 0.1467 | 2 | 14 | forebrain morphogenesis |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0000387 | 3e-04 | 26.3693 | 0.13 | 3 | 37 | spliceosomal snRNP assembly |
| GO:0070475 | 4e-04 | 83.974 | 0.0316 | 2 | 9 | rRNA base methylation |
| GO:1905205 | 9e-04 | 53.4248 | 0.0457 | 2 | 13 | positive regulation of connective tissue replacement |
| GO:0001510 | 0.0013 | 15.1723 | 0.2178 | 3 | 62 | RNA methylation |
| GO:0060044 | 0.0018 | 36.7182 | 0.0632 | 2 | 18 | negative regulation of cardiac muscle cell proliferation |
| GO:0035265 | 0.0021 | 8.0075 | 0.5444 | 4 | 155 | organ growth |
| GO:0000715 | 0.0024 | 30.9148 | 0.0738 | 2 | 21 | nucleotide-excision repair, DNA damage recognition |
| GO:0070098 | 0.0028 | 11.6126 | 0.281 | 3 | 80 | chemokine-mediated signaling pathway |
| GO:0061117 | 0.0029 | 27.9671 | 0.0808 | 2 | 23 | negative regulation of heart growth |
| GO:0055017 | 0.0034 | 10.7691 | 0.3021 | 3 | 86 | cardiac muscle tissue growth |
| GO:0061519 | 0.0035 | Inf | 0.0035 | 1 | 1 | macrophage homeostasis |
| GO:1901506 | 0.0035 | Inf | 0.0035 | 1 | 1 | regulation of acylglycerol transport |
| GO:1905884 | 0.0035 | Inf | 0.0035 | 1 | 1 | negative regulation of triglyceride transport |
| GO:0030593 | 0.0036 | 10.5144 | 0.3091 | 3 | 88 | neutrophil chemotaxis |
| GO:0071108 | 0.0037 | 24.4667 | 0.0913 | 2 | 26 | protein K48-linked deubiquitination |
| GO:0000377 | 0.0042 | 5.122 | 1.0642 | 5 | 303 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile |
| GO:0022613 | 0.0043 | 4.2662 | 1.5454 | 6 | 440 | ribonucleoprotein complex biogenesis |
| GO:0003298 | 0.0046 | 21.7441 | 0.1019 | 2 | 29 | physiological muscle hypertrophy |
| GO:0061049 | 0.0046 | 21.7441 | 0.1019 | 2 | 29 | cell growth involved in cardiac muscle cell development |
| GO:0030218 | 0.0048 | 9.5024 | 0.3407 | 3 | 97 | erythrocyte differentiation |
| GO:0006397 | 0.0052 | 4.101 | 1.6051 | 6 | 457 | mRNA processing |
| GO:0016049 | 0.0053 | 4.0823 | 1.6121 | 6 | 459 | cell growth |
| GO:0055026 | 0.0056 | 19.5661 | 0.1124 | 2 | 32 | negative regulation of cardiac muscle tissue development |
| GO:0006353 | 0.0061 | 8.6672 | 0.3723 | 3 | 106 | DNA-templated transcription, termination |
| GO:0071826 | 0.0063 | 5.8494 | 0.7376 | 4 | 210 | ribonucleoprotein complex subunit organization |
| GO:1901385 | 0.0063 | 18.3409 | 0.1194 | 2 | 34 | regulation of voltage-gated calcium channel activity |
| GO:0003430 | 0.007 | 288.7679 | 0.007 | 1 | 2 | growth plate cartilage chondrocyte growth |
| GO:0061766 | 0.007 | 288.7679 | 0.007 | 1 | 2 | positive regulation of lung blood pressure |
| GO:1901255 | 0.007 | 288.7679 | 0.007 | 1 | 2 | nucleotide-excision repair involved in interstrand cross-link repair |
| GO:1990108 | 0.007 | 288.7679 | 0.007 | 1 | 2 | protein linear deubiquitination |
| GO:0000154 | 0.0071 | 17.2599 | 0.1264 | 2 | 36 | rRNA modification |
| GO:0097530 | 0.009 | 7.4944 | 0.4285 | 3 | 122 | granulocyte migration |
| GO:0002262 | 0.0094 | 7.3856 | 0.4348 | 3 | 126 | myeloid cell homeostasis |
| GO:0000375 | 0.0098 | 155.6078 | 0.0098 | 1 | 3 | RNA splicing, via transesterification reactions |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0009593 | 0 | 9.9574 | 0.8873 | 7 | 450 | detection of chemical stimulus |
| GO:0050911 | 1e-04 | 10.0097 | 0.7315 | 6 | 371 | detection of chemical stimulus involved in sensory perception of smell |
| GO:1904628 | 1e-04 | 179.9 | 0.0158 | 2 | 8 | cellular response to phorbol 13-acetate 12-myristate |
| GO:0035195 | 1e-04 | 11.6703 | 0.5087 | 5 | 258 | gene silencing by miRNA |
| GO:0043207 | 1e-04 | 6.3652 | 1.605 | 8 | 814 | response to external biotic stimulus |
| GO:0016441 | 2e-04 | 11.3511 | 0.5225 | 5 | 265 | posttranscriptional gene silencing |
| GO:0031047 | 2e-04 | 10.4136 | 0.5679 | 5 | 288 | gene silencing by RNA |
| GO:0050906 | 2e-04 | 7.9661 | 0.911 | 6 | 462 | detection of stimulus involved in sensory perception |
| GO:0007606 | 3e-04 | 7.8596 | 0.9228 | 6 | 468 | sensory perception of chemical stimulus |
| GO:0050829 | 4e-04 | 22.8493 | 0.1499 | 3 | 76 | defense response to Gram-negative bacterium |
| GO:0045653 | 6e-04 | 67.4208 | 0.0355 | 2 | 18 | negative regulation of megakaryocyte differentiation |
| GO:0050830 | 6e-04 | 20.3301 | 0.1676 | 3 | 85 | defense response to Gram-positive bacterium |
| GO:0034249 | 7e-04 | 8.1466 | 0.7197 | 5 | 365 | negative regulation of cellular amide metabolic process |
| GO:0006959 | 8e-04 | 10.6696 | 0.4298 | 4 | 218 | humoral immune response |
| GO:0006335 | 0.0018 | 35.9267 | 0.0631 | 2 | 32 | DNA replication-dependent nucleosome assembly |
| GO:0000183 | 0.002 | 33.6771 | 0.067 | 2 | 34 | chromatin silencing at rDNA |
| GO:0031497 | 0.0027 | 11.9509 | 0.28 | 3 | 142 | chromatin assembly |
| GO:0034080 | 0.0028 | 28.3491 | 0.0789 | 2 | 40 | CENP-A containing nucleosome assembly |
| GO:0051290 | 0.0034 | 25.6429 | 0.0868 | 2 | 44 | protein heterotetramerization |
| GO:1904837 | 0.0034 | 25.6429 | 0.0868 | 2 | 44 | beta-catenin-TCF complex assembly |
| GO:0006417 | 0.0035 | 5.5609 | 1.0391 | 5 | 527 | regulation of translation |
| GO:0034724 | 0.0045 | 21.9701 | 0.1006 | 2 | 51 | DNA replication-independent nucleosome organization |
| GO:0016233 | 0.0052 | 20.3069 | 0.1084 | 2 | 55 | telomere capping |
| GO:0045087 | 0.0053 | 4.2617 | 1.6524 | 6 | 838 | innate immune response |
| GO:0050918 | 0.0056 | 19.5661 | 0.1124 | 2 | 57 | positive chemotaxis |
| GO:0002548 | 0.0066 | 17.93 | 0.1223 | 2 | 62 | monocyte chemotaxis |
| GO:0032269 | 0.0084 | 3.465 | 2.4016 | 7 | 1218 | negative regulation of cellular protein metabolic process |
| GO:0065004 | 0.0085 | 7.8376 | 0.422 | 3 | 214 | protein-DNA complex assembly |
| GO:0098542 | 0.0088 | 7.7628 | 0.4294 | 3 | 237 | defense response to other organism |
| GO:0006303 | 0.0088 | 15.359 | 0.142 | 2 | 72 | double-strand break repair via nonhomologous end joining |
| GO:0051607 | 0.0095 | 7.5127 | 0.4397 | 3 | 223 | defense response to virus |
| GO:0043044 | 0.0096 | 14.7251 | 0.1479 | 2 | 75 | ATP-dependent chromatin remodeling |
| GO:0007186 | 0.0097 | 3.3627 | 2.4687 | 7 | 1252 | G-protein coupled receptor signaling pathway |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0007186 | 0 | 5.119 | 3.6045 | 14 | 1216 | G-protein coupled receptor signaling pathway |
| GO:0030593 | 0 | 21.5475 | 0.2711 | 5 | 88 | neutrophil chemotaxis |
| GO:0070488 | 0 | Inf | 0.0062 | 2 | 2 | neutrophil aggregation |
| GO:0050911 | 0 | 8.2991 | 1.143 | 8 | 371 | detection of chemical stimulus involved in sensory perception of smell |
| GO:0097530 | 0 | 15.2536 | 0.3759 | 5 | 122 | granulocyte migration |
| GO:0010469 | 0 | 6.2143 | 1.7284 | 9 | 561 | regulation of receptor activity |
| GO:0009593 | 1e-04 | 6.7817 | 1.3864 | 8 | 450 | detection of chemical stimulus |
| GO:0050906 | 1e-04 | 6.5974 | 1.4234 | 8 | 462 | detection of stimulus involved in sensory perception |
| GO:0007606 | 1e-04 | 6.5089 | 1.4419 | 8 | 468 | sensory perception of chemical stimulus |
| GO:0048241 | 1e-04 | 168.4896 | 0.0185 | 2 | 6 | epinephrine transport |
| GO:0050832 | 2e-04 | 28.6223 | 0.1202 | 3 | 39 | defense response to fungus |
| GO:0006952 | 4e-04 | 3.5026 | 4.5844 | 13 | 1488 | defense response |
| GO:0017014 | 6e-04 | 67.3708 | 0.037 | 2 | 12 | protein nitrosylation |
| GO:0032119 | 6e-04 | 67.3708 | 0.037 | 2 | 12 | sequestering of zinc ion |
| GO:0048247 | 8e-04 | 18.7126 | 0.1787 | 3 | 58 | lymphocyte chemotaxis |
| GO:0042742 | 8e-04 | 7.6042 | 0.7333 | 5 | 238 | defense response to bacterium |
| GO:0002523 | 8e-04 | 56.1354 | 0.0431 | 2 | 14 | leukocyte migration involved in inflammatory response |
| GO:0046888 | 0.001 | 16.8657 | 0.1972 | 3 | 64 | negative regulation of hormone secretion |
| GO:0006935 | 0.0016 | 4.5913 | 1.7284 | 7 | 561 | chemotaxis |
| GO:0046903 | 0.0016 | 3.1155 | 4.6244 | 12 | 1501 | secretion |
| GO:0070098 | 0.0019 | 13.3479 | 0.2465 | 3 | 80 | chemokine-mediated signaling pathway |
| GO:0023052 | 0.0024 | 2.3157 | 18.7103 | 29 | 6073 | signaling |
| GO:0018198 | 0.0029 | 28.0469 | 0.0801 | 2 | 26 | peptidyl-cysteine modification |
| GO:0090276 | 0.003 | 7.3176 | 0.5977 | 4 | 194 | regulation of peptide hormone secretion |
| GO:0010817 | 0.003 | 4.6494 | 1.4388 | 6 | 467 | regulation of hormone levels |
| GO:0043312 | 0.003 | 4.6494 | 1.4388 | 6 | 467 | neutrophil degranulation |
| GO:0019730 | 0.003 | 11.2845 | 0.2896 | 3 | 94 | antimicrobial humoral response |
| GO:0007634 | 0.0031 | Inf | 0.0031 | 1 | 1 | optokinetic behavior |
| GO:0032646 | 0.0031 | Inf | 0.0031 | 1 | 1 | regulation of hepatocyte growth factor production |
| GO:0032812 | 0.0031 | Inf | 0.0031 | 1 | 1 | positive regulation of epinephrine secretion |
| GO:0048178 | 0.0031 | Inf | 0.0031 | 1 | 1 | negative regulation of hepatocyte growth factor biosynthetic process |
| GO:0071881 | 0.0031 | Inf | 0.0031 | 1 | 1 | adenylate cyclase-inhibiting adrenergic receptor signaling pathway |
| GO:0071882 | 0.0031 | Inf | 0.0031 | 1 | 1 | phospholipase C-activating adrenergic receptor signaling pathway |
| GO:1904109 | 0.0031 | Inf | 0.0031 | 1 | 1 | positive regulation of cholesterol import |
| GO:1904325 | 0.0031 | Inf | 0.0031 | 1 | 1 | positive regulation of inhibitory G-protein coupled receptor phosphorylation |
| GO:0006955 | 0.0032 | 2.7431 | 5.6997 | 13 | 1850 | immune response |
| GO:0055069 | 0.0033 | 25.8862 | 0.0863 | 2 | 28 | zinc ion homeostasis |
| GO:0051674 | 0.0033 | 2.9635 | 4.3656 | 11 | 1417 | localization of cell |
| GO:0042119 | 0.0034 | 4.5378 | 1.4727 | 6 | 478 | neutrophil activation |
| GO:0050877 | 0.0034 | 3.115 | 3.7341 | 10 | 1212 | nervous system process |
| GO:0001816 | 0.0039 | 3.8768 | 2.0303 | 7 | 659 | cytokine production |
| GO:0001775 | 0.0047 | 2.9627 | 3.9097 | 10 | 1269 | cell activation |
| GO:0002275 | 0.005 | 4.1643 | 1.599 | 6 | 519 | myeloid cell activation involved in immune response |
| GO:0031424 | 0.0051 | 6.2503 | 0.6963 | 4 | 226 | keratinization |
| GO:0016477 | 0.0051 | 2.9273 | 3.9528 | 10 | 1283 | cell migration |
| GO:0045124 | 0.0052 | 20.3864 | 0.1078 | 2 | 35 | regulation of bone resorption |
| GO:0002444 | 0.0052 | 4.131 | 1.6113 | 6 | 523 | myeloid leukocyte mediated immunity |
| GO:0045055 | 0.0057 | 3.589 | 2.1844 | 7 | 709 | regulated exocytosis |
| GO:0000387 | 0.0058 | 19.219 | 0.114 | 2 | 37 | spliceosomal snRNP assembly |
| GO:0046676 | 0.0058 | 19.219 | 0.114 | 2 | 37 | negative regulation of insulin secretion |
| GO:0007154 | 0.006 | 2.1213 | 18.7781 | 28 | 6095 | cell communication |
| GO:0002792 | 0.0061 | 8.6879 | 0.3728 | 3 | 121 | negative regulation of peptide secretion |
| GO:0021560 | 0.0062 | 330.1633 | 0.0062 | 1 | 2 | abducens nerve development |
| GO:0021599 | 0.0062 | 330.1633 | 0.0062 | 1 | 2 | abducens nerve formation |
| GO:0035606 | 0.0062 | 330.1633 | 0.0062 | 1 | 2 | peptidyl-cysteine S-trans-nitrosylation |
| GO:0044657 | 0.0062 | 330.1633 | 0.0062 | 1 | 2 | pore formation in membrane of other organism during symbiotic interaction |
| GO:0052043 | 0.0062 | 330.1633 | 0.0062 | 1 | 2 | modification by symbiont of host cellular component |
| GO:0052185 | 0.0062 | 330.1633 | 0.0062 | 1 | 2 | modification of structure of other organism involved in symbiotic interaction |
| GO:0052332 | 0.0062 | 330.1633 | 0.0062 | 1 | 2 | modification by organism of membrane in other organism involved in symbiotic interaction |
| GO:0060279 | 0.0062 | 330.1633 | 0.0062 | 1 | 2 | positive regulation of ovulation |
| GO:0060876 | 0.0062 | 330.1633 | 0.0062 | 1 | 2 | semicircular canal formation |
| GO:0071657 | 0.0062 | 330.1633 | 0.0062 | 1 | 2 | positive regulation of granulocyte colony-stimulating factor production |
| GO:0045744 | 0.0064 | 18.1779 | 0.1202 | 2 | 39 | negative regulation of G-protein coupled receptor protein signaling pathway |
| GO:0007292 | 0.0069 | 8.3321 | 0.3882 | 3 | 126 | female gamete generation |
| GO:0051050 | 0.0073 | 3.1339 | 2.8806 | 8 | 935 | positive regulation of transport |
| GO:1902533 | 0.0076 | 3.1125 | 2.8991 | 8 | 941 | positive regulation of intracellular signal transduction |
| GO:0030595 | 0.008 | 7.8982 | 0.4098 | 3 | 141 | leukocyte chemotaxis |
| GO:0023061 | 0.008 | 4.3831 | 1.2478 | 5 | 405 | signal release |
| GO:0048599 | 0.0085 | 15.6357 | 0.1386 | 2 | 45 | oocyte development |
| GO:0035821 | 0.0092 | 7.4741 | 0.4313 | 3 | 140 | modification of morphology or physiology of other organism |
| GO:0071346 | 0.0092 | 7.4741 | 0.4313 | 3 | 140 | cellular response to interferon-gamma |
| GO:0050433 | 0.0092 | 14.9389 | 0.1448 | 2 | 47 | regulation of catecholamine secretion |
| GO:0021524 | 0.0092 | 165.0714 | 0.0092 | 1 | 3 | visceral motor neuron differentiation |
| GO:0046882 | 0.0092 | 165.0714 | 0.0092 | 1 | 3 | negative regulation of follicle-stimulating hormone secretion |
| GO:0048936 | 0.0092 | 165.0714 | 0.0092 | 1 | 3 | peripheral nervous system neuron axonogenesis |
| GO:0060913 | 0.0092 | 165.0714 | 0.0092 | 1 | 3 | cardiac cell fate determination |
| GO:0070093 | 0.0092 | 165.0714 | 0.0092 | 1 | 3 | negative regulation of glucagon secretion |
| GO:0032103 | 0.0096 | 5.1822 | 0.8349 | 4 | 271 | positive regulation of response to external stimulus |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0065007 | 0 | 6.8841 | 34.7742 | 47 | 11287 | biological regulation |
| GO:0048568 | 0 | 7.4565 | 1.2663 | 8 | 411 | embryonic organ development |
| GO:0048598 | 3e-04 | 5.4415 | 1.7153 | 8 | 568 | embryonic morphogenesis |
| GO:0050794 | 4e-04 | 3.9887 | 22.6334 | 33 | 8509 | regulation of cellular process |
| GO:2000113 | 4e-04 | 3.5448 | 4.5351 | 13 | 1472 | negative regulation of cellular macromolecule biosynthetic process |
| GO:0000122 | 5e-04 | 4.5221 | 2.3353 | 9 | 758 | negative regulation of transcription from RNA polymerase II promoter |
| GO:0072498 | 0.001 | 51.8141 | 0.0462 | 2 | 15 | embryonic skeletal joint development |
| GO:0009890 | 0.001 | 3.1576 | 5.0311 | 13 | 1633 | negative regulation of biosynthetic process |
| GO:0080090 | 0.0011 | 2.4839 | 17.9001 | 29 | 5810 | regulation of primary metabolic process |
| GO:0032502 | 0.0012 | 2.4738 | 17.9463 | 29 | 5825 | developmental process |
| GO:0007186 | 0.0012 | 3.3951 | 3.8573 | 11 | 1252 | G-protein coupled receptor signaling pathway |
| GO:0007389 | 0.0015 | 5.3381 | 1.2601 | 6 | 409 | pattern specification process |
| GO:0048557 | 0.0015 | 39.6127 | 0.0585 | 2 | 19 | embryonic digestive tract morphogenesis |
| GO:0006357 | 0.0017 | 6.5043 | 0.8812 | 5 | 360 | regulation of transcription from RNA polymerase II promoter |
| GO:0000079 | 0.0019 | 13.3479 | 0.2465 | 3 | 80 | regulation of cyclin-dependent protein serine/threonine kinase activity |
| GO:1903507 | 0.0022 | 3.3358 | 3.5061 | 10 | 1138 | negative regulation of nucleic acid-templated transcription |
| GO:2001141 | 0.0022 | 2.4552 | 10.7061 | 20 | 3475 | regulation of RNA biosynthetic process |
| GO:0021549 | 0.0024 | 12.2302 | 0.268 | 3 | 87 | cerebellum development |
| GO:0009887 | 0.0024 | 3.5032 | 2.9669 | 9 | 963 | animal organ morphogenesis |
| GO:0009952 | 0.0027 | 7.5598 | 0.5798 | 4 | 192 | anterior/posterior pattern specification |
| GO:0010629 | 0.0028 | 2.7945 | 5.6072 | 13 | 1820 | negative regulation of gene expression |
| GO:0048704 | 0.0028 | 11.5396 | 0.2834 | 3 | 92 | embryonic skeletal system morphogenesis |
| GO:0061011 | 0.0031 | Inf | 0.0031 | 1 | 1 | hepatic duct development |
| GO:1903769 | 0.0031 | Inf | 0.0031 | 1 | 1 | negative regulation of cell proliferation in bone marrow |
| GO:0021761 | 0.0033 | 10.9224 | 0.2988 | 3 | 97 | limbic system development |
| GO:0051253 | 0.0034 | 3.115 | 3.7341 | 10 | 1212 | negative regulation of RNA metabolic process |
| GO:0060429 | 0.0034 | 3.115 | 3.7341 | 10 | 1212 | epithelium development |
| GO:0006351 | 0.0035 | 2.3411 | 11.1097 | 20 | 3606 | transcription, DNA-templated |
| GO:0030154 | 0.0035 | 2.3118 | 11.9539 | 21 | 3880 | cell differentiation |
| GO:0035239 | 0.0037 | 5.3035 | 1.0383 | 5 | 337 | tube morphogenesis |
| GO:0006308 | 0.0038 | 24.0342 | 0.0924 | 2 | 30 | DNA catabolic process |
| GO:0035115 | 0.0043 | 22.4292 | 0.0986 | 2 | 32 | embryonic forelimb morphogenesis |
| GO:0051172 | 0.0047 | 2.469 | 7.4188 | 15 | 2408 | negative regulation of nitrogen compound metabolic process |
| GO:0045944 | 0.0049 | 3.1309 | 3.2935 | 9 | 1069 | positive regulation of transcription from RNA polymerase II promoter |
| GO:0032467 | 0.0049 | 21.0247 | 0.1048 | 2 | 34 | positive regulation of cytokinesis |
| GO:0002384 | 0.0062 | 330.1633 | 0.0062 | 1 | 2 | hepatic immune response |
| GO:0003326 | 0.0062 | 330.1633 | 0.0062 | 1 | 2 | pancreatic A cell fate commitment |
| GO:0003329 | 0.0062 | 330.1633 | 0.0062 | 1 | 2 | pancreatic PP cell fate commitment |
| GO:0003335 | 0.0062 | 330.1633 | 0.0062 | 1 | 2 | corneocyte development |
| GO:0021722 | 0.0062 | 330.1633 | 0.0062 | 1 | 2 | superior olivary nucleus maturation |
| GO:0060730 | 0.0062 | 330.1633 | 0.0062 | 1 | 2 | regulation of intestinal epithelial structure maintenance |
| GO:0061017 | 0.0062 | 330.1633 | 0.0062 | 1 | 2 | hepatoblast differentiation |
| GO:0072272 | 0.0062 | 330.1633 | 0.0062 | 1 | 2 | proximal/distal pattern formation involved in metanephric nephron development |
| GO:0110023 | 0.0062 | 330.1633 | 0.0062 | 1 | 2 | negative regulation of cardiac muscle myoblast proliferation |
| GO:2000824 | 0.0062 | 330.1633 | 0.0062 | 1 | 2 | negative regulation of androgen receptor activity |
| GO:0032501 | 0.0062 | 2.243 | 18.2647 | 27 | 6567 | multicellular organismal process |
| GO:0048731 | 0.0063 | 2.2087 | 12.6095 | 21 | 4328 | system development |
| GO:0043009 | 0.0064 | 3.9417 | 1.6853 | 6 | 547 | chordate embryonic development |
| GO:0060255 | 0.0067 | 2.0984 | 17.9648 | 27 | 5831 | regulation of macromolecule metabolic process |
| GO:0042127 | 0.0072 | 2.6507 | 4.8278 | 11 | 1567 | regulation of cell proliferation |
| GO:0031324 | 0.0084 | 2.2949 | 7.8902 | 15 | 2561 | negative regulation of cellular metabolic process |
| GO:0031018 | 0.0085 | 15.6357 | 0.1386 | 2 | 45 | endocrine pancreas development |
| GO:0030902 | 0.0086 | 7.6429 | 0.4221 | 3 | 137 | hindbrain development |
| GO:0007157 | 0.0092 | 14.9389 | 0.1448 | 2 | 47 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules |
| GO:0010621 | 0.0092 | 165.0714 | 0.0092 | 1 | 3 | negative regulation of transcription by transcription factor localization |
| GO:0030538 | 0.0092 | 165.0714 | 0.0092 | 1 | 3 | embryonic genitalia morphogenesis |
| GO:0035054 | 0.0092 | 165.0714 | 0.0092 | 1 | 3 | embryonic heart tube anterior/posterior pattern specification |
| GO:0036023 | 0.0092 | 165.0714 | 0.0092 | 1 | 3 | embryonic skeletal limb joint morphogenesis |
| GO:0044336 | 0.0092 | 165.0714 | 0.0092 | 1 | 3 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process |
| GO:0048619 | 0.0092 | 165.0714 | 0.0092 | 1 | 3 | embryonic hindgut morphogenesis |
| GO:0061010 | 0.0092 | 165.0714 | 0.0092 | 1 | 3 | gall bladder development |
| GO:0009059 | 0.0092 | 2.0454 | 15.574 | 24 | 5055 | macromolecule biosynthetic process |
| GO:0050770 | 0.0097 | 7.3126 | 0.4406 | 3 | 143 | regulation of axonogenesis |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0006614 | 0 | 37.4495 | 0.1325 | 4 | 86 | SRP-dependent cotranslational protein targeting to membrane |
| GO:0072599 | 0 | 32.2987 | 0.1525 | 4 | 99 | establishment of protein localization to endoplasmic reticulum |
| GO:0050911 | 0 | 13.7035 | 0.5715 | 6 | 371 | detection of chemical stimulus involved in sensory perception of smell |
| GO:0000184 | 0 | 28.1258 | 0.1741 | 4 | 113 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay |
| GO:0009593 | 0 | 11.2091 | 0.6932 | 6 | 450 | detection of chemical stimulus |
| GO:0050906 | 1e-04 | 10.9058 | 0.7117 | 6 | 462 | detection of stimulus involved in sensory perception |
| GO:0007606 | 1e-04 | 10.7601 | 0.7209 | 6 | 468 | sensory perception of chemical stimulus |
| GO:0006612 | 1e-04 | 20.386 | 0.2372 | 4 | 154 | protein targeting to membrane |
| GO:0019083 | 1e-04 | 18.2914 | 0.2634 | 4 | 171 | viral transcription |
| GO:0006413 | 1e-04 | 17.8591 | 0.2696 | 4 | 175 | translational initiation |
| GO:0031424 | 4e-04 | 13.7126 | 0.3481 | 4 | 226 | keratinization |
| GO:0006364 | 5e-04 | 12.6165 | 0.3774 | 4 | 245 | rRNA processing |
| GO:0043043 | 0.0011 | 6.1127 | 1.2354 | 6 | 802 | peptide biosynthetic process |
| GO:0006402 | 0.0015 | 9.3652 | 0.5037 | 4 | 327 | mRNA catabolic process |
| GO:1901194 | 0.0015 | Inf | 0.0015 | 1 | 1 | negative regulation of formation of translation preinitiation complex |
| GO:0009913 | 0.0019 | 8.7558 | 0.5376 | 4 | 349 | epidermal cell differentiation |
| GO:0019835 | 0.0019 | 35.1391 | 0.0647 | 2 | 42 | cytolysis |
| GO:0060354 | 0.0031 | 675.125 | 0.0031 | 1 | 2 | negative regulation of cell adhesion molecule production |
| GO:0043588 | 0.0033 | 7.4493 | 0.6285 | 4 | 408 | skin development |
| GO:0022613 | 0.0043 | 6.8886 | 0.6778 | 4 | 440 | ribonucleoprotein complex biogenesis |
| GO:0061044 | 0.0046 | 337.5417 | 0.0046 | 1 | 3 | negative regulation of vascular wound healing |
| GO:0043603 | 0.0055 | 4.3616 | 1.6945 | 6 | 1100 | cellular amide metabolic process |
| GO:0034655 | 0.0058 | 6.2937 | 0.7394 | 4 | 480 | nucleobase-containing compound catabolic process |
| GO:0006952 | 0.0059 | 3.866 | 2.2922 | 7 | 1488 | defense response |
| GO:0090298 | 0.0061 | 225.0139 | 0.0062 | 1 | 4 | negative regulation of mitochondrial DNA replication |
| GO:1904688 | 0.0061 | 225.0139 | 0.0062 | 1 | 4 | regulation of cytoplasmic translational initiation |
| GO:0072657 | 0.0068 | 6.0197 | 0.7718 | 4 | 501 | protein localization to membrane |
| GO:0045590 | 0.0077 | 168.75 | 0.0077 | 1 | 5 | negative regulation of regulatory T cell differentiation |
| GO:0061760 | 0.0077 | 168.75 | 0.0077 | 1 | 5 | antifungal innate immune response |
| GO:1902565 | 0.0077 | 168.75 | 0.0077 | 1 | 5 | positive regulation of neutrophil activation |
| GO:1903847 | 0.0077 | 168.75 | 0.0077 | 1 | 5 | regulation of aorta morphogenesis |
| GO:0050877 | 0.0088 | 3.9272 | 1.867 | 6 | 1212 | nervous system process |
| GO:2000766 | 0.0092 | 134.9917 | 0.0092 | 1 | 6 | negative regulation of cytoplasmic translation |
| GO:0034660 | 0.0094 | 5.4521 | 0.8488 | 4 | 551 | ncRNA metabolic process |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0043312 | 0 | 19.6054 | 0.6331 | 8 | 467 | neutrophil degranulation |
| GO:0042119 | 0 | 19.1331 | 0.648 | 8 | 478 | neutrophil activation |
| GO:0002275 | 0 | 17.5521 | 0.7036 | 8 | 519 | myeloid cell activation involved in immune response |
| GO:0002444 | 0 | 17.4114 | 0.709 | 8 | 523 | myeloid leukocyte mediated immunity |
| GO:0043207 | 0 | 13.2459 | 1.1035 | 9 | 814 | response to external biotic stimulus |
| GO:0031640 | 0 | 69.0385 | 0.0759 | 4 | 56 | killing of cells of other organism |
| GO:0035821 | 0 | 35.0153 | 0.1898 | 5 | 140 | modification of morphology or physiology of other organism |
| GO:0002263 | 0 | 13.611 | 0.8961 | 8 | 661 | cell activation involved in immune response |
| GO:0070488 | 0 | Inf | 0.0027 | 2 | 2 | neutrophil aggregation |
| GO:0045055 | 0 | 12.6399 | 0.9611 | 8 | 709 | regulated exocytosis |
| GO:0019730 | 0 | 75.5578 | 0.0505 | 3 | 43 | antimicrobial humoral response |
| GO:0061844 | 0 | 53.1546 | 0.0691 | 3 | 51 | antimicrobial humoral immune response mediated by antimicrobial peptide |
| GO:0045321 | 1e-04 | 7.7271 | 1.5237 | 8 | 1124 | leukocyte activation |
| GO:0017014 | 1e-04 | 161.97 | 0.0163 | 2 | 12 | protein nitrosylation |
| GO:0032119 | 1e-04 | 161.97 | 0.0163 | 2 | 12 | sequestering of zinc ion |
| GO:0051873 | 1e-04 | 161.97 | 0.0163 | 2 | 12 | killing by host of symbiont cells |
| GO:0002523 | 2e-04 | 134.9583 | 0.019 | 2 | 14 | leukocyte migration involved in inflammatory response |
| GO:0050830 | 2e-04 | 31.0494 | 0.1152 | 3 | 85 | defense response to Gram-positive bacterium |
| GO:0051818 | 3e-04 | 101.1937 | 0.0244 | 2 | 18 | disruption of cells of other organism involved in symbiotic interaction |
| GO:0032940 | 3e-04 | 6.2083 | 1.8626 | 8 | 1374 | secretion by cell |
| GO:0016192 | 3e-04 | 5.6504 | 2.4103 | 9 | 1778 | vesicle-mediated transport |
| GO:0044116 | 3e-04 | 95.2353 | 0.0258 | 2 | 19 | growth of symbiont involved in interaction with host |
| GO:0006952 | 5e-04 | 5.6861 | 2.0171 | 8 | 1488 | defense response |
| GO:0018198 | 6e-04 | 67.4292 | 0.0352 | 2 | 26 | peptidyl-cysteine modification |
| GO:0055069 | 6e-04 | 62.2346 | 0.038 | 2 | 28 | zinc ion homeostasis |
| GO:0042742 | 7e-04 | 19.9688 | 0.1801 | 3 | 153 | defense response to bacterium |
| GO:0050832 | 0.0011 | 47.2836 | 0.0492 | 2 | 38 | defense response to fungus |
| GO:0009913 | 0.0011 | 10.2171 | 0.4731 | 4 | 349 | epidermal cell differentiation |
| GO:0019547 | 0.0014 | Inf | 0.0014 | 1 | 1 | arginine catabolic process to ornithine |
| GO:0044140 | 0.0014 | Inf | 0.0014 | 1 | 1 | negative regulation of growth of symbiont on or near host surface |
| GO:0070965 | 0.0014 | Inf | 0.0014 | 1 | 1 | positive regulation of neutrophil mediated killing of fungus |
| GO:1900150 | 0.0014 | Inf | 0.0014 | 1 | 1 | regulation of defense response to fungus |
| GO:0050911 | 0.0014 | 9.5913 | 0.5029 | 4 | 371 | detection of chemical stimulus involved in sensory perception of smell |
| GO:0019835 | 0.0015 | 40.4175 | 0.0569 | 2 | 42 | cytolysis |
| GO:0031343 | 0.0015 | 39.4293 | 0.0583 | 2 | 43 | positive regulation of cell killing |
| GO:0002221 | 0.0016 | 14.895 | 0.2345 | 3 | 173 | pattern recognition receptor signaling pathway |
| GO:0045088 | 0.0019 | 8.7817 | 0.5477 | 4 | 404 | regulation of innate immune response |
| GO:0051704 | 0.002 | 4.2031 | 3.1192 | 9 | 2301 | multi-organism process |
| GO:0010043 | 0.002 | 34.383 | 0.0664 | 2 | 49 | response to zinc ion |
| GO:0043588 | 0.002 | 8.6925 | 0.5531 | 4 | 408 | skin development |
| GO:2001244 | 0.0024 | 31.0673 | 0.0732 | 2 | 54 | positive regulation of intrinsic apoptotic signaling pathway |
| GO:0050896 | 0.0025 | 4.4082 | 11.1227 | 18 | 8205 | response to stimulus |
| GO:0010963 | 0.0027 | 771.7143 | 0.0027 | 1 | 2 | regulation of L-arginine import |
| GO:0035606 | 0.0027 | 771.7143 | 0.0027 | 1 | 2 | peptidyl-cysteine S-trans-nitrosylation |
| GO:0070949 | 0.0027 | 771.7143 | 0.0027 | 1 | 2 | regulation of neutrophil mediated killing of symbiont cell |
| GO:0070960 | 0.0027 | 771.7143 | 0.0027 | 1 | 2 | positive regulation of neutrophil mediated cytotoxicity |
| GO:0009593 | 0.0029 | 7.853 | 0.61 | 4 | 450 | detection of chemical stimulus |
| GO:0050906 | 0.0032 | 7.6414 | 0.6263 | 4 | 462 | detection of stimulus involved in sensory perception |
| GO:0007606 | 0.0033 | 7.5398 | 0.6344 | 4 | 468 | sensory perception of chemical stimulus |
| GO:0051851 | 0.0034 | 26.0403 | 0.0868 | 2 | 64 | modification by host of symbiont morphology or physiology |
| GO:0031424 | 0.0034 | 11.3174 | 0.3064 | 3 | 226 | keratinization |
| GO:0032827 | 0.0041 | 385.8333 | 0.0041 | 1 | 3 | negative regulation of natural killer cell differentiation involved in immune response |
| GO:0051714 | 0.0041 | 385.8333 | 0.0041 | 1 | 3 | positive regulation of cytolysis in other organism |
| GO:0032602 | 0.0047 | 21.8014 | 0.103 | 2 | 76 | chemokine production |
| GO:0006919 | 0.0051 | 20.9481 | 0.1071 | 2 | 79 | activation of cysteine-type endopeptidase activity involved in apoptotic process |
| GO:0007186 | 0.0053 | 4.5027 | 1.6972 | 6 | 1252 | G-protein coupled receptor signaling pathway |
| GO:0090467 | 0.0054 | 257.2063 | 0.0054 | 1 | 4 | arginine import |
| GO:2000552 | 0.0054 | 257.2063 | 0.0054 | 1 | 4 | negative regulation of T-helper 2 cell cytokine production |
| GO:0030593 | 0.0063 | 18.7453 | 0.1193 | 2 | 88 | neutrophil chemotaxis |
| GO:0002218 | 0.0064 | 8.9166 | 0.3863 | 3 | 285 | activation of innate immune response |
| GO:1902023 | 0.0068 | 192.8929 | 0.0068 | 1 | 5 | L-arginine transport |
| GO:0046916 | 0.0071 | 17.5163 | 0.1274 | 2 | 94 | cellular transition metal ion homeostasis |
| GO:0010269 | 0.0081 | 154.3048 | 0.0081 | 1 | 6 | response to selenium ion |
| GO:0060336 | 0.0081 | 154.3048 | 0.0081 | 1 | 6 | negative regulation of interferon-gamma-mediated signaling pathway |
| GO:0071947 | 0.0081 | 154.3048 | 0.0081 | 1 | 6 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process |
| GO:0032496 | 0.0082 | 8.1505 | 0.4216 | 3 | 311 | response to lipopolysaccharide |
| GO:0009253 | 0.0095 | 128.5794 | 0.0095 | 1 | 7 | peptidoglycan catabolic process |
| GO:0009635 | 0.0095 | 128.5794 | 0.0095 | 1 | 7 | response to herbicide |
| GO:0032815 | 0.0095 | 128.5794 | 0.0095 | 1 | 7 | negative regulation of natural killer cell activation |
| GO:0051597 | 0.0095 | 128.5794 | 0.0095 | 1 | 7 | response to methylmercury |
| GO:0050729 | 0.0096 | 14.9065 | 0.1491 | 2 | 110 | positive regulation of inflammatory response |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0050911 | 0 | 16.2419 | 0.8458 | 10 | 371 | detection of chemical stimulus involved in sensory perception of smell |
| GO:0009593 | 0 | 13.2593 | 1.0259 | 10 | 450 | detection of chemical stimulus |
| GO:0050906 | 0 | 12.8974 | 1.0533 | 10 | 462 | detection of stimulus involved in sensory perception |
| GO:0007606 | 0 | 12.7236 | 1.067 | 10 | 468 | sensory perception of chemical stimulus |
| GO:0007186 | 0 | 5.7879 | 2.8544 | 12 | 1252 | G-protein coupled receptor signaling pathway |
| GO:0070475 | 2e-04 | 132.1224 | 0.0205 | 2 | 9 | rRNA base methylation |
| GO:0050877 | 3e-04 | 4.6188 | 2.7632 | 10 | 1212 | nervous system process |
| GO:0030593 | 0.001 | 16.7201 | 0.2006 | 3 | 88 | neutrophil chemotaxis |
| GO:0046105 | 0.0023 | Inf | 0.0023 | 1 | 1 | thymidine biosynthetic process |
| GO:0046120 | 0.0023 | Inf | 0.0023 | 1 | 1 | deoxyribonucleoside biosynthetic process |
| GO:0097530 | 0.0027 | 11.9177 | 0.2781 | 3 | 122 | granulocyte migration |
| GO:0000154 | 0.003 | 27.1563 | 0.0821 | 2 | 36 | rRNA modification |
| GO:1903959 | 0.0032 | 26.3788 | 0.0844 | 2 | 37 | regulation of anion transmembrane transport |
| GO:0050832 | 0.0036 | 24.9498 | 0.0889 | 2 | 39 | defense response to fungus |
| GO:0035821 | 0.0039 | 10.3403 | 0.3192 | 3 | 140 | modification of morphology or physiology of other organism |
| GO:0035606 | 0.0046 | 449.75 | 0.0046 | 1 | 2 | peptidyl-cysteine S-trans-nitrosylation |
| GO:0070488 | 0.0046 | 449.75 | 0.0046 | 1 | 2 | neutrophil aggregation |
| GO:0051452 | 0.0058 | 19.219 | 0.114 | 2 | 50 | intracellular pH reduction |
| GO:0048247 | 0.0077 | 16.4653 | 0.1322 | 2 | 58 | lymphocyte chemotaxis |
| GO:0001510 | 0.0088 | 15.3638 | 0.1414 | 2 | 62 | RNA methylation |
| GO:0002548 | 0.0088 | 15.3638 | 0.1414 | 2 | 62 | monocyte chemotaxis |
| GO:0046125 | 0.0091 | 149.8981 | 0.0091 | 1 | 4 | pyrimidine deoxyribonucleoside metabolic process |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004082 | 2e-04 | 173.043 | 0.0235 | 2 | 4 | bisphosphoglycerate mutase activity |
| GO:0046538 | 2e-04 | 173.043 | 0.0235 | 2 | 4 | 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity |
| GO:1903231 | 5e-04 | 8.38 | 0.6513 | 5 | 111 | mRNA binding involved in posttranscriptional gene silencing |
| GO:0004252 | 6e-04 | 6.2779 | 1.0386 | 6 | 177 | serine-type endopeptidase activity |
| GO:0017171 | 0.0014 | 5.2777 | 1.2264 | 6 | 209 | serine hydrolase activity |
| GO:0050786 | 0.0018 | 38.4373 | 0.0645 | 2 | 11 | RAGE receptor binding |
| GO:0008201 | 0.0024 | 5.7887 | 0.9271 | 5 | 158 | heparin binding |
| GO:0004595 | 0.0059 | Inf | 0.0059 | 1 | 1 | pantetheine-phosphate adenylyltransferase activity |
| GO:0008493 | 0.0059 | Inf | 0.0059 | 1 | 1 | tetracycline transporter activity |
| GO:0031249 | 0.0059 | Inf | 0.0059 | 1 | 1 | denatured protein binding |
| GO:0031751 | 0.0059 | Inf | 0.0059 | 1 | 1 | D4 dopamine receptor binding |
| GO:0070191 | 0.0059 | Inf | 0.0059 | 1 | 1 | methionine-R-sulfoxide reductase activity |
| GO:0001848 | 0.0067 | 18.1958 | 0.1232 | 2 | 21 | complement binding |
| GO:0070011 | 0.0071 | 2.8349 | 3.4151 | 9 | 582 | peptidase activity, acting on L-amino acid peptides |
| GO:0004190 | 0.008 | 16.4608 | 0.135 | 2 | 23 | aspartic-type endopeptidase activity |
| GO:0001106 | 0.0094 | 15.0276 | 0.1467 | 2 | 25 | RNA polymerase II transcription corepressor activity |
| GO:0016866 | 0.0094 | 15.0276 | 0.1467 | 2 | 25 | intramolecular transferase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004082 | 2e-04 | 171.1915 | 0.0237 | 2 | 4 | bisphosphoglycerate mutase activity |
| GO:0046538 | 2e-04 | 171.1915 | 0.0237 | 2 | 4 | 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity |
| GO:1903231 | 5e-04 | 8.2874 | 0.6582 | 5 | 111 | mRNA binding involved in posttranscriptional gene silencing |
| GO:0050786 | 0.0018 | 38.026 | 0.0652 | 2 | 11 | RAGE receptor binding |
| GO:0016787 | 0.0057 | 1.9331 | 14.1776 | 24 | 2391 | hydrolase activity |
| GO:0004595 | 0.0059 | Inf | 0.0059 | 1 | 1 | pantetheine-phosphate adenylyltransferase activity |
| GO:0008493 | 0.0059 | Inf | 0.0059 | 1 | 1 | tetracycline transporter activity |
| GO:0031249 | 0.0059 | Inf | 0.0059 | 1 | 1 | denatured protein binding |
| GO:0070191 | 0.0059 | Inf | 0.0059 | 1 | 1 | methionine-R-sulfoxide reductase activity |
| GO:0001848 | 0.0068 | 18.0011 | 0.1245 | 2 | 21 | complement binding |
| GO:0005539 | 0.0081 | 4.2798 | 1.2393 | 5 | 209 | glycosaminoglycan binding |
| GO:0004190 | 0.0081 | 16.2847 | 0.1364 | 2 | 23 | aspartic-type endopeptidase activity |
| GO:0001106 | 0.0096 | 14.8668 | 0.1482 | 2 | 25 | RNA polymerase II transcription corepressor activity |
| GO:0016866 | 0.0096 | 14.8668 | 0.1482 | 2 | 25 | intramolecular transferase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0005515 | 5e-04 | 1.6566 | 156.3715 | 180 | 10773 | protein binding |
| GO:0003682 | 0.0039 | 2.307 | 6.8657 | 15 | 473 | chromatin binding |
| GO:0003708 | 0.0042 | 27.382 | 0.1016 | 2 | 7 | retinoic acid receptor activity |
| GO:0043565 | 0.0054 | 1.8371 | 14.4571 | 25 | 996 | sequence-specific DNA binding |
| GO:0000975 | 0.0081 | 1.8688 | 11.8589 | 21 | 817 | regulatory region DNA binding |
| GO:0016018 | 0.0087 | 17.1105 | 0.1452 | 2 | 10 | cyclosporin A binding |
| GO:0000976 | 0.0091 | 1.9469 | 9.7251 | 18 | 670 | transcription regulatory region sequence-specific DNA binding |
| GO:0099106 | 0.01 | 4.0588 | 1.3064 | 5 | 90 | ion channel regulator activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0005515 | 3e-04 | 1.7979 | 126.3494 | 149 | 10269 | protein binding |
| GO:1990837 | 8e-04 | 2.3813 | 9.0395 | 20 | 707 | sequence-specific double-stranded DNA binding |
| GO:0140110 | 0.0017 | 1.8516 | 19.4086 | 33 | 1518 | transcription regulator activity |
| GO:0003677 | 0.0018 | 1.698 | 30.0208 | 46 | 2348 | DNA binding |
| GO:0044212 | 0.0018 | 2.1598 | 10.4203 | 21 | 815 | transcription regulatory region DNA binding |
| GO:0001067 | 0.0019 | 2.1513 | 10.4587 | 21 | 818 | regulatory region nucleic acid binding |
| GO:0000981 | 0.0029 | 2.1549 | 9.3975 | 19 | 735 | RNA polymerase II transcription factor activity, sequence-specific DNA binding |
| GO:0098531 | 0.003 | 7.3044 | 0.6009 | 4 | 47 | transcription factor activity, direct ligand regulated sequence-specific DNA binding |
| GO:0003708 | 0.0033 | 31.1766 | 0.0895 | 2 | 7 | retinoic acid receptor activity |
| GO:0008134 | 0.0055 | 2.2936 | 6.444 | 14 | 504 | transcription factor binding |
| GO:0099106 | 0.0059 | 4.6296 | 1.1507 | 5 | 90 | ion channel regulator activity |
| GO:0003707 | 0.006 | 5.9225 | 0.7288 | 4 | 57 | steroid hormone receptor activity |
| GO:0005125 | 0.0067 | 3.0489 | 2.7617 | 8 | 216 | cytokine activity |
| GO:0005126 | 0.0068 | 2.8148 | 3.3626 | 9 | 263 | cytokine receptor binding |
| GO:0003682 | 0.008 | 2.2613 | 6.0476 | 13 | 473 | chromatin binding |
| GO:0017080 | 0.0085 | 7.8201 | 0.4219 | 3 | 33 | sodium channel regulator activity |
| GO:0000977 | 0.0091 | 2.0897 | 7.5563 | 15 | 591 | RNA polymerase II regulatory region sequence-specific DNA binding |
| GO:0004861 | 0.0099 | 15.5834 | 0.1534 | 2 | 12 | cyclin-dependent protein serine/threonine kinase inhibitor activity |
| GO:0043422 | 0.0099 | 15.5834 | 0.1534 | 2 | 12 | protein kinase B binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004930 | 1e-04 | 10.7934 | 0.8232 | 6 | 784 | G-protein coupled receptor activity |
| GO:0004984 | 5e-04 | 13.2517 | 0.3896 | 4 | 371 | olfactory receptor activity |
| GO:0099600 | 0.0011 | 6.7092 | 1.2831 | 6 | 1222 | transmembrane receptor activity |
| GO:0038023 | 0.0014 | 6.3735 | 1.3451 | 6 | 1281 | signaling receptor activity |
| GO:0071791 | 0.0021 | 1010.75 | 0.0021 | 1 | 2 | chemokine (C-C motif) ligand 5 binding |
| GO:0005549 | 0.0034 | 26.4889 | 0.0872 | 2 | 83 | odorant binding |
| GO:0060089 | 0.0036 | 5.2203 | 1.6128 | 6 | 1536 | molecular transducer activity |
| GO:0031728 | 0.0042 | 336.875 | 0.0042 | 1 | 4 | CCR3 chemokine receptor binding |
| GO:0005198 | 0.0046 | 7.1307 | 0.7067 | 4 | 673 | structural molecule activity |
| GO:0001849 | 0.0084 | 144.3393 | 0.0084 | 1 | 8 | complement component C1q binding |
| GO:0046790 | 0.0084 | 144.3393 | 0.0084 | 1 | 8 | virion binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0032394 | 0 | Inf | 0.0037 | 2 | 2 | MHC class Ib receptor activity |
| GO:0099600 | 0 | 6.1667 | 2.2644 | 10 | 1222 | transmembrane receptor activity |
| GO:0038023 | 1e-04 | 5.8572 | 2.3737 | 10 | 1281 | signaling receptor activity |
| GO:0060089 | 3e-04 | 4.7949 | 2.8462 | 10 | 1536 | molecular transducer activity |
| GO:0004930 | 4e-04 | 6.3242 | 1.3992 | 7 | 781 | G-protein coupled receptor activity |
| GO:0042288 | 5e-04 | 72.0714 | 0.0334 | 2 | 18 | MHC class I protein binding |
| GO:0004984 | 5e-04 | 8.6306 | 0.6875 | 5 | 371 | olfactory receptor activity |
| GO:1903231 | 0.0011 | 16.5144 | 0.2057 | 3 | 111 | mRNA binding involved in posttranscriptional gene silencing |
| GO:0005133 | 0.0019 | Inf | 0.0019 | 1 | 1 | interferon-gamma receptor binding |
| GO:0008009 | 0.0036 | 25.0217 | 0.0889 | 2 | 48 | chemokine activity |
| GO:0071791 | 0.0037 | 557.2069 | 0.0037 | 1 | 2 | chemokine (C-C motif) ligand 5 binding |
| GO:0004869 | 0.0048 | 21.3042 | 0.1038 | 2 | 56 | cysteine-type endopeptidase inhibitor activity |
| GO:0016503 | 0.0055 | 278.5862 | 0.0056 | 1 | 3 | pheromone receptor activity |
| GO:0004522 | 0.0074 | 185.7126 | 0.0074 | 1 | 4 | ribonuclease A activity |
| GO:0004698 | 0.0074 | 185.7126 | 0.0074 | 1 | 4 | calcium-dependent protein kinase C activity |
| GO:0048018 | 0.0088 | 5.4837 | 0.8246 | 4 | 445 | receptor ligand activity |
| GO:0031726 | 0.0092 | 139.2759 | 0.0093 | 1 | 5 | CCR1 chemokine receptor binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0003723 | 0 | 4.3203 | 5.6087 | 18 | 1651 | RNA binding |
| GO:1903231 | 5e-04 | 11.7486 | 0.3771 | 4 | 111 | mRNA binding involved in posttranscriptional gene silencing |
| GO:0008009 | 6e-04 | 20.6282 | 0.1631 | 3 | 48 | chemokine activity |
| GO:0000254 | 0.0034 | Inf | 0.0034 | 1 | 1 | C-4 methylsterol oxidase activity |
| GO:0005520 | 0.004 | 23.3803 | 0.0951 | 2 | 28 | insulin-like growth factor binding |
| GO:0030354 | 0.0068 | 298.7778 | 0.0068 | 1 | 2 | melanin-concentrating hormone activity |
| GO:1990188 | 0.0068 | 298.7778 | 0.0068 | 1 | 2 | euchromatin binding |
| GO:0048020 | 0.0077 | 16.4182 | 0.1325 | 2 | 39 | CCR chemokine receptor binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004984 | 0 | 7.7253 | 1.2145 | 8 | 371 | olfactory receptor activity |
| GO:0005549 | 0.0025 | 12.0427 | 0.2717 | 3 | 83 | odorant binding |
| GO:0004343 | 0.0033 | Inf | 0.0033 | 1 | 1 | glucosamine 6-phosphate N-acetyltransferase activity |
| GO:0005142 | 0.0033 | Inf | 0.0033 | 1 | 1 | interleukin-11 receptor binding |
| GO:0004930 | 0.0037 | 3.5191 | 2.5665 | 8 | 784 | G-protein coupled receptor activity |
| GO:0042056 | 0.004 | 23.3987 | 0.0949 | 2 | 29 | chemoattractant activity |
| GO:0004782 | 0.0065 | 310.3077 | 0.0065 | 1 | 2 | sulfinoalanine decarboxylase activity |
| GO:0000993 | 0.0069 | 17.5392 | 0.1244 | 2 | 38 | RNA polymerase II core binding |
| GO:0004663 | 0.0098 | 155.1442 | 0.0098 | 1 | 3 | Rab geranylgeranyltransferase activity |
| GO:0030395 | 0.0098 | 155.1442 | 0.0098 | 1 | 3 | lactose binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004984 | 0 | 11.2896 | 0.6645 | 6 | 371 | olfactory receptor activity |
| GO:1903231 | 0.001 | 17.1506 | 0.1988 | 3 | 111 | mRNA binding involved in posttranscriptional gene silencing |
| GO:0042056 | 0.0012 | 44.2634 | 0.0519 | 2 | 29 | chemoattractant activity |
| GO:0004930 | 0.0023 | 5.158 | 1.4043 | 6 | 784 | G-protein coupled receptor activity |
| GO:0031731 | 0.0054 | 288.5536 | 0.0054 | 1 | 3 | CCR6 chemokine receptor binding |
| GO:0005549 | 0.0096 | 14.7051 | 0.1487 | 2 | 83 | odorant binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004984 | 0 | 9.4003 | 1.0312 | 8 | 371 | olfactory receptor activity |
| GO:0035662 | 0 | 750.8837 | 0.0083 | 2 | 3 | Toll-like receptor 4 binding |
| GO:0050544 | 1e-04 | 250.2636 | 0.0139 | 2 | 5 | arachidonic acid binding |
| GO:0099600 | 1e-04 | 4.4884 | 3.3965 | 12 | 1222 | transmembrane receptor activity |
| GO:0004930 | 1e-04 | 5.5894 | 1.9631 | 9 | 737 | G-protein coupled receptor activity |
| GO:0038023 | 1e-04 | 4.2628 | 3.5605 | 12 | 1281 | signaling receptor activity |
| GO:0060089 | 2e-04 | 3.9003 | 4.2693 | 13 | 1536 | molecular transducer activity |
| GO:0008009 | 3e-04 | 25.5556 | 0.1334 | 3 | 48 | chemokine activity |
| GO:0005179 | 3e-04 | 13.5992 | 0.3308 | 4 | 119 | hormone activity |
| GO:0036041 | 4e-04 | 83.3902 | 0.0306 | 2 | 11 | long-chain fatty acid binding |
| GO:0050786 | 4e-04 | 83.3902 | 0.0306 | 2 | 11 | RAGE receptor binding |
| GO:1901567 | 0.0018 | 35.7121 | 0.0639 | 2 | 23 | fatty acid derivative binding |
| GO:0046789 | 0.0028 | Inf | 0.0028 | 1 | 1 | host cell surface receptor binding |
| GO:0042277 | 0.005 | 6.3315 | 0.6921 | 4 | 249 | peptide binding |
| GO:0048020 | 0.0052 | 20.2489 | 0.1084 | 2 | 39 | CCR chemokine receptor binding |
| GO:0031696 | 0.0056 | 366.9091 | 0.0056 | 1 | 2 | alpha-2C adrenergic receptor binding |
| GO:0001664 | 0.0056 | 6.1037 | 0.7171 | 4 | 258 | G-protein coupled receptor binding |
| GO:0005126 | 0.006 | 5.984 | 0.731 | 4 | 263 | cytokine receptor binding |
| GO:0015631 | 0.0075 | 5.6094 | 0.7783 | 4 | 280 | tubulin binding |
| GO:0008227 | 0.0075 | 16.6408 | 0.1306 | 2 | 47 | G-protein coupled amine receptor activity |
| GO:0004938 | 0.0083 | 183.4432 | 0.0083 | 1 | 3 | alpha2-adrenergic receptor activity |
| GO:0004980 | 0.0083 | 183.4432 | 0.0083 | 1 | 3 | melanocyte-stimulating hormone receptor activity |
| GO:0031692 | 0.0083 | 183.4432 | 0.0083 | 1 | 3 | alpha-1B adrenergic receptor binding |
| GO:0032795 | 0.0083 | 183.4432 | 0.0083 | 1 | 3 | heterotrimeric G-protein binding |
| GO:0048018 | 0.0093 | 5.2738 | 0.8317 | 4 | 326 | receptor ligand activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0005515 | 1e-04 | 2.0231 | 103.1387 | 124 | 10773 | protein binding |
| GO:0019956 | 0.0012 | 16.6371 | 0.2106 | 3 | 22 | chemokine binding |
| GO:0001637 | 0.0017 | 14.3657 | 0.2393 | 3 | 25 | G-protein coupled chemoattractant receptor activity |
| GO:0016004 | 0.0047 | 23.2767 | 0.1053 | 2 | 11 | phospholipase activator activity |
| GO:0005125 | 0.0048 | 3.5815 | 2.0679 | 7 | 216 | cytokine activity |
| GO:0016493 | 0.0056 | 20.9477 | 0.1149 | 2 | 12 | C-C chemokine receptor activity |
| GO:0048020 | 0.0061 | 8.7714 | 0.3734 | 3 | 39 | CCR chemokine receptor binding |
| GO:0004659 | 0.0077 | 17.4542 | 0.134 | 2 | 14 | prenyltransferase activity |
| GO:0004896 | 0.0083 | 5.3503 | 0.7946 | 4 | 83 | cytokine receptor activity |
| GO:0000254 | 0.0096 | Inf | 0.0096 | 1 | 1 | C-4 methylsterol oxidase activity |
| GO:0001133 | 0.0096 | Inf | 0.0096 | 1 | 1 | RNA polymerase II transcription factor activity, sequence-specific transcription regulatory region DNA binding |
| GO:0003827 | 0.0096 | Inf | 0.0096 | 1 | 1 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity |
| GO:0004733 | 0.0096 | Inf | 0.0096 | 1 | 1 | pyridoxamine-phosphate oxidase activity |
| GO:0004941 | 0.0096 | Inf | 0.0096 | 1 | 1 | beta2-adrenergic receptor activity |
| GO:0005141 | 0.0096 | Inf | 0.0096 | 1 | 1 | interleukin-10 receptor binding |
| GO:0008811 | 0.0096 | Inf | 0.0096 | 1 | 1 | chloramphenicol O-acetyltransferase activity |
| GO:0016495 | 0.0096 | Inf | 0.0096 | 1 | 1 | C-X3-C chemokine receptor activity |
| GO:0019969 | 0.0096 | Inf | 0.0096 | 1 | 1 | interleukin-10 binding |
| GO:0035717 | 0.0096 | Inf | 0.0096 | 1 | 1 | chemokine (C-C motif) ligand 7 binding |
| GO:0097260 | 0.0096 | Inf | 0.0096 | 1 | 1 | eoxin A4 synthase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0031727 | 0 | 174.4239 | 0.0435 | 3 | 5 | CCR2 chemokine receptor binding |
| GO:0042379 | 2e-04 | 10.6912 | 0.5225 | 5 | 60 | chemokine receptor binding |
| GO:0004896 | 8e-04 | 7.5278 | 0.7229 | 5 | 83 | cytokine receptor activity |
| GO:0019956 | 9e-04 | 18.341 | 0.1916 | 3 | 22 | chemokine binding |
| GO:0001637 | 0.0013 | 15.837 | 0.2177 | 3 | 25 | G-protein coupled chemoattractant receptor activity |
| GO:0005515 | 0.0019 | 1.7923 | 93.8229 | 110 | 10773 | protein binding |
| GO:0016004 | 0.0039 | 25.6435 | 0.0958 | 2 | 11 | phospholipase activator activity |
| GO:0016493 | 0.0047 | 23.0777 | 0.1045 | 2 | 12 | C-C chemokine receptor activity |
| GO:0008308 | 0.0083 | 16.48 | 0.1393 | 2 | 16 | voltage-gated anion channel activity |
| GO:0023026 | 0.0083 | 16.48 | 0.1393 | 2 | 16 | MHC class II protein complex binding |
| GO:0001133 | 0.0087 | Inf | 0.0087 | 1 | 1 | RNA polymerase II transcription factor activity, sequence-specific transcription regulatory region DNA binding |
| GO:0003827 | 0.0087 | Inf | 0.0087 | 1 | 1 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity |
| GO:0004941 | 0.0087 | Inf | 0.0087 | 1 | 1 | beta2-adrenergic receptor activity |
| GO:0005141 | 0.0087 | Inf | 0.0087 | 1 | 1 | interleukin-10 receptor binding |
| GO:0008811 | 0.0087 | Inf | 0.0087 | 1 | 1 | chloramphenicol O-acetyltransferase activity |
| GO:0016495 | 0.0087 | Inf | 0.0087 | 1 | 1 | C-X3-C chemokine receptor activity |
| GO:0019969 | 0.0087 | Inf | 0.0087 | 1 | 1 | interleukin-10 binding |
| GO:0035717 | 0.0087 | Inf | 0.0087 | 1 | 1 | chemokine (C-C motif) ligand 7 binding |
| GO:0097260 | 0.0087 | Inf | 0.0087 | 1 | 1 | eoxin A4 synthase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004984 | 1e-04 | 5.189 | 2.154 | 10 | 371 | olfactory receptor activity |
| GO:0004930 | 6e-04 | 3.1901 | 4.5519 | 13 | 784 | G-protein coupled receptor activity |
| GO:0016004 | 0.0018 | 38.8575 | 0.0639 | 2 | 11 | phospholipase activator activity |
| GO:0005200 | 0.003 | 7.1816 | 0.598 | 4 | 103 | structural constituent of cytoskeleton |
| GO:0055102 | 0.0038 | 24.972 | 0.0929 | 2 | 16 | lipase inhibitor activity |
| GO:0004506 | 0.0058 | Inf | 0.0058 | 1 | 1 | squalene monooxygenase activity |
| GO:0005141 | 0.0058 | Inf | 0.0058 | 1 | 1 | interleukin-10 receptor binding |
| GO:0018455 | 0.0058 | Inf | 0.0058 | 1 | 1 | alcohol dehydrogenase [NAD(P)+] activity |
| GO:0035717 | 0.0058 | Inf | 0.0058 | 1 | 1 | chemokine (C-C motif) ligand 7 binding |
| GO:0047800 | 0.0058 | Inf | 0.0058 | 1 | 1 | cysteamine dioxygenase activity |
| GO:0004033 | 0.0092 | 15.1919 | 0.1452 | 2 | 25 | aldo-keto reductase (NADP) activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004984 | 1e-04 | 5.15 | 1.9478 | 9 | 371 | olfactory receptor activity |
| GO:0005509 | 7e-04 | 3.5401 | 3.4651 | 11 | 660 | calcium ion binding |
| GO:0016004 | 0.0015 | 43.095 | 0.0578 | 2 | 11 | phospholipase activator activity |
| GO:0004930 | 0.0026 | 2.9484 | 4.1161 | 11 | 784 | G-protein coupled receptor activity |
| GO:0055102 | 0.0031 | 27.6954 | 0.084 | 2 | 16 | lipase inhibitor activity |
| GO:0005141 | 0.0053 | Inf | 0.0053 | 1 | 1 | interleukin-10 receptor binding |
| GO:0018455 | 0.0053 | Inf | 0.0053 | 1 | 1 | alcohol dehydrogenase [NAD(P)+] activity |
| GO:0019772 | 0.0053 | Inf | 0.0053 | 1 | 1 | low-affinity IgG receptor activity |
| GO:0035717 | 0.0053 | Inf | 0.0053 | 1 | 1 | chemokine (C-C motif) ligand 7 binding |
| GO:0019956 | 0.0059 | 19.3795 | 0.1155 | 2 | 22 | chemokine binding |
| GO:0019865 | 0.0064 | 18.4555 | 0.1208 | 2 | 23 | immunoglobulin binding |
| GO:0005549 | 0.0095 | 7.3285 | 0.4358 | 3 | 83 | odorant binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004984 | 0 | 9.2432 | 1.5812 | 12 | 371 | olfactory receptor activity |
| GO:0003735 | 0 | 14.7578 | 0.6393 | 8 | 150 | structural constituent of ribosome |
| GO:0048020 | 0 | 28.2831 | 0.1662 | 4 | 39 | CCR chemokine receptor binding |
| GO:0004930 | 0 | 4.6218 | 3.3413 | 13 | 784 | G-protein coupled receptor activity |
| GO:0099600 | 5e-04 | 3.1424 | 5.208 | 14 | 1222 | transmembrane receptor activity |
| GO:0038023 | 9e-04 | 2.9842 | 5.4595 | 14 | 1281 | signaling receptor activity |
| GO:0008009 | 0.0011 | 16.2384 | 0.2046 | 3 | 48 | chemokine activity |
| GO:0060089 | 0.0018 | 2.6664 | 6.5463 | 15 | 1536 | molecular transducer activity |
| GO:0003746 | 0.0021 | 34.3433 | 0.0682 | 2 | 16 | translation elongation factor activity |
| GO:0048018 | 0.0028 | 4.0426 | 1.8965 | 7 | 445 | receptor ligand activity |
| GO:0003723 | 0.0035 | 2.4594 | 7.0364 | 15 | 1651 | RNA binding |
| GO:0005163 | 0.0043 | Inf | 0.0043 | 1 | 1 | nerve growth factor receptor binding |
| GO:0008493 | 0.0043 | Inf | 0.0043 | 1 | 1 | tetracycline transporter activity |
| GO:0005126 | 0.0048 | 4.9182 | 1.0964 | 5 | 261 | cytokine receptor binding |
| GO:0001664 | 0.0048 | 4.9 | 1.0996 | 5 | 258 | G-protein coupled receptor binding |
| GO:0005549 | 0.0053 | 9.1142 | 0.3537 | 3 | 83 | odorant binding |
| GO:0005146 | 0.0085 | 237.0588 | 0.0085 | 1 | 2 | leukemia inhibitory factor receptor binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004984 | 0 | 11.6868 | 1.4208 | 13 | 371 | olfactory receptor activity |
| GO:0004930 | 0 | 5.8174 | 3.0023 | 14 | 784 | G-protein coupled receptor activity |
| GO:0003735 | 0 | 11.8929 | 0.5744 | 6 | 150 | structural constituent of ribosome |
| GO:0099600 | 0 | 3.9453 | 4.6797 | 15 | 1222 | transmembrane receptor activity |
| GO:0038023 | 1e-04 | 3.7466 | 4.9056 | 15 | 1281 | signaling receptor activity |
| GO:0004866 | 4e-04 | 8.8663 | 0.6242 | 5 | 163 | endopeptidase inhibitor activity |
| GO:0060089 | 5e-04 | 3.065 | 5.8821 | 15 | 1536 | molecular transducer activity |
| GO:0061134 | 0.0011 | 6.9508 | 0.7889 | 5 | 206 | peptidase regulator activity |
| GO:0004857 | 0.0032 | 4.5256 | 1.4514 | 6 | 379 | enzyme inhibitor activity |
| GO:0005163 | 0.0038 | Inf | 0.0038 | 1 | 1 | nerve growth factor receptor binding |
| GO:0008493 | 0.0038 | Inf | 0.0038 | 1 | 1 | tetracycline transporter activity |
| GO:0048018 | 0.007 | 3.8291 | 1.7041 | 6 | 445 | receptor ligand activity |
| GO:0001567 | 0.0076 | 264.377 | 0.0077 | 1 | 2 | cholesterol 25-hydroxylase activity |
| GO:0005146 | 0.0076 | 264.377 | 0.0077 | 1 | 2 | leukemia inhibitory factor receptor binding |
| GO:0019767 | 0.0076 | 264.377 | 0.0077 | 1 | 2 | IgE receptor activity |
| GO:0045550 | 0.0076 | 264.377 | 0.0077 | 1 | 2 | geranylgeranyl reductase activity |
| GO:0071791 | 0.0076 | 264.377 | 0.0077 | 1 | 2 | chemokine (C-C motif) ligand 5 binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0003735 | 0 | 36.8871 | 0.3799 | 10 | 150 | structural constituent of ribosome |
| GO:0016493 | 0 | 141.5789 | 0.0304 | 3 | 12 | C-C chemokine receptor activity |
| GO:0001637 | 0 | 57.872 | 0.0633 | 3 | 25 | G-protein coupled chemoattractant receptor activity |
| GO:0004896 | 1e-04 | 21.9911 | 0.2102 | 4 | 83 | cytokine receptor activity |
| GO:0004869 | 4e-04 | 23.9762 | 0.1418 | 3 | 56 | cysteine-type endopeptidase inhibitor activity |
| GO:0019843 | 4e-04 | 23.9762 | 0.1418 | 3 | 56 | rRNA binding |
| GO:0004930 | 7e-04 | 4.8026 | 1.9854 | 8 | 784 | G-protein coupled receptor activity |
| GO:0019969 | 0.0025 | Inf | 0.0025 | 1 | 1 | interleukin-10 binding |
| GO:1903231 | 0.0028 | 11.7259 | 0.2811 | 3 | 111 | mRNA binding involved in posttranscriptional gene silencing |
| GO:0099600 | 0.003 | 3.4631 | 3.0946 | 9 | 1222 | transmembrane receptor activity |
| GO:0001653 | 0.0037 | 10.5454 | 0.3115 | 3 | 123 | peptide receptor activity |
| GO:0070888 | 0.0039 | 23.6103 | 0.0937 | 2 | 37 | E-box binding |
| GO:0060089 | 0.0042 | 3.0912 | 3.8898 | 10 | 1536 | molecular transducer activity |
| GO:0002020 | 0.0042 | 10.0395 | 0.3267 | 3 | 129 | protease binding |
| GO:0005146 | 0.0051 | 403.7 | 0.0051 | 1 | 2 | leukemia inhibitory factor receptor binding |
| GO:0004871 | 0.0052 | 2.9808 | 4.019 | 10 | 1587 | signal transducer activity |
| GO:0003729 | 0.0089 | 7.6387 | 0.4278 | 3 | 181 | mRNA binding |
| GO:0061135 | 0.0089 | 7.6013 | 0.428 | 3 | 169 | endopeptidase regulator activity |
| GO:0030414 | 0.0092 | 7.5099 | 0.433 | 3 | 171 | peptidase inhibitor activity |
| GO:0003676 | 0.0096 | 2.262 | 9.7954 | 17 | 3868 | nucleic acid binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004984 | 0 | 14.4301 | 0.55 | 6 | 371 | olfactory receptor activity |
| GO:0003735 | 1e-04 | 21.9452 | 0.2224 | 4 | 150 | structural constituent of ribosome |
| GO:0004930 | 8e-04 | 6.593 | 1.1622 | 6 | 784 | G-protein coupled receptor activity |
| GO:0003729 | 8e-04 | 11.0264 | 0.4329 | 4 | 292 | mRNA binding |
| GO:0019843 | 0.0031 | 27.1246 | 0.083 | 2 | 56 | rRNA binding |
| GO:0004522 | 0.0059 | 234.2464 | 0.0059 | 1 | 4 | ribonuclease A activity |
| GO:0099600 | 0.0075 | 4.0981 | 1.8115 | 6 | 1222 | transmembrane receptor activity |
| GO:0038023 | 0.0094 | 3.8931 | 1.8989 | 6 | 1281 | signaling receptor activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0050786 | 0 | 378.8203 | 0.0129 | 3 | 11 | RAGE receptor binding |
| GO:0035662 | 0 | 1902.3529 | 0.0035 | 2 | 3 | Toll-like receptor 4 binding |
| GO:0050544 | 0 | 634.0392 | 0.0059 | 2 | 5 | arachidonic acid binding |
| GO:0036041 | 1e-04 | 211.268 | 0.0129 | 2 | 11 | long-chain fatty acid binding |
| GO:0004930 | 2e-04 | 9.1317 | 0.9201 | 6 | 784 | G-protein coupled receptor activity |
| GO:1901567 | 3e-04 | 90.4762 | 0.027 | 2 | 23 | fatty acid derivative binding |
| GO:0038023 | 4e-04 | 6.821 | 1.5033 | 7 | 1281 | signaling receptor activity |
| GO:0004984 | 8e-04 | 11.4834 | 0.4354 | 4 | 371 | olfactory receptor activity |
| GO:0046914 | 8e-04 | 6.9208 | 1.1935 | 6 | 1017 | transition metal ion binding |
| GO:0043177 | 0.0011 | 17.2381 | 0.2077 | 3 | 177 | organic acid binding |
| GO:0060089 | 0.0012 | 5.5861 | 1.8026 | 7 | 1536 | molecular transducer activity |
| GO:0033293 | 0.0021 | 33.855 | 0.0681 | 2 | 58 | monocarboxylic acid binding |
| GO:0099600 | 0.0021 | 5.6762 | 1.4341 | 6 | 1222 | transmembrane receptor activity |
| GO:0004053 | 0.0023 | 898.3333 | 0.0023 | 1 | 2 | arginase activity |
| GO:0005549 | 0.0042 | 23.3696 | 0.0974 | 2 | 83 | odorant binding |
| GO:0008745 | 0.0047 | 299.4074 | 0.0047 | 1 | 4 | N-acetylmuramoyl-L-alanine amidase activity |
| GO:0016019 | 0.0059 | 224.5417 | 0.0059 | 1 | 5 | peptidoglycan receptor activity |
| GO:0004966 | 0.0082 | 149.6759 | 0.0082 | 1 | 7 | galanin receptor activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004984 | 0 | 19.0244 | 0.7562 | 10 | 371 | olfactory receptor activity |
| GO:0004930 | 0 | 8.6412 | 1.598 | 10 | 784 | G-protein coupled receptor activity |
| GO:0005549 | 0 | 28.0716 | 0.1692 | 4 | 83 | odorant binding |
| GO:0099600 | 1e-04 | 5.3612 | 2.4908 | 10 | 1222 | transmembrane receptor activity |
| GO:0038023 | 2e-04 | 5.0922 | 2.6111 | 10 | 1281 | signaling receptor activity |
| GO:0008308 | 5e-04 | 74.3917 | 0.0326 | 2 | 16 | voltage-gated anion channel activity |
| GO:0060089 | 7e-04 | 4.1686 | 3.1308 | 10 | 1536 | molecular transducer activity |
| GO:0048020 | 0.0028 | 28.1081 | 0.0795 | 2 | 39 | CCR chemokine receptor binding |
| GO:0004146 | 0.0041 | 504.875 | 0.0041 | 1 | 2 | dihydrofolate reductase activity |
| GO:0038100 | 0.0041 | 504.875 | 0.0041 | 1 | 2 | nodal binding |
| GO:0008009 | 0.0043 | 22.5961 | 0.0978 | 2 | 48 | chemokine activity |
| GO:0008173 | 0.006 | 18.888 | 0.1162 | 2 | 57 | RNA methyltransferase activity |
| GO:0035662 | 0.0061 | 252.4219 | 0.0061 | 1 | 3 | Toll-like receptor 4 binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0048020 | 1e-04 | 34.4274 | 0.1012 | 3 | 39 | CCR chemokine receptor binding |
| GO:0008009 | 3e-04 | 27.5265 | 0.1245 | 3 | 48 | chemokine activity |
| GO:0008308 | 8e-04 | 57.6214 | 0.0415 | 2 | 16 | voltage-gated anion channel activity |
| GO:0005130 | 0.0026 | Inf | 0.0026 | 1 | 1 | granulocyte colony-stimulating factor receptor binding |
| GO:0051879 | 0.0027 | 28.7857 | 0.0778 | 2 | 30 | Hsp90 protein binding |
| GO:0005126 | 0.0042 | 6.6583 | 0.6635 | 4 | 262 | cytokine receptor binding |
| GO:0048018 | 0.0056 | 4.8243 | 1.1544 | 5 | 445 | receptor ligand activity |
| GO:0070653 | 0.0078 | 196.9024 | 0.0078 | 1 | 3 | high-density lipoprotein particle receptor binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0043295 | 0.0013 | 45.8718 | 0.0544 | 2 | 11 | glutathione binding |
| GO:0008191 | 0.0021 | 34.3974 | 0.0692 | 2 | 14 | metalloendopeptidase inhibitor activity |
| GO:1903231 | 0.0022 | 7.8716 | 0.5485 | 4 | 111 | mRNA binding involved in posttranscriptional gene silencing |
| GO:0005125 | 0.0043 | 5.0234 | 1.0673 | 5 | 216 | cytokine activity |
| GO:0008893 | 0.0049 | Inf | 0.0049 | 1 | 1 | guanosine-3',5'-bis(diphosphate) 3'-diphosphatase activity |
| GO:0015054 | 0.0049 | Inf | 0.0049 | 1 | 1 | gastrin receptor activity |
| GO:0031741 | 0.0049 | Inf | 0.0049 | 1 | 1 | type B gastrin/cholecystokinin receptor binding |
| GO:0031851 | 0.0049 | Inf | 0.0049 | 1 | 1 | kappa-type opioid receptor binding |
| GO:0050337 | 0.0049 | Inf | 0.0049 | 1 | 1 | thiosulfate-thiol sulfurtransferase activity |
| GO:0004364 | 0.0073 | 17.1859 | 0.1285 | 2 | 26 | glutathione transferase activity |
| GO:0030545 | 0.0087 | 3.2262 | 2.3323 | 7 | 472 | receptor regulator activity |
| GO:0004951 | 0.0099 | 203.9114 | 0.0099 | 1 | 2 | cholecystokinin receptor activity |
| GO:0030549 | 0.0099 | 203.9114 | 0.0099 | 1 | 2 | acetylcholine receptor activator activity |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:2000402 | 3e-04 | 31.4311 | 0.1425 | 3 | 9 | negative regulation of lymphocyte migration |
| GO:0036006 | 4e-04 | 26.9393 | 0.1583 | 3 | 10 | cellular response to macrophage colony-stimulating factor stimulus |
| GO:0007079 | 7e-04 | 125.2706 | 0.0475 | 2 | 3 | mitotic chromosome movement towards spindle pole |
| GO:2000502 | 7e-04 | 125.2706 | 0.0475 | 2 | 3 | negative regulation of natural killer cell chemotaxis |
| GO:0048523 | 8e-04 | 1.5355 | 70.5444 | 94 | 4455 | negative regulation of cellular process |
| GO:0030488 | 0.0011 | 10.0857 | 0.4592 | 4 | 29 | tRNA methylation |
| GO:0002689 | 0.0019 | 14.5003 | 0.2534 | 3 | 16 | negative regulation of leukocyte chemotaxis |
| GO:0051489 | 0.0033 | 7.1995 | 0.6176 | 4 | 39 | regulation of filopodium assembly |
| GO:0008063 | 0.0036 | 31.3118 | 0.095 | 2 | 6 | Toll signaling pathway |
| GO:0070383 | 0.0036 | 31.3118 | 0.095 | 2 | 6 | DNA cytosine deamination |
| GO:0043901 | 0.0042 | 3.322 | 2.5494 | 8 | 161 | negative regulation of multi-organism process |
| GO:1901687 | 0.0042 | 10.4692 | 0.3325 | 3 | 21 | glutathione derivative biosynthetic process |
| GO:0045869 | 0.005 | 25.0478 | 0.1108 | 2 | 7 | negative regulation of single stranded viral RNA replication via double stranded DNA intermediate |
| GO:0050870 | 0.0051 | 2.9517 | 3.2145 | 9 | 203 | positive regulation of T cell activation |
| GO:0039694 | 0.0055 | 9.4211 | 0.3642 | 3 | 23 | viral RNA genome replication |
| GO:0046580 | 0.0059 | 5.997 | 0.7284 | 4 | 46 | negative regulation of Ras protein signal transduction |
| GO:0017148 | 0.0062 | 2.3305 | 5.8589 | 13 | 370 | negative regulation of translation |
| GO:0000060 | 0.0064 | 5.8572 | 0.7442 | 4 | 47 | protein import into nucleus, translocation |
| GO:0030330 | 0.0068 | 3.7943 | 1.6785 | 6 | 106 | DNA damage response, signal transduction by p53 class mediator |
| GO:0002696 | 0.0068 | 2.5061 | 4.6079 | 11 | 291 | positive regulation of leukocyte activation |
| GO:0097435 | 0.0069 | 2.0479 | 8.725 | 17 | 551 | supramolecular fiber organization |
| GO:0030155 | 0.0075 | 1.9474 | 10.261 | 19 | 648 | regulation of cell adhesion |
| GO:1903671 | 0.0078 | 8.1907 | 0.4117 | 3 | 26 | negative regulation of sprouting angiogenesis |
| GO:0071822 | 0.0082 | 1.5884 | 25.51 | 38 | 1611 | protein complex subunit organization |
| GO:0009972 | 0.0084 | 17.8891 | 0.1425 | 2 | 9 | cytidine deamination |
| GO:0046087 | 0.0084 | 17.8891 | 0.1425 | 2 | 9 | cytidine metabolic process |
| GO:2000171 | 0.0087 | 7.8489 | 0.4275 | 3 | 27 | negative regulation of dendrite development |
| GO:0019058 | 0.0095 | 2.3847 | 4.8296 | 11 | 305 | viral life cycle |
| GO:0043623 | 0.0096 | 1.9714 | 9.0417 | 17 | 571 | cellular protein complex assembly |
| GO:0110053 | 0.0098 | 2.6473 | 3.5628 | 9 | 225 | regulation of actin filament organization |
| GO:0016458 | 0.0099 | 2.1922 | 6.2073 | 13 | 392 | gene silencing |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:1900239 | 2e-04 | 38.6468 | 0.1237 | 3 | 8 | regulation of phenotypic switching |
| GO:0048625 | 0.0023 | 42.7738 | 0.0773 | 2 | 5 | myoblast fate commitment |
| GO:0051489 | 0.003 | 7.3772 | 0.6031 | 4 | 39 | regulation of filopodium assembly |
| GO:0008063 | 0.0034 | 32.0783 | 0.0928 | 2 | 6 | Toll signaling pathway |
| GO:0070383 | 0.0034 | 32.0783 | 0.0928 | 2 | 6 | DNA cytosine deamination |
| GO:0090677 | 0.0034 | 32.0783 | 0.0928 | 2 | 6 | reversible differentiation |
| GO:0007159 | 0.0037 | 2.49 | 5.5056 | 13 | 356 | leukocyte cell-cell adhesion |
| GO:0050870 | 0.0044 | 3.026 | 3.1394 | 9 | 203 | positive regulation of T cell activation |
| GO:0045869 | 0.0048 | 25.661 | 0.1083 | 2 | 7 | negative regulation of single stranded viral RNA replication via double stranded DNA intermediate |
| GO:0090647 | 0.0048 | 25.661 | 0.1083 | 2 | 7 | modulation of age-related behavioral decline |
| GO:0008347 | 0.0051 | 6.2953 | 0.6959 | 4 | 45 | glial cell migration |
| GO:0039694 | 0.0051 | 9.6526 | 0.3557 | 3 | 23 | viral RNA genome replication |
| GO:2000300 | 0.0051 | 9.6526 | 0.3557 | 3 | 23 | regulation of synaptic vesicle exocytosis |
| GO:0001505 | 0.0052 | 3.1944 | 2.6445 | 8 | 171 | regulation of neurotransmitter levels |
| GO:0006342 | 0.0055 | 3.9686 | 1.6084 | 6 | 104 | chromatin silencing |
| GO:0002696 | 0.0058 | 2.5698 | 4.5004 | 11 | 291 | positive regulation of leukocyte activation |
| GO:0007215 | 0.0058 | 4.6866 | 1.1444 | 5 | 74 | glutamate receptor signaling pathway |
| GO:0030155 | 0.0058 | 1.9986 | 10.0214 | 19 | 648 | regulation of cell adhesion |
| GO:0032071 | 0.0063 | 21.3829 | 0.1237 | 2 | 8 | regulation of endodeoxyribonuclease activity |
| GO:0044351 | 0.0063 | 21.3829 | 0.1237 | 2 | 8 | macropinocytosis |
| GO:0010629 | 0.0063 | 1.584 | 28.4714 | 42 | 1841 | negative regulation of gene expression |
| GO:0050804 | 0.007 | 2.4971 | 4.6241 | 11 | 299 | modulation of chemical synaptic transmission |
| GO:1903671 | 0.0073 | 8.392 | 0.4021 | 3 | 26 | negative regulation of sprouting angiogenesis |
| GO:0001960 | 0.0074 | 5.6092 | 0.7733 | 4 | 50 | negative regulation of cytokine-mediated signaling pathway |
| GO:0007196 | 0.008 | 18.327 | 0.1392 | 2 | 9 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway |
| GO:0009972 | 0.008 | 18.327 | 0.1392 | 2 | 9 | cytidine deamination |
| GO:0010692 | 0.008 | 18.327 | 0.1392 | 2 | 9 | regulation of alkaline phosphatase activity |
| GO:0046087 | 0.008 | 18.327 | 0.1392 | 2 | 9 | cytidine metabolic process |
| GO:2000402 | 0.008 | 18.327 | 0.1392 | 2 | 9 | negative regulation of lymphocyte migration |
| GO:0006606 | 0.0086 | 2.5485 | 4.1137 | 10 | 266 | protein import into nucleus |
| GO:0030307 | 0.0088 | 3.177 | 2.3198 | 7 | 150 | positive regulation of cell growth |
| GO:0046824 | 0.0089 | 3.5656 | 1.7785 | 6 | 115 | positive regulation of nucleocytoplasmic transport |
| GO:0036006 | 0.0099 | 16.0351 | 0.1547 | 2 | 10 | cellular response to macrophage colony-stimulating factor stimulus |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0007156 | 0 | 6.2569 | 1.9574 | 11 | 152 | homophilic cell adhesion via plasma membrane adhesion molecules |
| GO:0001569 | 0 | 15.0782 | 0.3992 | 5 | 31 | branching involved in blood vessel morphogenesis |
| GO:0007399 | 1e-04 | 1.9818 | 27.5962 | 48 | 2143 | nervous system development |
| GO:0006355 | 1e-04 | 1.8064 | 44.3497 | 68 | 3444 | regulation of transcription, DNA-templated |
| GO:2001141 | 1e-04 | 1.7882 | 44.6974 | 68 | 3471 | regulation of RNA biosynthetic process |
| GO:0048762 | 1e-04 | 4.5502 | 2.3823 | 10 | 185 | mesenchymal cell differentiation |
| GO:0060562 | 1e-04 | 3.6233 | 3.8761 | 13 | 301 | epithelial tube morphogenesis |
| GO:0022610 | 2e-04 | 2.1447 | 17.011 | 33 | 1321 | biological adhesion |
| GO:0048701 | 2e-04 | 10.044 | 0.5666 | 5 | 44 | embryonic cranial skeleton morphogenesis |
| GO:0035413 | 3e-04 | 29.1499 | 0.1417 | 3 | 11 | positive regulation of catenin import into nucleus |
| GO:0060033 | 3e-04 | 29.1499 | 0.1417 | 3 | 11 | anatomical structure regression |
| GO:0001558 | 3e-04 | 3.1501 | 4.7775 | 14 | 371 | regulation of cell growth |
| GO:0061138 | 4e-04 | 4.298 | 2.2535 | 9 | 175 | morphogenesis of a branching epithelium |
| GO:0003274 | 5e-04 | 154.7826 | 0.0386 | 2 | 3 | endocardial cushion fusion |
| GO:0003214 | 7e-04 | 21.1959 | 0.1803 | 3 | 14 | cardiac left ventricle morphogenesis |
| GO:0042487 | 7e-04 | 21.1959 | 0.1803 | 3 | 14 | regulation of odontogenesis of dentin-containing tooth |
| GO:0060317 | 7e-04 | 11.1449 | 0.4121 | 4 | 32 | cardiac epithelial to mesenchymal transition |
| GO:0045600 | 8e-04 | 7.5269 | 0.734 | 5 | 57 | positive regulation of fat cell differentiation |
| GO:0061448 | 9e-04 | 3.5762 | 2.9876 | 10 | 232 | connective tissue development |
| GO:0021872 | 0.001 | 7.2472 | 0.7598 | 5 | 59 | forebrain generation of neurons |
| GO:0048706 | 0.001 | 4.8354 | 1.5582 | 7 | 121 | embryonic skeletal system development |
| GO:0006933 | 0.001 | 77.3865 | 0.0515 | 2 | 4 | negative regulation of cell adhesion involved in substrate-bound cell migration |
| GO:0021555 | 0.001 | 77.3865 | 0.0515 | 2 | 4 | midbrain-hindbrain boundary morphogenesis |
| GO:0035295 | 0.001 | 2.519 | 7.2242 | 17 | 561 | tube development |
| GO:0072132 | 0.0011 | 9.8405 | 0.4594 | 4 | 36 | mesenchyme morphogenesis |
| GO:0098609 | 0.0011 | 2.2461 | 10.0444 | 21 | 780 | cell-cell adhesion |
| GO:0043010 | 0.0015 | 3.1119 | 3.7602 | 11 | 292 | camera-type eye development |
| GO:1902262 | 0.0016 | 51.5878 | 0.0644 | 2 | 5 | apoptotic process involved in blood vessel morphogenesis |
| GO:1905007 | 0.0016 | 51.5878 | 0.0644 | 2 | 5 | positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation |
| GO:0060173 | 0.0016 | 3.8963 | 2.1892 | 8 | 170 | limb development |
| GO:0048863 | 0.0017 | 3.2628 | 3.258 | 10 | 253 | stem cell differentiation |
| GO:0019219 | 0.0017 | 1.5728 | 51.7671 | 71 | 4020 | regulation of nucleobase-containing compound metabolic process |
| GO:0032656 | 0.002 | 13.7099 | 0.2575 | 3 | 20 | regulation of interleukin-13 production |
| GO:0051094 | 0.0021 | 1.9471 | 14.9659 | 27 | 1177 | positive regulation of developmental process |
| GO:0060348 | 0.0023 | 3.6892 | 2.3051 | 8 | 179 | bone development |
| GO:0043586 | 0.0024 | 12.9474 | 0.2704 | 3 | 21 | tongue development |
| GO:0030098 | 0.0027 | 2.8627 | 4.0693 | 11 | 316 | lymphocyte differentiation |
| GO:0003272 | 0.0027 | 12.2652 | 0.2833 | 3 | 22 | endocardial cushion formation |
| GO:0032330 | 0.0029 | 7.4235 | 0.5924 | 4 | 46 | regulation of chondrocyte differentiation |
| GO:0046580 | 0.0029 | 7.4235 | 0.5924 | 4 | 46 | negative regulation of Ras protein signal transduction |
| GO:0070076 | 0.0031 | 11.6512 | 0.2962 | 3 | 23 | histone lysine demethylation |
| GO:1903507 | 0.0031 | 1.9049 | 14.6545 | 26 | 1138 | negative regulation of nucleic acid-templated transcription |
| GO:0003002 | 0.0033 | 2.7881 | 4.1723 | 11 | 324 | regionalization |
| GO:0048562 | 0.0034 | 2.9426 | 3.5928 | 10 | 279 | embryonic organ morphogenesis |
| GO:0040007 | 0.0034 | 2.0025 | 11.7313 | 22 | 911 | growth |
| GO:0032673 | 0.0035 | 11.0957 | 0.3091 | 3 | 24 | regulation of interleukin-4 production |
| GO:0051253 | 0.0037 | 1.8573 | 15.6074 | 27 | 1212 | negative regulation of RNA metabolic process |
| GO:0021953 | 0.0039 | 3.7269 | 1.9906 | 7 | 156 | central nervous system neuron differentiation |
| GO:0003148 | 0.0039 | 10.5907 | 0.3219 | 3 | 25 | outflow tract septum morphogenesis |
| GO:0061037 | 0.0039 | 10.5907 | 0.3219 | 3 | 25 | negative regulation of cartilage development |
| GO:0034654 | 0.0039 | 1.5099 | 52.5011 | 70 | 4077 | nucleobase-containing compound biosynthetic process |
| GO:0060350 | 0.0042 | 6.6317 | 0.6567 | 4 | 51 | endochondral bone morphogenesis |
| GO:0000122 | 0.0043 | 2.0679 | 9.7611 | 19 | 758 | negative regulation of transcription from RNA polymerase II promoter |
| GO:0010717 | 0.0043 | 5.0097 | 1.0688 | 5 | 83 | regulation of epithelial to mesenchymal transition |
| GO:0021859 | 0.0044 | 25.789 | 0.103 | 2 | 8 | pyramidal neuron differentiation |
| GO:0032909 | 0.0044 | 25.789 | 0.103 | 2 | 8 | regulation of transforming growth factor beta2 production |
| GO:0045630 | 0.0044 | 25.789 | 0.103 | 2 | 8 | positive regulation of T-helper 2 cell differentiation |
| GO:0060534 | 0.0044 | 25.789 | 0.103 | 2 | 8 | trachea cartilage development |
| GO:0002063 | 0.0044 | 10.1296 | 0.3348 | 3 | 26 | chondrocyte development |
| GO:0021884 | 0.0044 | 10.1296 | 0.3348 | 3 | 26 | forebrain neuron development |
| GO:0045165 | 0.0048 | 2.9842 | 3.1807 | 9 | 247 | cell fate commitment |
| GO:0090596 | 0.0048 | 2.9842 | 3.1807 | 9 | 247 | sensory organ morphogenesis |
| GO:0006482 | 0.0049 | 9.7069 | 0.3477 | 3 | 27 | protein demethylation |
| GO:0007405 | 0.0051 | 6.2326 | 0.6954 | 4 | 54 | neuroblast proliferation |
| GO:0009792 | 0.0052 | 2.2338 | 7.0954 | 15 | 551 | embryo development ending in birth or egg hatching |
| GO:0030851 | 0.0054 | 9.3181 | 0.3606 | 3 | 28 | granulocyte differentiation |
| GO:1902230 | 0.0054 | 9.3181 | 0.3606 | 3 | 28 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage |
| GO:0045944 | 0.0056 | 1.8592 | 13.7659 | 24 | 1069 | positive regulation of transcription from RNA polymerase II promoter |
| GO:0003149 | 0.0056 | 22.1035 | 0.1159 | 2 | 9 | membranous septum morphogenesis |
| GO:0010692 | 0.0056 | 22.1035 | 0.1159 | 2 | 9 | regulation of alkaline phosphatase activity |
| GO:0046549 | 0.0056 | 22.1035 | 0.1159 | 2 | 9 | retinal cone cell development |
| GO:0001773 | 0.006 | 8.9591 | 0.3734 | 3 | 29 | myeloid dendritic cell activation |
| GO:0061036 | 0.006 | 8.9591 | 0.3734 | 3 | 29 | positive regulation of cartilage development |
| GO:1902893 | 0.006 | 8.9591 | 0.3734 | 3 | 29 | regulation of pri-miRNA transcription from RNA polymerase II promoter |
| GO:2000516 | 0.006 | 8.9591 | 0.3734 | 3 | 29 | positive regulation of CD4-positive, alpha-beta T cell activation |
| GO:1902107 | 0.006 | 3.8839 | 1.6354 | 6 | 127 | positive regulation of leukocyte differentiation |
| GO:0045669 | 0.0066 | 5.7695 | 0.7469 | 4 | 58 | positive regulation of osteoblast differentiation |
| GO:0008584 | 0.0068 | 3.7892 | 1.6741 | 6 | 130 | male gonad development |
| GO:0046085 | 0.0069 | 19.3394 | 0.1288 | 2 | 10 | adenosine metabolic process |
| GO:0048340 | 0.0069 | 19.3394 | 0.1288 | 2 | 10 | paraxial mesoderm morphogenesis |
| GO:0051573 | 0.0069 | 19.3394 | 0.1288 | 2 | 10 | negative regulation of histone H3-K9 methylation |
| GO:0014032 | 0.0074 | 5.5627 | 0.7726 | 4 | 60 | neural crest cell development |
| GO:0030278 | 0.0078 | 3.2505 | 2.2664 | 7 | 176 | regulation of ossification |
| GO:1902742 | 0.0079 | 8.0308 | 0.4121 | 3 | 32 | apoptotic process involved in development |
| GO:0016477 | 0.0079 | 1.741 | 16.5474 | 27 | 1285 | cell migration |
| GO:0090288 | 0.0081 | 3.6412 | 1.7384 | 6 | 135 | negative regulation of cellular response to growth factor stimulus |
| GO:1904591 | 0.0084 | 4.2437 | 1.2491 | 5 | 97 | positive regulation of protein import |
| GO:0009889 | 0.0084 | 1.4445 | 55.9651 | 72 | 4346 | regulation of biosynthetic process |
| GO:0021521 | 0.0084 | 17.1895 | 0.1417 | 2 | 11 | ventral spinal cord interneuron specification |
| GO:0021670 | 0.0084 | 17.1895 | 0.1417 | 2 | 11 | lateral ventricle development |
| GO:0021903 | 0.0084 | 17.1895 | 0.1417 | 2 | 11 | rostrocaudal neural tube patterning |
| GO:0060439 | 0.0084 | 17.1895 | 0.1417 | 2 | 11 | trachea morphogenesis |
| GO:0001756 | 0.0088 | 5.2789 | 0.8113 | 4 | 63 | somitogenesis |
| GO:0072091 | 0.0088 | 5.2789 | 0.8113 | 4 | 63 | regulation of stem cell proliferation |
| GO:0010810 | 0.0091 | 3.1561 | 2.3308 | 7 | 181 | regulation of cell-substrate adhesion |
| GO:0031057 | 0.0094 | 7.5117 | 0.4378 | 3 | 34 | negative regulation of histone modification |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0051094 | 0 | 2.7976 | 16.4961 | 40 | 1206 | positive regulation of developmental process |
| GO:0060562 | 0 | 4.2849 | 4.1172 | 16 | 301 | epithelial tube morphogenesis |
| GO:0009792 | 0 | 3.2187 | 7.5368 | 22 | 551 | embryo development ending in birth or egg hatching |
| GO:0003002 | 0 | 7.3251 | 1.3772 | 9 | 105 | regionalization |
| GO:2001141 | 0 | 1.8562 | 47.4776 | 74 | 3471 | regulation of RNA biosynthetic process |
| GO:0048736 | 0 | 5.1965 | 2.3253 | 11 | 170 | appendage development |
| GO:0045944 | 0 | 2.4315 | 14.6222 | 32 | 1069 | positive regulation of transcription from RNA polymerase II promoter |
| GO:0006355 | 0 | 1.8366 | 47.1083 | 73 | 3444 | regulation of transcription, DNA-templated |
| GO:0014033 | 0 | 8.5116 | 0.9301 | 7 | 68 | neural crest cell differentiation |
| GO:0000122 | 0 | 2.6445 | 10.3682 | 25 | 758 | negative regulation of transcription from RNA polymerase II promoter |
| GO:0007156 | 0 | 5.2704 | 2.0791 | 10 | 152 | homophilic cell adhesion via plasma membrane adhesion molecules |
| GO:0001569 | 1e-04 | 14.1634 | 0.424 | 5 | 31 | branching involved in blood vessel morphogenesis |
| GO:1903507 | 1e-04 | 2.2693 | 15.566 | 32 | 1138 | negative regulation of nucleic acid-templated transcription |
| GO:0051240 | 1e-04 | 2.0845 | 20.2577 | 38 | 1481 | positive regulation of multicellular organismal process |
| GO:0051253 | 1e-04 | 2.1961 | 16.5782 | 33 | 1212 | negative regulation of RNA metabolic process |
| GO:0035108 | 2e-04 | 4.9312 | 1.9834 | 9 | 145 | limb morphogenesis |
| GO:0001709 | 2e-04 | 10.5155 | 0.5471 | 5 | 40 | cell fate determination |
| GO:0007275 | 2e-04 | 1.6845 | 59.286 | 83 | 4587 | multicellular organism development |
| GO:0014031 | 2e-04 | 7.6389 | 0.8754 | 6 | 64 | mesenchymal cell development |
| GO:0048864 | 2e-04 | 7.6389 | 0.8754 | 6 | 64 | stem cell development |
| GO:0003206 | 3e-04 | 5.212 | 1.6688 | 8 | 122 | cardiac chamber morphogenesis |
| GO:0021915 | 3e-04 | 4.5906 | 2.1201 | 9 | 155 | neural tube development |
| GO:0007218 | 3e-04 | 5.8901 | 1.2994 | 7 | 95 | neuropeptide signaling pathway |
| GO:0019219 | 3e-04 | 1.658 | 54.9871 | 78 | 4020 | regulation of nucleobase-containing compound metabolic process |
| GO:0021517 | 4e-04 | 13.507 | 0.3512 | 4 | 26 | ventral spinal cord development |
| GO:0007267 | 4e-04 | 1.9574 | 20.8048 | 37 | 1521 | cell-cell signaling |
| GO:0001764 | 5e-04 | 4.7121 | 1.8329 | 8 | 134 | neuron migration |
| GO:0034654 | 5e-04 | 1.6266 | 55.7667 | 78 | 4077 | nucleobase-containing compound biosynthetic process |
| GO:0021524 | 6e-04 | 145.5182 | 0.041 | 2 | 3 | visceral motor neuron differentiation |
| GO:0048936 | 6e-04 | 145.5182 | 0.041 | 2 | 3 | peripheral nervous system neuron axonogenesis |
| GO:0090596 | 6e-04 | 3.4841 | 3.3786 | 11 | 247 | sensory organ morphogenesis |
| GO:0048729 | 6e-04 | 2.5418 | 7.5971 | 18 | 564 | tissue morphogenesis |
| GO:0061138 | 7e-04 | 4.0324 | 2.3937 | 9 | 175 | morphogenesis of a branching epithelium |
| GO:0035148 | 7e-04 | 4.4621 | 1.9287 | 8 | 141 | tube formation |
| GO:0051960 | 7e-04 | 2.2793 | 10.3819 | 22 | 759 | regulation of nervous system development |
| GO:0032736 | 8e-04 | 19.9215 | 0.1915 | 3 | 14 | positive regulation of interleukin-13 production |
| GO:0042487 | 8e-04 | 19.9215 | 0.1915 | 3 | 14 | regulation of odontogenesis of dentin-containing tooth |
| GO:0007405 | 8e-04 | 7.5045 | 0.7386 | 5 | 54 | neuroblast proliferation |
| GO:0048513 | 9e-04 | 1.6385 | 44.2769 | 64 | 3237 | animal organ development |
| GO:0009952 | 9e-04 | 3.8569 | 2.4958 | 9 | 184 | anterior/posterior pattern specification |
| GO:0009890 | 0.001 | 1.8405 | 22.6104 | 38 | 1653 | negative regulation of biosynthetic process |
| GO:1903508 | 0.001 | 1.9159 | 18.7394 | 33 | 1370 | positive regulation of nucleic acid-templated transcription |
| GO:0060581 | 0.001 | 18.2603 | 0.2052 | 3 | 15 | cell fate commitment involved in pattern specification |
| GO:0021515 | 0.0011 | 9.9002 | 0.4593 | 4 | 34 | cell differentiation in spinal cord |
| GO:0021555 | 0.0011 | 72.7545 | 0.0547 | 2 | 4 | midbrain-hindbrain boundary morphogenesis |
| GO:0022008 | 0.0011 | 1.9864 | 15.8355 | 29 | 1189 | neurogenesis |
| GO:0045669 | 0.0012 | 6.9364 | 0.7933 | 5 | 58 | positive regulation of osteoblast differentiation |
| GO:0051254 | 0.0012 | 1.8768 | 19.7105 | 34 | 1441 | positive regulation of RNA metabolic process |
| GO:0021514 | 0.0015 | 15.6497 | 0.2325 | 3 | 17 | ventral spinal cord interneuron differentiation |
| GO:0001755 | 0.0016 | 8.8824 | 0.5061 | 4 | 37 | neural crest cell migration |
| GO:0040007 | 0.0016 | 2.0663 | 12.461 | 24 | 911 | growth |
| GO:0035113 | 0.0017 | 4.3472 | 1.7235 | 7 | 126 | embryonic appendage morphogenesis |
| GO:0002568 | 0.0018 | 48.5 | 0.0684 | 2 | 5 | somatic diversification of T cell receptor genes |
| GO:0033153 | 0.0018 | 48.5 | 0.0684 | 2 | 5 | T cell receptor V(D)J recombination |
| GO:0045636 | 0.0018 | 48.5 | 0.0684 | 2 | 5 | positive regulation of melanocyte differentiation |
| GO:1902107 | 0.0018 | 4.3107 | 1.7372 | 7 | 127 | positive regulation of leukocyte differentiation |
| GO:0001558 | 0.0018 | 2.7191 | 5.0747 | 13 | 371 | regulation of cell growth |
| GO:0008584 | 0.0021 | 4.2048 | 1.7782 | 7 | 130 | male gonad development |
| GO:0003215 | 0.0021 | 13.6918 | 0.2599 | 3 | 19 | cardiac right ventricle morphogenesis |
| GO:0032753 | 0.0021 | 13.6918 | 0.2599 | 3 | 19 | positive regulation of interleukin-4 production |
| GO:0048557 | 0.0021 | 13.6918 | 0.2599 | 3 | 19 | embryonic digestive tract morphogenesis |
| GO:2000113 | 0.0021 | 1.8034 | 20.4218 | 34 | 1493 | negative regulation of cellular macromolecule biosynthetic process |
| GO:0021953 | 0.0022 | 4.8152 | 1.3369 | 6 | 101 | central nervous system neuron differentiation |
| GO:0030534 | 0.0026 | 4.0392 | 1.8466 | 7 | 135 | adult behavior |
| GO:0032502 | 0.0027 | 1.8495 | 19.4347 | 32 | 1637 | developmental process |
| GO:0003180 | 0.0027 | 36.3727 | 0.0821 | 2 | 6 | aortic valve morphogenesis |
| GO:0033603 | 0.0027 | 36.3727 | 0.0821 | 2 | 6 | positive regulation of dopamine secretion |
| GO:0043586 | 0.0028 | 12.1689 | 0.2872 | 3 | 21 | tongue development |
| GO:0048485 | 0.0028 | 12.1689 | 0.2872 | 3 | 21 | sympathetic nervous system development |
| GO:0048701 | 0.003 | 7.3248 | 0.6018 | 4 | 44 | embryonic cranial skeleton morphogenesis |
| GO:0007399 | 0.0031 | 2.3101 | 7.4004 | 16 | 604 | nervous system development |
| GO:0048665 | 0.0031 | 11.6275 | 0.2984 | 3 | 22 | neuron fate specification |
| GO:0045596 | 0.0032 | 2.179 | 8.7678 | 18 | 641 | negative regulation of cell differentiation |
| GO:0021513 | 0.0032 | 11.5278 | 0.3009 | 3 | 22 | spinal cord dorsal/ventral patterning |
| GO:0043627 | 0.0032 | 5.4012 | 0.9985 | 5 | 73 | response to estrogen |
| GO:0051241 | 0.0034 | 1.9148 | 13.9603 | 25 | 1033 | negative regulation of multicellular organismal process |
| GO:0030900 | 0.0035 | 2.6254 | 4.8285 | 12 | 353 | forebrain development |
| GO:0021879 | 0.0035 | 11.0868 | 0.3108 | 3 | 23 | forebrain neuron differentiation |
| GO:0072132 | 0.0035 | 6.9751 | 0.6292 | 4 | 46 | mesenchyme morphogenesis |
| GO:0045664 | 0.0036 | 2.2594 | 7.4957 | 16 | 548 | regulation of neuron differentiation |
| GO:0010226 | 0.0037 | 10.9507 | 0.3146 | 3 | 23 | response to lithium ion |
| GO:0042832 | 0.0037 | 10.9507 | 0.3146 | 3 | 23 | defense response to protozoan |
| GO:0003357 | 0.0037 | 29.0964 | 0.0957 | 2 | 7 | noradrenergic neuron differentiation |
| GO:0048704 | 0.0039 | 6.7647 | 0.6465 | 4 | 48 | embryonic skeletal system morphogenesis |
| GO:0003148 | 0.0047 | 9.9539 | 0.342 | 3 | 25 | outflow tract septum morphogenesis |
| GO:0045992 | 0.0047 | 9.9539 | 0.342 | 3 | 25 | negative regulation of embryonic development |
| GO:0021859 | 0.0049 | 24.2455 | 0.1094 | 2 | 8 | pyramidal neuron differentiation |
| GO:0045630 | 0.0049 | 24.2455 | 0.1094 | 2 | 8 | positive regulation of T-helper 2 cell differentiation |
| GO:0060534 | 0.0049 | 24.2455 | 0.1094 | 2 | 8 | trachea cartilage development |
| GO:0071863 | 0.0049 | 24.2455 | 0.1094 | 2 | 8 | regulation of cell proliferation in bone marrow |
| GO:0007519 | 0.0049 | 3.5619 | 2.0791 | 7 | 152 | skeletal muscle tissue development |
| GO:0060541 | 0.005 | 3.215 | 2.6262 | 8 | 192 | respiratory system development |
| GO:0010628 | 0.005 | 1.6625 | 24.0192 | 37 | 1756 | positive regulation of gene expression |
| GO:0046661 | 0.0051 | 3.5372 | 2.0928 | 7 | 153 | male sex differentiation |
| GO:0042093 | 0.0052 | 6.2311 | 0.6976 | 4 | 51 | T-helper cell differentiation |
| GO:0021884 | 0.0052 | 9.5205 | 0.3556 | 3 | 26 | forebrain neuron development |
| GO:0061053 | 0.0053 | 4.7672 | 1.1216 | 5 | 82 | somite development |
| GO:0060537 | 0.0054 | 2.4768 | 5.102 | 12 | 373 | muscle tissue development |
| GO:0050768 | 0.0054 | 2.9244 | 3.2418 | 9 | 237 | negative regulation of neurogenesis |
| GO:0003231 | 0.0059 | 3.9073 | 1.6277 | 6 | 119 | cardiac ventricle development |
| GO:0001838 | 0.0061 | 8.9136 | 0.3765 | 3 | 28 | embryonic epithelial tube formation |
| GO:0014807 | 0.0063 | 20.7805 | 0.1231 | 2 | 9 | regulation of somitogenesis |
| GO:0046549 | 0.0063 | 20.7805 | 0.1231 | 2 | 9 | retinal cone cell development |
| GO:0048087 | 0.0063 | 20.7805 | 0.1231 | 2 | 9 | positive regulation of developmental pigmentation |
| GO:0050932 | 0.0063 | 20.7805 | 0.1231 | 2 | 9 | regulation of pigment cell differentiation |
| GO:0071773 | 0.0063 | 3.3963 | 2.1749 | 7 | 159 | cellular response to BMP stimulus |
| GO:0002293 | 0.0063 | 5.8561 | 0.7386 | 4 | 54 | alpha-beta T cell differentiation involved in immune response |
| GO:0010557 | 0.0064 | 1.6667 | 21.8991 | 34 | 1601 | positive regulation of macromolecule biosynthetic process |
| GO:0048706 | 0.0065 | 8.6938 | 0.3846 | 3 | 29 | embryonic skeletal system development |
| GO:0043010 | 0.007 | 2.6305 | 3.9941 | 10 | 292 | camera-type eye development |
| GO:0048869 | 0.0071 | 1.4582 | 53.6401 | 70 | 4002 | cellular developmental process |
| GO:0045137 | 0.0075 | 2.985 | 2.8177 | 8 | 206 | development of primary sexual characteristics |
| GO:0045600 | 0.0076 | 5.5236 | 0.7797 | 4 | 57 | positive regulation of fat cell differentiation |
| GO:0048935 | 0.0077 | 18.3475 | 0.1356 | 2 | 10 | peripheral nervous system neuron development |
| GO:0042415 | 0.0078 | 18.1818 | 0.1368 | 2 | 10 | norepinephrine metabolic process |
| GO:0002828 | 0.0078 | 8.1081 | 0.4104 | 3 | 30 | regulation of type 2 immune response |
| GO:0032689 | 0.0078 | 8.1081 | 0.4104 | 3 | 30 | negative regulation of interferon-gamma production |
| GO:0040036 | 0.0078 | 8.1081 | 0.4104 | 3 | 30 | regulation of fibroblast growth factor receptor signaling pathway |
| GO:0071353 | 0.0078 | 8.1081 | 0.4104 | 3 | 30 | cellular response to interleukin-4 |
| GO:0048562 | 0.0085 | 3.2004 | 2.3006 | 7 | 175 | embryonic organ morphogenesis |
| GO:0009954 | 0.0086 | 7.818 | 0.424 | 3 | 31 | proximal/distal pattern formation |
| GO:0032735 | 0.0086 | 7.818 | 0.424 | 3 | 31 | positive regulation of interleukin-12 production |
| GO:0014020 | 0.0086 | 4.2166 | 1.2584 | 5 | 92 | primary neural tube formation |
| GO:0035282 | 0.0086 | 4.2166 | 1.2584 | 5 | 92 | segmentation |
| GO:0035115 | 0.0093 | 7.5479 | 0.4377 | 3 | 32 | embryonic forelimb morphogenesis |
| GO:0021521 | 0.0094 | 16.1606 | 0.1505 | 2 | 11 | ventral spinal cord interneuron specification |
| GO:0021670 | 0.0094 | 16.1606 | 0.1505 | 2 | 11 | lateral ventricle development |
| GO:0021903 | 0.0094 | 16.1606 | 0.1505 | 2 | 11 | rostrocaudal neural tube patterning |
| GO:0032754 | 0.0094 | 16.1606 | 0.1505 | 2 | 11 | positive regulation of interleukin-5 production |
| GO:0060033 | 0.0094 | 16.1606 | 0.1505 | 2 | 11 | anatomical structure regression |
| GO:2000774 | 0.0094 | 16.1606 | 0.1505 | 2 | 11 | positive regulation of cellular senescence |
| GO:0048608 | 0.0099 | 2.2764 | 5.5261 | 12 | 404 | reproductive structure development |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0009593 | 0 | 12.3527 | 1.4109 | 13 | 449 | detection of chemical stimulus |
| GO:0050906 | 0 | 12.0126 | 1.4486 | 13 | 461 | detection of stimulus involved in sensory perception |
| GO:0007606 | 0 | 11.8494 | 1.4675 | 13 | 467 | sensory perception of chemical stimulus |
| GO:0050911 | 0 | 12.1184 | 1.1627 | 11 | 370 | detection of chemical stimulus involved in sensory perception of smell |
| GO:0050877 | 0 | 5.2245 | 3.8022 | 15 | 1210 | nervous system process |
| GO:0007186 | 0 | 5.033 | 3.9342 | 15 | 1252 | G-protein coupled receptor signaling pathway |
| GO:0006688 | 0 | 50.4969 | 0.0723 | 3 | 23 | glycosphingolipid biosynthetic process |
| GO:0019835 | 3e-04 | 25.8654 | 0.132 | 3 | 42 | cytolysis |
| GO:0006968 | 6e-04 | 19.7647 | 0.1697 | 3 | 54 | cellular defense response |
| GO:0010623 | 7e-04 | 59.9926 | 0.0409 | 2 | 13 | programmed cell death involved in cell development |
| GO:0006955 | 8e-04 | 3.1473 | 5.5509 | 14 | 1837 | immune response |
| GO:0002418 | 9e-04 | 54.9898 | 0.044 | 2 | 14 | immune response to tumor cell |
| GO:0052695 | 0.0013 | 43.9837 | 0.0534 | 2 | 17 | cellular glucuronidation |
| GO:0006874 | 0.0014 | 5.3979 | 1.2444 | 6 | 396 | cellular calcium ion homeostasis |
| GO:0055065 | 0.0018 | 4.4537 | 1.7754 | 7 | 565 | metal ion homeostasis |
| GO:0070098 | 0.002 | 13.0698 | 0.2514 | 3 | 80 | chemokine-mediated signaling pathway |
| GO:0006063 | 0.0021 | 32.9776 | 0.0691 | 2 | 22 | uronic acid metabolic process |
| GO:0045321 | 0.0023 | 3.3047 | 3.5257 | 10 | 1122 | leukocyte activation |
| GO:0072507 | 0.0024 | 4.8487 | 1.3795 | 6 | 439 | divalent inorganic cation homeostasis |
| GO:0002355 | 0.0031 | Inf | 0.0031 | 1 | 1 | detection of tumor cell |
| GO:0002642 | 0.0031 | Inf | 0.0031 | 1 | 1 | positive regulation of immunoglobulin biosynthetic process |
| GO:0030887 | 0.0031 | Inf | 0.0031 | 1 | 1 | positive regulation of myeloid dendritic cell activation |
| GO:0032078 | 0.0031 | Inf | 0.0031 | 1 | 1 | negative regulation of endodeoxyribonuclease activity |
| GO:1900758 | 0.0031 | Inf | 0.0031 | 1 | 1 | negative regulation of D-amino-acid oxidase activity |
| GO:1904155 | 0.0031 | Inf | 0.0031 | 1 | 1 | DN2 thymocyte differentiation |
| GO:1904156 | 0.0031 | Inf | 0.0031 | 1 | 1 | DN3 thymocyte differentiation |
| GO:0048265 | 0.0037 | 24.4172 | 0.0911 | 2 | 29 | response to pain |
| GO:0042113 | 0.0048 | 6.3794 | 0.6819 | 4 | 217 | B cell activation |
| GO:0050715 | 0.0052 | 9.2144 | 0.3519 | 3 | 112 | positive regulation of cytokine secretion |
| GO:1902042 | 0.0057 | 19.3818 | 0.1131 | 2 | 36 | negative regulation of extrinsic apoptotic signaling pathway via death domain receptors |
| GO:0006664 | 0.0058 | 8.8861 | 0.3645 | 3 | 116 | glycolipid metabolic process |
| GO:0002023 | 0.0063 | 323.56 | 0.0063 | 1 | 2 | reduction of food intake in response to dietary excess |
| GO:0034021 | 0.0063 | 323.56 | 0.0063 | 1 | 2 | response to silicon dioxide |
| GO:0035378 | 0.0063 | 323.56 | 0.0063 | 1 | 2 | carbon dioxide transmembrane transport |
| GO:0036345 | 0.0063 | 323.56 | 0.0063 | 1 | 2 | platelet maturation |
| GO:0043006 | 0.0063 | 323.56 | 0.0063 | 1 | 2 | activation of phospholipase A2 activity by calcium-mediated signaling |
| GO:2000016 | 0.0063 | 323.56 | 0.0063 | 1 | 2 | negative regulation of determination of dorsal identity |
| GO:0055082 | 0.0068 | 3.4662 | 2.253 | 7 | 717 | cellular chemical homeostasis |
| GO:0050801 | 0.007 | 3.4459 | 2.2656 | 7 | 721 | ion homeostasis |
| GO:2000351 | 0.0073 | 16.8917 | 0.1288 | 2 | 41 | regulation of endothelial cell apoptotic process |
| GO:0002793 | 0.0076 | 5.5581 | 0.7793 | 4 | 248 | positive regulation of peptide secretion |
| GO:0031343 | 0.0081 | 16.0657 | 0.1351 | 2 | 43 | positive regulation of cell killing |
| GO:0060443 | 0.0084 | 15.6822 | 0.1383 | 2 | 44 | mammary gland morphogenesis |
| GO:0030003 | 0.0093 | 3.6314 | 1.8194 | 6 | 579 | cellular cation homeostasis |
| GO:0021553 | 0.0094 | 161.77 | 0.0094 | 1 | 3 | olfactory nerve development |
| GO:0048388 | 0.0094 | 161.77 | 0.0094 | 1 | 3 | endosomal lumen acidification |
| GO:0060648 | 0.0094 | 161.77 | 0.0094 | 1 | 3 | mammary gland bud morphogenesis |
| GO:0060763 | 0.0094 | 161.77 | 0.0094 | 1 | 3 | mammary duct terminal end bud growth |
| GO:0061368 | 0.0094 | 161.77 | 0.0094 | 1 | 3 | behavioral response to formalin induced pain |
| GO:0099566 | 0.0094 | 161.77 | 0.0094 | 1 | 3 | regulation of postsynaptic cytosolic calcium ion concentration |
| GO:1990743 | 0.0094 | 161.77 | 0.0094 | 1 | 3 | protein sialylation |
| GO:0046467 | 0.0095 | 7.3727 | 0.4368 | 3 | 139 | membrane lipid biosynthetic process |
| GO:0002682 | 0.0095 | 2.647 | 4.3207 | 10 | 1375 | regulation of immune system process |
| GO:0070231 | 0.0096 | 14.634 | 0.1477 | 2 | 47 | T cell apoptotic process |
| GO:0072678 | 0.0096 | 14.634 | 0.1477 | 2 | 47 | T cell migration |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0007156 | 0 | 6.5586 | 1.8731 | 11 | 152 | homophilic cell adhesion via plasma membrane adhesion molecules |
| GO:0007399 | 0 | 3.1428 | 8.2336 | 23 | 717 | nervous system development |
| GO:0048736 | 0 | 5.8095 | 2.0949 | 11 | 170 | appendage development |
| GO:0007389 | 0 | 3.7059 | 5.04 | 17 | 409 | pattern specification process |
| GO:0048568 | 1e-04 | 3.4419 | 5.0647 | 16 | 411 | embryonic organ development |
| GO:0000122 | 1e-04 | 2.7041 | 9.3407 | 23 | 758 | negative regulation of transcription from RNA polymerase II promoter |
| GO:0035108 | 1e-04 | 5.5069 | 1.7868 | 9 | 145 | limb morphogenesis |
| GO:0045944 | 1e-04 | 2.344 | 13.1731 | 28 | 1069 | positive regulation of transcription from RNA polymerase II promoter |
| GO:0021884 | 3e-04 | 14.8497 | 0.3204 | 4 | 26 | forebrain neuron development |
| GO:0048704 | 3e-04 | 9.7084 | 0.5812 | 5 | 48 | embryonic skeletal system morphogenesis |
| GO:0001501 | 3e-04 | 2.9433 | 5.8657 | 16 | 476 | skeletal system development |
| GO:0009887 | 3e-04 | 2.2959 | 11.8792 | 25 | 964 | animal organ morphogenesis |
| GO:0022610 | 4e-04 | 2.096 | 16.2785 | 31 | 1321 | biological adhesion |
| GO:0051253 | 4e-04 | 2.1284 | 14.9353 | 29 | 1212 | negative regulation of RNA metabolic process |
| GO:0043009 | 4e-04 | 2.7168 | 6.7406 | 17 | 547 | chordate embryonic development |
| GO:0140076 | 4e-04 | 161.9091 | 0.037 | 2 | 3 | negative regulation of lipoprotein transport |
| GO:0048935 | 5e-04 | 24.3959 | 0.1602 | 3 | 13 | peripheral nervous system neuron development |
| GO:0051094 | 5e-04 | 3.3457 | 3.8606 | 12 | 335 | positive regulation of developmental process |
| GO:0001953 | 5e-04 | 12.096 | 0.382 | 4 | 31 | negative regulation of cell-matrix adhesion |
| GO:0098609 | 6e-04 | 2.3604 | 9.6118 | 21 | 780 | cell-cell adhesion |
| GO:0045669 | 7e-04 | 7.7296 | 0.7147 | 5 | 58 | positive regulation of osteoblast differentiation |
| GO:1903507 | 8e-04 | 2.0958 | 14.0234 | 27 | 1138 | negative regulation of nucleic acid-templated transcription |
| GO:0021872 | 8e-04 | 7.5859 | 0.727 | 5 | 59 | forebrain generation of neurons |
| GO:0014032 | 9e-04 | 7.4476 | 0.7394 | 5 | 60 | neural crest cell development |
| GO:0021555 | 9e-04 | 80.9495 | 0.0493 | 2 | 4 | midbrain-hindbrain boundary morphogenesis |
| GO:0035113 | 0.001 | 4.8494 | 1.5527 | 7 | 126 | embryonic appendage morphogenesis |
| GO:0072175 | 0.001 | 4.7687 | 1.5773 | 7 | 128 | epithelial tube formation |
| GO:0048863 | 0.0012 | 3.4193 | 3.1177 | 10 | 253 | stem cell differentiation |
| GO:0051240 | 0.0012 | 1.9167 | 18.2502 | 32 | 1481 | positive regulation of multicellular organismal process |
| GO:0006355 | 0.0012 | 1.6406 | 42.4399 | 61 | 3444 | regulation of transcription, DNA-templated |
| GO:0045636 | 0.0015 | 53.963 | 0.0616 | 2 | 5 | positive regulation of melanocyte differentiation |
| GO:2001141 | 0.0015 | 1.6241 | 42.7726 | 61 | 3471 | regulation of RNA biosynthetic process |
| GO:0035024 | 0.0015 | 15.2418 | 0.2341 | 3 | 19 | negative regulation of Rho protein signal transduction |
| GO:1903305 | 0.0018 | 5.028 | 1.2816 | 6 | 104 | regulation of regulated secretory pathway |
| GO:0009952 | 0.0019 | 3.7907 | 2.2463 | 8 | 184 | anterior/posterior pattern specification |
| GO:0019219 | 0.002 | 1.5744 | 49.5379 | 68 | 4020 | regulation of nucleobase-containing compound metabolic process |
| GO:0048701 | 0.0021 | 8.1582 | 0.5422 | 4 | 44 | embryonic cranial skeleton morphogenesis |
| GO:0043586 | 0.0021 | 13.5465 | 0.2588 | 3 | 21 | tongue development |
| GO:0048762 | 0.0021 | 3.7319 | 2.2797 | 8 | 185 | mesenchymal cell differentiation |
| GO:0016331 | 0.0021 | 4.1768 | 1.7868 | 7 | 145 | morphogenesis of embryonic epithelium |
| GO:0022008 | 0.0026 | 1.8499 | 17.5724 | 30 | 1426 | neurogenesis |
| GO:0003357 | 0.003 | 32.3737 | 0.0863 | 2 | 7 | noradrenergic neuron differentiation |
| GO:0021953 | 0.0031 | 3.9047 | 1.9041 | 7 | 156 | central nervous system neuron differentiation |
| GO:0035239 | 0.0031 | 2.8036 | 4.1528 | 11 | 337 | tube morphogenesis |
| GO:0002703 | 0.0033 | 3.8397 | 1.9347 | 7 | 157 | regulation of leukocyte mediated immunity |
| GO:0060561 | 0.0035 | 11.0808 | 0.3081 | 3 | 25 | apoptotic process involved in morphogenesis |
| GO:0045165 | 0.0036 | 3.1266 | 3.0437 | 9 | 247 | cell fate commitment |
| GO:0006672 | 0.004 | 5.1122 | 1.0474 | 5 | 85 | ceramide metabolic process |
| GO:0021859 | 0.004 | 26.9764 | 0.0986 | 2 | 8 | pyramidal neuron differentiation |
| GO:0010557 | 0.0042 | 1.7556 | 19.7289 | 32 | 1601 | positive regulation of macromolecule biosynthetic process |
| GO:0030851 | 0.0048 | 9.7492 | 0.345 | 3 | 28 | granulocyte differentiation |
| GO:0043304 | 0.0048 | 9.7492 | 0.345 | 3 | 28 | regulation of mast cell degranulation |
| GO:0002699 | 0.0048 | 3.5749 | 2.0702 | 7 | 168 | positive regulation of immune effector process |
| GO:0010628 | 0.0051 | 1.7018 | 21.6389 | 34 | 1756 | positive regulation of gene expression |
| GO:2000113 | 0.0051 | 1.7571 | 18.398 | 30 | 1493 | negative regulation of cellular macromolecule biosynthetic process |
| GO:0048087 | 0.0051 | 23.1212 | 0.1109 | 2 | 9 | positive regulation of developmental pigmentation |
| GO:0050932 | 0.0051 | 23.1212 | 0.1109 | 2 | 9 | regulation of pigment cell differentiation |
| GO:0090370 | 0.0051 | 23.1212 | 0.1109 | 2 | 9 | negative regulation of cholesterol efflux |
| GO:2000109 | 0.0051 | 23.1212 | 0.1109 | 2 | 9 | regulation of macrophage apoptotic process |
| GO:1903508 | 0.0055 | 1.7817 | 16.8823 | 28 | 1370 | positive regulation of nucleic acid-templated transcription |
| GO:0002221 | 0.0057 | 3.4661 | 2.1319 | 7 | 173 | pattern recognition receptor signaling pathway |
| GO:0051254 | 0.0058 | 1.7557 | 17.7572 | 29 | 1441 | positive regulation of RNA metabolic process |
| GO:1901616 | 0.006 | 5.9276 | 0.727 | 4 | 59 | organic hydroxy compound catabolic process |
| GO:0030278 | 0.0062 | 3.404 | 2.1688 | 7 | 176 | regulation of ossification |
| GO:0003211 | 0.0064 | 20.2298 | 0.1232 | 2 | 10 | cardiac ventricle formation |
| GO:1902563 | 0.0064 | 20.2298 | 0.1232 | 2 | 10 | regulation of neutrophil activation |
| GO:0009954 | 0.0064 | 8.703 | 0.382 | 3 | 31 | proximal/distal pattern formation |
| GO:0009890 | 0.0067 | 1.6931 | 20.3697 | 32 | 1653 | negative regulation of biosynthetic process |
| GO:0021510 | 0.0067 | 4.4911 | 1.183 | 5 | 96 | spinal cord development |
| GO:0010810 | 0.0072 | 3.3051 | 2.2304 | 7 | 181 | regulation of cell-substrate adhesion |
| GO:0034654 | 0.0073 | 1.4759 | 50.2403 | 66 | 4077 | nucleobase-containing compound biosynthetic process |
| GO:0022603 | 0.0074 | 1.8919 | 11.793 | 21 | 957 | regulation of anatomical structure morphogenesis |
| GO:0042733 | 0.0076 | 5.5244 | 0.7763 | 4 | 63 | embryonic digit morphogenesis |
| GO:0080134 | 0.0076 | 1.7493 | 16.5126 | 27 | 1340 | regulation of response to stress |
| GO:0010985 | 0.0077 | 17.9809 | 0.1356 | 2 | 11 | negative regulation of lipoprotein particle clearance |
| GO:0021521 | 0.0077 | 17.9809 | 0.1356 | 2 | 11 | ventral spinal cord interneuron specification |
| GO:0021670 | 0.0077 | 17.9809 | 0.1356 | 2 | 11 | lateral ventricle development |
| GO:0021903 | 0.0077 | 17.9809 | 0.1356 | 2 | 11 | rostrocaudal neural tube patterning |
| GO:0031987 | 0.0077 | 17.9809 | 0.1356 | 2 | 11 | locomotion involved in locomotory behavior |
| GO:0060033 | 0.0077 | 17.9809 | 0.1356 | 2 | 11 | anatomical structure regression |
| GO:0001841 | 0.0079 | 4.3009 | 1.2323 | 5 | 100 | neural tube formation |
| GO:0007275 | 0.0079 | 1.4836 | 50.7398 | 66 | 4460 | multicellular organism development |
| GO:0003341 | 0.008 | 5.432 | 0.7887 | 4 | 64 | cilium movement |
| GO:0061035 | 0.008 | 5.432 | 0.7887 | 4 | 64 | regulation of cartilage development |
| GO:0061448 | 0.0082 | 2.9401 | 2.8589 | 8 | 232 | connective tissue development |
| GO:0031057 | 0.0083 | 7.8593 | 0.419 | 3 | 34 | negative regulation of histone modification |
| GO:0017015 | 0.0086 | 4.2117 | 1.2569 | 5 | 102 | regulation of transforming growth factor beta receptor signaling pathway |
| GO:0032502 | 0.009 | 1.7643 | 16.9884 | 27 | 1637 | developmental process |
| GO:0048869 | 0.0091 | 1.4785 | 45.351 | 60 | 3795 | cellular developmental process |
| GO:0017121 | 0.0092 | 16.1818 | 0.1479 | 2 | 12 | phospholipid scrambling |
| GO:0042659 | 0.0092 | 16.1818 | 0.1479 | 2 | 12 | regulation of cell fate specification |
| GO:0045628 | 0.0092 | 16.1818 | 0.1479 | 2 | 12 | regulation of T-helper 2 cell differentiation |
| GO:0045597 | 0.0096 | 1.9421 | 9.8031 | 18 | 813 | positive regulation of cell differentiation |
| GO:0033003 | 0.0098 | 7.3821 | 0.4436 | 3 | 36 | regulation of mast cell activation |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0007156 | 0 | 8.8047 | 2.1353 | 16 | 152 | homophilic cell adhesion via plasma membrane adhesion molecules |
| GO:0007399 | 0 | 5.6755 | 3.4259 | 17 | 288 | nervous system development |
| GO:0021510 | 0 | 11.3911 | 1.0411 | 10 | 75 | spinal cord development |
| GO:0045944 | 0 | 2.717 | 15.0174 | 36 | 1069 | positive regulation of transcription from RNA polymerase II promoter |
| GO:0022008 | 0 | 2.8044 | 13.7816 | 34 | 1019 | neurogenesis |
| GO:0000122 | 0 | 3.0531 | 10.6484 | 29 | 758 | negative regulation of transcription from RNA polymerase II promoter |
| GO:0035107 | 0 | 6.6287 | 2.037 | 12 | 145 | appendage morphogenesis |
| GO:0060581 | 0 | 35.8565 | 0.2107 | 5 | 15 | cell fate commitment involved in pattern specification |
| GO:0060173 | 0 | 6.0038 | 2.2293 | 12 | 160 | limb development |
| GO:0021514 | 0 | 29.8767 | 0.2388 | 5 | 17 | ventral spinal cord interneuron differentiation |
| GO:0030182 | 0 | 2.8802 | 11.2918 | 29 | 841 | neuron differentiation |
| GO:0001764 | 0 | 6.5441 | 1.8824 | 11 | 134 | neuron migration |
| GO:0009790 | 0 | 2.7536 | 11.7245 | 29 | 849 | embryo development |
| GO:0003151 | 0 | 8.7802 | 1.0396 | 8 | 74 | outflow tract morphogenesis |
| GO:0009952 | 0 | 5.1824 | 2.5526 | 12 | 184 | anterior/posterior pattern specification |
| GO:0021513 | 0 | 21.0828 | 0.3091 | 5 | 22 | spinal cord dorsal/ventral patterning |
| GO:0007411 | 0 | 4.6138 | 3.0906 | 13 | 220 | axon guidance |
| GO:0007267 | 0 | 2.2173 | 21.3671 | 42 | 1521 | cell-cell signaling |
| GO:0048870 | 0 | 2.258 | 19.9201 | 40 | 1418 | cell motility |
| GO:0001709 | 0 | 12.6932 | 0.5619 | 6 | 40 | cell fate determination |
| GO:0048935 | 0 | 31.7321 | 0.1826 | 4 | 13 | peripheral nervous system neuron development |
| GO:0006355 | 0 | 1.8381 | 48.3815 | 75 | 3444 | regulation of transcription, DNA-templated |
| GO:2001141 | 0 | 1.8196 | 48.7608 | 75 | 3471 | regulation of RNA biosynthetic process |
| GO:0003214 | 0 | 28.5571 | 0.1967 | 4 | 14 | cardiac left ventricle morphogenesis |
| GO:0022610 | 0 | 2.2205 | 18.5575 | 37 | 1321 | biological adhesion |
| GO:0007218 | 1e-04 | 6.652 | 1.3346 | 8 | 95 | neuropeptide signaling pathway |
| GO:0021522 | 1e-04 | 13.7772 | 0.4355 | 5 | 31 | spinal cord motor neuron differentiation |
| GO:0045597 | 1e-04 | 3.4445 | 4.7279 | 15 | 359 | positive regulation of cell differentiation |
| GO:1903508 | 1e-04 | 2.1318 | 19.2458 | 37 | 1370 | positive regulation of nucleic acid-templated transcription |
| GO:0003357 | 1e-04 | 53.3267 | 0.0983 | 3 | 7 | noradrenergic neuron differentiation |
| GO:0060322 | 1e-04 | 2.608 | 9.5948 | 23 | 683 | head development |
| GO:0019219 | 1e-04 | 1.7206 | 56.4732 | 82 | 4020 | regulation of nucleobase-containing compound metabolic process |
| GO:1903507 | 1e-04 | 2.1989 | 15.9867 | 32 | 1138 | negative regulation of nucleic acid-templated transcription |
| GO:0030900 | 1e-04 | 3.2636 | 4.959 | 15 | 353 | forebrain development |
| GO:0048729 | 1e-04 | 2.6547 | 8.5693 | 21 | 610 | tissue morphogenesis |
| GO:0061564 | 2e-04 | 2.9388 | 6.2373 | 17 | 444 | axon development |
| GO:0072272 | 2e-04 | Inf | 0.0281 | 2 | 2 | proximal/distal pattern formation involved in metanephric nephron development |
| GO:0007268 | 2e-04 | 2.6271 | 8.2181 | 20 | 585 | chemical synaptic transmission |
| GO:0051254 | 2e-04 | 2.0142 | 20.2433 | 37 | 1441 | positive regulation of RNA metabolic process |
| GO:0099537 | 2e-04 | 2.6175 | 8.2462 | 20 | 587 | trans-synaptic signaling |
| GO:0072091 | 3e-04 | 7.5605 | 0.885 | 6 | 63 | regulation of stem cell proliferation |
| GO:0021879 | 3e-04 | 15.3444 | 0.3165 | 4 | 23 | forebrain neuron differentiation |
| GO:0048667 | 3e-04 | 2.7482 | 7.0521 | 18 | 502 | cell morphogenesis involved in neuron differentiation |
| GO:0003231 | 3e-04 | 5.2059 | 1.6717 | 8 | 119 | cardiac ventricle development |
| GO:0009887 | 3e-04 | 2.5229 | 9.0182 | 21 | 685 | animal organ morphogenesis |
| GO:0007275 | 3e-04 | 1.8818 | 30.4442 | 49 | 2532 | multicellular organism development |
| GO:0001667 | 3e-04 | 3.1857 | 4.7201 | 14 | 336 | ameboidal-type cell migration |
| GO:0007519 | 3e-04 | 4.5576 | 2.1353 | 9 | 152 | skeletal muscle tissue development |
| GO:0003211 | 3e-04 | 30.4667 | 0.1405 | 3 | 10 | cardiac ventricle formation |
| GO:0035640 | 3e-04 | 14.2696 | 0.3372 | 4 | 24 | exploration behavior |
| GO:0048812 | 3e-04 | 2.608 | 7.8388 | 19 | 558 | neuron projection morphogenesis |
| GO:0010720 | 4e-04 | 2.7718 | 6.5885 | 17 | 469 | positive regulation of cell development |
| GO:2000026 | 4e-04 | 1.8665 | 25.4972 | 43 | 1815 | regulation of multicellular organismal development |
| GO:0051253 | 4e-04 | 2.0508 | 17.0262 | 32 | 1212 | negative regulation of RNA metabolic process |
| GO:0021903 | 4e-04 | 26.6567 | 0.1545 | 3 | 11 | rostrocaudal neural tube patterning |
| GO:0001501 | 4e-04 | 2.7283 | 6.6869 | 17 | 476 | skeletal system development |
| GO:0034654 | 5e-04 | 1.6235 | 57.2739 | 80 | 4077 | nucleobase-containing compound biosynthetic process |
| GO:0048858 | 5e-04 | 2.5255 | 8.0776 | 19 | 575 | cell projection morphogenesis |
| GO:0048704 | 5e-04 | 8.4523 | 0.6643 | 5 | 48 | embryonic skeletal system morphogenesis |
| GO:0050768 | 5e-04 | 3.5385 | 3.3294 | 11 | 237 | negative regulation of neurogenesis |
| GO:0010454 | 5e-04 | 23.6933 | 0.1686 | 3 | 12 | negative regulation of cell fate commitment |
| GO:0021912 | 6e-04 | 141.6018 | 0.0421 | 2 | 3 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification |
| GO:0032989 | 6e-04 | 2.1259 | 13.739 | 27 | 978 | cellular component morphogenesis |
| GO:0048863 | 6e-04 | 3.4611 | 3.3995 | 11 | 244 | stem cell differentiation |
| GO:0098609 | 6e-04 | 2.2595 | 10.9575 | 23 | 780 | cell-cell adhesion |
| GO:0048869 | 7e-04 | 1.7187 | 38.0814 | 57 | 2996 | cellular developmental process |
| GO:0010811 | 7e-04 | 5.1403 | 1.475 | 7 | 105 | positive regulation of cell-substrate adhesion |
| GO:2000177 | 7e-04 | 6.0643 | 1.0817 | 6 | 77 | regulation of neural precursor cell proliferation |
| GO:0010628 | 8e-04 | 1.8265 | 24.6684 | 41 | 1756 | positive regulation of gene expression |
| GO:0060537 | 8e-04 | 2.8506 | 5.2399 | 14 | 373 | muscle tissue development |
| GO:0009954 | 9e-04 | 10.5655 | 0.4355 | 4 | 31 | proximal/distal pattern formation |
| GO:0010557 | 9e-04 | 1.8476 | 22.4909 | 38 | 1601 | positive regulation of macromolecule biosynthetic process |
| GO:0007626 | 9e-04 | 4.8846 | 1.5461 | 7 | 112 | locomotory behavior |
| GO:0048592 | 9e-04 | 4.2739 | 2.0089 | 8 | 143 | eye morphogenesis |
| GO:0007423 | 0.001 | 2.5187 | 7.2067 | 17 | 513 | sensory organ development |
| GO:0008038 | 0.001 | 10.1875 | 0.4495 | 4 | 32 | neuron recognition |
| GO:0035115 | 0.001 | 10.1875 | 0.4495 | 4 | 32 | embryonic forelimb morphogenesis |
| GO:0043009 | 0.001 | 2.7826 | 5.3649 | 14 | 392 | chordate embryonic development |
| GO:0048562 | 0.001 | 3.79 | 2.5377 | 9 | 187 | embryonic organ morphogenesis |
| GO:0008284 | 0.0011 | 2.1316 | 12.0954 | 24 | 861 | positive regulation of cell proliferation |
| GO:0007379 | 0.0011 | 17.7667 | 0.2107 | 3 | 15 | segment specification |
| GO:0021913 | 0.0012 | 70.7965 | 0.0562 | 2 | 4 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification |
| GO:0034287 | 0.0012 | 70.7965 | 0.0562 | 2 | 4 | detection of monosaccharide stimulus |
| GO:0042662 | 0.0012 | 70.7965 | 0.0562 | 2 | 4 | negative regulation of mesodermal cell fate specification |
| GO:0051594 | 0.0012 | 70.7965 | 0.0562 | 2 | 4 | detection of glucose |
| GO:0060214 | 0.0012 | 70.7965 | 0.0562 | 2 | 4 | endocardium formation |
| GO:0072086 | 0.0012 | 70.7965 | 0.0562 | 2 | 4 | specification of loop of Henle identity |
| GO:1905903 | 0.0012 | 70.7965 | 0.0562 | 2 | 4 | negative regulation of mesoderm formation |
| GO:0035295 | 0.0012 | 3.7099 | 2.5905 | 9 | 192 | tube development |
| GO:0048762 | 0.0012 | 3.6954 | 2.5989 | 9 | 185 | mesenchymal cell differentiation |
| GO:0045669 | 0.0013 | 6.7472 | 0.8148 | 5 | 58 | positive regulation of osteoblast differentiation |
| GO:0014032 | 0.0015 | 6.501 | 0.8429 | 5 | 60 | neural crest cell development |
| GO:0014003 | 0.0016 | 8.9118 | 0.5057 | 4 | 36 | oligodendrocyte development |
| GO:0021915 | 0.0016 | 3.9221 | 2.1774 | 8 | 155 | neural tube development |
| GO:1990830 | 0.0016 | 5.1837 | 1.2503 | 6 | 89 | cellular response to leukemia inhibitory factor |
| GO:0009890 | 0.0016 | 1.7817 | 23.2214 | 38 | 1653 | negative regulation of biosynthetic process |
| GO:0060219 | 0.0016 | 15.2267 | 0.2388 | 3 | 17 | camera-type eye photoreceptor cell differentiation |
| GO:0060021 | 0.0018 | 5.061 | 1.2784 | 6 | 91 | palate development |
| GO:2000113 | 0.0018 | 1.809 | 20.9738 | 35 | 1493 | negative regulation of cellular macromolecule biosynthetic process |
| GO:0016199 | 0.0019 | 47.1947 | 0.0702 | 2 | 5 | axon midline choice point recognition |
| GO:0021778 | 0.0019 | 47.1947 | 0.0702 | 2 | 5 | oligodendrocyte cell fate specification |
| GO:0045636 | 0.0019 | 47.1947 | 0.0702 | 2 | 5 | positive regulation of melanocyte differentiation |
| GO:0021543 | 0.0019 | 3.7919 | 2.2477 | 8 | 160 | pallium development |
| GO:0030326 | 0.0019 | 4.9685 | 1.2999 | 6 | 94 | embryonic limb morphogenesis |
| GO:0051962 | 0.002 | 2.4966 | 6.3778 | 15 | 454 | positive regulation of nervous system development |
| GO:0031328 | 0.0021 | 1.7394 | 24.3874 | 39 | 1736 | positive regulation of cellular biosynthetic process |
| GO:0021884 | 0.0022 | 13.4369 | 0.2647 | 3 | 19 | forebrain neuron development |
| GO:0002089 | 0.0022 | 13.3217 | 0.2669 | 3 | 19 | lens morphogenesis in camera-type eye |
| GO:0007517 | 0.0024 | 2.6272 | 5.2399 | 13 | 373 | muscle organ development |
| GO:0006935 | 0.0025 | 2.2894 | 7.881 | 17 | 561 | chemotaxis |
| GO:0046883 | 0.0025 | 3.0777 | 3.4418 | 10 | 245 | regulation of hormone secretion |
| GO:0060411 | 0.0025 | 5.7645 | 0.9412 | 5 | 67 | cardiac septum morphogenesis |
| GO:0030324 | 0.0025 | 3.6233 | 2.346 | 8 | 167 | lung development |
| GO:0045446 | 0.0026 | 4.6739 | 1.3767 | 6 | 98 | endothelial cell differentiation |
| GO:0023019 | 0.0026 | 12.5373 | 0.281 | 3 | 20 | signal transduction involved in regulation of gene expression |
| GO:0060039 | 0.0026 | 12.5373 | 0.281 | 3 | 20 | pericardium development |
| GO:0021902 | 0.0028 | 35.3938 | 0.0843 | 2 | 6 | commitment of neuronal cell to specific neuron type in forebrain |
| GO:0030240 | 0.0028 | 35.3938 | 0.0843 | 2 | 6 | skeletal muscle thin filament assembly |
| GO:0032229 | 0.0028 | 35.3938 | 0.0843 | 2 | 6 | negative regulation of synaptic transmission, GABAergic |
| GO:0033603 | 0.0028 | 35.3938 | 0.0843 | 2 | 6 | positive regulation of dopamine secretion |
| GO:0035239 | 0.003 | 2.6798 | 4.7342 | 12 | 337 | tube morphogenesis |
| GO:0002052 | 0.003 | 11.84 | 0.295 | 3 | 21 | positive regulation of neuroblast proliferation |
| GO:0007617 | 0.003 | 11.84 | 0.295 | 3 | 21 | mating behavior |
| GO:0021516 | 0.003 | 11.84 | 0.295 | 3 | 21 | dorsal spinal cord development |
| GO:0048485 | 0.003 | 11.84 | 0.295 | 3 | 21 | sympathetic nervous system development |
| GO:0008306 | 0.003 | 5.4974 | 0.9834 | 5 | 70 | associative learning |
| GO:0048646 | 0.0032 | 1.9209 | 13.9004 | 25 | 998 | anatomical structure formation involved in morphogenesis |
| GO:0048665 | 0.0033 | 11.4141 | 0.3038 | 3 | 22 | neuron fate specification |
| GO:0050793 | 0.0033 | 2.3641 | 6.7634 | 15 | 527 | regulation of developmental process |
| GO:0048701 | 0.0033 | 7.1259 | 0.6181 | 4 | 44 | embryonic cranial skeleton morphogenesis |
| GO:0032502 | 0.0034 | 1.9383 | 14.9857 | 26 | 1368 | developmental process |
| GO:0031018 | 0.0036 | 6.9517 | 0.6322 | 4 | 45 | endocrine pancreas development |
| GO:0007631 | 0.0036 | 4.3415 | 1.475 | 6 | 105 | feeding behavior |
| GO:0003206 | 0.0037 | 6.9098 | 0.635 | 4 | 46 | cardiac chamber morphogenesis |
| GO:0021521 | 0.0039 | 28.5625 | 0.0975 | 2 | 7 | ventral spinal cord interneuron specification |
| GO:0021860 | 0.0039 | 28.3133 | 0.0983 | 2 | 7 | pyramidal neuron development |
| GO:0003002 | 0.004 | 4.255 | 1.5015 | 6 | 114 | regionalization |
| GO:0043279 | 0.0042 | 4.213 | 1.5172 | 6 | 108 | response to alkaloid |
| GO:0040012 | 0.0042 | 1.9597 | 11.9268 | 22 | 849 | regulation of locomotion |
| GO:0002067 | 0.0042 | 6.6275 | 0.6603 | 4 | 47 | glandular epithelial cell differentiation |
| GO:0001655 | 0.0043 | 2.6805 | 4.3268 | 11 | 308 | urogenital system development |
| GO:0008344 | 0.0043 | 5.0309 | 1.0677 | 5 | 76 | adult locomotory behavior |
| GO:0001708 | 0.0044 | 6.5258 | 0.6686 | 4 | 49 | cell fate specification |
| GO:0016331 | 0.0044 | 3.6412 | 2.037 | 7 | 145 | morphogenesis of embryonic epithelium |
| GO:0048596 | 0.005 | 9.6848 | 0.3512 | 3 | 25 | embryonic camera-type eye morphogenesis |
| GO:0045666 | 0.0051 | 2.6176 | 4.4251 | 11 | 315 | positive regulation of neuron differentiation |
| GO:0033860 | 0.0052 | 23.5929 | 0.1124 | 2 | 8 | regulation of NAD(P)H oxidase activity |
| GO:0045924 | 0.0052 | 23.5929 | 0.1124 | 2 | 8 | regulation of female receptivity |
| GO:0061303 | 0.0052 | 23.5929 | 0.1124 | 2 | 8 | cornea development in camera-type eye |
| GO:2000035 | 0.0052 | 23.5929 | 0.1124 | 2 | 8 | regulation of stem cell division |
| GO:0061178 | 0.0053 | 6.1941 | 0.7024 | 4 | 50 | regulation of insulin secretion involved in cellular response to glucose stimulus |
| GO:0048732 | 0.0055 | 2.3706 | 5.7738 | 13 | 411 | gland development |
| GO:0002063 | 0.0056 | 9.2632 | 0.3652 | 3 | 26 | chondrocyte development |
| GO:0002011 | 0.0057 | 6.0619 | 0.7165 | 4 | 51 | morphogenesis of an epithelial sheet |
| GO:0061053 | 0.0059 | 4.6372 | 1.1519 | 5 | 82 | somite development |
| GO:0051240 | 0.0061 | 1.8434 | 13.8661 | 24 | 1027 | positive regulation of multicellular organismal process |
| GO:0061311 | 0.0062 | 8.8767 | 0.3793 | 3 | 27 | cell surface receptor signaling pathway involved in heart development |
| GO:0019098 | 0.0065 | 20.4702 | 0.1249 | 2 | 9 | reproductive behavior |
| GO:0030198 | 0.0065 | 2.5244 | 4.5797 | 11 | 326 | extracellular matrix organization |
| GO:0003266 | 0.0066 | 20.2212 | 0.1264 | 2 | 9 | regulation of secondary heart field cardioblast proliferation |
| GO:0007614 | 0.0066 | 20.2212 | 0.1264 | 2 | 9 | short-term memory |
| GO:0046549 | 0.0066 | 20.2212 | 0.1264 | 2 | 9 | retinal cone cell development |
| GO:0046877 | 0.0066 | 20.2212 | 0.1264 | 2 | 9 | regulation of saliva secretion |
| GO:0048087 | 0.0066 | 20.2212 | 0.1264 | 2 | 9 | positive regulation of developmental pigmentation |
| GO:0048865 | 0.0066 | 20.2212 | 0.1264 | 2 | 9 | stem cell fate commitment |
| GO:0050932 | 0.0066 | 20.2212 | 0.1264 | 2 | 9 | regulation of pigment cell differentiation |
| GO:0061004 | 0.0066 | 20.2212 | 0.1264 | 2 | 9 | pattern specification involved in kidney development |
| GO:1905770 | 0.0066 | 20.2212 | 0.1264 | 2 | 9 | regulation of mesodermal cell differentiation |
| GO:0000904 | 0.0066 | 3.806 | 1.669 | 6 | 125 | cell morphogenesis involved in differentiation |
| GO:0007417 | 0.0067 | 1.9744 | 10.181 | 19 | 764 | central nervous system development |
| GO:0045927 | 0.0068 | 2.8181 | 3.3575 | 9 | 239 | positive regulation of growth |
| GO:0071805 | 0.0072 | 3.0102 | 2.7956 | 8 | 199 | potassium ion transmembrane transport |
| GO:0010719 | 0.0076 | 8.1928 | 0.4074 | 3 | 29 | negative regulation of epithelial to mesenchymal transition |
| GO:0046530 | 0.0079 | 5.4773 | 0.7867 | 4 | 56 | photoreceptor cell differentiation |
| GO:0003263 | 0.0082 | 17.6925 | 0.1405 | 2 | 10 | cardioblast proliferation |
| GO:0035878 | 0.0082 | 17.6925 | 0.1405 | 2 | 10 | nail development |
| GO:0042415 | 0.0082 | 17.6925 | 0.1405 | 2 | 10 | norepinephrine metabolic process |
| GO:0048845 | 0.0082 | 17.6925 | 0.1405 | 2 | 10 | venous blood vessel morphogenesis |
| GO:0042063 | 0.0088 | 2.699 | 3.498 | 9 | 249 | gliogenesis |
| GO:0051241 | 0.0089 | 1.7787 | 14.2908 | 24 | 1029 | negative regulation of multicellular organismal process |
| GO:0045596 | 0.0092 | 2.0324 | 8.2781 | 16 | 601 | negative regulation of cell differentiation |
| GO:0001569 | 0.0092 | 7.6067 | 0.4355 | 3 | 31 | branching involved in blood vessel morphogenesis |
| GO:0003209 | 0.0092 | 7.6067 | 0.4355 | 3 | 31 | cardiac atrium morphogenesis |
| GO:0072175 | 0.0094 | 3.5179 | 1.7982 | 6 | 128 | epithelial tube formation |
| GO:0051270 | 0.0097 | 1.8358 | 12.0673 | 21 | 859 | regulation of cellular component movement |
| GO:0009914 | 0.0099 | 2.494 | 4.2004 | 10 | 299 | hormone transport |
| GO:0003157 | 0.0099 | 15.7257 | 0.1545 | 2 | 11 | endocardium development |
| GO:0009886 | 0.0099 | 15.7257 | 0.1545 | 2 | 11 | post-embryonic animal morphogenesis |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0007156 | 9e-04 | 4.8955 | 1.5359 | 7 | 152 | homophilic cell adhesion via plasma membrane adhesion molecules |
| GO:0061844 | 0.0017 | 8.5207 | 0.5153 | 4 | 51 | antimicrobial humoral immune response mediated by antimicrobial peptide |
| GO:0098660 | 0.0023 | 2.3194 | 7.8817 | 17 | 780 | inorganic ion transmembrane transport |
| GO:0006376 | 0.0025 | 12.455 | 0.2728 | 3 | 27 | mRNA splice site selection |
| GO:0016339 | 0.0028 | 11.956 | 0.2829 | 3 | 28 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules |
| GO:0006813 | 0.0028 | 3.5623 | 2.3847 | 8 | 236 | potassium ion transport |
| GO:0050684 | 0.0046 | 4.9217 | 1.0812 | 5 | 107 | regulation of mRNA processing |
| GO:0006812 | 0.005 | 2.0129 | 10.6807 | 20 | 1057 | cation transport |
| GO:0019731 | 0.0066 | 8.5347 | 0.384 | 3 | 38 | antibacterial humoral response |
| GO:0050832 | 0.0071 | 8.2971 | 0.3941 | 3 | 39 | defense response to fungus |
| GO:0070986 | 0.0074 | 18.0191 | 0.1314 | 2 | 13 | left/right axis specification |
| GO:0043269 | 0.008 | 2.2702 | 6.0628 | 13 | 600 | regulation of ion transport |
| GO:0051852 | 0.0085 | 16.5165 | 0.1415 | 2 | 14 | disruption by host of symbiont cells |
| GO:0007269 | 0.01 | 4.0429 | 1.3035 | 5 | 129 | neurotransmitter secretion |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0002263 | 0 | 5.2382 | 7.4011 | 32 | 660 | cell activation involved in immune response |
| GO:0045087 | 0 | 3.8773 | 9.3972 | 31 | 838 | innate immune response |
| GO:0050900 | 0 | 5.3065 | 4.5528 | 21 | 406 | leukocyte migration |
| GO:0002285 | 0 | 8.6781 | 1.7269 | 13 | 154 | lymphocyte activation involved in immune response |
| GO:0045321 | 0 | 4.1829 | 6.9465 | 25 | 664 | leukocyte activation |
| GO:0002275 | 0 | 4.3023 | 5.82 | 22 | 519 | myeloid cell activation involved in immune response |
| GO:0002444 | 0 | 3.9342 | 5.7034 | 20 | 514 | myeloid leukocyte mediated immunity |
| GO:0090026 | 0 | 34.8435 | 0.2018 | 5 | 18 | positive regulation of monocyte chemotaxis |
| GO:0032940 | 0 | 2.6134 | 15.419 | 35 | 1375 | secretion by cell |
| GO:0002684 | 0 | 5.168 | 2.7951 | 13 | 262 | positive regulation of immune system process |
| GO:0043312 | 0 | 3.8131 | 5.2368 | 18 | 467 | neutrophil degranulation |
| GO:0042119 | 0 | 3.7276 | 5.349 | 18 | 477 | neutrophil activation |
| GO:0007166 | 0 | 2.1654 | 28.7248 | 52 | 2600 | cell surface receptor signaling pathway |
| GO:0060326 | 0 | 4.9007 | 2.9268 | 13 | 261 | cell chemotaxis |
| GO:0002322 | 0 | 134.4637 | 0.0561 | 3 | 5 | B cell proliferation involved in immune response |
| GO:0050670 | 0 | 5.4561 | 2.2203 | 11 | 198 | regulation of lymphocyte proliferation |
| GO:0045055 | 0 | 3.0791 | 7.9394 | 22 | 708 | regulated exocytosis |
| GO:0071222 | 0 | 6.0005 | 1.8391 | 10 | 164 | cellular response to lipopolysaccharide |
| GO:0032946 | 0 | 6.7355 | 1.4802 | 9 | 132 | positive regulation of mononuclear cell proliferation |
| GO:0042330 | 0 | 3.3348 | 6.2909 | 19 | 561 | taxis |
| GO:0070663 | 0 | 5.1494 | 2.3437 | 11 | 209 | regulation of leukocyte proliferation |
| GO:0022610 | 0 | 2.4427 | 14.8134 | 32 | 1321 | biological adhesion |
| GO:1903039 | 0 | 5.0462 | 2.3885 | 11 | 213 | positive regulation of leukocyte cell-cell adhesion |
| GO:0070098 | 0 | 8.7534 | 0.8971 | 7 | 80 | chemokine-mediated signaling pathway |
| GO:0050867 | 0 | 4.1946 | 3.3866 | 13 | 302 | positive regulation of cell activation |
| GO:0051251 | 0 | 4.4972 | 2.9156 | 12 | 260 | positive regulation of lymphocyte activation |
| GO:0046651 | 0 | 10.846 | 0.6293 | 6 | 59 | lymphocyte proliferation |
| GO:0050863 | 0 | 4.1077 | 3.4539 | 13 | 308 | regulation of T cell activation |
| GO:0030593 | 1e-04 | 7.8849 | 0.9868 | 7 | 88 | neutrophil chemotaxis |
| GO:0071216 | 1e-04 | 5.0967 | 2.1418 | 10 | 191 | cellular response to biotic stimulus |
| GO:0097530 | 1e-04 | 6.4263 | 1.3681 | 8 | 122 | granulocyte migration |
| GO:0070661 | 1e-04 | 9.5697 | 0.7045 | 6 | 66 | leukocyte proliferation |
| GO:0043615 | 1e-04 | 53.7754 | 0.0897 | 3 | 8 | astrocyte cell migration |
| GO:0071675 | 1e-04 | 12.5643 | 0.4598 | 5 | 41 | regulation of mononuclear cell migration |
| GO:0045785 | 1e-04 | 3.5907 | 4.2388 | 14 | 378 | positive regulation of cell adhesion |
| GO:2000458 | 1e-04 | Inf | 0.0224 | 2 | 2 | regulation of astrocyte chemotaxis |
| GO:0035589 | 2e-04 | 38.4062 | 0.1121 | 3 | 10 | G-protein coupled purinergic nucleotide receptor signaling pathway |
| GO:0071346 | 2e-04 | 5.5437 | 1.5699 | 8 | 140 | cellular response to interferon-gamma |
| GO:0022407 | 2e-04 | 3.3109 | 4.5752 | 14 | 408 | regulation of cell-cell adhesion |
| GO:0002521 | 2e-04 | 3.1421 | 5.1696 | 15 | 461 | leukocyte differentiation |
| GO:0030183 | 3e-04 | 6.1323 | 1.2447 | 7 | 111 | B cell differentiation |
| GO:0050792 | 3e-04 | 4.6382 | 2.097 | 9 | 187 | regulation of viral process |
| GO:0032729 | 3e-04 | 9.7234 | 0.577 | 5 | 52 | positive regulation of interferon-gamma production |
| GO:0046631 | 3e-04 | 6.0158 | 1.2672 | 7 | 113 | alpha-beta T cell activation |
| GO:0051707 | 3e-04 | 2.5092 | 9.128 | 21 | 814 | response to other organism |
| GO:0001817 | 4e-04 | 3.1415 | 4.8156 | 14 | 445 | regulation of cytokine production |
| GO:0007194 | 5e-04 | 11.9985 | 0.3813 | 4 | 34 | negative regulation of adenylate cyclase activity |
| GO:0002292 | 6e-04 | 8.2142 | 0.6728 | 5 | 60 | T cell differentiation involved in immune response |
| GO:0002313 | 6e-04 | 22.3966 | 0.1682 | 3 | 15 | mature B cell differentiation involved in immune response |
| GO:0002440 | 6e-04 | 4.5945 | 1.8727 | 8 | 167 | production of molecular mediator of immune response |
| GO:0002694 | 6e-04 | 3.4915 | 3.3819 | 11 | 309 | regulation of leukocyte activation |
| GO:0002819 | 7e-04 | 5.1789 | 1.4578 | 7 | 130 | regulation of adaptive immune response |
| GO:0006959 | 8e-04 | 3.9235 | 2.4558 | 9 | 219 | humoral immune response |
| GO:0006955 | 0.001 | 4.2796 | 2.019 | 8 | 244 | immune response |
| GO:0050715 | 0.0011 | 5.6101 | 1.154 | 6 | 104 | positive regulation of cytokine secretion |
| GO:0042107 | 0.0012 | 5.4921 | 1.1774 | 6 | 105 | cytokine metabolic process |
| GO:0046641 | 0.0012 | 16.7933 | 0.2131 | 3 | 19 | positive regulation of alpha-beta T cell proliferation |
| GO:0002237 | 0.0012 | 3.2025 | 3.6669 | 11 | 327 | response to molecule of bacterial origin |
| GO:0043308 | 0.0012 | 59.4259 | 0.0561 | 2 | 5 | eosinophil degranulation |
| GO:1901078 | 0.0012 | 59.4259 | 0.0561 | 2 | 5 | negative regulation of relaxation of muscle |
| GO:0002688 | 0.0012 | 5.4368 | 1.1887 | 6 | 106 | regulation of leukocyte chemotaxis |
| GO:0006954 | 0.0013 | 2.621 | 6.1379 | 15 | 559 | inflammatory response |
| GO:0002548 | 0.0013 | 9.2457 | 0.4804 | 4 | 44 | monocyte chemotaxis |
| GO:1903901 | 0.0014 | 6.6384 | 0.8186 | 5 | 73 | negative regulation of viral life cycle |
| GO:0070374 | 0.0016 | 3.9209 | 2.1755 | 8 | 194 | positive regulation of ERK1 and ERK2 cascade |
| GO:0006950 | 0.0016 | 1.6485 | 40.4258 | 58 | 3605 | response to stress |
| GO:0023052 | 0.0016 | 1.574 | 68.1014 | 88 | 6073 | signaling |
| GO:0010818 | 0.0016 | 14.9255 | 0.2355 | 3 | 21 | T cell chemotaxis |
| GO:0042102 | 0.0016 | 6.3697 | 0.8502 | 5 | 77 | positive regulation of T cell proliferation |
| GO:0002824 | 0.0016 | 6.3567 | 0.8522 | 5 | 76 | positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains |
| GO:0045058 | 0.0017 | 8.5639 | 0.5158 | 4 | 46 | T cell selection |
| GO:0007154 | 0.0018 | 1.5649 | 68.3481 | 88 | 6095 | cell communication |
| GO:0043307 | 0.0018 | 44.5667 | 0.0673 | 2 | 6 | eosinophil activation |
| GO:0070383 | 0.0018 | 44.5667 | 0.0673 | 2 | 6 | DNA cytosine deamination |
| GO:0002703 | 0.002 | 4.2395 | 1.7606 | 7 | 157 | regulation of leukocyte mediated immunity |
| GO:0030803 | 0.002 | 8.1736 | 0.5383 | 4 | 48 | negative regulation of cyclic nucleotide biosynthetic process |
| GO:0032663 | 0.0022 | 7.9915 | 0.5495 | 4 | 49 | regulation of interleukin-2 production |
| GO:0002250 | 0.0022 | 4.8028 | 1.3354 | 6 | 125 | adaptive immune response |
| GO:0043901 | 0.0023 | 4.1283 | 1.8054 | 7 | 161 | negative regulation of multi-organism process |
| GO:0030815 | 0.0024 | 7.8173 | 0.5607 | 4 | 50 | negative regulation of cAMP metabolic process |
| GO:0016192 | 0.0024 | 1.8189 | 19.9045 | 33 | 1775 | vesicle-mediated transport |
| GO:0071310 | 0.0025 | 1.718 | 26.5094 | 41 | 2364 | cellular response to organic substance |
| GO:0035627 | 0.0025 | 35.6511 | 0.0785 | 2 | 7 | ceramide transport |
| GO:0045869 | 0.0025 | 35.6511 | 0.0785 | 2 | 7 | negative regulation of single stranded viral RNA replication via double stranded DNA intermediate |
| GO:0048007 | 0.0025 | 35.6511 | 0.0785 | 2 | 7 | antigen processing and presentation, exogenous lipid antigen via MHC class Ib |
| GO:1900372 | 0.0025 | 7.6505 | 0.5719 | 4 | 51 | negative regulation of purine nucleotide biosynthetic process |
| GO:0002449 | 0.0027 | 3.5887 | 2.3661 | 8 | 211 | lymphocyte mediated immunity |
| GO:0002407 | 0.0027 | 12.2087 | 0.2803 | 3 | 25 | dendritic cell chemotaxis |
| GO:0045730 | 0.003 | 11.6772 | 0.2916 | 3 | 26 | respiratory burst |
| GO:0048534 | 0.0031 | 2.1426 | 9.4981 | 19 | 847 | hematopoietic or lymphoid organ development |
| GO:0050921 | 0.0032 | 4.4503 | 1.4354 | 6 | 128 | positive regulation of chemotaxis |
| GO:0006909 | 0.0033 | 3.4509 | 2.4558 | 8 | 219 | phagocytosis |
| GO:0002887 | 0.0033 | 29.7074 | 0.0897 | 2 | 8 | negative regulation of myeloid leukocyte mediated immunity |
| GO:0031666 | 0.0033 | 29.7074 | 0.0897 | 2 | 8 | positive regulation of lipopolysaccharide-mediated signaling pathway |
| GO:1902715 | 0.0033 | 29.7074 | 0.0897 | 2 | 8 | positive regulation of interferon-gamma secretion |
| GO:0071347 | 0.0034 | 5.3051 | 1.0092 | 5 | 90 | cellular response to interleukin-1 |
| GO:0006171 | 0.0035 | 4.3779 | 1.4578 | 6 | 130 | cAMP biosynthetic process |
| GO:0050778 | 0.0036 | 2.2687 | 7.5132 | 16 | 670 | positive regulation of immune response |
| GO:0035587 | 0.0037 | 10.7417 | 0.314 | 3 | 28 | purinergic receptor signaling pathway |
| GO:1901137 | 0.004 | 2.187 | 8.287 | 17 | 739 | carbohydrate derivative biosynthetic process |
| GO:0002460 | 0.004 | 4.2443 | 1.5011 | 6 | 137 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains |
| GO:0032365 | 0.0041 | 10.3279 | 0.3252 | 3 | 29 | intracellular lipid transport |
| GO:2000403 | 0.0041 | 10.3279 | 0.3252 | 3 | 29 | positive regulation of lymphocyte migration |
| GO:0031279 | 0.0041 | 5.0654 | 1.0541 | 5 | 94 | regulation of cyclase activity |
| GO:0009972 | 0.0043 | 25.4619 | 0.1009 | 2 | 9 | cytidine deamination |
| GO:0032621 | 0.0043 | 25.4619 | 0.1009 | 2 | 9 | interleukin-18 production |
| GO:0043301 | 0.0043 | 25.4619 | 0.1009 | 2 | 9 | negative regulation of leukocyte degranulation |
| GO:0046087 | 0.0043 | 25.4619 | 0.1009 | 2 | 9 | cytidine metabolic process |
| GO:0051339 | 0.0043 | 5.0088 | 1.0653 | 5 | 95 | regulation of lyase activity |
| GO:0048870 | 0.0045 | 1.8355 | 15.9012 | 27 | 1418 | cell motility |
| GO:0042116 | 0.0049 | 6.3044 | 0.684 | 4 | 61 | macrophage activation |
| GO:0031347 | 0.0053 | 2.175 | 7.816 | 16 | 697 | regulation of defense response |
| GO:0002475 | 0.0053 | 22.2778 | 0.1121 | 2 | 10 | antigen processing and presentation via MHC class Ib |
| GO:2000551 | 0.0053 | 22.2778 | 0.1121 | 2 | 10 | regulation of T-helper 2 cell cytokine production |
| GO:0034612 | 0.0054 | 2.9296 | 3.2408 | 9 | 289 | response to tumor necrosis factor |
| GO:0032101 | 0.0054 | 2.1683 | 7.8384 | 16 | 699 | regulation of response to external stimulus |
| GO:0032760 | 0.0054 | 6.0899 | 0.7065 | 4 | 63 | positive regulation of tumor necrosis factor production |
| GO:0002369 | 0.0059 | 8.9486 | 0.3701 | 3 | 33 | T cell cytokine production |
| GO:0072529 | 0.0059 | 8.9486 | 0.3701 | 3 | 33 | pyrimidine-containing compound catabolic process |
| GO:0016553 | 0.0064 | 19.8012 | 0.1234 | 2 | 11 | base conversion or substitution editing |
| GO:0032754 | 0.0064 | 19.8012 | 0.1234 | 2 | 11 | positive regulation of interleukin-5 production |
| GO:0044546 | 0.0064 | 19.8012 | 0.1234 | 2 | 11 | NLRP3 inflammasome complex assembly |
| GO:0046133 | 0.0064 | 19.8012 | 0.1234 | 2 | 11 | pyrimidine ribonucleoside catabolic process |
| GO:0046348 | 0.0064 | 19.8012 | 0.1234 | 2 | 11 | amino sugar catabolic process |
| GO:0072672 | 0.0064 | 19.8012 | 0.1234 | 2 | 11 | neutrophil extravasation |
| GO:0002695 | 0.0067 | 3.7917 | 1.6709 | 6 | 149 | negative regulation of leukocyte activation |
| GO:0031295 | 0.0068 | 5.7018 | 0.7513 | 4 | 67 | T cell costimulation |
| GO:0002793 | 0.007 | 3.0284 | 2.781 | 8 | 248 | positive regulation of peptide secretion |
| GO:0009187 | 0.0072 | 3.3033 | 2.2315 | 7 | 199 | cyclic nucleotide metabolic process |
| GO:0045086 | 0.0077 | 17.82 | 0.1346 | 2 | 12 | positive regulation of interleukin-2 biosynthetic process |
| GO:0048247 | 0.0078 | 8.0194 | 0.4086 | 3 | 37 | lymphocyte chemotaxis |
| GO:0050729 | 0.008 | 4.2892 | 1.2335 | 5 | 110 | positive regulation of inflammatory response |
| GO:0042092 | 0.0081 | 7.8939 | 0.4149 | 3 | 37 | type 2 immune response |
| GO:0061028 | 0.0081 | 7.8939 | 0.4149 | 3 | 37 | establishment of endothelial barrier |
| GO:1903555 | 0.0086 | 4.2085 | 1.2559 | 5 | 112 | regulation of tumor necrosis factor superfamily cytokine production |
| GO:0006047 | 0.009 | 16.199 | 0.1458 | 2 | 13 | UDP-N-acetylglucosamine metabolic process |
| GO:0010623 | 0.009 | 16.199 | 0.1458 | 2 | 13 | programmed cell death involved in cell development |
| GO:0030335 | 0.009 | 2.4113 | 4.7995 | 11 | 428 | positive regulation of cell migration |
| GO:0045980 | 0.0091 | 5.204 | 0.8186 | 4 | 73 | negative regulation of nucleotide metabolic process |
| GO:0051716 | 0.0093 | 1.4521 | 71.2815 | 87 | 6647 | cellular response to stimulus |
| GO:0045807 | 0.0096 | 4.093 | 1.2896 | 5 | 115 | positive regulation of endocytosis |
| GO:0048584 | 0.0099 | 1.777 | 14.5197 | 24 | 1361 | positive regulation of response to stimulus |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0002263 | 0 | 4.9961 | 7.1978 | 30 | 660 | cell activation involved in immune response |
| GO:0045087 | 0 | 3.8505 | 9.139 | 30 | 838 | innate immune response |
| GO:0045321 | 0 | 4.0979 | 6.7781 | 24 | 664 | leukocyte activation |
| GO:0002285 | 0 | 8.149 | 1.6795 | 12 | 154 | lymphocyte activation involved in immune response |
| GO:0090026 | 0 | 35.8676 | 0.1963 | 5 | 18 | positive regulation of monocyte chemotaxis |
| GO:0002275 | 0 | 3.8822 | 5.4708 | 19 | 507 | myeloid cell activation involved in immune response |
| GO:0002322 | 0 | 138.3707 | 0.0545 | 3 | 5 | B cell proliferation involved in immune response |
| GO:0071222 | 0 | 6.1821 | 1.7885 | 10 | 164 | cellular response to lipopolysaccharide |
| GO:0007166 | 0 | 2.1166 | 28.6603 | 51 | 2628 | cell surface receptor signaling pathway |
| GO:0002684 | 0 | 4.9135 | 2.6941 | 12 | 262 | positive regulation of immune system process |
| GO:0097529 | 0 | 12.1113 | 0.5699 | 6 | 54 | myeloid leukocyte migration |
| GO:1903039 | 0 | 5.1998 | 2.3229 | 11 | 213 | positive regulation of leukocyte cell-cell adhesion |
| GO:0070098 | 0 | 9.0137 | 0.8725 | 7 | 80 | chemokine-mediated signaling pathway |
| GO:0046651 | 0 | 11.1182 | 0.6146 | 6 | 59 | lymphocyte proliferation |
| GO:0022610 | 0 | 2.4299 | 14.4065 | 31 | 1321 | biological adhesion |
| GO:0002444 | 0 | 3.3664 | 5.5449 | 17 | 514 | myeloid leukocyte mediated immunity |
| GO:0071216 | 0 | 5.2509 | 2.083 | 10 | 191 | cellular response to biotic stimulus |
| GO:0070661 | 1e-04 | 9.8099 | 0.688 | 6 | 66 | leukocyte proliferation |
| GO:0050670 | 1e-04 | 5.0532 | 2.1593 | 10 | 198 | regulation of lymphocyte proliferation |
| GO:0042119 | 1e-04 | 3.3612 | 5.202 | 16 | 477 | neutrophil activation |
| GO:0045785 | 1e-04 | 3.702 | 4.1224 | 14 | 378 | positive regulation of cell adhesion |
| GO:0071675 | 1e-04 | 12.9336 | 0.4471 | 5 | 41 | regulation of mononuclear cell migration |
| GO:0032940 | 1e-04 | 2.3238 | 14.9954 | 31 | 1375 | secretion by cell |
| GO:0032946 | 1e-04 | 6.0809 | 1.4396 | 8 | 132 | positive regulation of mononuclear cell proliferation |
| GO:0070663 | 1e-04 | 4.7706 | 2.2793 | 10 | 209 | regulation of leukocyte proliferation |
| GO:0050867 | 1e-04 | 3.9531 | 3.2935 | 12 | 302 | positive regulation of cell activation |
| GO:0034097 | 1e-04 | 2.5248 | 10.5022 | 24 | 963 | response to cytokine |
| GO:0051251 | 1e-04 | 4.2058 | 2.8355 | 11 | 260 | positive regulation of lymphocyte activation |
| GO:0022407 | 2e-04 | 3.4136 | 4.4495 | 14 | 408 | regulation of cell-cell adhesion |
| GO:0030098 | 2e-04 | 3.7677 | 3.4462 | 12 | 316 | lymphocyte differentiation |
| GO:0043312 | 2e-04 | 3.1959 | 5.093 | 15 | 467 | neutrophil degranulation |
| GO:0032729 | 2e-04 | 10.0125 | 0.561 | 5 | 52 | positive regulation of interferon-gamma production |
| GO:0001817 | 3e-04 | 2.9704 | 5.8483 | 16 | 547 | regulation of cytokine production |
| GO:0045055 | 3e-04 | 2.6815 | 7.7213 | 19 | 708 | regulated exocytosis |
| GO:0097530 | 4e-04 | 5.7067 | 1.3305 | 7 | 122 | granulocyte migration |
| GO:0030593 | 4e-04 | 6.834 | 0.9597 | 6 | 88 | neutrophil chemotaxis |
| GO:0007194 | 5e-04 | 12.3491 | 0.3708 | 4 | 34 | negative regulation of adenylate cyclase activity |
| GO:0002440 | 5e-04 | 4.7319 | 1.8213 | 8 | 167 | production of molecular mediator of immune response |
| GO:0002819 | 6e-04 | 5.3329 | 1.4177 | 7 | 130 | regulation of adaptive immune response |
| GO:0051707 | 6e-04 | 2.4481 | 8.8773 | 20 | 814 | response to other organism |
| GO:0071346 | 9e-04 | 4.9288 | 1.5268 | 7 | 140 | cellular response to interferon-gamma |
| GO:0023052 | 9e-04 | 1.6257 | 66.2305 | 87 | 6073 | signaling |
| GO:0050863 | 9e-04 | 3.8779 | 2.4846 | 9 | 232 | regulation of T cell activation |
| GO:0006955 | 9e-04 | 4.3207 | 2.0016 | 8 | 246 | immune response |
| GO:0050715 | 9e-04 | 5.7779 | 1.1219 | 6 | 104 | positive regulation of cytokine secretion |
| GO:0002237 | 9e-04 | 3.3 | 3.5662 | 11 | 327 | response to molecule of bacterial origin |
| GO:0006954 | 0.001 | 2.7054 | 5.9645 | 15 | 559 | inflammatory response |
| GO:0007154 | 0.001 | 1.6162 | 66.4704 | 87 | 6095 | cell communication |
| GO:0042107 | 0.001 | 5.6544 | 1.1451 | 6 | 105 | cytokine metabolic process |
| GO:0050778 | 0.0011 | 2.5057 | 7.3068 | 17 | 670 | positive regulation of immune response |
| GO:0002688 | 0.0011 | 5.5975 | 1.156 | 6 | 106 | regulation of leukocyte chemotaxis |
| GO:0002335 | 0.0011 | 17.2812 | 0.2072 | 3 | 19 | mature B cell differentiation |
| GO:0046641 | 0.0011 | 17.2812 | 0.2072 | 3 | 19 | positive regulation of alpha-beta T cell proliferation |
| GO:0043308 | 0.0012 | 61.1429 | 0.0545 | 2 | 5 | eosinophil degranulation |
| GO:1901078 | 0.0012 | 61.1429 | 0.0545 | 2 | 5 | negative regulation of relaxation of muscle |
| GO:1903901 | 0.0012 | 6.8335 | 0.7961 | 5 | 73 | negative regulation of viral life cycle |
| GO:0002683 | 0.0014 | 3.6273 | 2.6478 | 9 | 249 | negative regulation of immune system process |
| GO:0042102 | 0.0014 | 6.5602 | 0.8265 | 5 | 77 | positive regulation of T cell proliferation |
| GO:0002824 | 0.0014 | 6.5436 | 0.8288 | 5 | 76 | positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains |
| GO:0045058 | 0.0016 | 8.8142 | 0.5017 | 4 | 46 | T cell selection |
| GO:0031347 | 0.0016 | 2.402 | 7.6013 | 17 | 697 | regulation of defense response |
| GO:0002520 | 0.0017 | 2.2259 | 9.6952 | 20 | 889 | immune system development |
| GO:0072678 | 0.0017 | 8.6087 | 0.5126 | 4 | 47 | T cell migration |
| GO:0040011 | 0.0017 | 1.9008 | 17.929 | 31 | 1644 | locomotion |
| GO:0043307 | 0.0017 | 45.8543 | 0.0654 | 2 | 6 | eosinophil activation |
| GO:0070383 | 0.0017 | 45.8543 | 0.0654 | 2 | 6 | DNA cytosine deamination |
| GO:0002694 | 0.0018 | 3.2429 | 3.2858 | 10 | 309 | regulation of leukocyte activation |
| GO:0030803 | 0.0018 | 8.4125 | 0.5235 | 4 | 48 | negative regulation of cyclic nucleotide biosynthetic process |
| GO:0043901 | 0.0019 | 4.2511 | 1.7558 | 7 | 161 | negative regulation of multi-organism process |
| GO:0032663 | 0.002 | 8.225 | 0.5344 | 4 | 49 | regulation of interleukin-2 production |
| GO:0030815 | 0.0021 | 8.0457 | 0.5453 | 4 | 50 | negative regulation of cAMP metabolic process |
| GO:1900372 | 0.0023 | 7.8741 | 0.5562 | 4 | 51 | negative regulation of purine nucleotide biosynthetic process |
| GO:0006935 | 0.0023 | 2.7804 | 4.5984 | 12 | 433 | chemotaxis |
| GO:0035627 | 0.0024 | 36.6811 | 0.0763 | 2 | 7 | ceramide transport |
| GO:0045869 | 0.0024 | 36.6811 | 0.0763 | 2 | 7 | negative regulation of single stranded viral RNA replication via double stranded DNA intermediate |
| GO:0048007 | 0.0024 | 36.6811 | 0.0763 | 2 | 7 | antigen processing and presentation, exogenous lipid antigen via MHC class Ib |
| GO:0042113 | 0.0027 | 3.5886 | 2.3665 | 8 | 217 | B cell activation |
| GO:0045730 | 0.0028 | 12.0165 | 0.2835 | 3 | 26 | respiratory burst |
| GO:0050921 | 0.0028 | 4.5818 | 1.3959 | 6 | 128 | positive regulation of chemotaxis |
| GO:0006909 | 0.0028 | 3.5541 | 2.3884 | 8 | 219 | phagocytosis |
| GO:0006959 | 0.0028 | 3.5541 | 2.3884 | 8 | 219 | humoral immune response |
| GO:0048583 | 0.0029 | 1.6729 | 31.9906 | 47 | 3086 | regulation of response to stimulus |
| GO:0006171 | 0.003 | 4.5074 | 1.4177 | 6 | 130 | cAMP biosynthetic process |
| GO:0030097 | 0.0031 | 2.193 | 8.79 | 18 | 806 | hemopoiesis |
| GO:0002887 | 0.0032 | 30.5657 | 0.0872 | 2 | 8 | negative regulation of myeloid leukocyte mediated immunity |
| GO:0031666 | 0.0032 | 30.5657 | 0.0872 | 2 | 8 | positive regulation of lipopolysaccharide-mediated signaling pathway |
| GO:0043615 | 0.0032 | 30.5657 | 0.0872 | 2 | 8 | astrocyte cell migration |
| GO:1902715 | 0.0032 | 30.5657 | 0.0872 | 2 | 8 | positive regulation of interferon-gamma secretion |
| GO:0042110 | 0.0033 | 4.4277 | 1.442 | 6 | 140 | T cell activation |
| GO:0002697 | 0.0035 | 2.9347 | 3.6098 | 10 | 331 | regulation of immune effector process |
| GO:0031279 | 0.0037 | 5.2143 | 1.0251 | 5 | 94 | regulation of cyclase activity |
| GO:0048247 | 0.0037 | 6.8504 | 0.6325 | 4 | 58 | lymphocyte chemotaxis |
| GO:2000403 | 0.0038 | 10.628 | 0.3163 | 3 | 29 | positive regulation of lymphocyte migration |
| GO:0006950 | 0.0038 | 1.5878 | 39.3152 | 55 | 3605 | response to stress |
| GO:0051339 | 0.0038 | 5.156 | 1.036 | 5 | 95 | regulation of lyase activity |
| GO:0009972 | 0.004 | 26.1976 | 0.0982 | 2 | 9 | cytidine deamination |
| GO:0032621 | 0.004 | 26.1976 | 0.0982 | 2 | 9 | interleukin-18 production |
| GO:0043301 | 0.004 | 26.1976 | 0.0982 | 2 | 9 | negative regulation of leukocyte degranulation |
| GO:0046087 | 0.004 | 26.1976 | 0.0982 | 2 | 9 | cytidine metabolic process |
| GO:0030595 | 0.0041 | 6.6316 | 0.6511 | 4 | 62 | leukocyte chemotaxis |
| GO:0002292 | 0.0041 | 6.6049 | 0.6543 | 4 | 60 | T cell differentiation involved in immune response |
| GO:0032101 | 0.0042 | 2.2364 | 7.6231 | 16 | 699 | regulation of response to external stimulus |
| GO:0050792 | 0.0045 | 3.6311 | 2.0394 | 7 | 187 | regulation of viral process |
| GO:0051241 | 0.0047 | 1.9844 | 11.3575 | 21 | 1053 | negative regulation of multicellular organismal process |
| GO:0032760 | 0.0049 | 6.2679 | 0.6871 | 4 | 63 | positive regulation of tumor necrosis factor production |
| GO:0002475 | 0.005 | 22.9214 | 0.1091 | 2 | 10 | antigen processing and presentation via MHC class Ib |
| GO:0035589 | 0.005 | 22.9214 | 0.1091 | 2 | 10 | G-protein coupled purinergic nucleotide receptor signaling pathway |
| GO:2000551 | 0.005 | 22.9214 | 0.1091 | 2 | 10 | regulation of T-helper 2 cell cytokine production |
| GO:0016192 | 0.0055 | 1.7421 | 19.3577 | 31 | 1775 | vesicle-mediated transport |
| GO:0002369 | 0.0055 | 9.2086 | 0.3599 | 3 | 33 | T cell cytokine production |
| GO:0002695 | 0.0059 | 3.9038 | 1.625 | 6 | 149 | negative regulation of leukocyte activation |
| GO:0002793 | 0.0059 | 3.1189 | 2.7046 | 8 | 248 | positive regulation of peptide secretion |
| GO:0016553 | 0.0061 | 20.3733 | 0.12 | 2 | 11 | base conversion or substitution editing |
| GO:0032754 | 0.0061 | 20.3733 | 0.12 | 2 | 11 | positive regulation of interleukin-5 production |
| GO:0044546 | 0.0061 | 20.3733 | 0.12 | 2 | 11 | NLRP3 inflammasome complex assembly |
| GO:0046133 | 0.0061 | 20.3733 | 0.12 | 2 | 11 | pyrimidine ribonucleoside catabolic process |
| GO:0046348 | 0.0061 | 20.3733 | 0.12 | 2 | 11 | amino sugar catabolic process |
| GO:0072672 | 0.0061 | 20.3733 | 0.12 | 2 | 11 | neutrophil extravasation |
| GO:0031295 | 0.0061 | 5.8684 | 0.7307 | 4 | 67 | T cell costimulation |
| GO:0032637 | 0.0061 | 5.8684 | 0.7307 | 4 | 67 | interleukin-8 production |
| GO:0009187 | 0.0062 | 3.4016 | 2.1702 | 7 | 199 | cyclic nucleotide metabolic process |
| GO:0050729 | 0.0071 | 4.4153 | 1.1996 | 5 | 110 | positive regulation of inflammatory response |
| GO:0002281 | 0.0073 | 18.3349 | 0.1309 | 2 | 12 | macrophage activation involved in immune response |
| GO:0045086 | 0.0073 | 18.3349 | 0.1309 | 2 | 12 | positive regulation of interleukin-2 biosynthetic process |
| GO:1900029 | 0.0073 | 18.3349 | 0.1309 | 2 | 12 | positive regulation of ruffle assembly |
| GO:0030335 | 0.0074 | 2.4847 | 4.6677 | 11 | 428 | positive regulation of cell migration |
| GO:0002429 | 0.0081 | 2.7386 | 3.4571 | 9 | 317 | immune response-activating cell surface receptor signaling pathway |
| GO:0071310 | 0.0081 | 1.6134 | 25.7811 | 38 | 2364 | cellular response to organic substance |
| GO:0002460 | 0.0081 | 4.2629 | 1.2401 | 5 | 117 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains |
| GO:0045980 | 0.0083 | 5.3561 | 0.7961 | 4 | 73 | negative regulation of nucleotide metabolic process |
| GO:0006047 | 0.0085 | 16.667 | 0.1418 | 2 | 13 | UDP-N-acetylglucosamine metabolic process |
| GO:0010623 | 0.0085 | 16.667 | 0.1418 | 2 | 13 | programmed cell death involved in cell development |
| GO:0045807 | 0.0085 | 4.2133 | 1.2542 | 5 | 115 | positive regulation of endocytosis |
| GO:0042592 | 0.0087 | 1.7202 | 17.5473 | 28 | 1609 | homeostatic process |
| GO:0050896 | 0.009 | 1.7932 | 19.9925 | 30 | 2547 | response to stimulus |
| GO:0071674 | 0.0093 | 7.4645 | 0.4356 | 3 | 41 | mononuclear cell migration |
| GO:0042088 | 0.0094 | 7.4632 | 0.4362 | 3 | 40 | T-helper 1 type immune response |
| GO:0002706 | 0.0095 | 4.1006 | 1.2869 | 5 | 118 | regulation of lymphocyte mediated immunity |
| GO:0046634 | 0.0095 | 5.132 | 0.8288 | 4 | 76 | regulation of alpha-beta T cell activation |
| GO:0002250 | 0.0098 | 4.0686 | 1.2963 | 5 | 125 | adaptive immune response |
| GO:0002693 | 0.0099 | 15.2771 | 0.1527 | 2 | 14 | positive regulation of cellular extravasation |
| GO:0002829 | 0.0099 | 15.2771 | 0.1527 | 2 | 14 | negative regulation of type 2 immune response |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0061368 | 0 | 530.0328 | 0.0116 | 2 | 3 | behavioral response to formalin induced pain |
| GO:0002376 | 1e-04 | 2.9369 | 10.3641 | 23 | 2670 | immune system process |
| GO:0046649 | 1e-04 | 4.8784 | 2.3756 | 10 | 612 | lymphocyte activation |
| GO:0006959 | 2e-04 | 7.8844 | 0.8501 | 6 | 219 | humoral immune response |
| GO:0070098 | 3e-04 | 14.3541 | 0.3105 | 4 | 80 | chemokine-mediated signaling pathway |
| GO:0050906 | 4e-04 | 5.0456 | 1.7895 | 8 | 461 | detection of stimulus involved in sensory perception |
| GO:0071316 | 4e-04 | 88.3115 | 0.0311 | 2 | 8 | cellular response to nicotine |
| GO:0006952 | 5e-04 | 3.1104 | 5.7876 | 15 | 1491 | defense response |
| GO:0002286 | 5e-04 | 12.2476 | 0.361 | 4 | 93 | T cell activation involved in immune response |
| GO:0071345 | 5e-04 | 3.7559 | 3.3887 | 11 | 873 | cellular response to cytokine stimulus |
| GO:0050911 | 6e-04 | 5.4421 | 1.4362 | 7 | 370 | detection of chemical stimulus involved in sensory perception of smell |
| GO:0001775 | 0.001 | 3.092 | 4.9181 | 13 | 1267 | cell activation |
| GO:0051707 | 0.0011 | 3.6053 | 3.1597 | 10 | 814 | response to other organism |
| GO:0048266 | 0.0011 | 48.155 | 0.0505 | 2 | 13 | behavioral response to pain |
| GO:0009607 | 0.0016 | 3.4085 | 3.3305 | 10 | 858 | response to biotic stimulus |
| GO:0032729 | 0.0016 | 14.1316 | 0.2329 | 3 | 60 | positive regulation of interferon-gamma production |
| GO:0009593 | 0.0017 | 4.4471 | 1.7429 | 7 | 449 | detection of chemical stimulus |
| GO:0007635 | 0.0019 | 35.3049 | 0.066 | 2 | 17 | chemosensory behavior |
| GO:0002521 | 0.002 | 4.3263 | 1.7895 | 7 | 461 | leukocyte differentiation |
| GO:0050877 | 0.0021 | 2.94 | 4.6969 | 12 | 1210 | nervous system process |
| GO:0007606 | 0.0021 | 4.2682 | 1.8128 | 7 | 467 | sensory perception of chemical stimulus |
| GO:0042742 | 0.0024 | 5.8193 | 0.9355 | 5 | 241 | defense response to bacterium |
| GO:0007186 | 0.0028 | 2.8324 | 4.8599 | 12 | 1252 | G-protein coupled receptor signaling pathway |
| GO:0016050 | 0.0031 | 4.57 | 1.4362 | 6 | 370 | vesicle organization |
| GO:0045672 | 0.0036 | 25.2084 | 0.0893 | 2 | 23 | positive regulation of osteoclast differentiation |
| GO:0002719 | 0.0039 | 24.0611 | 0.0932 | 2 | 24 | negative regulation of cytokine production involved in immune response |
| GO:0036314 | 0.0039 | 24.0611 | 0.0932 | 2 | 24 | response to sterol |
| GO:0002737 | 0.0039 | Inf | 0.0039 | 1 | 1 | negative regulation of plasmacytoid dendritic cell cytokine production |
| GO:0015728 | 0.0039 | Inf | 0.0039 | 1 | 1 | mevalonate transport |
| GO:0051780 | 0.0039 | Inf | 0.0039 | 1 | 1 | behavioral response to nutrient |
| GO:0061048 | 0.0039 | Inf | 0.0039 | 1 | 1 | negative regulation of branching involved in lung morphogenesis |
| GO:1901625 | 0.0039 | Inf | 0.0039 | 1 | 1 | cellular response to ergosterol |
| GO:2000011 | 0.0039 | Inf | 0.0039 | 1 | 1 | regulation of adaxial/abaxial pattern formation |
| GO:0071514 | 0.0045 | 22.0533 | 0.1009 | 2 | 26 | genetic imprinting |
| GO:0048534 | 0.0052 | 3.0487 | 3.2878 | 9 | 847 | hematopoietic or lymphoid organ development |
| GO:0043244 | 0.0055 | 9.0326 | 0.3571 | 3 | 92 | regulation of protein complex disassembly |
| GO:0090279 | 0.0072 | 17.0661 | 0.1281 | 2 | 33 | regulation of calcium ion import |
| GO:0030595 | 0.0074 | 5.5531 | 0.7725 | 4 | 199 | leukocyte chemotaxis |
| GO:0002698 | 0.0077 | 7.9535 | 0.4037 | 3 | 104 | negative regulation of immune effector process |
| GO:0002644 | 0.0077 | 260.7419 | 0.0078 | 1 | 2 | negative regulation of tolerance induction |
| GO:0002876 | 0.0077 | 260.7419 | 0.0078 | 1 | 2 | positive regulation of chronic inflammatory response to antigenic stimulus |
| GO:0019075 | 0.0077 | 260.7419 | 0.0078 | 1 | 2 | virus maturation |
| GO:0038155 | 0.0077 | 260.7419 | 0.0078 | 1 | 2 | interleukin-23-mediated signaling pathway |
| GO:0040030 | 0.0077 | 260.7419 | 0.0078 | 1 | 2 | regulation of molecular function, epigenetic |
| GO:0045994 | 0.0077 | 260.7419 | 0.0078 | 1 | 2 | positive regulation of translational initiation by iron |
| GO:0046373 | 0.0077 | 260.7419 | 0.0078 | 1 | 2 | L-arabinose metabolic process |
| GO:0060125 | 0.0077 | 260.7419 | 0.0078 | 1 | 2 | negative regulation of growth hormone secretion |
| GO:1901253 | 0.0077 | 260.7419 | 0.0078 | 1 | 2 | negative regulation of intracellular transport of viral material |
| GO:1901671 | 0.0077 | 260.7419 | 0.0078 | 1 | 2 | positive regulation of superoxide dismutase activity |
| GO:1904999 | 0.0077 | 260.7419 | 0.0078 | 1 | 2 | positive regulation of leukocyte adhesion to arterial endothelial cell |
| GO:2000334 | 0.0077 | 260.7419 | 0.0078 | 1 | 2 | positive regulation of blood microparticle formation |
| GO:0002700 | 0.0092 | 7.4347 | 0.4309 | 3 | 111 | regulation of production of molecular mediator of immune response |
| GO:0030183 | 0.0092 | 7.4347 | 0.4309 | 3 | 111 | B cell differentiation |
| GO:0007166 | 0.0094 | 2.0777 | 10.2011 | 18 | 2628 | cell surface receptor signaling pathway |
| GO:1903039 | 0.0094 | 5.1765 | 0.8268 | 4 | 213 | positive regulation of leukocyte cell-cell adhesion |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0050911 | 0 | 7.4393 | 1.573 | 10 | 370 | detection of chemical stimulus involved in sensory perception of smell |
| GO:0050906 | 0 | 6.6215 | 1.9599 | 11 | 461 | detection of stimulus involved in sensory perception |
| GO:0009593 | 0 | 6.07 | 1.9089 | 10 | 449 | detection of chemical stimulus |
| GO:0007606 | 0 | 5.8243 | 1.9854 | 10 | 467 | sensory perception of chemical stimulus |
| GO:0002407 | 2e-04 | 33.345 | 0.1063 | 3 | 25 | dendritic cell chemotaxis |
| GO:0007186 | 2e-04 | 3.3513 | 5.3227 | 15 | 1252 | G-protein coupled receptor signaling pathway |
| GO:0097527 | 3e-04 | 120.5746 | 0.0255 | 2 | 6 | necroptotic signaling pathway |
| GO:0006959 | 3e-04 | 7.1308 | 0.9311 | 6 | 219 | humoral immune response |
| GO:0070098 | 4e-04 | 13.0243 | 0.3401 | 4 | 80 | chemokine-mediated signaling pathway |
| GO:0002376 | 4e-04 | 2.5527 | 11.3512 | 23 | 2670 | immune system process |
| GO:0050877 | 5e-04 | 3.185 | 5.1442 | 14 | 1210 | nervous system process |
| GO:0071316 | 5e-04 | 80.3731 | 0.034 | 2 | 8 | cellular response to nicotine |
| GO:0072676 | 6e-04 | 11.5027 | 0.3826 | 4 | 90 | lymphocyte migration |
| GO:0072577 | 0.0011 | 16.2788 | 0.2041 | 3 | 48 | endothelial cell apoptotic process |
| GO:0034116 | 0.0011 | 48.2119 | 0.051 | 2 | 12 | positive regulation of heterotypic cell-cell adhesion |
| GO:0010623 | 0.0013 | 43.8263 | 0.0553 | 2 | 13 | programmed cell death involved in cell development |
| GO:0070374 | 0.0014 | 6.6022 | 0.8248 | 5 | 194 | positive regulation of ERK1 and ERK2 cascade |
| GO:0046325 | 0.0016 | 40.1716 | 0.0595 | 2 | 14 | negative regulation of glucose import |
| GO:0055074 | 0.0017 | 4.4487 | 1.7303 | 7 | 407 | calcium ion homeostasis |
| GO:0051480 | 0.0018 | 5.0697 | 1.2924 | 6 | 304 | regulation of cytosolic calcium ion concentration |
| GO:0072503 | 0.002 | 4.2944 | 1.7898 | 7 | 421 | cellular divalent inorganic cation homeostasis |
| GO:0023052 | 0.0021 | 2.0568 | 25.8187 | 38 | 6073 | signaling |
| GO:0043242 | 0.0021 | 12.8421 | 0.2551 | 3 | 60 | negative regulation of protein complex disassembly |
| GO:0007154 | 0.0023 | 2.0448 | 25.9122 | 38 | 6095 | cell communication |
| GO:0010469 | 0.0025 | 3.7015 | 2.385 | 8 | 561 | regulation of receptor activity |
| GO:1901879 | 0.0029 | 11.4325 | 0.2848 | 3 | 67 | regulation of protein depolymerization |
| GO:0002544 | 0.0036 | 25.3606 | 0.0893 | 2 | 21 | chronic inflammatory response |
| GO:0010818 | 0.0036 | 25.3606 | 0.0893 | 2 | 21 | T cell chemotaxis |
| GO:0071345 | 0.0037 | 3.0045 | 3.7115 | 10 | 873 | cellular response to cytokine stimulus |
| GO:0007032 | 0.0041 | 10.0174 | 0.3231 | 3 | 76 | endosome organization |
| GO:0002642 | 0.0043 | Inf | 0.0043 | 1 | 1 | positive regulation of immunoglobulin biosynthetic process |
| GO:0015728 | 0.0043 | Inf | 0.0043 | 1 | 1 | mevalonate transport |
| GO:0036145 | 0.0043 | Inf | 0.0043 | 1 | 1 | dendritic cell homeostasis |
| GO:0043143 | 0.0043 | Inf | 0.0043 | 1 | 1 | regulation of translation by machinery localization |
| GO:0051780 | 0.0043 | Inf | 0.0043 | 1 | 1 | behavioral response to nutrient |
| GO:0061048 | 0.0043 | Inf | 0.0043 | 1 | 1 | negative regulation of branching involved in lung morphogenesis |
| GO:1902204 | 0.0043 | Inf | 0.0043 | 1 | 1 | positive regulation of hepatocyte growth factor receptor signaling pathway |
| GO:1904155 | 0.0043 | Inf | 0.0043 | 1 | 1 | DN2 thymocyte differentiation |
| GO:1904156 | 0.0043 | Inf | 0.0043 | 1 | 1 | DN3 thymocyte differentiation |
| GO:2000011 | 0.0043 | Inf | 0.0043 | 1 | 1 | regulation of adaxial/abaxial pattern formation |
| GO:0046649 | 0.0043 | 3.3779 | 2.6018 | 8 | 612 | lymphocyte activation |
| GO:0008625 | 0.0046 | 9.6202 | 0.3359 | 3 | 79 | extrinsic apoptotic signaling pathway via death domain receptors |
| GO:0060326 | 0.005 | 4.8538 | 1.1096 | 5 | 261 | cell chemotaxis |
| GO:0006875 | 0.0052 | 3.5882 | 2.1257 | 7 | 500 | cellular metal ion homeostasis |
| GO:0071514 | 0.0054 | 20.0709 | 0.1105 | 2 | 26 | genetic imprinting |
| GO:0051716 | 0.0057 | 1.8997 | 29.071 | 40 | 6838 | cellular response to stimulus |
| GO:0002377 | 0.0062 | 8.5968 | 0.3741 | 3 | 88 | immunoglobulin production |
| GO:0042100 | 0.0064 | 8.4963 | 0.3784 | 3 | 89 | B cell proliferation |
| GO:0002286 | 0.0073 | 8.1167 | 0.3954 | 3 | 93 | T cell activation involved in immune response |
| GO:0002644 | 0.0085 | 237.6471 | 0.0085 | 1 | 2 | negative regulation of tolerance induction |
| GO:0002876 | 0.0085 | 237.6471 | 0.0085 | 1 | 2 | positive regulation of chronic inflammatory response to antigenic stimulus |
| GO:0019075 | 0.0085 | 237.6471 | 0.0085 | 1 | 2 | virus maturation |
| GO:0036345 | 0.0085 | 237.6471 | 0.0085 | 1 | 2 | platelet maturation |
| GO:0040030 | 0.0085 | 237.6471 | 0.0085 | 1 | 2 | regulation of molecular function, epigenetic |
| GO:0045994 | 0.0085 | 237.6471 | 0.0085 | 1 | 2 | positive regulation of translational initiation by iron |
| GO:0046373 | 0.0085 | 237.6471 | 0.0085 | 1 | 2 | L-arabinose metabolic process |
| GO:1901671 | 0.0085 | 237.6471 | 0.0085 | 1 | 2 | positive regulation of superoxide dismutase activity |
| GO:1904999 | 0.0085 | 237.6471 | 0.0085 | 1 | 2 | positive regulation of leukocyte adhesion to arterial endothelial cell |
| GO:2000334 | 0.0085 | 237.6471 | 0.0085 | 1 | 2 | positive regulation of blood microparticle formation |
| GO:2000458 | 0.0085 | 237.6471 | 0.0085 | 1 | 2 | regulation of astrocyte chemotaxis |
| GO:2001237 | 0.0086 | 7.6065 | 0.4209 | 3 | 99 | negative regulation of extrinsic apoptotic signaling pathway |
| GO:1903514 | 0.0086 | 15.532 | 0.1403 | 2 | 33 | release of sequestered calcium ion into cytosol by endoplasmic reticulum |
| GO:0006952 | 0.0093 | 2.3062 | 6.3388 | 13 | 1491 | defense response |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0007218 | 1e-04 | 6.9339 | 1.1121 | 7 | 95 | neuropeptide signaling pathway |
| GO:0048935 | 4e-04 | 25.7166 | 0.1522 | 3 | 13 | peripheral nervous system neuron development |
| GO:0043553 | 8e-04 | 85.3085 | 0.0468 | 2 | 4 | negative regulation of phosphatidylinositol 3-kinase activity |
| GO:0032502 | 0.0011 | 1.5842 | 68.1565 | 89 | 5822 | developmental process |
| GO:0045636 | 0.0013 | 56.8688 | 0.0585 | 2 | 5 | positive regulation of melanocyte differentiation |
| GO:0060012 | 0.0013 | 56.8688 | 0.0585 | 2 | 5 | synaptic transmission, glycinergic |
| GO:0060437 | 0.0013 | 56.8688 | 0.0585 | 2 | 5 | lung growth |
| GO:0010529 | 0.0013 | 16.0668 | 0.2224 | 3 | 19 | negative regulation of transposition |
| GO:0048557 | 0.0013 | 16.0668 | 0.2224 | 3 | 19 | embryonic digestive tract morphogenesis |
| GO:0099537 | 0.0015 | 2.4911 | 6.8718 | 16 | 587 | trans-synaptic signaling |
| GO:0007626 | 0.0017 | 3.873 | 2.2009 | 8 | 188 | locomotory behavior |
| GO:0007275 | 0.0024 | 1.5783 | 51.1577 | 69 | 4547 | multicellular organism development |
| GO:0042110 | 0.0024 | 2.6348 | 5.2446 | 13 | 448 | T cell activation |
| GO:0061053 | 0.0027 | 5.603 | 0.96 | 5 | 82 | somite development |
| GO:0001838 | 0.0029 | 4.5555 | 1.4048 | 6 | 120 | embryonic epithelial tube formation |
| GO:0007399 | 0.0031 | 1.7107 | 25.0875 | 39 | 2143 | nervous system development |
| GO:0007389 | 0.0032 | 2.6564 | 4.788 | 12 | 409 | pattern specification process |
| GO:0048568 | 0.0034 | 2.6427 | 4.8115 | 12 | 411 | embryonic organ development |
| GO:0001501 | 0.0041 | 2.471 | 5.5724 | 13 | 476 | skeletal system development |
| GO:0035282 | 0.0045 | 4.9559 | 1.077 | 5 | 92 | segmentation |
| GO:0048704 | 0.0045 | 4.9559 | 1.077 | 5 | 92 | embryonic skeletal system morphogenesis |
| GO:0014807 | 0.0046 | 24.3663 | 0.1054 | 2 | 9 | regulation of somitogenesis |
| GO:0048087 | 0.0046 | 24.3663 | 0.1054 | 2 | 9 | positive regulation of developmental pigmentation |
| GO:0050932 | 0.0046 | 24.3663 | 0.1054 | 2 | 9 | regulation of pigment cell differentiation |
| GO:0040036 | 0.0051 | 9.5146 | 0.3512 | 3 | 30 | regulation of fibroblast growth factor receptor signaling pathway |
| GO:0070286 | 0.0051 | 9.5146 | 0.3512 | 3 | 30 | axonemal dynein complex assembly |
| GO:0043009 | 0.0051 | 2.3143 | 6.4036 | 14 | 547 | chordate embryonic development |
| GO:0030198 | 0.0051 | 2.7644 | 3.8164 | 10 | 326 | extracellular matrix organization |
| GO:0009954 | 0.0056 | 9.1742 | 0.3629 | 3 | 31 | proximal/distal pattern formation |
| GO:0003211 | 0.0058 | 21.3191 | 0.1171 | 2 | 10 | cardiac ventricle formation |
| GO:0006821 | 0.0061 | 4.5848 | 1.159 | 5 | 99 | chloride transport |
| GO:0035148 | 0.0063 | 3.8418 | 1.6506 | 6 | 141 | tube formation |
| GO:0035107 | 0.0072 | 3.7303 | 1.6975 | 6 | 145 | appendage morphogenesis |
| GO:0048598 | 0.0075 | 2.207 | 6.6962 | 14 | 572 | embryonic morphogenesis |
| GO:0007268 | 0.0077 | 2.1993 | 6.7205 | 14 | 580 | chemical synaptic transmission |
| GO:0009952 | 0.0082 | 3.2253 | 2.2828 | 7 | 195 | anterior/posterior pattern specification |
| GO:0060536 | 0.0083 | 17.0532 | 0.1405 | 2 | 12 | cartilage morphogenesis |
| GO:0035137 | 0.0085 | 7.7817 | 0.4214 | 3 | 36 | hindlimb morphogenesis |
| GO:0040019 | 0.0085 | 7.7817 | 0.4214 | 3 | 36 | positive regulation of embryonic development |
| GO:0007156 | 0.009 | 3.5499 | 1.7794 | 6 | 152 | homophilic cell adhesion via plasma membrane adhesion molecules |
| GO:0007519 | 0.009 | 3.5499 | 1.7794 | 6 | 152 | skeletal muscle tissue development |
| GO:0031274 | 0.0098 | 15.5019 | 0.1522 | 2 | 13 | positive regulation of pseudopodium assembly |
| GO:1905205 | 0.0098 | 15.5019 | 0.1522 | 2 | 13 | positive regulation of connective tissue replacement |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0016199 | 0 | 136.7812 | 0.0551 | 3 | 5 | axon midline choice point recognition |
| GO:0008038 | 0 | 17.0541 | 0.3529 | 5 | 32 | neuron recognition |
| GO:0099537 | 1e-04 | 3.042 | 6.474 | 18 | 587 | trans-synaptic signaling |
| GO:0050925 | 1e-04 | Inf | 0.0221 | 2 | 2 | negative regulation of negative chemotaxis |
| GO:0072272 | 1e-04 | Inf | 0.0221 | 2 | 2 | proximal/distal pattern formation involved in metanephric nephron development |
| GO:0019098 | 3e-04 | 14.0879 | 0.3309 | 4 | 30 | reproductive behavior |
| GO:0007417 | 5e-04 | 2.4098 | 9.4849 | 21 | 860 | central nervous system development |
| GO:0007379 | 5e-04 | 22.7827 | 0.1654 | 3 | 15 | segment specification |
| GO:0006933 | 7e-04 | 90.6723 | 0.0441 | 2 | 4 | negative regulation of cell adhesion involved in substrate-bound cell migration |
| GO:0007621 | 7e-04 | 90.6723 | 0.0441 | 2 | 4 | negative regulation of female receptivity |
| GO:0033600 | 7e-04 | 90.6723 | 0.0441 | 2 | 4 | negative regulation of mammary gland epithelial cell proliferation |
| GO:0072086 | 7e-04 | 90.6723 | 0.0441 | 2 | 4 | specification of loop of Henle identity |
| GO:2000648 | 8e-04 | 10.7677 | 0.4191 | 4 | 38 | positive regulation of stem cell proliferation |
| GO:0072488 | 8e-04 | 19.5256 | 0.1875 | 3 | 17 | ammonium transmembrane transport |
| GO:0072079 | 0.0011 | 17.0827 | 0.2096 | 3 | 19 | nephron tubule formation |
| GO:0071502 | 0.0012 | 60.4444 | 0.0551 | 2 | 5 | cellular response to temperature stimulus |
| GO:1903232 | 0.0012 | 60.4444 | 0.0551 | 2 | 5 | melanosome assembly |
| GO:0048812 | 0.0013 | 2.6122 | 6.1542 | 15 | 558 | neuron projection morphogenesis |
| GO:0045597 | 0.0015 | 2.2467 | 9.6062 | 20 | 871 | positive regulation of cell differentiation |
| GO:0009712 | 0.0016 | 8.7124 | 0.5073 | 4 | 46 | catechol-containing compound metabolic process |
| GO:0021891 | 0.0018 | 45.3305 | 0.0662 | 2 | 6 | olfactory bulb interneuron development |
| GO:0032229 | 0.0018 | 45.3305 | 0.0662 | 2 | 6 | negative regulation of synaptic transmission, GABAergic |
| GO:0048858 | 0.0018 | 2.5301 | 6.3417 | 15 | 575 | cell projection morphogenesis |
| GO:1903530 | 0.0021 | 2.4147 | 7.0916 | 16 | 643 | regulation of secretion by cell |
| GO:0021879 | 0.0021 | 8.13 | 0.5404 | 4 | 49 | forebrain neuron differentiation |
| GO:0035385 | 0.0024 | 36.2621 | 0.0772 | 2 | 7 | Roundabout signaling pathway |
| GO:0048539 | 0.0024 | 36.2621 | 0.0772 | 2 | 7 | bone marrow development |
| GO:0007267 | 0.0025 | 1.8866 | 16.775 | 29 | 1521 | cell-cell signaling |
| GO:0007155 | 0.0026 | 1.9461 | 14.5031 | 26 | 1315 | cell adhesion |
| GO:0036065 | 0.0028 | 11.8785 | 0.2868 | 3 | 26 | fucosylation |
| GO:0007411 | 0.0031 | 3.4953 | 2.4264 | 8 | 220 | axon guidance |
| GO:0006836 | 0.0031 | 3.8945 | 1.908 | 7 | 173 | neurotransmitter transport |
| GO:0048791 | 0.0032 | 11.3828 | 0.2978 | 3 | 27 | calcium ion-regulated exocytosis of neurotransmitter |
| GO:0007268 | 0.0032 | 2.6592 | 4.7951 | 12 | 446 | chemical synaptic transmission |
| GO:0021859 | 0.0032 | 30.2166 | 0.0882 | 2 | 8 | pyramidal neuron differentiation |
| GO:0048667 | 0.0038 | 2.4923 | 5.5365 | 13 | 502 | cell morphogenesis involved in neuron differentiation |
| GO:0060180 | 0.0041 | 25.8983 | 0.0993 | 2 | 9 | female mating behavior |
| GO:0061004 | 0.0041 | 25.8983 | 0.0993 | 2 | 9 | pattern specification involved in kidney development |
| GO:0006811 | 0.0043 | 1.8243 | 16.6427 | 28 | 1509 | ion transport |
| GO:0051960 | 0.0044 | 2.1651 | 8.371 | 17 | 759 | regulation of nervous system development |
| GO:0099531 | 0.0044 | 4.1509 | 1.533 | 6 | 139 | presynaptic process involved in chemical synaptic transmission |
| GO:0050769 | 0.0046 | 2.6572 | 4.3785 | 11 | 397 | positive regulation of neurogenesis |
| GO:0061025 | 0.0047 | 3.2467 | 2.6028 | 8 | 236 | membrane fusion |
| GO:0035646 | 0.0051 | 22.6596 | 0.1103 | 2 | 10 | endosome to melanosome transport |
| GO:0042415 | 0.0051 | 22.6596 | 0.1103 | 2 | 10 | norepinephrine metabolic process |
| GO:0048757 | 0.0051 | 22.6596 | 0.1103 | 2 | 10 | pigment granule maturation |
| GO:0048864 | 0.0054 | 6.0918 | 0.7059 | 4 | 64 | stem cell development |
| GO:0021954 | 0.0057 | 5.9916 | 0.7169 | 4 | 65 | central nervous system neuron development |
| GO:0009886 | 0.0062 | 20.1406 | 0.1213 | 2 | 11 | post-embryonic animal morphogenesis |
| GO:0043476 | 0.0062 | 20.1406 | 0.1213 | 2 | 11 | pigment accumulation |
| GO:0050713 | 0.0062 | 20.1406 | 0.1213 | 2 | 11 | negative regulation of interleukin-1 beta secretion |
| GO:0032879 | 0.0063 | 1.6173 | 27.9253 | 41 | 2532 | regulation of localization |
| GO:0071805 | 0.0066 | 3.3616 | 2.1948 | 7 | 199 | potassium ion transmembrane transport |
| GO:0006906 | 0.0068 | 3.7782 | 1.6764 | 6 | 152 | vesicle fusion |
| GO:0007156 | 0.0068 | 3.7782 | 1.6764 | 6 | 152 | homophilic cell adhesion via plasma membrane adhesion molecules |
| GO:0060284 | 0.007 | 2.0573 | 8.7791 | 17 | 796 | regulation of cell development |
| GO:0030182 | 0.0071 | 1.8513 | 13.312 | 23 | 1207 | neuron differentiation |
| GO:0099504 | 0.0072 | 4.4062 | 1.2022 | 5 | 109 | synaptic vesicle cycle |
| GO:0014003 | 0.0072 | 8.2738 | 0.397 | 3 | 36 | oligodendrocyte development |
| GO:0002031 | 0.0074 | 18.1254 | 0.1323 | 2 | 12 | G-protein coupled receptor internalization |
| GO:0046903 | 0.0076 | 1.7567 | 16.5545 | 27 | 1501 | secretion |
| GO:0015695 | 0.0078 | 8.0299 | 0.4081 | 3 | 37 | organic cation transport |
| GO:0050772 | 0.0078 | 5.453 | 0.7831 | 4 | 71 | positive regulation of axonogenesis |
| GO:0015844 | 0.0082 | 5.3724 | 0.7941 | 4 | 72 | monoamine transport |
| GO:0007618 | 0.0084 | 7.8 | 0.4191 | 3 | 38 | mating |
| GO:0051952 | 0.0095 | 5.1445 | 0.8272 | 4 | 75 | regulation of amine transport |
| GO:0045598 | 0.0096 | 4.0894 | 1.2904 | 5 | 117 | regulation of fat cell differentiation |
| GO:0015872 | 0.0097 | 7.3775 | 0.4412 | 3 | 40 | dopamine transport |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0050777 | 4e-04 | 5.657 | 1.3407 | 7 | 128 | negative regulation of immune response |
| GO:0043570 | 6e-04 | 95.5833 | 0.0419 | 2 | 4 | maintenance of DNA repeat elements |
| GO:0002698 | 8e-04 | 5.9589 | 1.0893 | 6 | 104 | negative regulation of immune effector process |
| GO:1904837 | 0.001 | 10.1598 | 0.4399 | 4 | 42 | beta-catenin-TCF complex assembly |
| GO:0010718 | 0.0012 | 9.4146 | 0.4713 | 4 | 45 | positive regulation of epithelial to mesenchymal transition |
| GO:0042373 | 0.0016 | 47.7857 | 0.0628 | 2 | 6 | vitamin K metabolic process |
| GO:0045590 | 0.0016 | 47.7857 | 0.0628 | 2 | 6 | negative regulation of regulatory T cell differentiation |
| GO:0045123 | 0.0018 | 8.3887 | 0.5237 | 4 | 50 | cellular extravasation |
| GO:1901570 | 0.0021 | 5.9779 | 0.9008 | 5 | 86 | fatty acid derivative biosynthetic process |
| GO:0032667 | 0.0029 | 31.8532 | 0.0838 | 2 | 8 | regulation of interleukin-23 production |
| GO:0043114 | 0.0037 | 10.6673 | 0.3142 | 3 | 30 | regulation of vascular permeability |
| GO:1901750 | 0.0037 | 27.301 | 0.0943 | 2 | 9 | leukotriene D4 biosynthetic process |
| GO:0006751 | 0.0046 | 23.8869 | 0.1047 | 2 | 10 | glutathione catabolic process |
| GO:0072537 | 0.0046 | 23.8869 | 0.1047 | 2 | 10 | fibroblast activation |
| GO:0006690 | 0.0047 | 4.8855 | 1.0893 | 5 | 104 | icosanoid metabolic process |
| GO:0002695 | 0.0048 | 4.0722 | 1.5607 | 6 | 149 | negative regulation of leukocyte activation |
| GO:0003413 | 0.0056 | 21.2315 | 0.1152 | 2 | 11 | chondrocyte differentiation involved in endochondral bone morphogenesis |
| GO:0032700 | 0.0056 | 21.2315 | 0.1152 | 2 | 11 | negative regulation of interleukin-17 production |
| GO:0042398 | 0.0078 | 7.996 | 0.4085 | 3 | 39 | cellular modified amino acid biosynthetic process |
| GO:0032736 | 0.0091 | 15.9206 | 0.1466 | 2 | 14 | positive regulation of interleukin-13 production |
| GO:0060312 | 0.0091 | 15.9206 | 0.1466 | 2 | 14 | regulation of blood vessel remodeling |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0019864 | 0.0028 | 31.1085 | 0.0809 | 2 | 10 | IgG binding |
| GO:0031406 | 0.0031 | 4.4866 | 1.424 | 6 | 176 | carboxylic acid binding |
| GO:0050786 | 0.0034 | 27.6503 | 0.089 | 2 | 11 | RAGE receptor binding |
| GO:0002020 | 0.004 | 5.0998 | 1.0437 | 5 | 129 | protease binding |
| GO:0004152 | 0.0081 | Inf | 0.0081 | 1 | 1 | dihydroorotate dehydrogenase activity |
| GO:0004336 | 0.0081 | Inf | 0.0081 | 1 | 1 | galactosylceramidase activity |
| GO:0005130 | 0.0081 | Inf | 0.0081 | 1 | 1 | granulocyte colony-stimulating factor receptor binding |
| GO:0005353 | 0.0081 | Inf | 0.0081 | 1 | 1 | fructose transmembrane transporter activity |
| GO:0008120 | 0.0081 | Inf | 0.0081 | 1 | 1 | ceramide glucosyltransferase activity |
| GO:0030272 | 0.0081 | Inf | 0.0081 | 1 | 1 | 5-formyltetrahydrofolate cyclo-ligase activity |
| GO:0030294 | 0.0081 | Inf | 0.0081 | 1 | 1 | receptor signaling protein tyrosine kinase inhibitor activity |
| GO:0031962 | 0.0081 | Inf | 0.0081 | 1 | 1 | mineralocorticoid receptor binding |
| GO:0036470 | 0.0081 | Inf | 0.0081 | 1 | 1 | tyrosine 3-monooxygenase activator activity |
| GO:0036478 | 0.0081 | Inf | 0.0081 | 1 | 1 | L-dopa decarboxylase activator activity |
| GO:0036524 | 0.0081 | Inf | 0.0081 | 1 | 1 | protein deglycase activity |
| GO:0045340 | 0.0081 | Inf | 0.0081 | 1 | 1 | mercury ion binding |
| GO:0055103 | 0.0081 | Inf | 0.0081 | 1 | 1 | ligase regulator activity |
| GO:0070012 | 0.0081 | Inf | 0.0081 | 1 | 1 | oligopeptidase activity |
| GO:0102769 | 0.0081 | Inf | 0.0081 | 1 | 1 | dihydroceramide glucosyltransferase activity |
| GO:1990175 | 0.0081 | Inf | 0.0081 | 1 | 1 | EH domain binding |
| GO:1990698 | 0.0081 | Inf | 0.0081 | 1 | 1 | palmitoleoyltransferase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0031406 | 5e-04 | 5.4408 | 1.3914 | 7 | 176 | carboxylic acid binding |
| GO:0005504 | 0.0012 | 16.039 | 0.2135 | 3 | 27 | fatty acid binding |
| GO:0050786 | 0.0033 | 28.3139 | 0.087 | 2 | 11 | RAGE receptor binding |
| GO:0002020 | 0.0036 | 5.2252 | 1.0198 | 5 | 129 | protease binding |
| GO:0005215 | 0.0039 | 2.0821 | 10.5303 | 20 | 1332 | transporter activity |
| GO:0004152 | 0.0079 | Inf | 0.0079 | 1 | 1 | dihydroorotate dehydrogenase activity |
| GO:0004336 | 0.0079 | Inf | 0.0079 | 1 | 1 | galactosylceramidase activity |
| GO:0005130 | 0.0079 | Inf | 0.0079 | 1 | 1 | granulocyte colony-stimulating factor receptor binding |
| GO:0005353 | 0.0079 | Inf | 0.0079 | 1 | 1 | fructose transmembrane transporter activity |
| GO:0008120 | 0.0079 | Inf | 0.0079 | 1 | 1 | ceramide glucosyltransferase activity |
| GO:0030272 | 0.0079 | Inf | 0.0079 | 1 | 1 | 5-formyltetrahydrofolate cyclo-ligase activity |
| GO:0030294 | 0.0079 | Inf | 0.0079 | 1 | 1 | receptor signaling protein tyrosine kinase inhibitor activity |
| GO:0036470 | 0.0079 | Inf | 0.0079 | 1 | 1 | tyrosine 3-monooxygenase activator activity |
| GO:0036478 | 0.0079 | Inf | 0.0079 | 1 | 1 | L-dopa decarboxylase activator activity |
| GO:0036524 | 0.0079 | Inf | 0.0079 | 1 | 1 | protein deglycase activity |
| GO:0039552 | 0.0079 | Inf | 0.0079 | 1 | 1 | RIG-I binding |
| GO:0045340 | 0.0079 | Inf | 0.0079 | 1 | 1 | mercury ion binding |
| GO:0055103 | 0.0079 | Inf | 0.0079 | 1 | 1 | ligase regulator activity |
| GO:0102769 | 0.0079 | Inf | 0.0079 | 1 | 1 | dihydroceramide glucosyltransferase activity |
| GO:1990175 | 0.0079 | Inf | 0.0079 | 1 | 1 | EH domain binding |
| GO:1990698 | 0.0079 | Inf | 0.0079 | 1 | 1 | palmitoleoyltransferase activity |
| GO:0004869 | 0.0099 | 7.2498 | 0.4427 | 3 | 56 | cysteine-type endopeptidase inhibitor activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0042288 | 0.0027 | 12.5346 | 0.2857 | 3 | 18 | MHC class I protein binding |
| GO:0016427 | 0.0036 | 31.2353 | 0.0952 | 2 | 6 | tRNA (cytosine) methyltransferase activity |
| GO:0004601 | 0.0036 | 6.982 | 0.6349 | 4 | 40 | peroxidase activity |
| GO:0046332 | 0.0051 | 4.844 | 1.1111 | 5 | 70 | SMAD binding |
| GO:0004126 | 0.0066 | 20.8209 | 0.127 | 2 | 8 | cytidine deaminase activity |
| GO:0004364 | 0.0078 | 8.1707 | 0.4127 | 3 | 26 | glutathione transferase activity |
| GO:0003691 | 0.0084 | 17.8454 | 0.1429 | 2 | 9 | double-stranded telomeric DNA binding |
| GO:0003924 | 0.01 | 2.4893 | 4.2063 | 10 | 265 | GTPase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0005547 | 0.0018 | 8.6238 | 0.525 | 4 | 34 | phosphatidylinositol-3,4,5-trisphosphate binding |
| GO:0016427 | 0.0034 | 32.131 | 0.0926 | 2 | 6 | tRNA (cytosine) methyltransferase activity |
| GO:0043325 | 0.0051 | 9.6686 | 0.3551 | 3 | 23 | phosphatidylinositol-3,4-bisphosphate binding |
| GO:0008013 | 0.0057 | 4.6945 | 1.1426 | 5 | 74 | beta-catenin binding |
| GO:0004126 | 0.0063 | 21.418 | 0.1235 | 2 | 8 | cytidine deaminase activity |
| GO:0008066 | 0.0073 | 8.4059 | 0.4015 | 3 | 26 | glutamate receptor activity |
| GO:0003691 | 0.008 | 18.3571 | 0.139 | 2 | 9 | double-stranded telomeric DNA binding |
| GO:0070016 | 0.0098 | 16.0615 | 0.1544 | 2 | 10 | armadillo repeat domain binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0048020 | 0 | 23.3707 | 0.2553 | 5 | 39 | CCR chemokine receptor binding |
| GO:0008009 | 0 | 18.4688 | 0.3142 | 5 | 48 | chemokine activity |
| GO:0032394 | 0 | Inf | 0.0131 | 2 | 2 | MHC class Ib receptor activity |
| GO:0030246 | 1e-04 | 5.8531 | 1.7022 | 9 | 260 | carbohydrate binding |
| GO:0042288 | 2e-04 | 31.2039 | 0.1178 | 3 | 18 | MHC class I protein binding |
| GO:0016427 | 6e-04 | 77.3125 | 0.0393 | 2 | 6 | tRNA (cytosine) methyltransferase activity |
| GO:0001055 | 0.0022 | 34.3504 | 0.072 | 2 | 11 | RNA polymerase II activity |
| GO:0016705 | 0.0031 | 5.4421 | 0.982 | 5 | 150 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen |
| GO:0004497 | 0.0031 | 7.1288 | 0.6023 | 4 | 92 | monooxygenase activity |
| GO:0008173 | 0.0062 | 8.6467 | 0.3732 | 3 | 57 | RNA methyltransferase activity |
| GO:0004034 | 0.0065 | Inf | 0.0065 | 1 | 1 | aldose 1-epimerase activity |
| GO:0005133 | 0.0065 | Inf | 0.0065 | 1 | 1 | interferon-gamma receptor binding |
| GO:0035375 | 0.0065 | Inf | 0.0065 | 1 | 1 | zymogen binding |
| GO:0035757 | 0.0065 | Inf | 0.0065 | 1 | 1 | chemokine (C-C motif) ligand 19 binding |
| GO:0035758 | 0.0065 | Inf | 0.0065 | 1 | 1 | chemokine (C-C motif) ligand 21 binding |
| GO:0038117 | 0.0065 | Inf | 0.0065 | 1 | 1 | C-C motif chemokine 19 receptor activity |
| GO:0038121 | 0.0065 | Inf | 0.0065 | 1 | 1 | C-C motif chemokine 21 receptor activity |
| GO:0047042 | 0.0065 | Inf | 0.0065 | 1 | 1 | androsterone dehydrogenase (B-specific) activity |
| GO:0050528 | 0.0065 | Inf | 0.0065 | 1 | 1 | acyloxyacyl hydrolase activity |
| GO:0102116 | 0.0065 | Inf | 0.0065 | 1 | 1 | laurate hydroxylase activity |
| GO:0103002 | 0.0065 | Inf | 0.0065 | 1 | 1 | 16-hydroxypalmitate dehydrogenase activity |
| GO:0001664 | 0.007 | 3.7698 | 1.6891 | 6 | 258 | G-protein coupled receptor binding |
| GO:0019956 | 0.009 | 15.4471 | 0.144 | 2 | 22 | chemokine binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0016494 | 0.0018 | 42.7573 | 0.0657 | 2 | 7 | C-X-C chemokine receptor activity |
| GO:0005102 | 0.0021 | 2.0203 | 13.6031 | 25 | 1449 | receptor binding |
| GO:0016840 | 0.003 | 30.5371 | 0.0845 | 2 | 9 | carbon-nitrogen lyase activity |
| GO:0004888 | 0.0032 | 2.0677 | 11.0308 | 21 | 1175 | transmembrane signaling receptor activity |
| GO:0004871 | 0.0034 | 1.9166 | 14.8799 | 26 | 1585 | signal transducer activity |
| GO:0048020 | 0.0058 | 8.9502 | 0.3661 | 3 | 39 | CCR chemokine receptor binding |
| GO:0008528 | 0.0059 | 4.6288 | 1.1453 | 5 | 122 | G-protein coupled peptide receptor activity |
| GO:0019842 | 0.0074 | 4.3655 | 1.211 | 5 | 129 | vitamin binding |
| GO:0001716 | 0.0094 | Inf | 0.0094 | 1 | 1 | L-amino-acid oxidase activity |
| GO:0004397 | 0.0094 | Inf | 0.0094 | 1 | 1 | histidine ammonia-lyase activity |
| GO:0004979 | 0.0094 | Inf | 0.0094 | 1 | 1 | beta-endorphin receptor activity |
| GO:0005142 | 0.0094 | Inf | 0.0094 | 1 | 1 | interleukin-11 receptor binding |
| GO:0008555 | 0.0094 | Inf | 0.0094 | 1 | 1 | chloride-transporting ATPase activity |
| GO:0016517 | 0.0094 | Inf | 0.0094 | 1 | 1 | interleukin-12 receptor activity |
| GO:0019969 | 0.0094 | Inf | 0.0094 | 1 | 1 | interleukin-10 binding |
| GO:0031768 | 0.0094 | Inf | 0.0094 | 1 | 1 | ghrelin receptor binding |
| GO:0038047 | 0.0094 | Inf | 0.0094 | 1 | 1 | morphine receptor activity |
| GO:0042007 | 0.0094 | Inf | 0.0094 | 1 | 1 | interleukin-18 binding |
| GO:0047042 | 0.0094 | Inf | 0.0094 | 1 | 1 | androsterone dehydrogenase (B-specific) activity |
| GO:0050459 | 0.0094 | Inf | 0.0094 | 1 | 1 | ethanolamine-phosphate phospho-lyase activity |
| GO:0097260 | 0.0094 | Inf | 0.0094 | 1 | 1 | eoxin A4 synthase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0019966 | 0.002 | 37.6112 | 0.0689 | 2 | 9 | interleukin-1 binding |
| GO:0004984 | 0.0076 | 2.992 | 2.8337 | 8 | 370 | olfactory receptor activity |
| GO:0001631 | 0.0077 | Inf | 0.0077 | 1 | 1 | cysteinyl leukotriene receptor activity |
| GO:0001716 | 0.0077 | Inf | 0.0077 | 1 | 1 | L-amino-acid oxidase activity |
| GO:0004489 | 0.0077 | Inf | 0.0077 | 1 | 1 | methylenetetrahydrofolate reductase (NAD(P)H) activity |
| GO:0004588 | 0.0077 | Inf | 0.0077 | 1 | 1 | orotate phosphoribosyltransferase activity |
| GO:0004590 | 0.0077 | Inf | 0.0077 | 1 | 1 | orotidine-5'-phosphate decarboxylase activity |
| GO:0052591 | 0.0077 | Inf | 0.0077 | 1 | 1 | sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity |
| GO:0004869 | 0.009 | 7.4913 | 0.4289 | 3 | 56 | cysteine-type endopeptidase inhibitor activity |
| GO:0061135 | 0.0097 | 4.0743 | 1.2943 | 5 | 169 | endopeptidase regulator activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0022803 | 1e-04 | 3.6287 | 4.5317 | 15 | 442 | passive transmembrane transporter activity |
| GO:0022836 | 1e-04 | 4.0983 | 3.1886 | 12 | 311 | gated channel activity |
| GO:0022838 | 1e-04 | 3.6164 | 4.2241 | 14 | 412 | substrate-specific channel activity |
| GO:0005244 | 1e-04 | 5.1035 | 1.9172 | 9 | 187 | voltage-gated ion channel activity |
| GO:0005261 | 3e-04 | 3.8238 | 3.1065 | 11 | 303 | cation channel activity |
| GO:0005249 | 3e-04 | 7.0324 | 0.933 | 6 | 91 | voltage-gated potassium channel activity |
| GO:0022890 | 0.001 | 2.7963 | 5.3826 | 14 | 525 | inorganic cation transmembrane transporter activity |
| GO:0015079 | 0.0011 | 4.6909 | 1.5994 | 7 | 156 | potassium ion transmembrane transporter activity |
| GO:0005509 | 0.0012 | 2.5517 | 6.7565 | 16 | 659 | calcium ion binding |
| GO:0015075 | 0.0021 | 2.2845 | 8.4892 | 18 | 828 | ion transmembrane transporter activity |
| GO:1904680 | 0.0026 | 12.2707 | 0.2768 | 3 | 27 | peptide transmembrane transporter activity |
| GO:0015450 | 0.0028 | 32.5589 | 0.082 | 2 | 8 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity |
| GO:0022892 | 0.0037 | 2.0364 | 11.1241 | 21 | 1085 | substrate-specific transporter activity |
| GO:0005283 | 0.0064 | 19.5305 | 0.123 | 2 | 12 | sodium:amino acid symporter activity |
| GO:0005245 | 0.0069 | 8.4084 | 0.3896 | 3 | 38 | voltage-gated calcium channel activity |
| GO:0008528 | 0.0084 | 4.2225 | 1.2508 | 5 | 122 | G-protein coupled peptide receptor activity |
| GO:0004659 | 0.0088 | 16.2734 | 0.1435 | 2 | 14 | prenyltransferase activity |
| GO:0004953 | 0.0088 | 16.2734 | 0.1435 | 2 | 14 | icosanoid receptor activity |
| GO:0003700 | 0.0094 | 1.8576 | 12.0981 | 21 | 1180 | DNA binding transcription factor activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0030246 | 0 | 5.4048 | 2.8905 | 14 | 260 | carbohydrate binding |
| GO:0048020 | 0 | 16.6959 | 0.4336 | 6 | 39 | CCR chemokine receptor binding |
| GO:0005126 | 0 | 4.4849 | 2.9238 | 12 | 263 | cytokine receptor binding |
| GO:0045028 | 2e-04 | 38.7506 | 0.1112 | 3 | 10 | G-protein coupled purinergic nucleotide receptor activity |
| GO:0071723 | 2e-04 | 38.7506 | 0.1112 | 3 | 10 | lipopeptide binding |
| GO:0016502 | 8e-04 | 19.3668 | 0.189 | 3 | 17 | nucleotide receptor activity |
| GO:0019863 | 0.0012 | 59.9551 | 0.0556 | 2 | 5 | IgE binding |
| GO:0030883 | 0.0012 | 59.9551 | 0.0556 | 2 | 5 | endogenous lipid antigen binding |
| GO:0030884 | 0.0012 | 59.9551 | 0.0556 | 2 | 5 | exogenous lipid antigen binding |
| GO:0035586 | 0.0016 | 15.0593 | 0.2335 | 3 | 21 | purinergic receptor activity |
| GO:0008009 | 0.002 | 8.2474 | 0.5336 | 4 | 48 | chemokine activity |
| GO:0004872 | 0.002 | 1.9141 | 16.5536 | 29 | 1489 | receptor activity |
| GO:0001664 | 0.0024 | 3.3316 | 2.8683 | 9 | 258 | G-protein coupled receptor binding |
| GO:0042608 | 0.0025 | 35.9685 | 0.0778 | 2 | 7 | T cell receptor binding |
| GO:0001637 | 0.0026 | 12.3182 | 0.2779 | 3 | 25 | G-protein coupled chemoattractant receptor activity |
| GO:0004126 | 0.0033 | 29.9719 | 0.0889 | 2 | 8 | cytidine deaminase activity |
| GO:0030881 | 0.0042 | 25.6886 | 0.1001 | 2 | 9 | beta-2-microglobulin binding |
| GO:0052650 | 0.0042 | 25.6886 | 0.1001 | 2 | 9 | NADP-retinol dehydrogenase activity |
| GO:0097001 | 0.0052 | 22.4761 | 0.1112 | 2 | 10 | ceramide binding |
| GO:0005068 | 0.0063 | 19.9775 | 0.1223 | 2 | 11 | transmembrane receptor protein tyrosine kinase adaptor activity |
| GO:0016493 | 0.0075 | 17.9787 | 0.1334 | 2 | 12 | C-C chemokine receptor activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0030246 | 0 | 5.7549 | 2.7299 | 14 | 260 | carbohydrate binding |
| GO:0048020 | 1e-04 | 14.2487 | 0.4095 | 5 | 39 | CCR chemokine receptor binding |
| GO:0005126 | 1e-04 | 4.3291 | 2.7614 | 11 | 263 | cytokine receptor binding |
| GO:0071723 | 1e-04 | 41.0967 | 0.105 | 3 | 10 | lipopeptide binding |
| GO:0019863 | 0.0011 | 63.5635 | 0.0525 | 2 | 5 | IgE binding |
| GO:0030883 | 0.0011 | 63.5635 | 0.0525 | 2 | 5 | endogenous lipid antigen binding |
| GO:0030884 | 0.0011 | 63.5635 | 0.0525 | 2 | 5 | exogenous lipid antigen binding |
| GO:0004872 | 0.0015 | 3.6128 | 2.669 | 9 | 270 | receptor activity |
| GO:0008528 | 0.0018 | 5.0163 | 1.281 | 6 | 122 | G-protein coupled peptide receptor activity |
| GO:0042608 | 0.0022 | 38.1333 | 0.0735 | 2 | 7 | T cell receptor binding |
| GO:0004126 | 0.0029 | 31.7758 | 0.084 | 2 | 8 | cytidine deaminase activity |
| GO:0030881 | 0.0038 | 27.2347 | 0.0945 | 2 | 9 | beta-2-microglobulin binding |
| GO:0052650 | 0.0038 | 27.2347 | 0.0945 | 2 | 9 | NADP-retinol dehydrogenase activity |
| GO:0045028 | 0.0047 | 23.8289 | 0.105 | 2 | 10 | G-protein coupled purinergic nucleotide receptor activity |
| GO:0097001 | 0.0047 | 23.8289 | 0.105 | 2 | 10 | ceramide binding |
| GO:0005068 | 0.0057 | 21.1799 | 0.1155 | 2 | 11 | transmembrane receptor protein tyrosine kinase adaptor activity |
| GO:0001664 | 0.006 | 3.1153 | 2.7089 | 8 | 258 | G-protein coupled receptor binding |
| GO:0016493 | 0.0068 | 19.0607 | 0.126 | 2 | 12 | C-C chemokine receptor activity |
| GO:0004950 | 0.0078 | 17.5246 | 0.135 | 2 | 13 | chemokine receptor activity |
| GO:0005125 | 0.0079 | 3.249 | 2.2679 | 7 | 216 | cytokine activity |
| GO:0099600 | 0.0088 | 1.8409 | 12.7991 | 22 | 1219 | transmembrane receptor activity |
| GO:0015144 | 0.0097 | 7.3616 | 0.441 | 3 | 42 | carbohydrate transmembrane transporter activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0048020 | 0 | 20.7948 | 0.3517 | 6 | 39 | CCR chemokine receptor binding |
| GO:0008061 | 0 | 67.3007 | 0.0721 | 3 | 8 | chitin binding |
| GO:0008009 | 1e-04 | 13.1964 | 0.4328 | 5 | 48 | chemokine activity |
| GO:0032394 | 1e-04 | Inf | 0.018 | 2 | 2 | MHC class Ib receptor activity |
| GO:0001664 | 6e-04 | 4.1674 | 2.3265 | 9 | 258 | G-protein coupled receptor binding |
| GO:0016004 | 0.0042 | 24.7469 | 0.0992 | 2 | 11 | phospholipase activator activity |
| GO:0005549 | 0.0067 | 5.693 | 0.7484 | 4 | 83 | odorant binding |
| GO:0008308 | 0.0089 | 15.9038 | 0.1443 | 2 | 16 | voltage-gated anion channel activity |
| GO:0008808 | 0.009 | Inf | 0.009 | 1 | 1 | cardiolipin synthase activity |
| GO:0008843 | 0.009 | Inf | 0.009 | 1 | 1 | endochitinase activity |
| GO:0031764 | 0.009 | Inf | 0.009 | 1 | 1 | type 1 galanin receptor binding |
| GO:0031765 | 0.009 | Inf | 0.009 | 1 | 1 | type 2 galanin receptor binding |
| GO:0031766 | 0.009 | Inf | 0.009 | 1 | 1 | type 3 galanin receptor binding |
| GO:0036470 | 0.009 | Inf | 0.009 | 1 | 1 | tyrosine 3-monooxygenase activator activity |
| GO:0036478 | 0.009 | Inf | 0.009 | 1 | 1 | L-dopa decarboxylase activator activity |
| GO:0036524 | 0.009 | Inf | 0.009 | 1 | 1 | protein deglycase activity |
| GO:0043337 | 0.009 | Inf | 0.009 | 1 | 1 | CDP-diacylglycerol-phosphatidylglycerol phosphatidyltransferase activity |
| GO:0045340 | 0.009 | Inf | 0.009 | 1 | 1 | mercury ion binding |
| GO:0005126 | 0.0099 | 3.106 | 2.3716 | 7 | 263 | cytokine receptor binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0048020 | 0 | 24.4966 | 0.3011 | 6 | 39 | CCR chemokine receptor binding |
| GO:0008061 | 0 | 78.9885 | 0.0618 | 3 | 8 | chitin binding |
| GO:0008009 | 0 | 15.5262 | 0.3706 | 5 | 48 | chemokine activity |
| GO:0032394 | 1e-04 | Inf | 0.0154 | 2 | 2 | MHC class Ib receptor activity |
| GO:0016004 | 0.0031 | 29.0099 | 0.0849 | 2 | 11 | phospholipase activator activity |
| GO:0001664 | 0.0039 | 3.7378 | 1.9918 | 7 | 258 | G-protein coupled receptor binding |
| GO:0005126 | 0.0043 | 3.6636 | 2.0304 | 7 | 263 | cytokine receptor binding |
| GO:0008017 | 0.0053 | 3.9998 | 1.5904 | 6 | 206 | microtubule binding |
| GO:0008445 | 0.0077 | Inf | 0.0077 | 1 | 1 | D-aspartate oxidase activity |
| GO:0008843 | 0.0077 | Inf | 0.0077 | 1 | 1 | endochitinase activity |
| GO:0036470 | 0.0077 | Inf | 0.0077 | 1 | 1 | tyrosine 3-monooxygenase activator activity |
| GO:0036478 | 0.0077 | Inf | 0.0077 | 1 | 1 | L-dopa decarboxylase activator activity |
| GO:0036524 | 0.0077 | Inf | 0.0077 | 1 | 1 | protein deglycase activity |
| GO:0045340 | 0.0077 | Inf | 0.0077 | 1 | 1 | mercury ion binding |
| GO:0047127 | 0.0077 | Inf | 0.0077 | 1 | 1 | thiomorpholine-carboxylate dehydrogenase activity |
| GO:0016638 | 0.0083 | 16.311 | 0.139 | 2 | 18 | oxidoreductase activity, acting on the CH-NH2 group of donors |
| GO:0042288 | 0.0083 | 16.311 | 0.139 | 2 | 18 | MHC class I protein binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0005125 | 2e-04 | 7.8409 | 0.8538 | 6 | 216 | cytokine activity |
| GO:0060089 | 2e-04 | 3.2103 | 6.0597 | 16 | 1533 | molecular transducer activity |
| GO:0099600 | 2e-04 | 3.4674 | 4.8185 | 14 | 1219 | transmembrane receptor activity |
| GO:0038023 | 4e-04 | 3.2896 | 5.0556 | 14 | 1279 | signaling receptor activity |
| GO:0005126 | 5e-04 | 6.6952 | 0.9958 | 6 | 260 | cytokine receptor binding |
| GO:0004984 | 6e-04 | 5.3331 | 1.4625 | 7 | 370 | olfactory receptor activity |
| GO:0004930 | 0.0035 | 3.2459 | 3.0951 | 9 | 783 | G-protein coupled receptor activity |
| GO:0015130 | 0.004 | Inf | 0.004 | 1 | 1 | mevalonate transmembrane transporter activity |
| GO:0030380 | 0.004 | Inf | 0.004 | 1 | 1 | interleukin-17E receptor binding |
| GO:0004950 | 0.0044 | 22.5863 | 0.0988 | 2 | 25 | chemokine receptor activity |
| GO:0001069 | 0.0079 | 255.9683 | 0.0079 | 1 | 2 | regulatory region RNA binding |
| GO:0010465 | 0.0079 | 255.9683 | 0.0079 | 1 | 2 | nerve growth factor receptor activity |
| GO:0042019 | 0.0079 | 255.9683 | 0.0079 | 1 | 2 | interleukin-23 binding |
| GO:0042020 | 0.0079 | 255.9683 | 0.0079 | 1 | 2 | interleukin-23 receptor activity |
| GO:0045523 | 0.0079 | 255.9683 | 0.0079 | 1 | 2 | interleukin-27 receptor binding |
| GO:0046556 | 0.0079 | 255.9683 | 0.0079 | 1 | 2 | alpha-L-arabinofuranosidase activity |
| GO:0070095 | 0.0079 | 255.9683 | 0.0079 | 1 | 2 | fructose-6-phosphate binding |
| GO:0071791 | 0.0079 | 255.9683 | 0.0079 | 1 | 2 | chemokine (C-C motif) ligand 5 binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004984 | 0 | 7.4209 | 1.5768 | 10 | 370 | olfactory receptor activity |
| GO:0005125 | 0 | 10.034 | 0.9205 | 8 | 216 | cytokine activity |
| GO:0099600 | 0 | 4.058 | 5.1949 | 17 | 1219 | transmembrane receptor activity |
| GO:0038023 | 0 | 3.8495 | 5.4506 | 17 | 1279 | signaling receptor activity |
| GO:0004930 | 0 | 4.6284 | 3.3369 | 13 | 783 | G-protein coupled receptor activity |
| GO:0060089 | 2e-04 | 3.1498 | 6.5331 | 17 | 1533 | molecular transducer activity |
| GO:0005126 | 7e-04 | 6.1444 | 1.0761 | 6 | 260 | cytokine receptor binding |
| GO:0030545 | 9e-04 | 4.4257 | 2.0115 | 8 | 472 | receptor regulator activity |
| GO:0016493 | 0.0011 | 48.0955 | 0.0511 | 2 | 12 | C-C chemokine receptor activity |
| GO:0019956 | 0.0039 | 24.0328 | 0.0938 | 2 | 22 | chemokine binding |
| GO:0015130 | 0.0043 | Inf | 0.0043 | 1 | 1 | mevalonate transmembrane transporter activity |
| GO:0030380 | 0.0043 | Inf | 0.0043 | 1 | 1 | interleukin-17E receptor binding |
| GO:0043843 | 0.0043 | Inf | 0.0043 | 1 | 1 | ADP-specific glucokinase activity |
| GO:0001637 | 0.005 | 20.8942 | 0.1065 | 2 | 25 | G-protein coupled chemoattractant receptor activity |
| GO:0004896 | 0.0053 | 9.1148 | 0.3537 | 3 | 83 | cytokine receptor activity |
| GO:0005164 | 0.0067 | 17.7944 | 0.1236 | 2 | 29 | tumor necrosis factor receptor binding |
| GO:0004775 | 0.0085 | 237.0735 | 0.0085 | 1 | 2 | succinate-CoA ligase (ADP-forming) activity |
| GO:0004776 | 0.0085 | 237.0735 | 0.0085 | 1 | 2 | succinate-CoA ligase (GDP-forming) activity |
| GO:0005171 | 0.0085 | 237.0735 | 0.0085 | 1 | 2 | hepatocyte growth factor receptor binding |
| GO:0010465 | 0.0085 | 237.0735 | 0.0085 | 1 | 2 | nerve growth factor receptor activity |
| GO:0045523 | 0.0085 | 237.0735 | 0.0085 | 1 | 2 | interleukin-27 receptor binding |
| GO:0046556 | 0.0085 | 237.0735 | 0.0085 | 1 | 2 | alpha-L-arabinofuranosidase activity |
| GO:0070095 | 0.0085 | 237.0735 | 0.0085 | 1 | 2 | fructose-6-phosphate binding |
| GO:0071791 | 0.0085 | 237.0735 | 0.0085 | 1 | 2 | chemokine (C-C motif) ligand 5 binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0048248 | 1e-04 | 224.1389 | 0.0154 | 2 | 5 | CXCR3 chemokine receptor binding |
| GO:0005129 | 0.0031 | Inf | 0.0031 | 1 | 1 | granulocyte macrophage colony-stimulating factor receptor binding |
| GO:0030380 | 0.0031 | Inf | 0.0031 | 1 | 1 | interleukin-17E receptor binding |
| GO:0030332 | 0.0041 | 23.1494 | 0.0957 | 2 | 31 | cyclin binding |
| GO:0017099 | 0.0062 | 329.3878 | 0.0062 | 1 | 2 | very-long-chain-acyl-CoA dehydrogenase activity |
| GO:0043028 | 0.0068 | 17.6568 | 0.1235 | 2 | 40 | cysteine-type endopeptidase regulator activity involved in apoptotic process |
| GO:0030369 | 0.0092 | 164.6837 | 0.0093 | 1 | 3 | ICAM-3 receptor activity |
| GO:0008009 | 0.0096 | 14.5788 | 0.1482 | 2 | 48 | chemokine activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0008009 | 0 | 26.5917 | 0.1749 | 4 | 48 | chemokine activity |
| GO:0048020 | 4e-04 | 23.9524 | 0.1421 | 3 | 39 | CCR chemokine receptor binding |
| GO:0048018 | 0.0011 | 4.8234 | 1.6216 | 7 | 445 | receptor ligand activity |
| GO:0005201 | 0.0023 | 12.4713 | 0.2624 | 3 | 72 | extracellular matrix structural constituent |
| GO:0005126 | 0.0024 | 5.8274 | 0.9386 | 5 | 262 | cytokine receptor binding |
| GO:0070330 | 0.0029 | 28.2667 | 0.0802 | 2 | 22 | aromatase activity |
| GO:0005133 | 0.0036 | Inf | 0.0036 | 1 | 1 | interferon-gamma receptor binding |
| GO:0008389 | 0.0073 | 278.1207 | 0.0073 | 1 | 2 | coumarin 7-hydroxylase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0008502 | 1e-04 | Inf | 0.0214 | 2 | 2 | melatonin receptor activity |
| GO:0036461 | 1e-04 | Inf | 0.0214 | 2 | 2 | BLOC-2 complex binding |
| GO:0008519 | 2e-04 | 15.7732 | 0.2992 | 4 | 28 | ammonium transmembrane transporter activity |
| GO:0035651 | 3e-04 | 187.3333 | 0.0321 | 2 | 3 | AP-3 adaptor complex binding |
| GO:0035650 | 7e-04 | 93.6608 | 0.0427 | 2 | 4 | AP-1 adaptor complex binding |
| GO:0016812 | 0.0017 | 46.8246 | 0.0641 | 2 | 6 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides |
| GO:0005509 | 0.0019 | 2.4368 | 7.0414 | 16 | 659 | calcium ion binding |
| GO:0008046 | 0.0023 | 37.4573 | 0.0748 | 2 | 7 | axon guidance receptor activity |
| GO:0004871 | 0.0028 | 1.8718 | 16.9356 | 29 | 1585 | signal transducer activity |
| GO:0004872 | 0.0045 | 1.8412 | 15.9099 | 27 | 1489 | receptor activity |
| GO:0051378 | 0.0048 | 23.4064 | 0.1068 | 2 | 10 | serotonin binding |
| GO:0089720 | 0.0048 | 23.4064 | 0.1068 | 2 | 10 | caspase binding |
| GO:0015081 | 0.0055 | 3.9606 | 1.6027 | 6 | 150 | sodium ion transmembrane transporter activity |
| GO:0008376 | 0.0056 | 9.1008 | 0.3633 | 3 | 34 | acetylgalactosaminyltransferase activity |
| GO:0004888 | 0.0059 | 1.9155 | 12.3411 | 22 | 1168 | transmembrane signaling receptor activity |
| GO:0022836 | 0.0063 | 2.8558 | 3.323 | 9 | 311 | gated channel activity |
| GO:0004222 | 0.0073 | 4.3844 | 1.2074 | 5 | 113 | metalloendopeptidase activity |
| GO:0019905 | 0.0097 | 5.0996 | 0.8334 | 4 | 78 | syntaxin binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0016409 | 4e-04 | 24.3864 | 0.1401 | 3 | 36 | palmitoyltransferase activity |
| GO:0008106 | 0.0017 | 37.7377 | 0.0623 | 2 | 16 | alcohol dehydrogenase (NADP+) activity |
| GO:0001760 | 0.0039 | Inf | 0.0039 | 1 | 1 | aminocarboxymuconate-semialdehyde decarboxylase activity |
| GO:0018455 | 0.0039 | Inf | 0.0039 | 1 | 1 | alcohol dehydrogenase [NAD(P)+] activity |
| GO:0047042 | 0.0039 | Inf | 0.0039 | 1 | 1 | androsterone dehydrogenase (B-specific) activity |
| GO:1990698 | 0.0039 | Inf | 0.0039 | 1 | 1 | palmitoleoyltransferase activity |
| GO:0015020 | 0.0073 | 17.0249 | 0.1284 | 2 | 33 | glucuronosyltransferase activity |
| GO:0004053 | 0.0078 | 260.1129 | 0.0078 | 1 | 2 | arginase activity |
| GO:0032089 | 0.0078 | 260.1129 | 0.0078 | 1 | 2 | NACHT domain binding |
| GO:0047006 | 0.0078 | 260.1129 | 0.0078 | 1 | 2 | 17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity |
| GO:0048101 | 0.0078 | 260.1129 | 0.0078 | 1 | 2 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0003755 | 0.0025 | 12.1669 | 0.2723 | 3 | 38 | peptidyl-prolyl cis-trans isomerase activity |
| GO:0004476 | 0.0072 | Inf | 0.0072 | 1 | 1 | mannose-6-phosphate isomerase activity |
| GO:0005459 | 0.0072 | Inf | 0.0072 | 1 | 1 | UDP-galactose transmembrane transporter activity |
| GO:0030377 | 0.0072 | Inf | 0.0072 | 1 | 1 | urokinase plasminogen activator receptor activity |
| GO:0042922 | 0.0072 | Inf | 0.0072 | 1 | 1 | neuromedin U receptor binding |
| GO:0047915 | 0.0072 | Inf | 0.0072 | 1 | 1 | ganglioside galactosyltransferase activity |
| GO:0102339 | 0.0072 | Inf | 0.0072 | 1 | 1 | 3-oxo-arachidoyl-CoA reductase activity |
| GO:0102340 | 0.0072 | Inf | 0.0072 | 1 | 1 | 3-oxo-behenoyl-CoA reductase activity |
| GO:0102341 | 0.0072 | Inf | 0.0072 | 1 | 1 | 3-oxo-lignoceroyl-CoA reductase activity |
| GO:0102342 | 0.0072 | Inf | 0.0072 | 1 | 1 | 3-oxo-cerotoyl-CoA reductase activity |
| GO:0015197 | 0.0076 | 5.4845 | 0.7738 | 4 | 108 | peptide transporter activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0102953 | 0.001 | 66.775 | 0.05 | 2 | 5 | hypoglycin A gamma-glutamyl transpeptidase activity |
| GO:0036374 | 0.002 | 40.06 | 0.07 | 2 | 7 | glutathione hydrolase activity |
| GO:0015643 | 0.0042 | 25.0328 | 0.1001 | 2 | 10 | toxic substance binding |
| GO:0015271 | 0.0052 | 22.25 | 0.1101 | 2 | 11 | outward rectifier potassium channel activity |
| GO:0004896 | 0.0096 | 5.1114 | 0.8305 | 4 | 83 | cytokine receptor activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0032394 | 2e-04 | Inf | 0.0273 | 2 | 2 | MHC class Ib receptor activity |
| GO:0031720 | 6e-04 | 145.8356 | 0.0409 | 2 | 3 | haptoglobin binding |
| GO:0035663 | 6e-04 | 145.8356 | 0.0409 | 2 | 3 | Toll-like receptor 2 binding |
| GO:0031014 | 0.0011 | 72.9132 | 0.0546 | 2 | 4 | troponin T binding |
| GO:0015057 | 0.0018 | 48.6058 | 0.0682 | 2 | 5 | thrombin-activated receptor activity |
| GO:0004565 | 0.0027 | 36.4521 | 0.0819 | 2 | 6 | beta-galactosidase activity |
| GO:0019825 | 0.0032 | 7.1615 | 0.6142 | 4 | 45 | oxygen binding |
| GO:0098634 | 0.0037 | 29.1598 | 0.0955 | 2 | 7 | cell-matrix adhesion mediator activity |
| GO:0015386 | 0.0063 | 20.8258 | 0.1228 | 2 | 9 | potassium:proton antiporter activity |
| GO:0005072 | 0.0078 | 18.2215 | 0.1365 | 2 | 10 | transforming growth factor beta receptor, cytoplasmic mediator activity |
| GO:0071723 | 0.0078 | 18.2215 | 0.1365 | 2 | 10 | lipopeptide binding |
| GO:0015385 | 0.0094 | 16.1958 | 0.1501 | 2 | 11 | sodium:proton antiporter activity |
| GO:0043295 | 0.0094 | 16.1958 | 0.1501 | 2 | 11 | glutathione binding |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| NA. |
| n/a |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:2000402 | 3e-04 | 31.3255 | 0.143 | 3 | 9 | negative regulation of lymphocyte migration |
| GO:0036006 | 4e-04 | 26.8487 | 0.1589 | 3 | 10 | cellular response to macrophage colony-stimulating factor stimulus |
| GO:0007079 | 7e-04 | 124.8516 | 0.0477 | 2 | 3 | mitotic chromosome movement towards spindle pole |
| GO:2000502 | 7e-04 | 124.8516 | 0.0477 | 2 | 3 | negative regulation of natural killer cell chemotaxis |
| GO:0048523 | 9e-04 | 1.5283 | 70.7435 | 94 | 4453 | negative regulation of cellular process |
| GO:0030488 | 0.0011 | 10.0517 | 0.4607 | 4 | 29 | tRNA methylation |
| GO:0002689 | 0.0019 | 14.4516 | 0.2542 | 3 | 16 | negative regulation of leukocyte chemotaxis |
| GO:0051489 | 0.0033 | 7.1753 | 0.6196 | 4 | 39 | regulation of filopodium assembly |
| GO:0008063 | 0.0036 | 31.207 | 0.0953 | 2 | 6 | Toll signaling pathway |
| GO:0070383 | 0.0036 | 31.207 | 0.0953 | 2 | 6 | DNA cytosine deamination |
| GO:0043901 | 0.0042 | 3.3106 | 2.5578 | 8 | 161 | negative regulation of multi-organism process |
| GO:1901687 | 0.0043 | 10.434 | 0.3336 | 3 | 21 | glutathione derivative biosynthetic process |
| GO:0045869 | 0.005 | 24.9641 | 0.1112 | 2 | 7 | negative regulation of single stranded viral RNA replication via double stranded DNA intermediate |
| GO:0050870 | 0.0052 | 2.9415 | 3.225 | 9 | 203 | positive regulation of T cell activation |
| GO:0039694 | 0.0055 | 9.3894 | 0.3654 | 3 | 23 | viral RNA genome replication |
| GO:0032956 | 0.0059 | 2.5626 | 4.5118 | 11 | 284 | regulation of actin cytoskeleton organization |
| GO:0046580 | 0.006 | 5.9768 | 0.7308 | 4 | 46 | negative regulation of Ras protein signal transduction |
| GO:0017148 | 0.0061 | 2.3357 | 5.8463 | 13 | 368 | negative regulation of translation |
| GO:0000060 | 0.0065 | 5.8374 | 0.7467 | 4 | 47 | protein import into nucleus, translocation |
| GO:0030330 | 0.0069 | 3.7814 | 1.684 | 6 | 106 | DNA damage response, signal transduction by p53 class mediator |
| GO:0002696 | 0.007 | 2.4974 | 4.623 | 11 | 291 | positive regulation of leukocyte activation |
| GO:0097435 | 0.0071 | 2.0406 | 8.7536 | 17 | 551 | supramolecular fiber organization |
| GO:0030155 | 0.0077 | 1.9404 | 10.2946 | 19 | 648 | regulation of cell adhesion |
| GO:1903671 | 0.0079 | 8.1632 | 0.4131 | 3 | 26 | negative regulation of sprouting angiogenesis |
| GO:0009972 | 0.0084 | 17.8292 | 0.143 | 2 | 9 | cytidine deamination |
| GO:0046087 | 0.0084 | 17.8292 | 0.143 | 2 | 9 | cytidine metabolic process |
| GO:0071822 | 0.0086 | 1.5822 | 25.5935 | 38 | 1611 | protein complex subunit organization |
| GO:2000171 | 0.0087 | 7.8225 | 0.4289 | 3 | 27 | negative regulation of dendrite development |
| GO:0016458 | 0.0097 | 2.1963 | 6.1958 | 13 | 390 | gene silencing |
| GO:0019058 | 0.0098 | 2.3764 | 4.8454 | 11 | 305 | viral life cycle |
| GO:0043623 | 0.0099 | 1.9644 | 9.0713 | 17 | 571 | cellular protein complex assembly |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:1900239 | 2e-04 | 38.5133 | 0.1241 | 3 | 8 | regulation of phenotypic switching |
| GO:0048625 | 0.0023 | 42.6267 | 0.0776 | 2 | 5 | myoblast fate commitment |
| GO:0051489 | 0.003 | 7.3516 | 0.6052 | 4 | 39 | regulation of filopodium assembly |
| GO:0008063 | 0.0035 | 31.968 | 0.0931 | 2 | 6 | Toll signaling pathway |
| GO:0070383 | 0.0035 | 31.968 | 0.0931 | 2 | 6 | DNA cytosine deamination |
| GO:0090677 | 0.0035 | 31.968 | 0.0931 | 2 | 6 | reversible differentiation |
| GO:0007159 | 0.0038 | 2.481 | 5.5241 | 13 | 356 | leukocyte cell-cell adhesion |
| GO:0010629 | 0.0039 | 1.6258 | 28.5362 | 43 | 1839 | negative regulation of gene expression |
| GO:0050870 | 0.0045 | 3.0153 | 3.15 | 9 | 203 | positive regulation of T cell activation |
| GO:0045869 | 0.0048 | 25.5728 | 0.1086 | 2 | 7 | negative regulation of single stranded viral RNA replication via double stranded DNA intermediate |
| GO:0090647 | 0.0048 | 25.5728 | 0.1086 | 2 | 7 | modulation of age-related behavioral decline |
| GO:0008347 | 0.0051 | 6.2734 | 0.6983 | 4 | 45 | glial cell migration |
| GO:0039694 | 0.0052 | 9.6193 | 0.3569 | 3 | 23 | viral RNA genome replication |
| GO:2000300 | 0.0052 | 9.6193 | 0.3569 | 3 | 23 | regulation of synaptic vesicle exocytosis |
| GO:0001505 | 0.0055 | 3.1635 | 2.669 | 8 | 172 | regulation of neurotransmitter levels |
| GO:0006342 | 0.0056 | 3.9547 | 1.6138 | 6 | 104 | chromatin silencing |
| GO:0007215 | 0.0058 | 4.6702 | 1.1483 | 5 | 74 | glutamate receptor signaling pathway |
| GO:0002696 | 0.0059 | 2.5606 | 4.5155 | 11 | 291 | positive regulation of leukocyte activation |
| GO:0030155 | 0.006 | 1.9912 | 10.0552 | 19 | 648 | regulation of cell adhesion |
| GO:0032071 | 0.0063 | 21.3093 | 0.1241 | 2 | 8 | regulation of endodeoxyribonuclease activity |
| GO:0044351 | 0.0063 | 21.3093 | 0.1241 | 2 | 8 | macropinocytosis |
| GO:0050804 | 0.0072 | 2.4882 | 4.6397 | 11 | 299 | modulation of chemical synaptic transmission |
| GO:1903671 | 0.0074 | 8.363 | 0.4034 | 3 | 26 | negative regulation of sprouting angiogenesis |
| GO:0001960 | 0.0075 | 5.5898 | 0.7759 | 4 | 50 | negative regulation of cytokine-mediated signaling pathway |
| GO:0048523 | 0.0075 | 1.4036 | 69.0983 | 87 | 4453 | negative regulation of cellular process |
| GO:0007196 | 0.008 | 18.264 | 0.1397 | 2 | 9 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway |
| GO:0009972 | 0.008 | 18.264 | 0.1397 | 2 | 9 | cytidine deamination |
| GO:0010692 | 0.008 | 18.264 | 0.1397 | 2 | 9 | regulation of alkaline phosphatase activity |
| GO:0046087 | 0.008 | 18.264 | 0.1397 | 2 | 9 | cytidine metabolic process |
| GO:2000402 | 0.008 | 18.264 | 0.1397 | 2 | 9 | negative regulation of lymphocyte migration |
| GO:2000113 | 0.0088 | 1.6098 | 23.1362 | 35 | 1491 | negative regulation of cellular macromolecule biosynthetic process |
| GO:0006606 | 0.0088 | 2.5394 | 4.1276 | 10 | 266 | protein import into nucleus |
| GO:0030307 | 0.009 | 3.1658 | 2.3276 | 7 | 150 | positive regulation of cell growth |
| GO:0046824 | 0.0091 | 3.5531 | 1.7845 | 6 | 115 | positive regulation of nucleocytoplasmic transport |
| GO:0040029 | 0.0093 | 2.1385 | 6.8586 | 14 | 442 | regulation of gene expression, epigenetic |
| GO:0036006 | 0.0099 | 15.98 | 0.1552 | 2 | 10 | cellular response to macrophage colony-stimulating factor stimulus |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0006355 | 0 | 1.916 | 44.5474 | 71 | 3445 | regulation of transcription, DNA-templated |
| GO:2001141 | 0 | 1.8967 | 44.8966 | 71 | 3472 | regulation of RNA biosynthetic process |
| GO:0048762 | 0 | 5.0371 | 2.3922 | 11 | 185 | mesenchymal cell differentiation |
| GO:0060562 | 0 | 3.9181 | 3.8922 | 14 | 301 | epithelial tube morphogenesis |
| GO:0001569 | 0 | 15.0131 | 0.4009 | 5 | 31 | branching involved in blood vessel morphogenesis |
| GO:0007399 | 1e-04 | 1.9708 | 27.7112 | 48 | 2143 | nervous system development |
| GO:0035295 | 1e-04 | 2.8426 | 7.2543 | 19 | 561 | tube development |
| GO:0007156 | 2e-04 | 4.9745 | 1.9655 | 9 | 152 | homophilic cell adhesion via plasma membrane adhesion molecules |
| GO:0048706 | 2e-04 | 5.5786 | 1.5647 | 8 | 121 | embryonic skeletal system development |
| GO:0061448 | 2e-04 | 3.9541 | 3 | 11 | 232 | connective tissue development |
| GO:0048701 | 2e-04 | 10.0006 | 0.569 | 5 | 44 | embryonic cranial skeleton morphogenesis |
| GO:0003002 | 3e-04 | 3.3354 | 4.1897 | 13 | 324 | regionalization |
| GO:0021521 | 3e-04 | 29.0254 | 0.1422 | 3 | 11 | ventral spinal cord interneuron specification |
| GO:0021903 | 3e-04 | 29.0254 | 0.1422 | 3 | 11 | rostrocaudal neural tube patterning |
| GO:0035413 | 3e-04 | 29.0254 | 0.1422 | 3 | 11 | positive regulation of catenin import into nucleus |
| GO:0060033 | 3e-04 | 29.0254 | 0.1422 | 3 | 11 | anatomical structure regression |
| GO:0001558 | 3e-04 | 3.1359 | 4.7974 | 14 | 371 | regulation of cell growth |
| GO:0060173 | 4e-04 | 4.4134 | 2.1983 | 9 | 170 | limb development |
| GO:0019219 | 4e-04 | 1.6657 | 51.9957 | 74 | 4021 | regulation of nucleobase-containing compound metabolic process |
| GO:0043010 | 4e-04 | 3.4091 | 3.7759 | 12 | 292 | camera-type eye development |
| GO:0061138 | 5e-04 | 4.2791 | 2.2629 | 9 | 175 | morphogenesis of a branching epithelium |
| GO:0048863 | 5e-04 | 3.6062 | 3.2716 | 11 | 253 | stem cell differentiation |
| GO:0051094 | 5e-04 | 2.1083 | 15.0292 | 29 | 1177 | positive regulation of developmental process |
| GO:0003274 | 5e-04 | 154.125 | 0.0388 | 2 | 3 | endocardial cushion fusion |
| GO:0003214 | 7e-04 | 21.1054 | 0.181 | 3 | 14 | cardiac left ventricle morphogenesis |
| GO:0042487 | 7e-04 | 21.1054 | 0.181 | 3 | 14 | regulation of odontogenesis of dentin-containing tooth |
| GO:0010717 | 7e-04 | 6.0936 | 1.0733 | 6 | 83 | regulation of epithelial to mesenchymal transition |
| GO:0060317 | 7e-04 | 11.0971 | 0.4138 | 4 | 32 | cardiac epithelial to mesenchymal transition |
| GO:1903507 | 8e-04 | 2.0679 | 14.7155 | 28 | 1138 | negative regulation of nucleic acid-templated transcription |
| GO:0045600 | 8e-04 | 7.4944 | 0.7371 | 5 | 57 | positive regulation of fat cell differentiation |
| GO:0009792 | 8e-04 | 2.5561 | 7.125 | 17 | 551 | embryo development ending in birth or egg hatching |
| GO:0000122 | 8e-04 | 2.3056 | 9.8017 | 21 | 758 | negative regulation of transcription from RNA polymerase II promoter |
| GO:0022610 | 9e-04 | 1.9789 | 17.0819 | 31 | 1321 | biological adhesion |
| GO:0060581 | 9e-04 | 19.3454 | 0.194 | 3 | 15 | cell fate commitment involved in pattern specification |
| GO:0051253 | 9e-04 | 2.0108 | 15.6724 | 29 | 1212 | negative regulation of RNA metabolic process |
| GO:0006933 | 0.001 | 77.0577 | 0.0517 | 2 | 4 | negative regulation of cell adhesion involved in substrate-bound cell migration |
| GO:0021555 | 0.001 | 77.0577 | 0.0517 | 2 | 4 | midbrain-hindbrain boundary morphogenesis |
| GO:0014032 | 0.0011 | 7.0843 | 0.7759 | 5 | 60 | neural crest cell development |
| GO:0034654 | 0.0011 | 1.5988 | 52.7586 | 73 | 4080 | nucleobase-containing compound biosynthetic process |
| GO:0072132 | 0.0011 | 9.7978 | 0.4614 | 4 | 36 | mesenchyme morphogenesis |
| GO:0021514 | 0.0013 | 16.5797 | 0.2198 | 3 | 17 | ventral spinal cord interneuron differentiation |
| GO:0072091 | 0.0013 | 6.7166 | 0.8147 | 5 | 63 | regulation of stem cell proliferation |
| GO:0045944 | 0.0014 | 2.0325 | 13.8103 | 26 | 1068 | positive regulation of transcription from RNA polymerase II promoter |
| GO:0090596 | 0.0014 | 3.3319 | 3.194 | 10 | 247 | sensory organ morphogenesis |
| GO:0061351 | 0.0016 | 4.4232 | 1.694 | 7 | 131 | neural precursor cell proliferation |
| GO:1902262 | 0.0016 | 51.3686 | 0.0647 | 2 | 5 | apoptotic process involved in blood vessel morphogenesis |
| GO:1905007 | 0.0016 | 51.3686 | 0.0647 | 2 | 5 | positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation |
| GO:0032656 | 0.0021 | 13.6513 | 0.2586 | 3 | 20 | regulation of interleukin-13 production |
| GO:0016477 | 0.0023 | 1.8846 | 16.6164 | 29 | 1285 | cell migration |
| GO:0060348 | 0.0023 | 3.673 | 2.3147 | 8 | 179 | bone development |
| GO:0002052 | 0.0024 | 12.8921 | 0.2716 | 3 | 21 | positive regulation of neuroblast proliferation |
| GO:0043586 | 0.0024 | 12.8921 | 0.2716 | 3 | 21 | tongue development |
| GO:0009889 | 0.0025 | 1.5301 | 56.1853 | 75 | 4345 | regulation of biosynthetic process |
| GO:0003272 | 0.0027 | 12.2128 | 0.2845 | 3 | 22 | endocardial cushion formation |
| GO:0021513 | 0.0027 | 12.2128 | 0.2845 | 3 | 22 | spinal cord dorsal/ventral patterning |
| GO:0030098 | 0.0028 | 2.8499 | 4.0862 | 11 | 316 | lymphocyte differentiation |
| GO:0035107 | 0.0028 | 3.971 | 1.875 | 7 | 145 | appendage morphogenesis |
| GO:0032330 | 0.0029 | 7.3916 | 0.5948 | 4 | 46 | regulation of chondrocyte differentiation |
| GO:0046580 | 0.0029 | 7.3916 | 0.5948 | 4 | 46 | negative regulation of Ras protein signal transduction |
| GO:0021879 | 0.003 | 11.7551 | 0.2936 | 3 | 23 | forebrain neuron differentiation |
| GO:0070076 | 0.0031 | 11.6014 | 0.2974 | 3 | 23 | histone lysine demethylation |
| GO:0032673 | 0.0035 | 11.0483 | 0.3103 | 3 | 24 | regulation of interleukin-4 production |
| GO:0040007 | 0.0036 | 1.993 | 11.7802 | 22 | 911 | growth |
| GO:0003148 | 0.004 | 10.5455 | 0.3233 | 3 | 25 | outflow tract septum morphogenesis |
| GO:0061037 | 0.004 | 10.5455 | 0.3233 | 3 | 25 | negative regulation of cartilage development |
| GO:0060350 | 0.0042 | 6.6032 | 0.6595 | 4 | 51 | endochondral bone morphogenesis |
| GO:0048562 | 0.0043 | 3.036 | 3.1294 | 9 | 245 | embryonic organ morphogenesis |
| GO:0021859 | 0.0044 | 25.6795 | 0.1034 | 2 | 8 | pyramidal neuron differentiation |
| GO:0032909 | 0.0044 | 25.6795 | 0.1034 | 2 | 8 | regulation of transforming growth factor beta2 production |
| GO:0045630 | 0.0044 | 25.6795 | 0.1034 | 2 | 8 | positive regulation of T-helper 2 cell differentiation |
| GO:0060534 | 0.0044 | 25.6795 | 0.1034 | 2 | 8 | trachea cartilage development |
| GO:0002063 | 0.0045 | 10.0863 | 0.3362 | 3 | 26 | chondrocyte development |
| GO:0021884 | 0.0045 | 10.0863 | 0.3362 | 3 | 26 | forebrain neuron development |
| GO:0001843 | 0.0049 | 4.8628 | 1.0991 | 5 | 85 | neural tube closure |
| GO:0006482 | 0.005 | 9.6655 | 0.3491 | 3 | 27 | protein demethylation |
| GO:0051674 | 0.005 | 1.7568 | 18.3491 | 30 | 1419 | localization of cell |
| GO:0030851 | 0.0055 | 9.2783 | 0.3621 | 3 | 28 | granulocyte differentiation |
| GO:1902230 | 0.0055 | 9.2783 | 0.3621 | 3 | 28 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage |
| GO:0003149 | 0.0056 | 22.0096 | 0.1164 | 2 | 9 | membranous septum morphogenesis |
| GO:0010692 | 0.0056 | 22.0096 | 0.1164 | 2 | 9 | regulation of alkaline phosphatase activity |
| GO:0046549 | 0.0056 | 22.0096 | 0.1164 | 2 | 9 | retinal cone cell development |
| GO:0048705 | 0.0059 | 3.1189 | 2.7026 | 8 | 209 | skeletal system morphogenesis |
| GO:0030326 | 0.0059 | 3.8995 | 1.6293 | 6 | 126 | embryonic limb morphogenesis |
| GO:0001773 | 0.0061 | 8.9208 | 0.375 | 3 | 29 | myeloid dendritic cell activation |
| GO:0061036 | 0.0061 | 8.9208 | 0.375 | 3 | 29 | positive regulation of cartilage development |
| GO:1902893 | 0.0061 | 8.9208 | 0.375 | 3 | 29 | regulation of pri-miRNA transcription from RNA polymerase II promoter |
| GO:2000516 | 0.0061 | 8.9208 | 0.375 | 3 | 29 | positive regulation of CD4-positive, alpha-beta T cell activation |
| GO:0098609 | 0.0061 | 1.9959 | 10.0862 | 19 | 780 | cell-cell adhesion |
| GO:1902107 | 0.0062 | 3.867 | 1.6422 | 6 | 127 | positive regulation of leukocyte differentiation |
| GO:0060021 | 0.0065 | 4.5218 | 1.1767 | 5 | 91 | palate development |
| GO:0045669 | 0.0067 | 5.7447 | 0.75 | 4 | 58 | positive regulation of osteoblast differentiation |
| GO:0008584 | 0.0069 | 3.7728 | 1.681 | 6 | 130 | male gonad development |
| GO:0046085 | 0.007 | 19.2572 | 0.1293 | 2 | 10 | adenosine metabolic process |
| GO:0048340 | 0.007 | 19.2572 | 0.1293 | 2 | 10 | paraxial mesoderm morphogenesis |
| GO:0051573 | 0.007 | 19.2572 | 0.1293 | 2 | 10 | negative regulation of histone H3-K9 methylation |
| GO:0097659 | 0.0074 | 1.5832 | 29.9096 | 43 | 2482 | nucleic acid-templated transcription |
| GO:0060255 | 0.0076 | 1.4215 | 75.5431 | 93 | 5842 | regulation of macromolecule metabolic process |
| GO:0030278 | 0.008 | 3.2363 | 2.2759 | 7 | 176 | regulation of ossification |
| GO:1902742 | 0.008 | 7.9965 | 0.4138 | 3 | 32 | apoptotic process involved in development |
| GO:0090288 | 0.0082 | 3.6254 | 1.7457 | 6 | 135 | negative regulation of cellular response to growth factor stimulus |
| GO:0021670 | 0.0085 | 17.1165 | 0.1422 | 2 | 11 | lateral ventricle development |
| GO:0060439 | 0.0085 | 17.1165 | 0.1422 | 2 | 11 | trachea morphogenesis |
| GO:1904591 | 0.0085 | 4.2253 | 1.2543 | 5 | 97 | positive regulation of protein import |
| GO:0007435 | 0.0087 | 7.7295 | 0.4267 | 3 | 33 | salivary gland morphogenesis |
| GO:0001756 | 0.0089 | 5.2562 | 0.8147 | 4 | 63 | somitogenesis |
| GO:0010810 | 0.0093 | 3.1423 | 2.3405 | 7 | 181 | regulation of cell-substrate adhesion |
| GO:0031057 | 0.0095 | 7.4797 | 0.4397 | 3 | 34 | negative regulation of histone modification |
| GO:0048048 | 0.0095 | 7.4797 | 0.4397 | 3 | 34 | embryonic eye morphogenesis |
| GO:0010558 | 0.0096 | 1.6532 | 20.056 | 31 | 1551 | negative regulation of macromolecule biosynthetic process |
| GO:0001841 | 0.0096 | 4.0911 | 1.2931 | 5 | 100 | neural tube formation |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0051094 | 0 | 2.6698 | 16.2632 | 38 | 1206 | positive regulation of developmental process |
| GO:0048568 | 0 | 3.7876 | 5.5424 | 19 | 411 | embryonic organ development |
| GO:0060562 | 0 | 4.3518 | 4.0591 | 16 | 301 | epithelial tube morphogenesis |
| GO:0009792 | 0 | 3.1 | 7.4304 | 21 | 551 | embryo development ending in birth or egg hatching |
| GO:0048736 | 0 | 5.2758 | 2.2925 | 11 | 170 | appendage development |
| GO:0009887 | 0 | 2.825 | 9.3699 | 24 | 717 | animal organ morphogenesis |
| GO:0007156 | 0 | 5.3504 | 2.0498 | 10 | 152 | homophilic cell adhesion via plasma membrane adhesion molecules |
| GO:0045944 | 0 | 2.3826 | 14.4022 | 31 | 1068 | positive regulation of transcription from RNA polymerase II promoter |
| GO:0021510 | 0 | 6.8647 | 1.2946 | 8 | 96 | spinal cord development |
| GO:2001141 | 0 | 1.8182 | 46.8207 | 72 | 3472 | regulation of RNA biosynthetic process |
| GO:0001569 | 1e-04 | 14.3737 | 0.418 | 5 | 31 | branching involved in blood vessel morphogenesis |
| GO:0006355 | 1e-04 | 1.7982 | 46.4566 | 71 | 3445 | regulation of transcription, DNA-templated |
| GO:0048729 | 1e-04 | 2.7788 | 8.226 | 21 | 610 | tissue morphogenesis |
| GO:0035108 | 2e-04 | 5.0058 | 1.9554 | 9 | 145 | limb morphogenesis |
| GO:0000122 | 2e-04 | 2.4405 | 10.2218 | 23 | 758 | negative regulation of transcription from RNA polymerase II promoter |
| GO:0021915 | 3e-04 | 4.66 | 2.0902 | 9 | 155 | neural tube development |
| GO:0030182 | 3e-04 | 2.1168 | 16.0414 | 31 | 1200 | neuron differentiation |
| GO:1903507 | 3e-04 | 2.1364 | 15.3462 | 30 | 1138 | negative regulation of nucleic acid-templated transcription |
| GO:0051240 | 4e-04 | 1.9844 | 19.9716 | 36 | 1481 | positive regulation of multicellular organismal process |
| GO:0051253 | 4e-04 | 2.072 | 16.3441 | 31 | 1212 | negative regulation of RNA metabolic process |
| GO:0003002 | 4e-04 | 5.6129 | 1.3567 | 7 | 105 | regionalization |
| GO:0021879 | 5e-04 | 8.484 | 0.6608 | 5 | 49 | forebrain neuron differentiation |
| GO:0019219 | 6e-04 | 1.6269 | 54.2241 | 76 | 4021 | regulation of nucleobase-containing compound metabolic process |
| GO:0061138 | 6e-04 | 4.0934 | 2.3599 | 9 | 175 | morphogenesis of a branching epithelium |
| GO:0048935 | 6e-04 | 22.2375 | 0.1753 | 3 | 13 | peripheral nervous system neuron development |
| GO:0035148 | 7e-04 | 4.5292 | 1.9014 | 8 | 141 | tube formation |
| GO:0032736 | 8e-04 | 20.2146 | 0.1888 | 3 | 14 | positive regulation of interleukin-13 production |
| GO:0042487 | 8e-04 | 20.2146 | 0.1888 | 3 | 14 | regulation of odontogenesis of dentin-containing tooth |
| GO:0009952 | 8e-04 | 3.9157 | 2.4603 | 9 | 184 | anterior/posterior pattern specification |
| GO:0034654 | 9e-04 | 1.5951 | 55.0197 | 76 | 4080 | nucleobase-containing compound biosynthetic process |
| GO:0060581 | 0.001 | 18.5289 | 0.2023 | 3 | 15 | cell fate commitment involved in pattern specification |
| GO:0021555 | 0.0011 | 73.8203 | 0.0539 | 2 | 4 | midbrain-hindbrain boundary morphogenesis |
| GO:0045669 | 0.0011 | 7.0393 | 0.7821 | 5 | 58 | positive regulation of osteoblast differentiation |
| GO:0007267 | 0.0012 | 1.8592 | 20.5245 | 35 | 1522 | cell-cell signaling |
| GO:0014032 | 0.0013 | 6.7825 | 0.8091 | 5 | 60 | neural crest cell development |
| GO:0021514 | 0.0014 | 15.88 | 0.2292 | 3 | 17 | ventral spinal cord interneuron differentiation |
| GO:1903508 | 0.0015 | 1.8794 | 18.4613 | 32 | 1369 | positive regulation of nucleic acid-templated transcription |
| GO:0035113 | 0.0016 | 4.4123 | 1.6991 | 7 | 126 | embryonic appendage morphogenesis |
| GO:0001558 | 0.0016 | 2.761 | 5.003 | 13 | 371 | regulation of cell growth |
| GO:1902107 | 0.0017 | 4.3753 | 1.7126 | 7 | 127 | positive regulation of leukocyte differentiation |
| GO:0002568 | 0.0018 | 49.2104 | 0.0674 | 2 | 5 | somatic diversification of T cell receptor genes |
| GO:0033153 | 0.0018 | 49.2104 | 0.0674 | 2 | 5 | T cell receptor V(D)J recombination |
| GO:0045636 | 0.0018 | 49.2104 | 0.0674 | 2 | 5 | positive regulation of melanocyte differentiation |
| GO:0051254 | 0.0018 | 1.8428 | 19.4187 | 33 | 1440 | positive regulation of RNA metabolic process |
| GO:0007218 | 0.0018 | 5.0426 | 1.2811 | 6 | 95 | neuropeptide signaling pathway |
| GO:0008584 | 0.0019 | 4.2678 | 1.7531 | 7 | 130 | male gonad development |
| GO:0090596 | 0.002 | 3.1866 | 3.3308 | 10 | 247 | sensory organ morphogenesis |
| GO:0032753 | 0.002 | 13.8932 | 0.2562 | 3 | 19 | positive regulation of interleukin-4 production |
| GO:0048557 | 0.002 | 13.8932 | 0.2562 | 3 | 19 | embryonic digestive tract morphogenesis |
| GO:0048598 | 0.002 | 2.5821 | 5.7616 | 14 | 442 | embryonic morphogenesis |
| GO:2000026 | 0.0022 | 1.7378 | 24.4757 | 39 | 1815 | regulation of multicellular organismal development |
| GO:0001764 | 0.0023 | 4.1323 | 1.807 | 7 | 134 | neuron migration |
| GO:0007399 | 0.0023 | 2.3215 | 7.8521 | 17 | 643 | nervous system development |
| GO:0048863 | 0.0023 | 3.1067 | 3.4118 | 10 | 253 | stem cell differentiation |
| GO:0009890 | 0.0026 | 1.7548 | 22.2641 | 36 | 1651 | negative regulation of biosynthetic process |
| GO:0003180 | 0.0026 | 36.9055 | 0.0809 | 2 | 6 | aortic valve morphogenesis |
| GO:0043586 | 0.0027 | 12.348 | 0.2832 | 3 | 21 | tongue development |
| GO:0048485 | 0.0027 | 12.348 | 0.2832 | 3 | 21 | sympathetic nervous system development |
| GO:0040007 | 0.0028 | 1.9998 | 12.285 | 23 | 911 | growth |
| GO:0048701 | 0.0029 | 7.433 | 0.5933 | 4 | 44 | embryonic cranial skeleton morphogenesis |
| GO:0003208 | 0.0029 | 5.5635 | 0.9709 | 5 | 72 | cardiac ventricle morphogenesis |
| GO:0021513 | 0.0031 | 11.6974 | 0.2967 | 3 | 22 | spinal cord dorsal/ventral patterning |
| GO:0003151 | 0.0032 | 5.4016 | 0.9979 | 5 | 74 | outflow tract morphogenesis |
| GO:0010226 | 0.0035 | 11.1118 | 0.3102 | 3 | 23 | response to lithium ion |
| GO:0042832 | 0.0035 | 11.1118 | 0.3102 | 3 | 23 | defense response to protozoan |
| GO:0003357 | 0.0036 | 29.5226 | 0.0944 | 2 | 7 | noradrenergic neuron differentiation |
| GO:0048762 | 0.0037 | 3.3939 | 2.4948 | 8 | 185 | mesenchymal cell differentiation |
| GO:0048704 | 0.0037 | 6.8664 | 0.6372 | 4 | 48 | embryonic skeletal system morphogenesis |
| GO:0007275 | 0.0037 | 1.6123 | 35.8061 | 51 | 2945 | multicellular organism development |
| GO:0022008 | 0.0043 | 2.0696 | 9.7711 | 19 | 753 | neurogenesis |
| GO:0045992 | 0.0045 | 10.1004 | 0.3371 | 3 | 25 | negative regulation of embryonic development |
| GO:0032502 | 0.0045 | 1.7922 | 19.2844 | 31 | 1637 | developmental process |
| GO:0060541 | 0.0046 | 3.2633 | 2.5892 | 8 | 192 | respiratory system development |
| GO:0007519 | 0.0046 | 3.6152 | 2.0498 | 7 | 152 | skeletal muscle tissue development |
| GO:0046661 | 0.0047 | 3.5902 | 2.0632 | 7 | 153 | male sex differentiation |
| GO:0045630 | 0.0048 | 24.6006 | 0.1079 | 2 | 8 | positive regulation of T-helper 2 cell differentiation |
| GO:0060534 | 0.0048 | 24.6006 | 0.1079 | 2 | 8 | trachea cartilage development |
| GO:0071863 | 0.0048 | 24.6006 | 0.1079 | 2 | 8 | regulation of cell proliferation in bone marrow |
| GO:0042093 | 0.0049 | 6.3232 | 0.6877 | 4 | 51 | T-helper cell differentiation |
| GO:0001708 | 0.005 | 4.838 | 1.1058 | 5 | 82 | cell fate specification |
| GO:0061053 | 0.005 | 4.838 | 1.1058 | 5 | 82 | somite development |
| GO:0003205 | 0.0053 | 3.5173 | 2.1037 | 7 | 156 | cardiac chamber development |
| GO:2000113 | 0.0057 | 1.7079 | 20.1065 | 32 | 1491 | negative regulation of cellular macromolecule biosynthetic process |
| GO:0071773 | 0.0058 | 3.4472 | 2.1442 | 7 | 159 | cellular response to BMP stimulus |
| GO:0001838 | 0.0059 | 9.0478 | 0.3711 | 3 | 28 | embryonic epithelial tube formation |
| GO:0002293 | 0.006 | 5.9427 | 0.7282 | 4 | 54 | alpha-beta T cell differentiation involved in immune response |
| GO:0007405 | 0.006 | 5.9427 | 0.7282 | 4 | 54 | neuroblast proliferation |
| GO:0014807 | 0.0061 | 21.0849 | 0.1214 | 2 | 9 | regulation of somitogenesis |
| GO:0046549 | 0.0061 | 21.0849 | 0.1214 | 2 | 9 | retinal cone cell development |
| GO:0048087 | 0.0061 | 21.0849 | 0.1214 | 2 | 9 | positive regulation of developmental pigmentation |
| GO:0050932 | 0.0061 | 21.0849 | 0.1214 | 2 | 9 | regulation of pigment cell differentiation |
| GO:0048706 | 0.0063 | 8.8264 | 0.3789 | 3 | 29 | embryonic skeletal system development |
| GO:0043010 | 0.0064 | 2.6704 | 3.9377 | 10 | 292 | camera-type eye development |
| GO:0045595 | 0.0067 | 1.6622 | 21.9794 | 34 | 1644 | regulation of cell differentiation |
| GO:0010628 | 0.0069 | 1.6367 | 23.6666 | 36 | 1755 | positive regulation of gene expression |
| GO:0045137 | 0.0069 | 3.0299 | 2.778 | 8 | 206 | development of primary sexual characteristics |
| GO:0045600 | 0.0073 | 5.6053 | 0.7687 | 4 | 57 | positive regulation of fat cell differentiation |
| GO:0002828 | 0.0075 | 8.2274 | 0.4046 | 3 | 30 | regulation of type 2 immune response |
| GO:0032689 | 0.0075 | 8.2274 | 0.4046 | 3 | 30 | negative regulation of interferon-gamma production |
| GO:0040036 | 0.0075 | 8.2274 | 0.4046 | 3 | 30 | regulation of fibroblast growth factor receptor signaling pathway |
| GO:0071353 | 0.0075 | 8.2274 | 0.4046 | 3 | 30 | cellular response to interleukin-4 |
| GO:0014020 | 0.0081 | 4.2792 | 1.2406 | 5 | 92 | primary neural tube formation |
| GO:0035282 | 0.0081 | 4.2792 | 1.2406 | 5 | 92 | segmentation |
| GO:0009954 | 0.0082 | 7.933 | 0.418 | 3 | 31 | proximal/distal pattern formation |
| GO:0021522 | 0.0082 | 7.933 | 0.418 | 3 | 31 | spinal cord motor neuron differentiation |
| GO:0048608 | 0.0089 | 2.3113 | 5.448 | 12 | 404 | reproductive structure development |
| GO:0010557 | 0.0089 | 1.6365 | 21.5764 | 33 | 1600 | positive regulation of macromolecule biosynthetic process |
| GO:0035115 | 0.009 | 7.659 | 0.4315 | 3 | 32 | embryonic forelimb morphogenesis |
| GO:0021521 | 0.0092 | 16.3973 | 0.1483 | 2 | 11 | ventral spinal cord interneuron specification |
| GO:0021670 | 0.0092 | 16.3973 | 0.1483 | 2 | 11 | lateral ventricle development |
| GO:0021903 | 0.0092 | 16.3973 | 0.1483 | 2 | 11 | rostrocaudal neural tube patterning |
| GO:0032754 | 0.0092 | 16.3973 | 0.1483 | 2 | 11 | positive regulation of interleukin-5 production |
| GO:0042415 | 0.0092 | 16.3973 | 0.1483 | 2 | 11 | norepinephrine metabolic process |
| GO:0060033 | 0.0092 | 16.3973 | 0.1483 | 2 | 11 | anatomical structure regression |
| GO:2000774 | 0.0092 | 16.3973 | 0.1483 | 2 | 11 | positive regulation of cellular senescence |
| GO:0048869 | 0.0094 | 1.4418 | 52.4603 | 68 | 3961 | cellular developmental process |
| GO:0001662 | 0.0098 | 7.4032 | 0.445 | 3 | 33 | behavioral fear response |
| GO:0050767 | 0.0098 | 1.9712 | 9.0756 | 17 | 673 | regulation of neurogenesis |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0009593 | 0 | 13.3419 | 1.4377 | 14 | 449 | detection of chemical stimulus |
| GO:0050906 | 0 | 12.9739 | 1.4761 | 14 | 461 | detection of stimulus involved in sensory perception |
| GO:0007606 | 0 | 12.7971 | 1.4953 | 14 | 467 | sensory perception of chemical stimulus |
| GO:0050911 | 0 | 13.2654 | 1.1847 | 12 | 370 | detection of chemical stimulus involved in sensory perception of smell |
| GO:0050877 | 0 | 5.5812 | 3.8744 | 16 | 1210 | nervous system process |
| GO:0007186 | 0 | 4.8999 | 4.0089 | 15 | 1252 | G-protein coupled receptor signaling pathway |
| GO:0006688 | 1e-04 | 49.4939 | 0.0736 | 3 | 23 | glycosphingolipid biosynthetic process |
| GO:0019835 | 3e-04 | 25.3516 | 0.1345 | 3 | 42 | cytolysis |
| GO:0010623 | 8e-04 | 58.8255 | 0.0416 | 2 | 13 | programmed cell death involved in cell development |
| GO:0002418 | 9e-04 | 53.92 | 0.0448 | 2 | 14 | immune response to tumor cell |
| GO:0006955 | 0.001 | 3.0618 | 5.6607 | 14 | 1837 | immune response |
| GO:0052695 | 0.0013 | 43.128 | 0.0544 | 2 | 17 | cellular glucuronidation |
| GO:0030101 | 0.0016 | 14.0974 | 0.2337 | 3 | 73 | natural killer cell activation |
| GO:0006063 | 0.0022 | 32.336 | 0.0704 | 2 | 22 | uronic acid metabolic process |
| GO:0045321 | 0.0026 | 3.228 | 3.5926 | 10 | 1122 | leukocyte activation |
| GO:0002355 | 0.0032 | Inf | 0.0032 | 1 | 1 | detection of tumor cell |
| GO:0002642 | 0.0032 | Inf | 0.0032 | 1 | 1 | positive regulation of immunoglobulin biosynthetic process |
| GO:0030887 | 0.0032 | Inf | 0.0032 | 1 | 1 | positive regulation of myeloid dendritic cell activation |
| GO:0032078 | 0.0032 | Inf | 0.0032 | 1 | 1 | negative regulation of endodeoxyribonuclease activity |
| GO:1900758 | 0.0032 | Inf | 0.0032 | 1 | 1 | negative regulation of D-amino-acid oxidase activity |
| GO:0048265 | 0.0039 | 23.9422 | 0.0929 | 2 | 29 | response to pain |
| GO:0042113 | 0.0051 | 6.25 | 0.6948 | 4 | 217 | B cell activation |
| GO:0050715 | 0.0055 | 9.0315 | 0.3586 | 3 | 112 | positive regulation of cytokine secretion |
| GO:0009607 | 0.0056 | 3.2809 | 2.7473 | 8 | 858 | response to biotic stimulus |
| GO:1902042 | 0.0059 | 19.0047 | 0.1153 | 2 | 36 | negative regulation of extrinsic apoptotic signaling pathway via death domain receptors |
| GO:0006664 | 0.0061 | 8.7096 | 0.3714 | 3 | 116 | glycolipid metabolic process |
| GO:0002023 | 0.0064 | 317.3922 | 0.0064 | 1 | 2 | reduction of food intake in response to dietary excess |
| GO:0034021 | 0.0064 | 317.3922 | 0.0064 | 1 | 2 | response to silicon dioxide |
| GO:0035378 | 0.0064 | 317.3922 | 0.0064 | 1 | 2 | carbon dioxide transmembrane transport |
| GO:0036345 | 0.0064 | 317.3922 | 0.0064 | 1 | 2 | platelet maturation |
| GO:0043006 | 0.0064 | 317.3922 | 0.0064 | 1 | 2 | activation of phospholipase A2 activity by calcium-mediated signaling |
| GO:2000016 | 0.0064 | 317.3922 | 0.0064 | 1 | 2 | negative regulation of determination of dorsal identity |
| GO:2000351 | 0.0076 | 16.5631 | 0.1313 | 2 | 41 | regulation of endothelial cell apoptotic process |
| GO:0002793 | 0.0081 | 5.4454 | 0.7941 | 4 | 248 | positive regulation of peptide secretion |
| GO:0031343 | 0.0083 | 15.7532 | 0.1377 | 2 | 43 | positive regulation of cell killing |
| GO:0006874 | 0.0085 | 4.298 | 1.268 | 5 | 396 | cellular calcium ion homeostasis |
| GO:0060443 | 0.0087 | 15.3771 | 0.1409 | 2 | 44 | mammary gland morphogenesis |
| GO:0010469 | 0.0088 | 3.674 | 1.7963 | 6 | 561 | regulation of receptor activity |
| GO:0055065 | 0.009 | 3.6468 | 1.8091 | 6 | 565 | metal ion homeostasis |
| GO:0021553 | 0.0096 | 158.6863 | 0.0096 | 1 | 3 | olfactory nerve development |
| GO:0048388 | 0.0096 | 158.6863 | 0.0096 | 1 | 3 | endosomal lumen acidification |
| GO:0060648 | 0.0096 | 158.6863 | 0.0096 | 1 | 3 | mammary gland bud morphogenesis |
| GO:0060763 | 0.0096 | 158.6863 | 0.0096 | 1 | 3 | mammary duct terminal end bud growth |
| GO:0061368 | 0.0096 | 158.6863 | 0.0096 | 1 | 3 | behavioral response to formalin induced pain |
| GO:0099566 | 0.0096 | 158.6863 | 0.0096 | 1 | 3 | regulation of postsynaptic cytosolic calcium ion concentration |
| GO:1990743 | 0.0096 | 158.6863 | 0.0096 | 1 | 3 | protein sialylation |
| GO:0070231 | 0.0099 | 14.3493 | 0.1505 | 2 | 47 | T cell apoptotic process |
| GO:0046467 | 0.01 | 7.2263 | 0.4451 | 3 | 139 | membrane lipid biosynthetic process |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0007156 | 0 | 6.5627 | 1.8719 | 11 | 152 | homophilic cell adhesion via plasma membrane adhesion molecules |
| GO:0007399 | 0 | 3.145 | 8.228 | 23 | 717 | nervous system development |
| GO:0048736 | 0 | 5.8132 | 2.0936 | 11 | 170 | appendage development |
| GO:0007389 | 0 | 3.7083 | 5.0369 | 17 | 409 | pattern specification process |
| GO:0048568 | 1e-04 | 3.4441 | 5.0616 | 16 | 411 | embryonic organ development |
| GO:0000122 | 1e-04 | 2.7058 | 9.335 | 23 | 758 | negative regulation of transcription from RNA polymerase II promoter |
| GO:0035108 | 1e-04 | 5.5103 | 1.7857 | 9 | 145 | limb morphogenesis |
| GO:0045944 | 1e-04 | 2.3479 | 13.1527 | 28 | 1068 | positive regulation of transcription from RNA polymerase II promoter |
| GO:0021884 | 3e-04 | 14.859 | 0.3202 | 4 | 26 | forebrain neuron development |
| GO:0048704 | 3e-04 | 9.7145 | 0.5809 | 5 | 48 | embryonic skeletal system morphogenesis |
| GO:0001501 | 3e-04 | 2.9452 | 5.8621 | 16 | 476 | skeletal system development |
| GO:0009887 | 3e-04 | 2.2974 | 11.8719 | 25 | 964 | animal organ morphogenesis |
| GO:0022610 | 4e-04 | 2.0974 | 16.2685 | 31 | 1321 | biological adhesion |
| GO:0051253 | 4e-04 | 2.1298 | 14.9261 | 29 | 1212 | negative regulation of RNA metabolic process |
| GO:0043009 | 4e-04 | 2.7185 | 6.7365 | 17 | 547 | chordate embryonic development |
| GO:0140076 | 4e-04 | 162.0101 | 0.0369 | 2 | 3 | negative regulation of lipoprotein transport |
| GO:0048935 | 5e-04 | 24.4112 | 0.1601 | 3 | 13 | peripheral nervous system neuron development |
| GO:0051094 | 5e-04 | 3.3479 | 3.8581 | 12 | 335 | positive regulation of developmental process |
| GO:0001953 | 5e-04 | 12.1036 | 0.3818 | 4 | 31 | negative regulation of cell-matrix adhesion |
| GO:0098609 | 6e-04 | 2.362 | 9.6059 | 21 | 780 | cell-cell adhesion |
| GO:0045669 | 7e-04 | 7.7344 | 0.7143 | 5 | 58 | positive regulation of osteoblast differentiation |
| GO:1903507 | 8e-04 | 2.0972 | 14.0148 | 27 | 1138 | negative regulation of nucleic acid-templated transcription |
| GO:0021872 | 8e-04 | 7.5907 | 0.7266 | 5 | 59 | forebrain generation of neurons |
| GO:0014032 | 8e-04 | 7.4522 | 0.7389 | 5 | 60 | neural crest cell development |
| GO:0021555 | 9e-04 | 81 | 0.0493 | 2 | 4 | midbrain-hindbrain boundary morphogenesis |
| GO:0035113 | 9e-04 | 4.8525 | 1.5517 | 7 | 126 | embryonic appendage morphogenesis |
| GO:0072175 | 0.001 | 4.7717 | 1.5764 | 7 | 128 | epithelial tube formation |
| GO:0048863 | 0.0012 | 3.4215 | 3.1158 | 10 | 253 | stem cell differentiation |
| GO:0051240 | 0.0012 | 1.918 | 18.2389 | 32 | 1481 | positive regulation of multicellular organismal process |
| GO:0006355 | 0.0012 | 1.6413 | 42.4261 | 61 | 3445 | regulation of transcription, DNA-templated |
| GO:0045636 | 0.0015 | 53.9966 | 0.0616 | 2 | 5 | positive regulation of melanocyte differentiation |
| GO:2001141 | 0.0015 | 1.6248 | 42.7586 | 61 | 3472 | regulation of RNA biosynthetic process |
| GO:0035024 | 0.0015 | 15.2513 | 0.234 | 3 | 19 | negative regulation of Rho protein signal transduction |
| GO:1903305 | 0.0018 | 5.0311 | 1.2808 | 6 | 104 | regulation of regulated secretory pathway |
| GO:0009952 | 0.0019 | 3.7931 | 2.2449 | 8 | 184 | anterior/posterior pattern specification |
| GO:0019219 | 0.002 | 1.5752 | 49.5197 | 68 | 4021 | regulation of nucleobase-containing compound metabolic process |
| GO:0048701 | 0.0021 | 8.1633 | 0.5419 | 4 | 44 | embryonic cranial skeleton morphogenesis |
| GO:0043586 | 0.0021 | 13.555 | 0.2586 | 3 | 21 | tongue development |
| GO:0048762 | 0.0021 | 3.7342 | 2.2783 | 8 | 185 | mesenchymal cell differentiation |
| GO:0016331 | 0.0021 | 4.1794 | 1.7857 | 7 | 145 | morphogenesis of embryonic epithelium |
| GO:0022008 | 0.0026 | 1.8512 | 17.5616 | 30 | 1426 | neurogenesis |
| GO:0003357 | 0.003 | 32.3939 | 0.0862 | 2 | 7 | noradrenergic neuron differentiation |
| GO:0021953 | 0.0031 | 3.9072 | 1.9029 | 7 | 156 | central nervous system neuron differentiation |
| GO:0035239 | 0.0031 | 2.8054 | 4.1502 | 11 | 337 | tube morphogenesis |
| GO:0002703 | 0.0033 | 3.8421 | 1.9335 | 7 | 157 | regulation of leukocyte mediated immunity |
| GO:0060561 | 0.0035 | 11.0877 | 0.3079 | 3 | 25 | apoptotic process involved in morphogenesis |
| GO:0045165 | 0.0036 | 3.1286 | 3.0419 | 9 | 247 | cell fate commitment |
| GO:0006672 | 0.004 | 5.1154 | 1.0468 | 5 | 85 | ceramide metabolic process |
| GO:0021859 | 0.004 | 26.9933 | 0.0985 | 2 | 8 | pyramidal neuron differentiation |
| GO:0010557 | 0.0041 | 1.758 | 19.7044 | 32 | 1600 | positive regulation of macromolecule biosynthetic process |
| GO:0030851 | 0.0048 | 9.7553 | 0.3448 | 3 | 28 | granulocyte differentiation |
| GO:0043304 | 0.0048 | 9.7553 | 0.3448 | 3 | 28 | regulation of mast cell degranulation |
| GO:0002699 | 0.0048 | 3.5772 | 2.069 | 7 | 168 | positive regulation of immune effector process |
| GO:2000113 | 0.005 | 1.761 | 18.3621 | 30 | 1491 | negative regulation of cellular macromolecule biosynthetic process |
| GO:0010628 | 0.005 | 1.7041 | 21.6133 | 34 | 1755 | positive regulation of gene expression |
| GO:0048087 | 0.0051 | 23.1356 | 0.1108 | 2 | 9 | positive regulation of developmental pigmentation |
| GO:0050932 | 0.0051 | 23.1356 | 0.1108 | 2 | 9 | regulation of pigment cell differentiation |
| GO:0090370 | 0.0051 | 23.1356 | 0.1108 | 2 | 9 | negative regulation of cholesterol efflux |
| GO:2000109 | 0.0051 | 23.1356 | 0.1108 | 2 | 9 | regulation of macrophage apoptotic process |
| GO:1903508 | 0.0054 | 1.7844 | 16.8596 | 28 | 1369 | positive regulation of nucleic acid-templated transcription |
| GO:0002221 | 0.0057 | 3.4683 | 2.1305 | 7 | 173 | pattern recognition receptor signaling pathway |
| GO:0051254 | 0.0057 | 1.7583 | 17.734 | 29 | 1440 | positive regulation of RNA metabolic process |
| GO:0030278 | 0.0062 | 3.4061 | 2.1675 | 7 | 176 | regulation of ossification |
| GO:1901616 | 0.0064 | 5.8251 | 0.7389 | 4 | 60 | organic hydroxy compound catabolic process |
| GO:0003211 | 0.0064 | 20.2424 | 0.1232 | 2 | 10 | cardiac ventricle formation |
| GO:1902563 | 0.0064 | 20.2424 | 0.1232 | 2 | 10 | regulation of neutrophil activation |
| GO:0009954 | 0.0064 | 8.7085 | 0.3818 | 3 | 31 | proximal/distal pattern formation |
| GO:0009890 | 0.0065 | 1.6966 | 20.3325 | 32 | 1651 | negative regulation of biosynthetic process |
| GO:0021510 | 0.0067 | 4.4939 | 1.1823 | 5 | 96 | spinal cord development |
| GO:0010810 | 0.0072 | 3.3072 | 2.2291 | 7 | 181 | regulation of cell-substrate adhesion |
| GO:0034654 | 0.0073 | 1.4756 | 50.2463 | 66 | 4080 | nucleobase-containing compound biosynthetic process |
| GO:0022603 | 0.0074 | 1.8931 | 11.7857 | 21 | 957 | regulation of anatomical structure morphogenesis |
| GO:0042733 | 0.0075 | 5.5278 | 0.7759 | 4 | 63 | embryonic digit morphogenesis |
| GO:0080134 | 0.0076 | 1.7505 | 16.5025 | 27 | 1340 | regulation of response to stress |
| GO:0010985 | 0.0077 | 17.9921 | 0.1355 | 2 | 11 | negative regulation of lipoprotein particle clearance |
| GO:0021521 | 0.0077 | 17.9921 | 0.1355 | 2 | 11 | ventral spinal cord interneuron specification |
| GO:0021670 | 0.0077 | 17.9921 | 0.1355 | 2 | 11 | lateral ventricle development |
| GO:0021903 | 0.0077 | 17.9921 | 0.1355 | 2 | 11 | rostrocaudal neural tube patterning |
| GO:0031987 | 0.0077 | 17.9921 | 0.1355 | 2 | 11 | locomotion involved in locomotory behavior |
| GO:0060033 | 0.0077 | 17.9921 | 0.1355 | 2 | 11 | anatomical structure regression |
| GO:0007275 | 0.0078 | 1.4849 | 50.7076 | 66 | 4460 | multicellular organism development |
| GO:0001841 | 0.0079 | 4.3036 | 1.2315 | 5 | 100 | neural tube formation |
| GO:0061035 | 0.008 | 5.4354 | 0.7882 | 4 | 64 | regulation of cartilage development |
| GO:0061448 | 0.0082 | 2.942 | 2.8571 | 8 | 232 | connective tissue development |
| GO:0031057 | 0.0083 | 7.8643 | 0.4187 | 3 | 34 | negative regulation of histone modification |
| GO:0003341 | 0.0084 | 5.3459 | 0.8005 | 4 | 65 | cilium movement |
| GO:0017015 | 0.0086 | 4.2144 | 1.2562 | 5 | 102 | regulation of transforming growth factor beta receptor signaling pathway |
| GO:0032502 | 0.0089 | 1.7658 | 16.9757 | 27 | 1637 | developmental process |
| GO:0048869 | 0.0091 | 1.4792 | 45.3346 | 60 | 3796 | cellular developmental process |
| GO:0017121 | 0.0092 | 16.1919 | 0.1478 | 2 | 12 | phospholipid scrambling |
| GO:0042659 | 0.0092 | 16.1919 | 0.1478 | 2 | 12 | regulation of cell fate specification |
| GO:0045628 | 0.0092 | 16.1919 | 0.1478 | 2 | 12 | regulation of T-helper 2 cell differentiation |
| GO:0045597 | 0.0095 | 1.9433 | 9.797 | 18 | 813 | positive regulation of cell differentiation |
| GO:0033003 | 0.0097 | 7.3867 | 0.4433 | 3 | 36 | regulation of mast cell activation |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0007156 | 0 | 8.3185 | 2.0966 | 15 | 152 | homophilic cell adhesion via plasma membrane adhesion molecules |
| GO:0021510 | 0 | 11.6172 | 1.0219 | 10 | 75 | spinal cord development |
| GO:0045944 | 0 | 2.7803 | 14.731 | 36 | 1068 | positive regulation of transcription from RNA polymerase II promoter |
| GO:0045597 | 0 | 3.0773 | 11.0028 | 30 | 813 | positive regulation of cell differentiation |
| GO:0035107 | 0 | 6.7597 | 2 | 12 | 145 | appendage morphogenesis |
| GO:0060581 | 0 | 36.5434 | 0.2069 | 5 | 15 | cell fate commitment involved in pattern specification |
| GO:0000122 | 0 | 2.9914 | 10.4552 | 28 | 758 | negative regulation of transcription from RNA polymerase II promoter |
| GO:0060173 | 0 | 6.1236 | 2.1885 | 12 | 160 | limb development |
| GO:0021514 | 0 | 30.449 | 0.2345 | 5 | 17 | ventral spinal cord interneuron differentiation |
| GO:0007399 | 0 | 3.468 | 7.1489 | 22 | 604 | nervous system development |
| GO:0007389 | 0 | 3.9809 | 4.9981 | 18 | 375 | pattern specification process |
| GO:0022008 | 0 | 2.8686 | 11.3649 | 29 | 865 | neurogenesis |
| GO:0030182 | 0 | 3.1988 | 7.9926 | 23 | 613 | neuron differentiation |
| GO:0003151 | 0 | 8.9506 | 1.0207 | 8 | 74 | outflow tract morphogenesis |
| GO:0009952 | 0 | 5.2863 | 2.5056 | 12 | 184 | anterior/posterior pattern specification |
| GO:0021513 | 0 | 21.4867 | 0.3034 | 5 | 22 | spinal cord dorsal/ventral patterning |
| GO:0009790 | 0 | 2.6995 | 11.5071 | 28 | 849 | embryo development |
| GO:0001764 | 0 | 5.9888 | 1.8483 | 10 | 134 | neuron migration |
| GO:0048935 | 0 | 32.3374 | 0.1793 | 4 | 13 | peripheral nervous system neuron development |
| GO:0006355 | 0 | 1.8505 | 47.5172 | 74 | 3445 | regulation of transcription, DNA-templated |
| GO:2001141 | 0 | 1.8319 | 47.8897 | 74 | 3472 | regulation of RNA biosynthetic process |
| GO:0003214 | 0 | 29.1018 | 0.1931 | 4 | 14 | cardiac left ventricle morphogenesis |
| GO:0007218 | 1e-04 | 6.7812 | 1.3103 | 8 | 95 | neuropeptide signaling pathway |
| GO:0007267 | 1e-04 | 2.132 | 20.9931 | 40 | 1522 | cell-cell signaling |
| GO:0048870 | 1e-04 | 2.1651 | 19.5724 | 38 | 1419 | cell motility |
| GO:0007411 | 1e-04 | 4.3019 | 3.0345 | 12 | 220 | axon guidance |
| GO:1903508 | 1e-04 | 2.1812 | 18.8828 | 37 | 1369 | positive regulation of nucleic acid-templated transcription |
| GO:0021522 | 1e-04 | 14.0411 | 0.4276 | 5 | 31 | spinal cord motor neuron differentiation |
| GO:0022610 | 1e-04 | 2.1952 | 18.2207 | 36 | 1321 | biological adhesion |
| GO:0019219 | 1e-04 | 1.7361 | 55.4621 | 81 | 4021 | regulation of nucleobase-containing compound metabolic process |
| GO:0003357 | 1e-04 | 54.3394 | 0.0966 | 3 | 7 | noradrenergic neuron differentiation |
| GO:0060284 | 1e-04 | 2.484 | 10.9793 | 25 | 796 | regulation of cell development |
| GO:0048729 | 1e-04 | 2.7095 | 8.4138 | 21 | 610 | tissue morphogenesis |
| GO:0051240 | 1e-04 | 2.0633 | 20.4276 | 38 | 1481 | positive regulation of multicellular organismal process |
| GO:0051254 | 2e-04 | 2.0608 | 19.8621 | 37 | 1440 | positive regulation of RNA metabolic process |
| GO:0072089 | 2e-04 | 5.6667 | 1.5448 | 8 | 112 | stem cell proliferation |
| GO:0007268 | 2e-04 | 2.6762 | 8.0828 | 20 | 586 | chemical synaptic transmission |
| GO:0072272 | 2e-04 | Inf | 0.0276 | 2 | 2 | proximal/distal pattern formation involved in metanephric nephron development |
| GO:0099537 | 2e-04 | 2.6664 | 8.1103 | 20 | 588 | trans-synaptic signaling |
| GO:0060322 | 2e-04 | 2.53 | 9.4207 | 22 | 683 | head development |
| GO:1903507 | 2e-04 | 2.1632 | 15.6966 | 31 | 1138 | negative regulation of nucleic acid-templated transcription |
| GO:0001709 | 2e-04 | 10.4247 | 0.5517 | 5 | 40 | cell fate determination |
| GO:0009887 | 2e-04 | 2.5658 | 8.8838 | 21 | 685 | animal organ morphogenesis |
| GO:0021879 | 2e-04 | 15.5702 | 0.3121 | 4 | 23 | forebrain neuron differentiation |
| GO:0003231 | 2e-04 | 5.307 | 1.6414 | 8 | 119 | cardiac ventricle development |
| GO:0001667 | 2e-04 | 3.2493 | 4.6345 | 14 | 336 | ameboidal-type cell migration |
| GO:0007519 | 3e-04 | 4.6465 | 2.0966 | 9 | 152 | skeletal muscle tissue development |
| GO:0003211 | 3e-04 | 31.0452 | 0.1379 | 3 | 10 | cardiac ventricle formation |
| GO:0035640 | 3e-04 | 14.5418 | 0.331 | 4 | 24 | exploration behavior |
| GO:0001501 | 3e-04 | 2.7835 | 6.5655 | 17 | 476 | skeletal system development |
| GO:0051960 | 3e-04 | 2.3756 | 10.469 | 23 | 759 | regulation of nervous system development |
| GO:0021903 | 4e-04 | 27.1629 | 0.1517 | 3 | 11 | rostrocaudal neural tube patterning |
| GO:0030900 | 4e-04 | 3.083 | 4.869 | 14 | 353 | forebrain development |
| GO:0021884 | 4e-04 | 13.2182 | 0.3586 | 4 | 26 | forebrain neuron development |
| GO:0034654 | 4e-04 | 1.6361 | 56.2759 | 79 | 4080 | nucleobase-containing compound biosynthetic process |
| GO:0048869 | 4e-04 | 1.7586 | 37.4773 | 57 | 2997 | cellular developmental process |
| GO:0061564 | 5e-04 | 2.8016 | 6.1241 | 16 | 444 | axon development |
| GO:0007275 | 5e-04 | 1.723 | 44.7093 | 65 | 3729 | multicellular organism development |
| GO:0048704 | 5e-04 | 8.6171 | 0.652 | 5 | 48 | embryonic skeletal system morphogenesis |
| GO:0010628 | 5e-04 | 1.8695 | 24.2069 | 41 | 1755 | positive regulation of gene expression |
| GO:0010454 | 5e-04 | 24.1433 | 0.1655 | 3 | 12 | negative regulation of cell fate commitment |
| GO:0048863 | 6e-04 | 3.5298 | 3.3373 | 11 | 244 | stem cell differentiation |
| GO:0021912 | 6e-04 | 144.2793 | 0.0414 | 2 | 3 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification |
| GO:0010557 | 6e-04 | 1.8905 | 22.069 | 38 | 1600 | positive regulation of macromolecule biosynthetic process |
| GO:0048667 | 6e-04 | 2.6299 | 6.9241 | 17 | 502 | cell morphogenesis involved in neuron differentiation |
| GO:0051253 | 6e-04 | 2.0176 | 16.7172 | 31 | 1212 | negative regulation of RNA metabolic process |
| GO:0010811 | 6e-04 | 5.2396 | 1.4483 | 7 | 105 | positive regulation of cell-substrate adhesion |
| GO:0060537 | 7e-04 | 2.9075 | 5.1448 | 14 | 373 | muscle tissue development |
| GO:0048812 | 8e-04 | 2.5042 | 7.6966 | 18 | 558 | neuron projection morphogenesis |
| GO:0009954 | 8e-04 | 10.767 | 0.4276 | 4 | 31 | proximal/distal pattern formation |
| GO:0007626 | 8e-04 | 4.9811 | 1.5174 | 7 | 112 | locomotory behavior |
| GO:0048592 | 8e-04 | 4.3569 | 1.9724 | 8 | 143 | eye morphogenesis |
| GO:0043009 | 9e-04 | 2.8403 | 5.264 | 14 | 392 | chordate embryonic development |
| GO:0051093 | 9e-04 | 2.1653 | 11.931 | 24 | 865 | negative regulation of developmental process |
| GO:0035115 | 9e-04 | 10.3818 | 0.4414 | 4 | 32 | embryonic forelimb morphogenesis |
| GO:0032989 | 0.001 | 2.0778 | 13.4897 | 26 | 978 | cellular component morphogenesis |
| GO:0007379 | 0.001 | 18.1041 | 0.2069 | 3 | 15 | segment specification |
| GO:0035295 | 0.0011 | 3.7871 | 2.5405 | 9 | 192 | tube development |
| GO:0048858 | 0.0011 | 2.4251 | 7.931 | 18 | 575 | cell projection morphogenesis |
| GO:0048762 | 0.0011 | 3.7674 | 2.5517 | 9 | 185 | mesenchymal cell differentiation |
| GO:0021913 | 0.0011 | 72.1351 | 0.0552 | 2 | 4 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification |
| GO:0034287 | 0.0011 | 72.1351 | 0.0552 | 2 | 4 | detection of monosaccharide stimulus |
| GO:0042662 | 0.0011 | 72.1351 | 0.0552 | 2 | 4 | negative regulation of mesodermal cell fate specification |
| GO:0051594 | 0.0011 | 72.1351 | 0.0552 | 2 | 4 | detection of glucose |
| GO:0060214 | 0.0011 | 72.1351 | 0.0552 | 2 | 4 | endocardium formation |
| GO:0072086 | 0.0011 | 72.1351 | 0.0552 | 2 | 4 | specification of loop of Henle identity |
| GO:1905903 | 0.0011 | 72.1351 | 0.0552 | 2 | 4 | negative regulation of mesoderm formation |
| GO:0098609 | 0.0012 | 2.1923 | 10.7586 | 22 | 780 | cell-cell adhesion |
| GO:0045669 | 0.0012 | 6.8765 | 0.8 | 5 | 58 | positive regulation of osteoblast differentiation |
| GO:0021915 | 0.0014 | 3.9982 | 2.1379 | 8 | 155 | neural tube development |
| GO:0014032 | 0.0014 | 6.6256 | 0.8276 | 5 | 60 | neural crest cell development |
| GO:0050793 | 0.0014 | 1.879 | 19.213 | 33 | 1477 | regulation of developmental process |
| GO:1990830 | 0.0014 | 5.2834 | 1.2276 | 6 | 89 | cellular response to leukemia inhibitory factor |
| GO:0031328 | 0.0015 | 1.78 | 23.931 | 39 | 1735 | positive regulation of cellular biosynthetic process |
| GO:0014003 | 0.0015 | 9.0818 | 0.4966 | 4 | 36 | oligodendrocyte development |
| GO:0060219 | 0.0015 | 15.5158 | 0.2345 | 3 | 17 | camera-type eye photoreceptor cell differentiation |
| GO:0045664 | 0.0016 | 2.3949 | 7.5586 | 17 | 548 | regulation of neuron differentiation |
| GO:0060021 | 0.0016 | 5.1584 | 1.2552 | 6 | 91 | palate development |
| GO:0050768 | 0.0017 | 3.2502 | 3.269 | 10 | 237 | negative regulation of neurogenesis |
| GO:0030326 | 0.0018 | 5.0658 | 1.2759 | 6 | 94 | embryonic limb morphogenesis |
| GO:0021778 | 0.0018 | 48.0871 | 0.069 | 2 | 5 | oligodendrocyte cell fate specification |
| GO:0045636 | 0.0018 | 48.0871 | 0.069 | 2 | 5 | positive regulation of melanocyte differentiation |
| GO:0007423 | 0.0021 | 2.402 | 7.0759 | 16 | 513 | sensory organ development |
| GO:0009890 | 0.0021 | 1.7655 | 22.7724 | 37 | 1651 | negative regulation of biosynthetic process |
| GO:0007517 | 0.0021 | 2.6794 | 5.1448 | 13 | 373 | muscle organ development |
| GO:0002089 | 0.0021 | 13.5747 | 0.2621 | 3 | 19 | lens morphogenesis in camera-type eye |
| GO:0046883 | 0.0022 | 3.138 | 3.3793 | 10 | 245 | regulation of hormone secretion |
| GO:0030324 | 0.0022 | 3.6937 | 2.3034 | 8 | 167 | lung development |
| GO:0060411 | 0.0023 | 5.8749 | 0.9241 | 5 | 67 | cardiac septum morphogenesis |
| GO:0045446 | 0.0024 | 4.7639 | 1.3517 | 6 | 98 | endothelial cell differentiation |
| GO:2000113 | 0.0024 | 1.7881 | 20.5655 | 34 | 1491 | negative regulation of cellular macromolecule biosynthetic process |
| GO:0023019 | 0.0025 | 12.7754 | 0.2759 | 3 | 20 | signal transduction involved in regulation of gene expression |
| GO:0060039 | 0.0025 | 12.7754 | 0.2759 | 3 | 20 | pericardium development |
| GO:0048646 | 0.0025 | 1.9617 | 13.646 | 25 | 998 | anatomical structure formation involved in morphogenesis |
| GO:0035239 | 0.0026 | 2.7328 | 4.6483 | 12 | 337 | tube morphogenesis |
| GO:0021902 | 0.0027 | 36.0631 | 0.0828 | 2 | 6 | commitment of neuronal cell to specific neuron type in forebrain |
| GO:0030240 | 0.0027 | 36.0631 | 0.0828 | 2 | 6 | skeletal muscle thin filament assembly |
| GO:0032229 | 0.0027 | 36.0631 | 0.0828 | 2 | 6 | negative regulation of synaptic transmission, GABAergic |
| GO:0033603 | 0.0027 | 36.0631 | 0.0828 | 2 | 6 | positive regulation of dopamine secretion |
| GO:0008306 | 0.0028 | 5.6027 | 0.9655 | 5 | 70 | associative learning |
| GO:0007617 | 0.0029 | 12.0649 | 0.2897 | 3 | 21 | mating behavior |
| GO:0021516 | 0.0029 | 12.0649 | 0.2897 | 3 | 21 | dorsal spinal cord development |
| GO:0048485 | 0.0029 | 12.0649 | 0.2897 | 3 | 21 | sympathetic nervous system development |
| GO:0048701 | 0.0031 | 7.2618 | 0.6069 | 4 | 44 | embryonic cranial skeleton morphogenesis |
| GO:0048665 | 0.0031 | 11.6347 | 0.2982 | 3 | 22 | neuron fate specification |
| GO:0007631 | 0.0033 | 4.4251 | 1.4483 | 6 | 105 | feeding behavior |
| GO:0031018 | 0.0034 | 7.0843 | 0.6207 | 4 | 45 | endocrine pancreas development |
| GO:0003206 | 0.0034 | 7.0445 | 0.6232 | 4 | 46 | cardiac chamber morphogenesis |
| GO:0050769 | 0.0035 | 2.5081 | 5.4759 | 13 | 397 | positive regulation of neurogenesis |
| GO:0048562 | 0.0036 | 3.4014 | 2.4898 | 8 | 187 | embryonic organ morphogenesis |
| GO:0021521 | 0.0037 | 29.1073 | 0.0957 | 2 | 7 | ventral spinal cord interneuron specification |
| GO:0001655 | 0.0037 | 2.7333 | 4.2483 | 11 | 308 | urogenital system development |
| GO:0043279 | 0.0038 | 4.2941 | 1.4897 | 6 | 108 | response to alkaloid |
| GO:0002067 | 0.004 | 6.7539 | 0.6483 | 4 | 47 | glandular epithelial cell differentiation |
| GO:2000179 | 0.004 | 6.7539 | 0.6483 | 4 | 47 | positive regulation of neural precursor cell proliferation |
| GO:0008344 | 0.004 | 5.1273 | 1.0483 | 5 | 76 | adult locomotory behavior |
| GO:0016331 | 0.004 | 3.7115 | 2 | 7 | 145 | morphogenesis of embryonic epithelium |
| GO:0001708 | 0.0041 | 6.6541 | 0.6561 | 4 | 49 | cell fate specification |
| GO:0048732 | 0.0047 | 2.4177 | 5.669 | 13 | 411 | gland development |
| GO:0048596 | 0.0048 | 9.8688 | 0.3448 | 3 | 25 | embryonic camera-type eye morphogenesis |
| GO:0032502 | 0.0049 | 1.9013 | 14.6261 | 25 | 1368 | developmental process |
| GO:0061178 | 0.0049 | 6.3123 | 0.6897 | 4 | 50 | regulation of insulin secretion involved in cellular response to glucose stimulus |
| GO:0021859 | 0.005 | 24.039 | 0.1103 | 2 | 8 | pyramidal neuron differentiation |
| GO:0033860 | 0.005 | 24.039 | 0.1103 | 2 | 8 | regulation of NAD(P)H oxidase activity |
| GO:0045924 | 0.005 | 24.039 | 0.1103 | 2 | 8 | regulation of female receptivity |
| GO:0061303 | 0.005 | 24.039 | 0.1103 | 2 | 8 | cornea development in camera-type eye |
| GO:2000035 | 0.005 | 24.039 | 0.1103 | 2 | 8 | regulation of stem cell division |
| GO:0002011 | 0.0053 | 6.1776 | 0.7034 | 4 | 51 | morphogenesis of an epithelial sheet |
| GO:0002063 | 0.0053 | 9.4391 | 0.3586 | 3 | 26 | chondrocyte development |
| GO:0061053 | 0.0055 | 4.726 | 1.131 | 5 | 82 | somite development |
| GO:0030198 | 0.0057 | 2.5741 | 4.4966 | 11 | 326 | extracellular matrix organization |
| GO:0061311 | 0.0059 | 9.0452 | 0.3724 | 3 | 27 | cell surface receptor signaling pathway involved in heart development |
| GO:0045927 | 0.006 | 2.8731 | 3.2966 | 9 | 239 | positive regulation of growth |
| GO:0000904 | 0.0062 | 3.866 | 1.6441 | 6 | 125 | cell morphogenesis involved in differentiation |
| GO:0019098 | 0.0062 | 20.8624 | 0.1226 | 2 | 9 | reproductive behavior |
| GO:0003266 | 0.0064 | 20.6036 | 0.1241 | 2 | 9 | regulation of secondary heart field cardioblast proliferation |
| GO:0007614 | 0.0064 | 20.6036 | 0.1241 | 2 | 9 | short-term memory |
| GO:0046549 | 0.0064 | 20.6036 | 0.1241 | 2 | 9 | retinal cone cell development |
| GO:0046877 | 0.0064 | 20.6036 | 0.1241 | 2 | 9 | regulation of saliva secretion |
| GO:0048087 | 0.0064 | 20.6036 | 0.1241 | 2 | 9 | positive regulation of developmental pigmentation |
| GO:0048865 | 0.0064 | 20.6036 | 0.1241 | 2 | 9 | stem cell fate commitment |
| GO:0050932 | 0.0064 | 20.6036 | 0.1241 | 2 | 9 | regulation of pigment cell differentiation |
| GO:0061004 | 0.0064 | 20.6036 | 0.1241 | 2 | 9 | pattern specification involved in kidney development |
| GO:1905770 | 0.0064 | 20.6036 | 0.1241 | 2 | 9 | regulation of mesodermal cell differentiation |
| GO:1902692 | 0.0066 | 8.6829 | 0.3862 | 3 | 28 | regulation of neuroblast proliferation |
| GO:0071805 | 0.0067 | 3.0525 | 2.7586 | 8 | 200 | potassium ion transmembrane transport |
| GO:0021543 | 0.0068 | 3.3445 | 2.2069 | 7 | 160 | pallium development |
| GO:0040012 | 0.007 | 1.8976 | 11.7103 | 21 | 849 | regulation of locomotion |
| GO:0010719 | 0.0073 | 8.3484 | 0.4 | 3 | 29 | negative regulation of epithelial to mesenchymal transition |
| GO:0046530 | 0.0074 | 5.5818 | 0.7724 | 4 | 56 | photoreceptor cell differentiation |
| GO:0003263 | 0.0079 | 18.027 | 0.1379 | 2 | 10 | cardioblast proliferation |
| GO:0035878 | 0.0079 | 18.027 | 0.1379 | 2 | 10 | nail development |
| GO:0048845 | 0.0079 | 18.027 | 0.1379 | 2 | 10 | venous blood vessel morphogenesis |
| GO:0072175 | 0.0087 | 3.5857 | 1.7655 | 6 | 128 | epithelial tube formation |
| GO:0009914 | 0.0087 | 2.5429 | 4.1241 | 10 | 299 | hormone transport |
| GO:0001569 | 0.0088 | 7.7511 | 0.4276 | 3 | 31 | branching involved in blood vessel morphogenesis |
| GO:0003209 | 0.0088 | 7.7511 | 0.4276 | 3 | 31 | cardiac atrium morphogenesis |
| GO:0090130 | 0.0093 | 2.6725 | 3.531 | 9 | 256 | tissue migration |
| GO:0051705 | 0.0094 | 5.1818 | 0.8276 | 4 | 60 | multi-organism behavior |
| GO:0008038 | 0.0096 | 7.4834 | 0.4414 | 3 | 32 | neuron recognition |
| GO:0043278 | 0.0096 | 7.4834 | 0.4414 | 3 | 32 | response to morphine |
| GO:0003157 | 0.0096 | 16.023 | 0.1517 | 2 | 11 | endocardium development |
| GO:0009886 | 0.0096 | 16.023 | 0.1517 | 2 | 11 | post-embryonic animal morphogenesis |
| GO:0042415 | 0.0096 | 16.023 | 0.1517 | 2 | 11 | norepinephrine metabolic process |
| GO:0050890 | 0.0097 | 2.6507 | 3.5586 | 9 | 258 | cognition |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0007156 | 9e-04 | 4.8673 | 1.5443 | 7 | 152 | homophilic cell adhesion via plasma membrane adhesion molecules |
| GO:0061844 | 0.0018 | 8.4726 | 0.5182 | 4 | 51 | antimicrobial humoral immune response mediated by antimicrobial peptide |
| GO:0006376 | 0.0025 | 12.385 | 0.2743 | 3 | 27 | mRNA splice site selection |
| GO:0098660 | 0.0026 | 2.2988 | 7.9452 | 17 | 782 | inorganic ion transmembrane transport |
| GO:0016339 | 0.0028 | 11.8889 | 0.2845 | 3 | 28 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules |
| GO:0006813 | 0.0029 | 3.5259 | 2.4079 | 8 | 237 | potassium ion transport |
| GO:0050684 | 0.0047 | 4.8937 | 1.0871 | 5 | 107 | regulation of mRNA processing |
| GO:0006812 | 0.0054 | 1.9961 | 10.7595 | 20 | 1059 | cation transport |
| GO:0019731 | 0.0067 | 8.4868 | 0.3861 | 3 | 38 | antibacterial humoral response |
| GO:0050832 | 0.0072 | 8.2505 | 0.3962 | 3 | 39 | defense response to fungus |
| GO:0070986 | 0.0074 | 17.9186 | 0.1321 | 2 | 13 | left/right axis specification |
| GO:0043269 | 0.0083 | 2.2566 | 6.0961 | 13 | 600 | regulation of ion transport |
| GO:0006836 | 0.0085 | 3.5946 | 1.7577 | 6 | 173 | neurotransmitter transport |
| GO:0051852 | 0.0086 | 16.4243 | 0.1422 | 2 | 14 | disruption by host of symbiont cells |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0002263 | 0 | 5.4879 | 7.3559 | 33 | 660 | cell activation involved in immune response |
| GO:0045087 | 0 | 4.0643 | 9.3398 | 32 | 838 | innate immune response |
| GO:0002285 | 0 | 9.5323 | 1.7164 | 14 | 154 | lymphocyte activation involved in immune response |
| GO:0050900 | 0 | 5.3434 | 4.525 | 21 | 406 | leukocyte migration |
| GO:0045321 | 0 | 4.2469 | 6.8579 | 25 | 664 | leukocyte activation |
| GO:0002275 | 0 | 4.3325 | 5.7844 | 22 | 519 | myeloid cell activation involved in immune response |
| GO:0002444 | 0 | 3.9618 | 5.6682 | 20 | 514 | myeloid leukocyte mediated immunity |
| GO:0090026 | 0 | 35.0656 | 0.2006 | 5 | 18 | positive regulation of monocyte chemotaxis |
| GO:0071222 | 0 | 6.7269 | 1.8278 | 11 | 164 | cellular response to lipopolysaccharide |
| GO:0007166 | 0 | 2.2452 | 28.5468 | 53 | 2600 | cell surface receptor signaling pathway |
| GO:1903039 | 0 | 5.602 | 2.374 | 12 | 213 | positive regulation of leukocyte cell-cell adhesion |
| GO:0043312 | 0 | 3.8392 | 5.2049 | 18 | 467 | neutrophil degranulation |
| GO:0032940 | 0 | 2.5932 | 15.0545 | 34 | 1365 | secretion by cell |
| GO:0042119 | 0 | 3.7532 | 5.3163 | 18 | 477 | neutrophil activation |
| GO:0051251 | 0 | 4.9536 | 2.8978 | 13 | 260 | positive regulation of lymphocyte activation |
| GO:0060326 | 0 | 4.9333 | 2.9089 | 13 | 261 | cell chemotaxis |
| GO:0050867 | 0 | 4.5907 | 3.3659 | 14 | 302 | positive regulation of cell activation |
| GO:0022610 | 0 | 2.5571 | 14.723 | 33 | 1321 | biological adhesion |
| GO:0050863 | 0 | 4.4953 | 3.4328 | 14 | 308 | regulation of T cell activation |
| GO:0071216 | 0 | 5.7081 | 2.1288 | 11 | 191 | cellular response to biotic stimulus |
| GO:0002322 | 0 | 135.3118 | 0.0557 | 3 | 5 | B cell proliferation involved in immune response |
| GO:0045055 | 0 | 3.1007 | 7.8909 | 22 | 708 | regulated exocytosis |
| GO:0042330 | 0 | 3.3577 | 6.2525 | 19 | 561 | taxis |
| GO:0032946 | 0 | 6.7794 | 1.4712 | 9 | 132 | positive regulation of mononuclear cell proliferation |
| GO:0045785 | 0 | 3.9072 | 4.2129 | 15 | 378 | positive regulation of cell adhesion |
| GO:0070098 | 0 | 8.8098 | 0.8916 | 7 | 80 | chemokine-mediated signaling pathway |
| GO:0046651 | 0 | 10.9874 | 0.6216 | 6 | 59 | lymphocyte proliferation |
| GO:0046631 | 0 | 7.0263 | 1.2594 | 8 | 113 | alpha-beta T cell activation |
| GO:0002684 | 0 | 4.7799 | 2.5212 | 11 | 242 | positive regulation of immune system process |
| GO:0022407 | 1e-04 | 3.602 | 4.5473 | 15 | 408 | regulation of cell-cell adhesion |
| GO:0030593 | 1e-04 | 7.9357 | 0.9808 | 7 | 88 | neutrophil chemotaxis |
| GO:0002521 | 1e-04 | 3.4024 | 5.138 | 16 | 461 | leukocyte differentiation |
| GO:0097530 | 1e-04 | 6.4679 | 1.3597 | 8 | 122 | granulocyte migration |
| GO:0070661 | 1e-04 | 9.6945 | 0.6958 | 6 | 66 | leukocyte proliferation |
| GO:0043615 | 1e-04 | 54.1146 | 0.0892 | 3 | 8 | astrocyte cell migration |
| GO:0071675 | 1e-04 | 12.6444 | 0.457 | 5 | 41 | regulation of mononuclear cell migration |
| GO:0002440 | 1e-04 | 5.266 | 1.8613 | 9 | 167 | production of molecular mediator of immune response |
| GO:0050670 | 1e-04 | 6.0111 | 1.4554 | 8 | 133 | regulation of lymphocyte proliferation |
| GO:0051707 | 1e-04 | 2.6672 | 9.0723 | 22 | 814 | response to other organism |
| GO:0042107 | 1e-04 | Inf | 0.0218 | 2 | 2 | cytokine metabolic process |
| GO:2000458 | 1e-04 | Inf | 0.0223 | 2 | 2 | regulation of astrocyte chemotaxis |
| GO:0070663 | 2e-04 | 5.6884 | 1.5324 | 8 | 140 | regulation of leukocyte proliferation |
| GO:0035589 | 2e-04 | 38.6485 | 0.1115 | 3 | 10 | G-protein coupled purinergic nucleotide receptor signaling pathway |
| GO:0071346 | 2e-04 | 5.5796 | 1.5603 | 8 | 140 | cellular response to interferon-gamma |
| GO:0030183 | 2e-04 | 6.1718 | 1.2371 | 7 | 111 | B cell differentiation |
| GO:0050792 | 3e-04 | 4.6684 | 2.0842 | 9 | 187 | regulation of viral process |
| GO:0032729 | 3e-04 | 9.786 | 0.5734 | 5 | 52 | positive regulation of interferon-gamma production |
| GO:0002237 | 3e-04 | 3.5489 | 3.6445 | 12 | 327 | response to molecule of bacterial origin |
| GO:0007194 | 5e-04 | 12.0746 | 0.3789 | 4 | 34 | negative regulation of adenylate cyclase activity |
| GO:0002292 | 5e-04 | 8.2665 | 0.6687 | 5 | 60 | T cell differentiation involved in immune response |
| GO:0002694 | 6e-04 | 3.5371 | 3.3414 | 11 | 309 | regulation of leukocyte activation |
| GO:0002313 | 6e-04 | 22.5379 | 0.1672 | 3 | 15 | mature B cell differentiation involved in immune response |
| GO:0023052 | 8e-04 | 1.6288 | 67.6855 | 89 | 6073 | signaling |
| GO:0006950 | 8e-04 | 1.7078 | 40.1566 | 59 | 3603 | response to stress |
| GO:0006959 | 8e-04 | 3.9491 | 2.4408 | 9 | 219 | humoral immune response |
| GO:0002710 | 8e-04 | 19.3158 | 0.1895 | 3 | 17 | negative regulation of T cell mediated immunity |
| GO:0006955 | 9e-04 | 4.3604 | 1.9843 | 8 | 244 | immune response |
| GO:0007154 | 9e-04 | 1.6197 | 67.9196 | 89 | 6094 | cell communication |
| GO:0050715 | 0.001 | 5.6465 | 1.1469 | 6 | 104 | positive regulation of cytokine secretion |
| GO:0016192 | 0.0011 | 1.9009 | 19.7941 | 34 | 1776 | vesicle-mediated transport |
| GO:0046641 | 0.0012 | 16.8992 | 0.2118 | 3 | 19 | positive regulation of alpha-beta T cell proliferation |
| GO:0002688 | 0.0012 | 5.4717 | 1.1814 | 6 | 106 | regulation of leukocyte chemotaxis |
| GO:0002309 | 0.0012 | 59.7989 | 0.0557 | 2 | 5 | T cell proliferation involved in immune response |
| GO:0043308 | 0.0012 | 59.7989 | 0.0557 | 2 | 5 | eosinophil degranulation |
| GO:1901078 | 0.0012 | 59.7989 | 0.0557 | 2 | 5 | negative regulation of relaxation of muscle |
| GO:0071310 | 0.0012 | 1.7885 | 26.3364 | 42 | 2363 | cellular response to organic substance |
| GO:0006954 | 0.0012 | 2.6392 | 6.0994 | 15 | 559 | inflammatory response |
| GO:0048534 | 0.0012 | 2.288 | 9.4401 | 20 | 847 | hematopoietic or lymphoid organ development |
| GO:0002548 | 0.0013 | 9.3058 | 0.4774 | 4 | 44 | monocyte chemotaxis |
| GO:1903901 | 0.0013 | 6.6807 | 0.8136 | 5 | 73 | negative regulation of viral life cycle |
| GO:0002374 | 0.0013 | 15.9042 | 0.2229 | 3 | 20 | cytokine secretion involved in immune response |
| GO:0050778 | 0.0014 | 2.4456 | 7.4674 | 17 | 670 | positive regulation of immune response |
| GO:0002695 | 0.0014 | 4.5094 | 1.6607 | 7 | 149 | negative regulation of leukocyte activation |
| GO:0070374 | 0.0015 | 3.9463 | 2.1622 | 8 | 194 | positive regulation of ERK1 and ERK2 cascade |
| GO:0010818 | 0.0016 | 15.0197 | 0.2341 | 3 | 21 | T cell chemotaxis |
| GO:0042102 | 0.0016 | 6.411 | 0.845 | 5 | 77 | positive regulation of T cell proliferation |
| GO:0002824 | 0.0016 | 6.3972 | 0.847 | 5 | 76 | positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains |
| GO:1903555 | 0.0016 | 5.16 | 1.2483 | 6 | 112 | regulation of tumor necrosis factor superfamily cytokine production |
| GO:0045058 | 0.0017 | 8.6182 | 0.5127 | 4 | 46 | T cell selection |
| GO:0002460 | 0.0017 | 5.0721 | 1.2683 | 6 | 117 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains |
| GO:0043307 | 0.0018 | 44.8464 | 0.0669 | 2 | 6 | eosinophil activation |
| GO:0070383 | 0.0018 | 44.8464 | 0.0669 | 2 | 6 | DNA cytosine deamination |
| GO:0030803 | 0.002 | 8.2255 | 0.535 | 4 | 48 | negative regulation of cyclic nucleotide biosynthetic process |
| GO:0031347 | 0.0021 | 2.3444 | 7.7683 | 17 | 697 | regulation of defense response |
| GO:0002706 | 0.0021 | 4.8817 | 1.3151 | 6 | 118 | regulation of lymphocyte mediated immunity |
| GO:0002250 | 0.0021 | 4.8654 | 1.3189 | 6 | 125 | adaptive immune response |
| GO:0032101 | 0.0021 | 2.3372 | 7.7906 | 17 | 699 | regulation of response to external stimulus |
| GO:0032663 | 0.0021 | 8.0422 | 0.5461 | 4 | 49 | regulation of interleukin-2 production |
| GO:0043901 | 0.0022 | 4.1549 | 1.7944 | 7 | 161 | negative regulation of multi-organism process |
| GO:0030815 | 0.0023 | 7.8669 | 0.5573 | 4 | 50 | negative regulation of cAMP metabolic process |
| GO:0002230 | 0.0023 | 12.8716 | 0.2675 | 3 | 24 | positive regulation of defense response to virus by host |
| GO:0002831 | 0.0025 | 4.7122 | 1.3597 | 6 | 122 | regulation of response to biotic stimulus |
| GO:1900372 | 0.0025 | 7.699 | 0.5684 | 4 | 51 | negative regulation of purine nucleotide biosynthetic process |
| GO:0035627 | 0.0025 | 35.8749 | 0.078 | 2 | 7 | ceramide transport |
| GO:0045869 | 0.0025 | 35.8749 | 0.078 | 2 | 7 | negative regulation of single stranded viral RNA replication via double stranded DNA intermediate |
| GO:0048007 | 0.0025 | 35.8749 | 0.078 | 2 | 7 | antigen processing and presentation, exogenous lipid antigen via MHC class Ib |
| GO:0002407 | 0.0026 | 12.2858 | 0.2786 | 3 | 25 | dendritic cell chemotaxis |
| GO:0002699 | 0.0028 | 3.9725 | 1.8724 | 7 | 168 | positive regulation of immune effector process |
| GO:0045730 | 0.0029 | 11.7509 | 0.2898 | 3 | 26 | respiratory burst |
| GO:0050921 | 0.0031 | 4.4788 | 1.4266 | 6 | 128 | positive regulation of chemotaxis |
| GO:0006909 | 0.0032 | 3.4732 | 2.4408 | 8 | 219 | phagocytosis |
| GO:0002819 | 0.0033 | 5.3559 | 0.9998 | 5 | 91 | regulation of adaptive immune response |
| GO:0002887 | 0.0033 | 29.8939 | 0.0892 | 2 | 8 | negative regulation of myeloid leukocyte mediated immunity |
| GO:0031666 | 0.0033 | 29.8939 | 0.0892 | 2 | 8 | positive regulation of lipopolysaccharide-mediated signaling pathway |
| GO:1902715 | 0.0033 | 29.8939 | 0.0892 | 2 | 8 | positive regulation of interferon-gamma secretion |
| GO:2001185 | 0.0033 | 29.8939 | 0.0892 | 2 | 8 | regulation of CD8-positive, alpha-beta T cell activation |
| GO:0071347 | 0.0033 | 5.3389 | 1.0031 | 5 | 90 | cellular response to interleukin-1 |
| GO:0006171 | 0.0034 | 4.406 | 1.4489 | 6 | 130 | cAMP biosynthetic process |
| GO:0035587 | 0.0036 | 10.8094 | 0.3121 | 3 | 28 | purinergic receptor signaling pathway |
| GO:1901137 | 0.0038 | 2.1988 | 8.2475 | 17 | 740 | carbohydrate derivative biosynthetic process |
| GO:0031279 | 0.004 | 5.0977 | 1.0477 | 5 | 94 | regulation of cyclase activity |
| GO:0032365 | 0.004 | 10.393 | 0.3232 | 3 | 29 | intracellular lipid transport |
| GO:2000403 | 0.004 | 10.393 | 0.3232 | 3 | 29 | positive regulation of lymphocyte migration |
| GO:0048870 | 0.0042 | 1.8473 | 15.8152 | 27 | 1419 | cell motility |
| GO:0051339 | 0.0042 | 5.0407 | 1.0588 | 5 | 95 | regulation of lyase activity |
| GO:0009972 | 0.0042 | 25.6217 | 0.1003 | 2 | 9 | cytidine deamination |
| GO:0032621 | 0.0042 | 25.6217 | 0.1003 | 2 | 9 | interleukin-18 production |
| GO:0043301 | 0.0042 | 25.6217 | 0.1003 | 2 | 9 | negative regulation of leukocyte degranulation |
| GO:0046087 | 0.0042 | 25.6217 | 0.1003 | 2 | 9 | cytidine metabolic process |
| GO:0033993 | 0.0044 | 2.0702 | 9.8079 | 19 | 880 | response to lipid |
| GO:0042116 | 0.0048 | 6.3443 | 0.6799 | 4 | 61 | macrophage activation |
| GO:0001818 | 0.0049 | 3.2252 | 2.6192 | 8 | 235 | negative regulation of cytokine production |
| GO:0034612 | 0.0052 | 2.9487 | 3.221 | 9 | 289 | response to tumor necrosis factor |
| GO:0001820 | 0.0052 | 22.4176 | 0.1115 | 2 | 10 | serotonin secretion |
| GO:0002475 | 0.0052 | 22.4176 | 0.1115 | 2 | 10 | antigen processing and presentation via MHC class Ib |
| GO:2000551 | 0.0052 | 22.4176 | 0.1115 | 2 | 10 | regulation of T-helper 2 cell cytokine production |
| GO:0007162 | 0.0053 | 3.1825 | 2.6526 | 8 | 238 | negative regulation of cell adhesion |
| GO:0032760 | 0.0053 | 6.1285 | 0.7022 | 4 | 63 | positive regulation of tumor necrosis factor production |
| GO:0002718 | 0.0056 | 6.026 | 0.7133 | 4 | 64 | regulation of cytokine production involved in immune response |
| GO:0001817 | 0.0058 | 3.1364 | 2.6932 | 8 | 258 | regulation of cytokine production |
| GO:0002369 | 0.0058 | 9.0051 | 0.3678 | 3 | 33 | T cell cytokine production |
| GO:0072529 | 0.0058 | 9.0051 | 0.3678 | 3 | 33 | pyrimidine-containing compound catabolic process |
| GO:0042089 | 0.0059 | 4.6269 | 1.148 | 5 | 103 | cytokine biosynthetic process |
| GO:0050672 | 0.006 | 5.9268 | 0.7244 | 4 | 65 | negative regulation of lymphocyte proliferation |
| GO:0051716 | 0.0062 | 1.489 | 70.4087 | 87 | 6647 | cellular response to stimulus |
| GO:0016553 | 0.0064 | 19.9255 | 0.1226 | 2 | 11 | base conversion or substitution editing |
| GO:0032754 | 0.0064 | 19.9255 | 0.1226 | 2 | 11 | positive regulation of interleukin-5 production |
| GO:0044546 | 0.0064 | 19.9255 | 0.1226 | 2 | 11 | NLRP3 inflammasome complex assembly |
| GO:0046133 | 0.0064 | 19.9255 | 0.1226 | 2 | 11 | pyrimidine ribonucleoside catabolic process |
| GO:0046348 | 0.0064 | 19.9255 | 0.1226 | 2 | 11 | amino sugar catabolic process |
| GO:0072672 | 0.0064 | 19.9255 | 0.1226 | 2 | 11 | neutrophil extravasation |
| GO:0031295 | 0.0066 | 5.738 | 0.7467 | 4 | 67 | T cell costimulation |
| GO:0002793 | 0.0067 | 3.048 | 2.764 | 8 | 248 | positive regulation of peptide secretion |
| GO:0009187 | 0.007 | 3.3246 | 2.2179 | 7 | 199 | cyclic nucleotide metabolic process |
| GO:0002704 | 0.0072 | 8.2748 | 0.397 | 3 | 36 | negative regulation of leukocyte mediated immunity |
| GO:0070664 | 0.0073 | 5.5607 | 0.769 | 4 | 69 | negative regulation of leukocyte proliferation |
| GO:0045086 | 0.0076 | 17.9318 | 0.1337 | 2 | 12 | positive regulation of interleukin-2 biosynthetic process |
| GO:0048247 | 0.0077 | 8.0708 | 0.4061 | 3 | 37 | lymphocyte chemotaxis |
| GO:0050729 | 0.0078 | 4.3166 | 1.226 | 5 | 110 | positive regulation of inflammatory response |
| GO:0042092 | 0.008 | 7.9437 | 0.4124 | 3 | 37 | type 2 immune response |
| GO:0061028 | 0.008 | 7.9437 | 0.4124 | 3 | 37 | establishment of endothelial barrier |
| GO:0098657 | 0.0083 | 2.1183 | 7.4897 | 15 | 672 | import into cell |
| GO:0048584 | 0.0084 | 1.8054 | 14.325 | 24 | 1360 | positive regulation of response to stimulus |
| GO:0030335 | 0.0086 | 2.4272 | 4.7702 | 11 | 428 | positive regulation of cell migration |
| GO:0043900 | 0.0088 | 3.1787 | 2.3158 | 7 | 214 | regulation of multi-organism process |
| GO:0006047 | 0.0089 | 16.3007 | 0.1449 | 2 | 13 | UDP-N-acetylglucosamine metabolic process |
| GO:0010623 | 0.0089 | 16.3007 | 0.1449 | 2 | 13 | programmed cell death involved in cell development |
| GO:0045072 | 0.0089 | 16.3007 | 0.1449 | 2 | 13 | regulation of interferon-gamma biosynthetic process |
| GO:0045980 | 0.0089 | 5.237 | 0.8136 | 4 | 73 | negative regulation of nucleotide metabolic process |
| GO:0002820 | 0.0093 | 7.5014 | 0.4347 | 3 | 39 | negative regulation of adaptive immune response |
| GO:0045807 | 0.0093 | 4.1191 | 1.2817 | 5 | 115 | positive regulation of endocytosis |
| GO:0042221 | 0.0094 | 1.4793 | 46.4537 | 61 | 4168 | response to chemical |
| GO:0032653 | 0.0099 | 7.2982 | 0.4458 | 3 | 40 | regulation of interleukin-10 production |
| GO:0042088 | 0.0099 | 7.2982 | 0.4458 | 3 | 40 | T-helper 1 type immune response |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0002263 | 0 | 5.2463 | 7.1527 | 31 | 660 | cell activation involved in immune response |
| GO:0045087 | 0 | 4.0419 | 9.0818 | 31 | 838 | innate immune response |
| GO:0002285 | 0 | 9.0066 | 1.669 | 13 | 154 | lymphocyte activation involved in immune response |
| GO:0045321 | 0 | 4.1619 | 6.6896 | 24 | 664 | leukocyte activation |
| GO:0090026 | 0 | 36.1021 | 0.1951 | 5 | 18 | positive regulation of monocyte chemotaxis |
| GO:0071222 | 0 | 6.9329 | 1.7773 | 11 | 164 | cellular response to lipopolysaccharide |
| GO:0002275 | 0 | 3.91 | 5.4362 | 19 | 507 | myeloid cell activation involved in immune response |
| GO:1903039 | 0 | 5.7747 | 2.3084 | 12 | 213 | positive regulation of leukocyte cell-cell adhesion |
| GO:0007166 | 0 | 2.1958 | 28.4808 | 52 | 2628 | cell surface receptor signaling pathway |
| GO:0050863 | 0 | 4.6355 | 3.3379 | 14 | 308 | regulation of T cell activation |
| GO:0071216 | 0 | 5.883 | 2.07 | 11 | 191 | cellular response to biotic stimulus |
| GO:0002322 | 0 | 139.2659 | 0.0542 | 3 | 5 | B cell proliferation involved in immune response |
| GO:0022610 | 0 | 2.5472 | 14.3163 | 32 | 1321 | biological adhesion |
| GO:0045785 | 0 | 4.0298 | 4.0966 | 15 | 378 | positive regulation of cell adhesion |
| GO:0097529 | 0 | 12.194 | 0.5662 | 6 | 54 | myeloid leukocyte migration |
| GO:0070098 | 0 | 9.0733 | 0.867 | 7 | 80 | chemokine-mediated signaling pathway |
| GO:0050867 | 0 | 4.3534 | 3.2729 | 13 | 302 | positive regulation of cell activation |
| GO:0051251 | 0 | 4.6664 | 2.8177 | 12 | 260 | positive regulation of lymphocyte activation |
| GO:0046651 | 0 | 11.2666 | 0.6068 | 6 | 59 | lymphocyte proliferation |
| GO:0002444 | 0 | 3.3902 | 5.5099 | 17 | 514 | myeloid leukocyte mediated immunity |
| GO:0022407 | 0 | 3.7151 | 4.4217 | 15 | 408 | regulation of cell-cell adhesion |
| GO:0070661 | 1e-04 | 9.9409 | 0.6793 | 6 | 66 | leukocyte proliferation |
| GO:0042119 | 1e-04 | 3.3846 | 5.1695 | 16 | 477 | neutrophil activation |
| GO:0071675 | 1e-04 | 13.0182 | 0.4443 | 5 | 41 | regulation of mononuclear cell migration |
| GO:0002440 | 1e-04 | 5.4254 | 1.8099 | 9 | 167 | production of molecular mediator of immune response |
| GO:0032946 | 1e-04 | 6.1214 | 1.4305 | 8 | 132 | positive regulation of mononuclear cell proliferation |
| GO:0042107 | 1e-04 | Inf | 0.0212 | 2 | 2 | cytokine metabolic process |
| GO:0034097 | 1e-04 | 2.5433 | 10.4365 | 24 | 963 | response to cytokine |
| GO:0002684 | 2e-04 | 4.4763 | 2.4278 | 10 | 242 | positive regulation of immune system process |
| GO:0030098 | 2e-04 | 3.7933 | 3.4246 | 12 | 316 | lymphocyte differentiation |
| GO:0043312 | 2e-04 | 3.218 | 5.0611 | 15 | 467 | neutrophil degranulation |
| GO:0051707 | 2e-04 | 2.609 | 8.8217 | 21 | 814 | response to other organism |
| GO:0046631 | 2e-04 | 6.2357 | 1.2246 | 7 | 113 | alpha-beta T cell activation |
| GO:0032729 | 2e-04 | 10.0787 | 0.5574 | 5 | 52 | positive regulation of interferon-gamma production |
| GO:0002237 | 2e-04 | 3.6583 | 3.5438 | 12 | 327 | response to molecule of bacterial origin |
| GO:0045055 | 3e-04 | 2.7005 | 7.6729 | 19 | 708 | regulated exocytosis |
| GO:0050778 | 4e-04 | 2.6929 | 7.2611 | 18 | 670 | positive regulation of immune response |
| GO:0097530 | 4e-04 | 5.7444 | 1.3222 | 7 | 122 | granulocyte migration |
| GO:0030593 | 4e-04 | 6.8789 | 0.9537 | 6 | 88 | neutrophil chemotaxis |
| GO:0007194 | 5e-04 | 12.4295 | 0.3685 | 4 | 34 | negative regulation of adenylate cyclase activity |
| GO:0050670 | 6e-04 | 5.3458 | 1.4143 | 7 | 133 | regulation of lymphocyte proliferation |
| GO:0031347 | 6e-04 | 2.5813 | 7.5537 | 18 | 697 | regulation of defense response |
| GO:0002520 | 6e-04 | 2.3719 | 9.6345 | 21 | 889 | immune system development |
| GO:0023052 | 7e-04 | 1.6458 | 65.8158 | 87 | 6073 | signaling |
| GO:0070663 | 7e-04 | 5.0609 | 1.4891 | 7 | 140 | regulation of leukocyte proliferation |
| GO:0002710 | 8e-04 | 19.8803 | 0.1842 | 3 | 17 | negative regulation of T cell mediated immunity |
| GO:0007154 | 8e-04 | 1.6366 | 66.0433 | 87 | 6094 | cell communication |
| GO:0071346 | 8e-04 | 4.9614 | 1.5172 | 7 | 140 | cellular response to interferon-gamma |
| GO:0050715 | 9e-04 | 5.8163 | 1.1148 | 6 | 104 | positive regulation of cytokine secretion |
| GO:0006954 | 9e-04 | 2.7247 | 5.9262 | 15 | 559 | inflammatory response |
| GO:0002688 | 0.001 | 5.6344 | 1.1488 | 6 | 106 | regulation of leukocyte chemotaxis |
| GO:0002335 | 0.0011 | 17.3931 | 0.2059 | 3 | 19 | mature B cell differentiation |
| GO:0046641 | 0.0011 | 17.3931 | 0.2059 | 3 | 19 | positive regulation of alpha-beta T cell proliferation |
| GO:0002309 | 0.0011 | 61.5364 | 0.0542 | 2 | 5 | T cell proliferation involved in immune response |
| GO:0043308 | 0.0011 | 61.5364 | 0.0542 | 2 | 5 | eosinophil degranulation |
| GO:1901078 | 0.0011 | 61.5364 | 0.0542 | 2 | 5 | negative regulation of relaxation of muscle |
| GO:1903901 | 0.0012 | 6.8782 | 0.7911 | 5 | 73 | negative regulation of viral life cycle |
| GO:0002695 | 0.0012 | 4.6443 | 1.6148 | 7 | 149 | negative regulation of leukocyte activation |
| GO:0030097 | 0.0012 | 2.3492 | 8.735 | 19 | 806 | hemopoiesis |
| GO:0002374 | 0.0012 | 16.3689 | 0.2167 | 3 | 20 | cytokine secretion involved in immune response |
| GO:0002683 | 0.0013 | 3.6755 | 2.6152 | 9 | 249 | negative regulation of immune system process |
| GO:0042102 | 0.0014 | 6.6038 | 0.8212 | 5 | 77 | positive regulation of T cell proliferation |
| GO:0002824 | 0.0014 | 6.5864 | 0.8236 | 5 | 76 | positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains |
| GO:0002460 | 0.0015 | 5.2284 | 1.232 | 6 | 117 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains |
| GO:0045058 | 0.0015 | 8.8715 | 0.4985 | 4 | 46 | T cell selection |
| GO:0032940 | 0.0015 | 2.3014 | 8.9439 | 19 | 863 | secretion by cell |
| GO:0040011 | 0.0016 | 1.9141 | 17.8276 | 31 | 1645 | locomotion |
| GO:0032101 | 0.0016 | 2.4115 | 7.5754 | 17 | 699 | regulation of response to external stimulus |
| GO:0002694 | 0.0016 | 3.2862 | 3.2454 | 10 | 309 | regulation of leukocyte activation |
| GO:0072678 | 0.0017 | 8.6647 | 0.5094 | 4 | 47 | T cell migration |
| GO:0043307 | 0.0017 | 46.1494 | 0.065 | 2 | 6 | eosinophil activation |
| GO:0070383 | 0.0017 | 46.1494 | 0.065 | 2 | 6 | DNA cytosine deamination |
| GO:0030803 | 0.0018 | 8.4672 | 0.5202 | 4 | 48 | negative regulation of cyclic nucleotide biosynthetic process |
| GO:0002706 | 0.0018 | 5.0269 | 1.2788 | 6 | 118 | regulation of lymphocyte mediated immunity |
| GO:0043901 | 0.0019 | 4.2792 | 1.7448 | 7 | 161 | negative regulation of multi-organism process |
| GO:0032663 | 0.0019 | 8.2786 | 0.531 | 4 | 49 | regulation of interleukin-2 production |
| GO:0051241 | 0.002 | 2.11 | 11.2856 | 22 | 1053 | negative regulation of multicellular organismal process |
| GO:0048583 | 0.002 | 1.709 | 31.5052 | 47 | 3078 | regulation of response to stimulus |
| GO:0030815 | 0.0021 | 8.0981 | 0.5419 | 4 | 50 | negative regulation of cAMP metabolic process |
| GO:0002831 | 0.0021 | 4.8523 | 1.3222 | 6 | 122 | regulation of response to biotic stimulus |
| GO:0002230 | 0.0021 | 13.2477 | 0.2601 | 3 | 24 | positive regulation of defense response to virus by host |
| GO:0006935 | 0.0022 | 2.8 | 4.5686 | 12 | 433 | chemotaxis |
| GO:1900372 | 0.0022 | 7.9253 | 0.5527 | 4 | 51 | negative regulation of purine nucleotide biosynthetic process |
| GO:0045638 | 0.0023 | 5.8421 | 0.9212 | 5 | 85 | negative regulation of myeloid cell differentiation |
| GO:0045869 | 0.0024 | 36.9172 | 0.0759 | 2 | 7 | negative regulation of single stranded viral RNA replication via double stranded DNA intermediate |
| GO:0048007 | 0.0024 | 36.9172 | 0.0759 | 2 | 7 | antigen processing and presentation, exogenous lipid antigen via MHC class Ib |
| GO:0002699 | 0.0024 | 4.0913 | 1.8207 | 7 | 168 | positive regulation of immune effector process |
| GO:0042113 | 0.0026 | 3.6124 | 2.3517 | 8 | 217 | B cell activation |
| GO:0016192 | 0.0027 | 1.8247 | 19.2473 | 32 | 1776 | vesicle-mediated transport |
| GO:0006909 | 0.0027 | 3.5777 | 2.3734 | 8 | 219 | phagocytosis |
| GO:0006959 | 0.0027 | 3.5777 | 2.3734 | 8 | 219 | humoral immune response |
| GO:0045730 | 0.0027 | 12.0942 | 0.2818 | 3 | 26 | respiratory burst |
| GO:0050921 | 0.0027 | 4.612 | 1.3872 | 6 | 128 | positive regulation of chemotaxis |
| GO:0002819 | 0.0029 | 5.517 | 0.9717 | 5 | 91 | regulation of adaptive immune response |
| GO:0006171 | 0.0029 | 4.537 | 1.4089 | 6 | 130 | cAMP biosynthetic process |
| GO:0002887 | 0.0031 | 30.7625 | 0.0867 | 2 | 8 | negative regulation of myeloid leukocyte mediated immunity |
| GO:0031666 | 0.0031 | 30.7625 | 0.0867 | 2 | 8 | positive regulation of lipopolysaccharide-mediated signaling pathway |
| GO:0043615 | 0.0031 | 30.7625 | 0.0867 | 2 | 8 | astrocyte cell migration |
| GO:1902715 | 0.0031 | 30.7625 | 0.0867 | 2 | 8 | positive regulation of interferon-gamma secretion |
| GO:2001185 | 0.0031 | 30.7625 | 0.0867 | 2 | 8 | regulation of CD8-positive, alpha-beta T cell activation |
| GO:0006950 | 0.0032 | 1.6035 | 39.0473 | 55 | 3603 | response to stress |
| GO:0031279 | 0.0036 | 5.2484 | 1.0187 | 5 | 94 | regulation of cyclase activity |
| GO:0048247 | 0.0036 | 6.8949 | 0.6286 | 4 | 58 | lymphocyte chemotaxis |
| GO:0006955 | 0.0036 | 3.8019 | 1.9667 | 7 | 246 | immune response |
| GO:2000403 | 0.0037 | 10.6968 | 0.3143 | 3 | 29 | positive regulation of lymphocyte migration |
| GO:0051339 | 0.0037 | 5.1897 | 1.0296 | 5 | 95 | regulation of lyase activity |
| GO:0030595 | 0.004 | 6.6766 | 0.6468 | 4 | 62 | leukocyte chemotaxis |
| GO:0009972 | 0.004 | 26.3662 | 0.0975 | 2 | 9 | cytidine deamination |
| GO:0032621 | 0.004 | 26.3662 | 0.0975 | 2 | 9 | interleukin-18 production |
| GO:0043301 | 0.004 | 26.3662 | 0.0975 | 2 | 9 | negative regulation of leukocyte degranulation |
| GO:0046087 | 0.004 | 26.3662 | 0.0975 | 2 | 9 | cytidine metabolic process |
| GO:0002292 | 0.0041 | 6.6478 | 0.6502 | 4 | 60 | T cell differentiation involved in immune response |
| GO:0071310 | 0.0042 | 1.683 | 25.6089 | 39 | 2363 | cellular response to organic substance |
| GO:0050792 | 0.0043 | 3.6551 | 2.0266 | 7 | 187 | regulation of viral process |
| GO:0007162 | 0.0045 | 3.2783 | 2.5793 | 8 | 238 | negative regulation of cell adhesion |
| GO:0032760 | 0.0048 | 6.3086 | 0.6828 | 4 | 63 | positive regulation of tumor necrosis factor production |
| GO:0001820 | 0.005 | 23.069 | 0.1084 | 2 | 10 | serotonin secretion |
| GO:0002475 | 0.005 | 23.069 | 0.1084 | 2 | 10 | antigen processing and presentation via MHC class Ib |
| GO:0035589 | 0.005 | 23.069 | 0.1084 | 2 | 10 | G-protein coupled purinergic nucleotide receptor signaling pathway |
| GO:2000551 | 0.005 | 23.069 | 0.1084 | 2 | 10 | regulation of T-helper 2 cell cytokine production |
| GO:0002718 | 0.0051 | 6.2031 | 0.6936 | 4 | 64 | regulation of cytokine production involved in immune response |
| GO:0042089 | 0.0053 | 4.7637 | 1.1163 | 5 | 103 | cytokine biosynthetic process |
| GO:0002369 | 0.0054 | 9.2682 | 0.3576 | 3 | 33 | T cell cytokine production |
| GO:0050672 | 0.0054 | 6.101 | 0.7044 | 4 | 65 | negative regulation of lymphocyte proliferation |
| GO:0002793 | 0.0057 | 3.1397 | 2.6877 | 8 | 248 | positive regulation of peptide secretion |
| GO:0031295 | 0.006 | 5.9066 | 0.7261 | 4 | 67 | T cell costimulation |
| GO:0032637 | 0.006 | 5.9066 | 0.7261 | 4 | 67 | interleukin-8 production |
| GO:0016553 | 0.006 | 20.5045 | 0.1192 | 2 | 11 | base conversion or substitution editing |
| GO:0032754 | 0.006 | 20.5045 | 0.1192 | 2 | 11 | positive regulation of interleukin-5 production |
| GO:0044546 | 0.006 | 20.5045 | 0.1192 | 2 | 11 | NLRP3 inflammasome complex assembly |
| GO:0046133 | 0.006 | 20.5045 | 0.1192 | 2 | 11 | pyrimidine ribonucleoside catabolic process |
| GO:0046348 | 0.006 | 20.5045 | 0.1192 | 2 | 11 | amino sugar catabolic process |
| GO:0072672 | 0.006 | 20.5045 | 0.1192 | 2 | 11 | neutrophil extravasation |
| GO:0009187 | 0.006 | 3.4241 | 2.1567 | 7 | 199 | cyclic nucleotide metabolic process |
| GO:0001817 | 0.0064 | 2.6791 | 3.943 | 10 | 383 | regulation of cytokine production |
| GO:0098657 | 0.0065 | 2.1848 | 7.2828 | 15 | 672 | import into cell |
| GO:0070664 | 0.0067 | 5.7242 | 0.7478 | 4 | 69 | negative regulation of leukocyte proliferation |
| GO:0002704 | 0.0067 | 8.5194 | 0.3859 | 3 | 36 | negative regulation of leukocyte mediated immunity |
| GO:0050729 | 0.0069 | 4.4442 | 1.1921 | 5 | 110 | positive regulation of inflammatory response |
| GO:0030335 | 0.0071 | 2.5015 | 4.6384 | 11 | 428 | positive regulation of cell migration |
| GO:0002281 | 0.0072 | 18.4529 | 0.13 | 2 | 12 | macrophage activation involved in immune response |
| GO:0045086 | 0.0072 | 18.4529 | 0.13 | 2 | 12 | positive regulation of interleukin-2 biosynthetic process |
| GO:1900029 | 0.0072 | 18.4529 | 0.13 | 2 | 12 | positive regulation of ruffle assembly |
| GO:0033993 | 0.0072 | 2.0091 | 9.5369 | 18 | 880 | response to lipid |
| GO:0050896 | 0.0074 | 1.8288 | 19.7448 | 30 | 2549 | response to stimulus |
| GO:1903555 | 0.0075 | 4.3606 | 1.2138 | 5 | 112 | regulation of tumor necrosis factor superfamily cytokine production |
| GO:0002764 | 0.0076 | 2.3705 | 5.3429 | 12 | 493 | immune response-regulating signaling pathway |
| GO:0002429 | 0.0078 | 2.7569 | 3.4355 | 9 | 317 | immune response-activating cell surface receptor signaling pathway |
| GO:0045980 | 0.0081 | 5.391 | 0.7911 | 4 | 73 | negative regulation of nucleotide metabolic process |
| GO:0045807 | 0.0083 | 4.2408 | 1.2463 | 5 | 115 | positive regulation of endocytosis |
| GO:0006047 | 0.0084 | 16.7743 | 0.1409 | 2 | 13 | UDP-N-acetylglucosamine metabolic process |
| GO:0010623 | 0.0084 | 16.7743 | 0.1409 | 2 | 13 | programmed cell death involved in cell development |
| GO:0045072 | 0.0084 | 16.7743 | 0.1409 | 2 | 13 | regulation of interferon-gamma biosynthetic process |
| GO:0002820 | 0.0086 | 7.7206 | 0.4227 | 3 | 39 | negative regulation of adaptive immune response |
| GO:0009306 | 0.0091 | 2.311 | 5.4729 | 12 | 505 | protein secretion |
| GO:0071674 | 0.0092 | 7.5141 | 0.4328 | 3 | 41 | mononuclear cell migration |
| GO:0032653 | 0.0092 | 7.5115 | 0.4335 | 3 | 40 | regulation of interleukin-10 production |
| GO:0042088 | 0.0092 | 7.5115 | 0.4335 | 3 | 40 | T-helper 1 type immune response |
| GO:0002250 | 0.0093 | 4.1229 | 1.2799 | 5 | 125 | adaptive immune response |
| GO:0051240 | 0.0095 | 1.7404 | 16.0502 | 26 | 1481 | positive regulation of multicellular organismal process |
| GO:0002693 | 0.0098 | 15.3755 | 0.1517 | 2 | 14 | positive regulation of cellular extravasation |
| GO:0002829 | 0.0098 | 15.3755 | 0.1517 | 2 | 14 | negative regulation of type 2 immune response |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0007218 | 1e-04 | 6.9768 | 1.1056 | 7 | 95 | neuropeptide signaling pathway |
| GO:0048935 | 4e-04 | 25.8726 | 0.1513 | 3 | 13 | peripheral nervous system neuron development |
| GO:0043553 | 8e-04 | 85.8235 | 0.0466 | 2 | 4 | negative regulation of phosphatidylinositol 3-kinase activity |
| GO:0032502 | 9e-04 | 1.6013 | 67.7677 | 89 | 5823 | developmental process |
| GO:0010529 | 0.0013 | 16.1643 | 0.2211 | 3 | 19 | negative regulation of transposition |
| GO:0048557 | 0.0013 | 16.1643 | 0.2211 | 3 | 19 | embryonic digestive tract morphogenesis |
| GO:0045636 | 0.0013 | 57.2121 | 0.0582 | 2 | 5 | positive regulation of melanocyte differentiation |
| GO:0060012 | 0.0013 | 57.2121 | 0.0582 | 2 | 5 | synaptic transmission, glycinergic |
| GO:0060437 | 0.0013 | 57.2121 | 0.0582 | 2 | 5 | lung growth |
| GO:0007626 | 0.0016 | 3.8971 | 2.1879 | 8 | 188 | locomotory behavior |
| GO:0007275 | 0.002 | 1.5945 | 50.8382 | 69 | 4547 | multicellular organism development |
| GO:0042110 | 0.0023 | 2.6516 | 5.2138 | 13 | 448 | T cell activation |
| GO:0061053 | 0.0027 | 5.6374 | 0.9543 | 5 | 82 | somite development |
| GO:0007399 | 0.0028 | 1.7235 | 24.9401 | 39 | 2143 | nervous system development |
| GO:0001838 | 0.0028 | 4.5835 | 1.3966 | 6 | 120 | embryonic epithelial tube formation |
| GO:0007389 | 0.0031 | 2.6733 | 4.7599 | 12 | 409 | pattern specification process |
| GO:0048568 | 0.0032 | 2.6595 | 4.7832 | 12 | 411 | embryonic organ development |
| GO:0098916 | 0.0036 | 2.3371 | 6.8198 | 15 | 586 | anterograde trans-synaptic signaling |
| GO:0099536 | 0.0037 | 2.3286 | 6.8431 | 15 | 588 | synaptic signaling |
| GO:0001501 | 0.0039 | 2.4868 | 5.5397 | 13 | 476 | skeletal system development |
| GO:0035282 | 0.0044 | 4.9863 | 1.0707 | 5 | 92 | segmentation |
| GO:0048704 | 0.0044 | 4.9863 | 1.0707 | 5 | 92 | embryonic skeletal system morphogenesis |
| GO:0014807 | 0.0046 | 24.5134 | 0.1047 | 2 | 9 | regulation of somitogenesis |
| GO:0048087 | 0.0046 | 24.5134 | 0.1047 | 2 | 9 | positive regulation of developmental pigmentation |
| GO:0050932 | 0.0046 | 24.5134 | 0.1047 | 2 | 9 | regulation of pigment cell differentiation |
| GO:0043009 | 0.0049 | 2.3292 | 6.3659 | 14 | 547 | chordate embryonic development |
| GO:0030198 | 0.0049 | 2.7818 | 3.794 | 10 | 326 | extracellular matrix organization |
| GO:0040036 | 0.005 | 9.5723 | 0.3491 | 3 | 30 | regulation of fibroblast growth factor receptor signaling pathway |
| GO:0070286 | 0.005 | 9.5723 | 0.3491 | 3 | 30 | axonemal dynein complex assembly |
| GO:0009954 | 0.0055 | 9.2298 | 0.3608 | 3 | 31 | proximal/distal pattern formation |
| GO:0003211 | 0.0057 | 21.4479 | 0.1164 | 2 | 10 | cardiac ventricle formation |
| GO:0035148 | 0.0062 | 3.8655 | 1.6409 | 6 | 141 | tube formation |
| GO:0006821 | 0.0063 | 4.5641 | 1.1638 | 5 | 100 | chloride transport |
| GO:0035107 | 0.007 | 3.7533 | 1.6875 | 6 | 145 | appendage morphogenesis |
| GO:0048598 | 0.0071 | 2.2212 | 6.6569 | 14 | 572 | embryonic morphogenesis |
| GO:0009952 | 0.0079 | 3.2453 | 2.2694 | 7 | 195 | anterior/posterior pattern specification |
| GO:0060536 | 0.0082 | 17.1561 | 0.1397 | 2 | 12 | cartilage morphogenesis |
| GO:0035137 | 0.0084 | 7.8289 | 0.419 | 3 | 36 | hindlimb morphogenesis |
| GO:0040019 | 0.0084 | 7.8289 | 0.419 | 3 | 36 | positive regulation of embryonic development |
| GO:0007156 | 0.0088 | 3.5717 | 1.769 | 6 | 152 | homophilic cell adhesion via plasma membrane adhesion molecules |
| GO:0007519 | 0.0088 | 3.5717 | 1.769 | 6 | 152 | skeletal muscle tissue development |
| GO:0031274 | 0.0097 | 15.5955 | 0.1513 | 2 | 13 | positive regulation of pseudopodium assembly |
| GO:1905205 | 0.0097 | 15.5955 | 0.1513 | 2 | 13 | positive regulation of connective tissue replacement |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0099537 | 1e-04 | 3.0771 | 6.4086 | 18 | 588 | trans-synaptic signaling |
| GO:0050925 | 1e-04 | Inf | 0.0218 | 2 | 2 | negative regulation of negative chemotaxis |
| GO:0072272 | 1e-04 | Inf | 0.0218 | 2 | 2 | proximal/distal pattern formation involved in metanephric nephron development |
| GO:0019098 | 3e-04 | 14.2614 | 0.327 | 4 | 30 | reproductive behavior |
| GO:0008038 | 4e-04 | 13.2411 | 0.3488 | 4 | 32 | neuron recognition |
| GO:0007379 | 5e-04 | 23.0618 | 0.1635 | 3 | 15 | segment specification |
| GO:0006933 | 7e-04 | 91.7771 | 0.0436 | 2 | 4 | negative regulation of cell adhesion involved in substrate-bound cell migration |
| GO:0007621 | 7e-04 | 91.7771 | 0.0436 | 2 | 4 | negative regulation of female receptivity |
| GO:0033600 | 7e-04 | 91.7771 | 0.0436 | 2 | 4 | negative regulation of mammary gland epithelial cell proliferation |
| GO:0072086 | 7e-04 | 91.7771 | 0.0436 | 2 | 4 | specification of loop of Henle identity |
| GO:0072488 | 8e-04 | 19.7648 | 0.1853 | 3 | 17 | ammonium transmembrane transport |
| GO:0072079 | 0.0011 | 17.292 | 0.2071 | 3 | 19 | nephron tubule formation |
| GO:0016199 | 0.0012 | 61.181 | 0.0545 | 2 | 5 | axon midline choice point recognition |
| GO:0071502 | 0.0012 | 61.181 | 0.0545 | 2 | 5 | cellular response to temperature stimulus |
| GO:1903232 | 0.0012 | 61.181 | 0.0545 | 2 | 5 | melanosome assembly |
| GO:0009712 | 0.0017 | 8.6141 | 0.5123 | 4 | 47 | catechol-containing compound metabolic process |
| GO:0021891 | 0.0017 | 45.8829 | 0.0654 | 2 | 6 | olfactory bulb interneuron development |
| GO:0032229 | 0.0017 | 45.8829 | 0.0654 | 2 | 6 | negative regulation of synaptic transmission, GABAergic |
| GO:1903530 | 0.0018 | 2.4466 | 7.0081 | 16 | 643 | regulation of secretion by cell |
| GO:0007267 | 0.0021 | 1.9122 | 16.5883 | 29 | 1522 | cell-cell signaling |
| GO:0021953 | 0.0022 | 4.1717 | 1.7874 | 7 | 164 | central nervous system neuron differentiation |
| GO:0007155 | 0.0022 | 1.9735 | 14.3322 | 26 | 1315 | cell adhesion |
| GO:0035385 | 0.0024 | 36.704 | 0.0763 | 2 | 7 | Roundabout signaling pathway |
| GO:0048539 | 0.0024 | 36.704 | 0.0763 | 2 | 7 | bone marrow development |
| GO:0006836 | 0.0029 | 3.9433 | 1.8855 | 7 | 173 | neurotransmitter transport |
| GO:0007268 | 0.003 | 2.6884 | 4.7473 | 12 | 447 | chemical synaptic transmission |
| GO:0048791 | 0.0031 | 11.5223 | 0.2943 | 3 | 27 | calcium ion-regulated exocytosis of neurotransmitter |
| GO:0045597 | 0.0031 | 2.1469 | 9.493 | 19 | 871 | positive regulation of cell differentiation |
| GO:0048812 | 0.0032 | 2.4502 | 6.0817 | 14 | 558 | neuron projection morphogenesis |
| GO:0006811 | 0.0037 | 1.8475 | 16.4684 | 28 | 1511 | ion transport |
| GO:0060180 | 0.004 | 26.2139 | 0.0981 | 2 | 9 | female mating behavior |
| GO:0061004 | 0.004 | 26.2139 | 0.0981 | 2 | 9 | pattern specification involved in kidney development |
| GO:0051962 | 0.0042 | 2.5703 | 4.9482 | 12 | 454 | positive regulation of nervous system development |
| GO:0099531 | 0.0042 | 4.2026 | 1.515 | 6 | 139 | presynaptic process involved in chemical synaptic transmission |
| GO:0048858 | 0.0042 | 2.3734 | 6.2669 | 14 | 575 | cell projection morphogenesis |
| GO:0035646 | 0.005 | 22.9357 | 0.109 | 2 | 10 | endosome to melanosome transport |
| GO:0048757 | 0.005 | 22.9357 | 0.109 | 2 | 10 | pigment granule maturation |
| GO:0048864 | 0.0052 | 6.1669 | 0.6975 | 4 | 64 | stem cell development |
| GO:0009886 | 0.0061 | 20.386 | 0.1199 | 2 | 11 | post-embryonic animal morphogenesis |
| GO:0042415 | 0.0061 | 20.386 | 0.1199 | 2 | 11 | norepinephrine metabolic process |
| GO:0043476 | 0.0061 | 20.386 | 0.1199 | 2 | 11 | pigment accumulation |
| GO:0050713 | 0.0061 | 20.386 | 0.1199 | 2 | 11 | negative regulation of interleukin-1 beta secretion |
| GO:0071805 | 0.0064 | 3.3859 | 2.1798 | 7 | 200 | potassium ion transmembrane transport |
| GO:0007156 | 0.0064 | 3.8253 | 1.6567 | 6 | 152 | homophilic cell adhesion via plasma membrane adhesion molecules |
| GO:0046903 | 0.0065 | 1.7816 | 16.3594 | 27 | 1501 | secretion |
| GO:0099504 | 0.0068 | 4.4608 | 1.188 | 5 | 109 | synaptic vesicle cycle |
| GO:0050767 | 0.0069 | 2.1678 | 7.335 | 15 | 673 | regulation of neurogenesis |
| GO:0014003 | 0.007 | 8.3751 | 0.3924 | 3 | 36 | oligodendrocyte development |
| GO:0002031 | 0.0073 | 18.3463 | 0.1308 | 2 | 12 | G-protein coupled receptor internalization |
| GO:0050772 | 0.0075 | 5.5201 | 0.7738 | 4 | 71 | positive regulation of axonogenesis |
| GO:0015695 | 0.0075 | 8.1283 | 0.4033 | 3 | 37 | organic cation transport |
| GO:0015844 | 0.0079 | 5.4386 | 0.7847 | 4 | 72 | monoamine transport |
| GO:0007618 | 0.0081 | 7.8956 | 0.4142 | 3 | 38 | mating |
| GO:2000648 | 0.0081 | 7.8956 | 0.4142 | 3 | 38 | positive regulation of stem cell proliferation |
| GO:0032879 | 0.0086 | 1.59 | 27.5963 | 40 | 2532 | regulation of localization |
| GO:0048667 | 0.009 | 2.3114 | 5.4713 | 12 | 502 | cell morphogenesis involved in neuron differentiation |
| GO:0051952 | 0.0091 | 5.2078 | 0.8174 | 4 | 75 | regulation of amine transport |
| GO:0045598 | 0.0091 | 4.1401 | 1.2752 | 5 | 117 | regulation of fat cell differentiation |
| GO:0015872 | 0.0094 | 7.4678 | 0.436 | 3 | 40 | dopamine transport |
| GO:0030198 | 0.0096 | 2.661 | 3.5531 | 9 | 326 | extracellular matrix organization |
| GO:0050707 | 0.0097 | 3.4875 | 1.8092 | 6 | 166 | regulation of cytokine secretion |
| GO:0048489 | 0.0098 | 4.067 | 1.297 | 5 | 119 | synaptic vesicle transport |
| GO:0036066 | 0.0099 | 15.2867 | 0.1526 | 2 | 14 | protein O-linked fucosylation |
| GO:0042711 | 0.0099 | 15.2867 | 0.1526 | 2 | 14 | maternal behavior |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0050777 | 4e-04 | 5.6605 | 1.3399 | 7 | 128 | negative regulation of immune response |
| GO:0043570 | 6e-04 | 95.6429 | 0.0419 | 2 | 4 | maintenance of DNA repeat elements |
| GO:0002698 | 8e-04 | 5.9627 | 1.0887 | 6 | 104 | negative regulation of immune effector process |
| GO:1904837 | 0.001 | 10.1661 | 0.4397 | 4 | 42 | beta-catenin-TCF complex assembly |
| GO:0010718 | 0.0012 | 9.4205 | 0.4711 | 4 | 45 | positive regulation of epithelial to mesenchymal transition |
| GO:0042373 | 0.0016 | 47.8155 | 0.0628 | 2 | 6 | vitamin K metabolic process |
| GO:0045590 | 0.0016 | 47.8155 | 0.0628 | 2 | 6 | negative regulation of regulatory T cell differentiation |
| GO:0045123 | 0.0018 | 8.3939 | 0.5234 | 4 | 50 | cellular extravasation |
| GO:1901570 | 0.0021 | 5.9817 | 0.9002 | 5 | 86 | fatty acid derivative biosynthetic process |
| GO:0032667 | 0.0029 | 31.873 | 0.0837 | 2 | 8 | regulation of interleukin-23 production |
| GO:0043114 | 0.0037 | 10.674 | 0.314 | 3 | 30 | regulation of vascular permeability |
| GO:1901750 | 0.0037 | 27.318 | 0.0942 | 2 | 9 | leukotriene D4 biosynthetic process |
| GO:0006751 | 0.0046 | 23.9018 | 0.1047 | 2 | 10 | glutathione catabolic process |
| GO:0072537 | 0.0046 | 23.9018 | 0.1047 | 2 | 10 | fibroblast activation |
| GO:0002695 | 0.0048 | 4.0748 | 1.5597 | 6 | 149 | negative regulation of leukocyte activation |
| GO:0006690 | 0.0049 | 4.8394 | 1.0991 | 5 | 105 | icosanoid metabolic process |
| GO:0003413 | 0.0056 | 21.2447 | 0.1151 | 2 | 11 | chondrocyte differentiation involved in endochondral bone morphogenesis |
| GO:0032700 | 0.0056 | 21.2447 | 0.1151 | 2 | 11 | negative regulation of interleukin-17 production |
| GO:0042398 | 0.0078 | 8.001 | 0.4083 | 3 | 39 | cellular modified amino acid biosynthetic process |
| GO:0032736 | 0.0091 | 15.9306 | 0.1466 | 2 | 14 | positive regulation of interleukin-13 production |
| GO:0060312 | 0.0091 | 15.9306 | 0.1466 | 2 | 14 | regulation of blood vessel remodeling |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0019864 | 0.0027 | 31.6299 | 0.0796 | 2 | 10 | IgG binding |
| GO:0031406 | 0.0029 | 4.5372 | 1.409 | 6 | 177 | carboxylic acid binding |
| GO:0050786 | 0.0033 | 28.1137 | 0.0876 | 2 | 11 | RAGE receptor binding |
| GO:0002020 | 0.0037 | 5.1873 | 1.0269 | 5 | 129 | protease binding |
| GO:0004152 | 0.008 | Inf | 0.008 | 1 | 1 | dihydroorotate dehydrogenase activity |
| GO:0004336 | 0.008 | Inf | 0.008 | 1 | 1 | galactosylceramidase activity |
| GO:0005130 | 0.008 | Inf | 0.008 | 1 | 1 | granulocyte colony-stimulating factor receptor binding |
| GO:0005353 | 0.008 | Inf | 0.008 | 1 | 1 | fructose transmembrane transporter activity |
| GO:0008120 | 0.008 | Inf | 0.008 | 1 | 1 | ceramide glucosyltransferase activity |
| GO:0030272 | 0.008 | Inf | 0.008 | 1 | 1 | 5-formyltetrahydrofolate cyclo-ligase activity |
| GO:0030294 | 0.008 | Inf | 0.008 | 1 | 1 | receptor signaling protein tyrosine kinase inhibitor activity |
| GO:0031962 | 0.008 | Inf | 0.008 | 1 | 1 | mineralocorticoid receptor binding |
| GO:0036470 | 0.008 | Inf | 0.008 | 1 | 1 | tyrosine 3-monooxygenase activator activity |
| GO:0036478 | 0.008 | Inf | 0.008 | 1 | 1 | L-dopa decarboxylase activator activity |
| GO:0036524 | 0.008 | Inf | 0.008 | 1 | 1 | protein deglycase activity |
| GO:0045340 | 0.008 | Inf | 0.008 | 1 | 1 | mercury ion binding |
| GO:0055103 | 0.008 | Inf | 0.008 | 1 | 1 | ligase regulator activity |
| GO:0102769 | 0.008 | Inf | 0.008 | 1 | 1 | dihydroceramide glucosyltransferase activity |
| GO:1990175 | 0.008 | Inf | 0.008 | 1 | 1 | EH domain binding |
| GO:1990698 | 0.008 | Inf | 0.008 | 1 | 1 | palmitoleoyltransferase activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0031406 | 5e-04 | 5.4586 | 1.3872 | 7 | 177 | carboxylic acid binding |
| GO:0005504 | 0.0012 | 16.1835 | 0.2116 | 3 | 27 | fatty acid binding |
| GO:0050786 | 0.0032 | 28.5671 | 0.0862 | 2 | 11 | RAGE receptor binding |
| GO:0002020 | 0.0035 | 5.273 | 1.011 | 5 | 129 | protease binding |
| GO:0004152 | 0.0078 | Inf | 0.0078 | 1 | 1 | dihydroorotate dehydrogenase activity |
| GO:0004336 | 0.0078 | Inf | 0.0078 | 1 | 1 | galactosylceramidase activity |
| GO:0005130 | 0.0078 | Inf | 0.0078 | 1 | 1 | granulocyte colony-stimulating factor receptor binding |
| GO:0005353 | 0.0078 | Inf | 0.0078 | 1 | 1 | fructose transmembrane transporter activity |
| GO:0008120 | 0.0078 | Inf | 0.0078 | 1 | 1 | ceramide glucosyltransferase activity |
| GO:0030272 | 0.0078 | Inf | 0.0078 | 1 | 1 | 5-formyltetrahydrofolate cyclo-ligase activity |
| GO:0030294 | 0.0078 | Inf | 0.0078 | 1 | 1 | receptor signaling protein tyrosine kinase inhibitor activity |
| GO:0036470 | 0.0078 | Inf | 0.0078 | 1 | 1 | tyrosine 3-monooxygenase activator activity |
| GO:0036478 | 0.0078 | Inf | 0.0078 | 1 | 1 | L-dopa decarboxylase activator activity |
| GO:0036524 | 0.0078 | Inf | 0.0078 | 1 | 1 | protein deglycase activity |
| GO:0039552 | 0.0078 | Inf | 0.0078 | 1 | 1 | RIG-I binding |
| GO:0045340 | 0.0078 | Inf | 0.0078 | 1 | 1 | mercury ion binding |
| GO:0055103 | 0.0078 | Inf | 0.0078 | 1 | 1 | ligase regulator activity |
| GO:0102769 | 0.0078 | Inf | 0.0078 | 1 | 1 | dihydroceramide glucosyltransferase activity |
| GO:1990175 | 0.0078 | Inf | 0.0078 | 1 | 1 | EH domain binding |
| GO:1990698 | 0.0078 | Inf | 0.0078 | 1 | 1 | palmitoleoyltransferase activity |
| GO:0005215 | 0.0079 | 1.9734 | 10.4625 | 19 | 1335 | transporter activity |
| GO:0004869 | 0.0096 | 7.3151 | 0.4389 | 3 | 56 | cysteine-type endopeptidase inhibitor activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0042288 | 0.0027 | 12.4957 | 0.2866 | 3 | 18 | MHC class I protein binding |
| GO:0016427 | 0.0036 | 31.1387 | 0.0955 | 2 | 6 | tRNA (cytosine) methyltransferase activity |
| GO:0004601 | 0.0037 | 6.9602 | 0.6368 | 4 | 40 | peroxidase activity |
| GO:0046332 | 0.0051 | 4.8288 | 1.1145 | 5 | 70 | SMAD binding |
| GO:0004126 | 0.0066 | 20.7565 | 0.1274 | 2 | 8 | cytidine deaminase activity |
| GO:0004364 | 0.0079 | 8.1453 | 0.4139 | 3 | 26 | glutathione transferase activity |
| GO:0003691 | 0.0084 | 17.7902 | 0.1433 | 2 | 9 | double-stranded telomeric DNA binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0005547 | 0.0018 | 8.596 | 0.5266 | 4 | 34 | phosphatidylinositol-3,4,5-trisphosphate binding |
| GO:0046976 | 0.0023 | 42.7068 | 0.0774 | 2 | 5 | histone methyltransferase activity (H3-K27 specific) |
| GO:0016427 | 0.0034 | 32.0281 | 0.0929 | 2 | 6 | tRNA (cytosine) methyltransferase activity |
| GO:0043325 | 0.0052 | 9.6375 | 0.3562 | 3 | 23 | phosphatidylinositol-3,4-bisphosphate binding |
| GO:0008013 | 0.0058 | 4.6792 | 1.1462 | 5 | 74 | beta-catenin binding |
| GO:0004126 | 0.0063 | 21.3494 | 0.1239 | 2 | 8 | cytidine deaminase activity |
| GO:0008066 | 0.0073 | 8.3789 | 0.4027 | 3 | 26 | glutamate receptor activity |
| GO:0003691 | 0.008 | 18.2983 | 0.1394 | 2 | 9 | double-stranded telomeric DNA binding |
| GO:0070016 | 0.0099 | 16.01 | 0.1549 | 2 | 10 | armadillo repeat domain binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0004984 | 0 | 13.9344 | 1.1416 | 12 | 370 | olfactory receptor activity |
| GO:0060089 | 0 | 5.4356 | 4.73 | 18 | 1533 | molecular transducer activity |
| GO:0099600 | 0 | 5.8489 | 3.7612 | 16 | 1219 | transmembrane receptor activity |
| GO:0004930 | 0 | 7.0202 | 2.4159 | 13 | 783 | G-protein coupled receptor activity |
| GO:0038023 | 0 | 5.5487 | 3.9463 | 16 | 1279 | signaling receptor activity |
| GO:0003828 | 1e-04 | 168.2396 | 0.0185 | 2 | 6 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity |
| GO:0005126 | 0.0011 | 7.0295 | 0.7923 | 5 | 262 | cytokine receptor binding |
| GO:0016757 | 0.0014 | 6.6625 | 0.8331 | 5 | 270 | transferase activity, transferring glycosyl groups |
| GO:0005125 | 0.0015 | 8.8387 | 0.4991 | 4 | 168 | cytokine activity |
| GO:0005129 | 0.0031 | Inf | 0.0031 | 1 | 1 | granulocyte macrophage colony-stimulating factor receptor binding |
| GO:0042924 | 0.0031 | Inf | 0.0031 | 1 | 1 | neuromedin U binding |
| GO:0030545 | 0.0032 | 4.591 | 1.4563 | 6 | 472 | receptor regulator activity |
| GO:0015020 | 0.0046 | 21.672 | 0.1018 | 2 | 33 | glucuronosyltransferase activity |
| GO:0001607 | 0.0062 | 329.6735 | 0.0062 | 1 | 2 | neuromedin U receptor activity |
| GO:0010465 | 0.0062 | 329.6735 | 0.0062 | 1 | 2 | nerve growth factor receptor activity |
| GO:0035379 | 0.0062 | 329.6735 | 0.0062 | 1 | 2 | carbon dioxide transmembrane transporter activity |
| GO:0047275 | 0.0062 | 329.6735 | 0.0062 | 1 | 2 | glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity |
| GO:0004971 | 0.0092 | 164.8265 | 0.0093 | 1 | 3 | AMPA glutamate receptor activity |
| GO:0005166 | 0.0092 | 164.8265 | 0.0093 | 1 | 3 | neurotrophin p75 receptor binding |
| GO:0099583 | 0.0092 | 164.8265 | 0.0093 | 1 | 3 | neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration |
| GO:0008009 | 0.0096 | 14.5915 | 0.1481 | 2 | 48 | chemokine activity |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0048020 | 0 | 23.6265 | 0.2527 | 5 | 39 | CCR chemokine receptor binding |
| GO:0008009 | 0 | 18.6709 | 0.311 | 5 | 48 | chemokine activity |
| GO:0032394 | 0 | Inf | 0.013 | 2 | 2 | MHC class Ib receptor activity |
| GO:0030246 | 0 | 5.9197 | 1.6847 | 9 | 260 | carbohydrate binding |
| GO:0042288 | 2e-04 | 31.5392 | 0.1166 | 3 | 18 | MHC class I protein binding |
| GO:0016427 | 6e-04 | 78.1359 | 0.0389 | 2 | 6 | tRNA (cytosine) methyltransferase activity |
| GO:0001055 | 0.0022 | 34.7163 | 0.0713 | 2 | 11 | RNA polymerase II activity |
| GO:0016705 | 0.0031 | 5.4262 | 0.9849 | 5 | 152 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen |
| GO:0004497 | 0.0032 | 7.0451 | 0.6091 | 4 | 94 | monooxygenase activity |
| GO:0008173 | 0.006 | 8.7397 | 0.3693 | 3 | 57 | RNA methyltransferase activity |
| GO:0004034 | 0.0065 | Inf | 0.0065 | 1 | 1 | aldose 1-epimerase activity |
| GO:0005133 | 0.0065 | Inf | 0.0065 | 1 | 1 | interferon-gamma receptor binding |
| GO:0035375 | 0.0065 | Inf | 0.0065 | 1 | 1 | zymogen binding |
| GO:0035757 | 0.0065 | Inf | 0.0065 | 1 | 1 | chemokine (C-C motif) ligand 19 binding |
| GO:0035758 | 0.0065 | Inf | 0.0065 | 1 | 1 | chemokine (C-C motif) ligand 21 binding |
| GO:0038117 | 0.0065 | Inf | 0.0065 | 1 | 1 | C-C motif chemokine 19 receptor activity |
| GO:0038121 | 0.0065 | Inf | 0.0065 | 1 | 1 | C-C motif chemokine 21 receptor activity |
| GO:0047042 | 0.0065 | Inf | 0.0065 | 1 | 1 | androsterone dehydrogenase (B-specific) activity |
| GO:0050528 | 0.0065 | Inf | 0.0065 | 1 | 1 | acyloxyacyl hydrolase activity |
| GO:0102116 | 0.0065 | Inf | 0.0065 | 1 | 1 | laurate hydroxylase activity |
| GO:0103002 | 0.0065 | Inf | 0.0065 | 1 | 1 | 16-hydroxypalmitate dehydrogenase activity |
| GO:0001664 | 0.0067 | 3.8114 | 1.6717 | 6 | 258 | G-protein coupled receptor binding |
| GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0016427 | 0.0011 | 58.192 | 0.0518 | 2 | 6 | tRNA (cytosine) methyltransferase activity |
| GO:0048020 | 0.0046 | 9.75 | 0.3369 | 3 | 39 | CCR chemokine receptor binding |
| GO:0043028 | 0.0049 | 9.4859 | 0.3456 | 3 | 40 | cysteine-type endopeptidase regulator activity involved in apoptotic process |
| GO:0005313 | 0.0063 | 19.3877 | 0.121 | 2 | 14 | L-glutamate transmembrane transporter activity |
| GO:0097153 | 0.0072 | 17.8952 | 0.1296 | 2 | 15 | cysteine-type endopeptidase activity involved in apoptotic process |
| GO:0008009 |
